0001078782-13-000576.txt : 20130329 0001078782-13-000576.hdr.sgml : 20130329 20130329150013 ACCESSION NUMBER: 0001078782-13-000576 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130329 DATE AS OF CHANGE: 20130329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001419051 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 331176182 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54554 FILM NUMBER: 13727549 BUSINESS ADDRESS: STREET 1: 4093 OCEANSIDE BLVD, SUITE B CITY: OCEANSIDE STATE: CA ZIP: 92056 BUSINESS PHONE: (760) 295-7208 MAIL ADDRESS: STREET 1: 4093 OCEANSIDE BLVD, SUITE B CITY: OCEANSIDE STATE: CA ZIP: 92056 FORMER COMPANY: FORMER CONFORMED NAME: Friendly Auto Dealers, Inc. DATE OF NAME CHANGE: 20071120 10-K 1 f10k123112_10k.htm FORM 10-K ANNUAL REPORT DECEMBER 31 2012 FORM 10-K Annual Report December 31 2012

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 10-K 


  X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the fiscal year ended December 31, 2012


OR


      . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from ____________ to ___________


Commission File Number:  000-54554


Therapeutic Solutions International, Inc.

(Exact name of registrant as specified in its charter)


Nevada

  

45-1226465

(State or other jurisdiction of incorporation or organization)

  

(I.R.S. Employer Identification No.)


4093 Oceanside Boulevard, Suite B

Oceanside, California 92056

(Address of principal executive offices, including zip code)


(760) 295-7208

(Registrant's telephone number, including area code)


Securities registered pursuant to Section 12(b) of the Act:

None


Securities registered pursuant to Section 12(g) of the Act:


Title of class

Common Stock, $0.001 par value per share


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes      . No  X .


Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes      . No  X .


Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  X . No      .


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  X . No      .


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.      .


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act. 


Large accelerated filer

      .

Accelerated filer

      .

Non-accelerated filer

      . (Do not check if a smaller reporting company)

Smaller reporting company

  X .


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes      . No  X .


The aggregate market value of the voting and non-voting common equity held by non-affiliates was $2,019,250 based on a closing price of $0.05 at June 28, 2012.


As of March 26, 2013, 83,466,400 shares of the registrant’s common stock, par value of $0.001 per share, were outstanding.





INDEX

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.


  

  

PAGE NO

PART I

  

 

  

  

 

ITEM 1

BUSINESS

4

ITEM 1A

RISK FACTORS

6

ITEM 1B

UNRESOLVED STAFF COMMENTS

11

ITEM 2

PROPERTIES

11

ITEM 3

LEGAL PROCEEDINGS

11

ITEM 4

MINE SAFETY DISCLOSURES

11

  

  

 

PART II

  

 

  

  

 

ITEM 5

MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

11

ITEM 6

SELECTED FINANCIAL DATA

11

ITEM 7

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

12

ITEM 7A

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

15

ITEM 8

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

15

ITEM 9

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

15

ITEM 9A

CONTROLS AND PROCEDURES

15

ITEM 9B

OTHER INFORMATION

16

  

  

 

PART III

  

 

  

  

 

ITEM 10

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

17

ITEM 11

EXECUTIVE COMPENSATION

19

ITEM 12

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

21

ITEM 13

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

22

ITEM 14

PRINCIPAL ACCOUNTANT FEES AND SERVICES

22

  

  

 

PART IV

  

 

  

  

 

ITEM 15

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

23

  

  

 

SIGNATURES

24




2




PART I.


IMPORTANT PREFATORY NOTE


On August 24, 2012, we entered into a Master Dispute Resolution Agreement (the “MDRA”) with James P. Boyd (“Boyd”), Boyd Research, Inc. (“Boyd Research”) and TMD Courses, Inc. (“TMD” and together with Boyd and Boyd Research, the “Boyd Parties”) and Timothy G. Dixon (“Dixon”) and Gerry B. Berg (“Berg”), and on August 24, 2012 we also entered into a License Agreement with Boyd Research and TMD (the “New License Agreement”), an Escrow Agreement with Boyd and with Chicago Title Company as escrow agent (the “Escrow Agreement”), and a Voting Agreement with Boyd.  We filed Form 8-K’s with the Securities and Exchange Commission on August 28, 2012, August 29, 2012 and August 30, 2012 in regard to these matters.


FORWARD-LOOKING STATEMENTS


This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are subject to a number of risks and uncertainties. All statements that are not historical facts are forward-looking statements, including statements about our business strategy, uncertainty regarding our future operating results and our profitability, anticipated sources of funds and all plans, objectives, expectations and intentions and any statements regarding future potential revenue, gross margins and our prospects for fiscal 2012 and thereafter. These statements may appear in a number of places and can be identified by the use of forward-looking terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "future," "intend," or "certain" or the negative of these terms or other variations or comparable terminology, or by discussions of strategy.


The following factors are among those that may cause actual results to differ materially from our forward-looking statements:


·

Need for additional capital;

·

Limited operating history in our new business model;

·

Exclusion from the United States market for AMPSA Products;

·

Limited experience introducing new products;

·

Limited operating history in international markets;

·

Our ability to successfully expand our operations and manage our future growth;

·

Difficulty in managing our growth and expansion;

·

Dilutive effects of any raising of additional capital;

·

The deterioration of global economic conditions and the decline of consumer confidence and spending;

·

Material weaknesses reported in our internal control over financial reporting;

·

Our ability to retain independent distributors or to hire new independent distributors on an ongoing basis;

·

The potential for government or third party actions against us resulting from independent distributor activities that violate applicable laws or regulations;

·

Our ability to protect intellectual property rights and the value of our products;

·

Potential competition from an authorized seller of identical products;

·

The potential for product liability claims against us;

·

Our dependence on third party manufacturers to manufacture our products;

·

Our common stock is currently classified as a penny stock;

·

Our stock price may experience future volatility;

·

The illiquidity of our common stock; and

·

Substantial sales of shares of our common stock.


Actual results may vary materially from those in such forward-looking statements as a result of various factors, including those identified in "Item 1A. Risk Factors" and elsewhere in this document. No assurance can be given that the risk factors described in this Annual Report on Form 10-K are all of the factors that could cause actual results to vary materially from the forward-looking statements.  References in this Annual Report on Form 10-K to the “Company,” “TSOI,” “we,” “our,” and “us” refer to Therapeutic Solutions International, Inc.




3




ITEM 1

BUSINESS.


General

Therapeutic Solutions International, Inc. is a Nevada corporation which was incorporated on August 6, 2007 under the name “Friendly Auto Dealers, Inc.”  In the first quarter of 2011, we acquired Splint Decisions Inc. and changed our name from Friendly Auto Dealers, Inc. to Therapeutic Solutions International, Inc. and our ticker symbol from “FYAD” to “TSOI.”  This Annual Report on Form 10-K, and the financial statements included herein, reflect the treatment of Splint Decisions Inc. as the “accounting acquirer” in the transaction.  Our principal executive office is located at 4093 Oceanside Blvd., Suite B, Oceanside, California 92056, our telephone number is (760) 295-7208 and our website is www.therapeuticsolutionsint.com.  The reference to our website does not constitute incorporation by reference of the information contained on our website.


We file our quarterly and annual reports with the Securities and Exchange Commission (“SEC”), which the public may view and copy at the SEC’s Public Reference Room at 100 F Street, N.E. Washington D.C. 20549, on official business days during the hours of 10 a.m. to 3 p.m.  The public may obtain information on the operation of the SEC’s Public Reference Room by calling the SEC at 1-800-SEC-0330.  The SEC also maintains an Internet site, the address of which is www.sec.gov, which contains reports, proxy and information statements, and other information regarding issuers which file electronically with the SEC.  The periodic and current reports that we file with the SEC can also be obtained from us free of charge by directing a request to Therapeutic Solutions International, Inc., 4093 Oceanside Blvd, Suite B, Oceanside, California  92056, Attn:  Corporate Secretary.  


Description of Business


We manufacture and sell (directly and through distributors and sublicensees), in non-US countries, plastic intraoral devices known as Anterior Midpoint Stop Appliances (“AMPSA Products”).  Our customers are dentists and doctors; we do not sell directly to patients or consumers.  The AMPSA Products, which are used for the treatment and prevention of common neurological and temporomandibular disorders including migraine headaches, migraine pain and bruxism, are based on patents which we in-license from the Boyd Parties.  We sell our AMPSA Products under our registered trademarks AMPSA CS® and Migran-X®, and under the legacy in-licensed trademarks “NTI” and NTI-tss ®.  


We also provide AMPSA-related educational programs; we have been approved as a Program Approval for Continuing Education (PACE) Provider of Dental Continuing Education by the Academy of General Dentistry.  


The AMPSA Products are US FDA cleared for the prophylactic treatment of medically diagnosed migraine pain as well as migraine associated tension-type headaches, by reducing their signs and symptoms through reduction of trigeminally innervated muscular activity.  The trigeminal nucleus complex of nerves is a relay nucleus for head and face pain and has three distinct branches: ophthalmic, mandibular and maxillary.  From studies and clinical trials, we have determined that many migraine headaches most likely result from a dysfunction of the trigeminal nerve that is triggered by the clenching of the teeth, usually, but not always, at night.  When such migraine sufferers clench their teeth, their distinct pathology allows for the trigeminal innervation of the surrounding blood vessels and meninges, the reflex connections of the trigeminal system with the cranial parasympathetic outflow, and local and descending pain modulation.


AMPSA Products are either fitted chairside by licensed dentists or produced and sold on a semi-custom basis by dental laboratories.  AMPSA Products are made of polycarbonate plastic and are designed to fit over either the upper or lower front incisor teeth and protect teeth, muscles and joints by significantly suppressing parafunctional muscle contraction.


[f10k123112_10k001.jpg]


AMPSA Products treat patients suffering from tension and migraine headaches by reducing the intensity of jaw clenching while the patient sleeps.  Specifically, AMPSA Products’ patented design prevents the posterior and canine teeth from clenching, as studies have found that when these particular teeth are clenched, the trigeminally induced muscular activity is exacerbated and the pathology of a migraine exists.



4




AMPSA Products include a patented design that we refer to as the “discluding element.” This discluding element prevents the posterior and canine teeth from clenching, thereby preventing the triggering pathology leading to many migraine headaches from occurring.  As noted above, we in-license the relevant patents.  We have not engaged in research and development.


We manufacture the chairside-fitted AMPSA Products through a sole-source contract manufacturer in the United States.  The raw materials used in AMPSA Products are readily available.


We have CE Mark certification for our AMPSA Products.  Our AMPSA Products received 510(k) clearance from the US Food and Drug Administration.


AMPSA Products generally also require, in each national market, some sort of clearance or approval from the national government agency with jurisdiction over dental and/or medical devices.


Business until December 31, 2012


Through December 31, 2012 we made (through our contract manufacturer) and sold chairside-fitted AMPSA Products directly to licensed dentists in the United States, and to licensed dentists in foreign countries both directly and through distributors.  


On April 1, 2011, we entered into an Exclusive License Agreement (as amended on November 1, 2011, the “2011 Agreement”) with Boyd Research.  Our predecessor, Splint Decisions Inc., and Boyd Research and TMD were party to an Exclusive License Agreement dated October 22, 2010, as amended on July 8, 2011 (together with the 2011 Agreement, the “Exclusive Agreements”). The Exclusive Agreements provided us with, among other things, an exclusive worldwide license for all patents and other information regarding the design, manufacture, operation, use, or sale of the AMPSA Products theretofore sold by Boyd Research.  The only exception to such worldwide exclusivity was that Keller Laboratories, Inc. had the exclusive right to manufacture and distribute laboratory fabricated semi-custom versions of the AMPSA Products in the United States.  The Exclusive Agreements called for us to pay a 30% royalty rate and a $3,000,000 license inception fee.  


From the time we entered into the 2011 Agreement until December 31, 2012, essentially our entire active business consisted of the manufacture and sale of AMPSA Products to licensed dentists as authorized by the Exclusive Agreements.  


On August 24, 2012, in connection with the MDRA, we entered into the New License Agreement with Boyd Research and TMD.


The New License Agreement terminated the Exclusive Agreements.  However, the New License Agreement granted us new licenses under the applicable patent rights and related technology of the Boyd Parties to manufacture and sell our existing AMPSA Products (but not any such products other than our currently existing ones) and laboratory-manufactured semi-custom AMPSA Products.  


The New License Agreement essentially carried forward the Exclusive Agreements’ terms as to the United States market for the remainder of 2012, but under the New License Agreement our rights to sell AMPSA Products to the United States market expired at the end of 2012.  Specifically, for chairside AMPSA Product in the United States market, the New License Agreement granted us an exclusive license, carrying a 30% royalty on net sales; but such license expired on December 31, 2012.  


For sales of the existing AMPSA Products to non-US markets, the New License Agreement granted us for the remainder of 2012 an exclusive license, which converted to a non-exclusive license on January 1, 2013.  Under the New License Agreement, we paid a 30% royalty on 2012 net sales of the existing AMPSA Products to both US and non-US markets.  


In the transition from the Exclusive Agreements to the New License Agreement, we gave up our license rights to the “Total Splint System” intraoral devices (which we had not successfully commercialized) and to all potential chairside AMPSA Products which could have been commercialized using our Exclusive Agreements rights but which we were not selling as of August 2012.  


The MDRA and New License Agreement contained various provisions pertaining to the transition of US market sales of the existing AMPSA Products from us to a Boyd Party on January 1, 2013, joint access to AMPSA Products production molds, website and toll-free telephone number transition, regulatory matters, etc.  We provided a limited supply of the existing AMPSA Products to the Boyd Parties so they were able to begin selling and shipping without interruption effective January 1, 2013.




5




Our Business Going Forward


Under the New License Agreement, we have the non-exclusive right to manufacture and sell, free of any royalty or inception-fee obligations, our existing AMPSA Products in all non-US countries beginning January 1, 2013.  However, beginning January 1, 2013, we have no right to sell AMPSA Products in the United States.


On January 1, 2013, the Boyd Parties began selling to the US market the AMPSA Products which we had previously sold to the US market (and which, beginning on that date, we were no longer allowed to sell to the US market) and new AMPSA Products as well.  The Boyd Parties also have the right to sell AMPSA Products in all foreign countries beginning January 1, 2013, on a non-exclusive basis.


Sales of chairside AMPSA Products to the US market constituted over 80% of our AMPSA business in 2011 and 2012.  Our challenge in 2013 and future years is to counter the loss of our chairside AMPSA Products sales to the US market and the loss of the ability to introduce new products based on Boyd Party technology, by increasing sales of our existing AMPSA Products to non-US markets, making sales of laboratory-produced AMPSA Products to non-US markets and/or by successfully introducing into the US and non-US markets new products which do not require licenses from the Boyd Parties.  


We currently have distributors for chairside-fitted AMPSA Products in the following markets:  Canada, the United Kingdom, Ireland, France, Spain, Scandinavia, Germany, Switzerland, Austria, the Netherlands, Poland, Russia, Israel, Morocco, Turkey, South Africa, China, Singapore, Japan, Cambodia, Australia, New Zealand, and Hong Kong.  In addition, we have a sublicensee for semi-custom laboratory-produced AMPSA Products in the United Kingdom, Ireland, France, Spain and Scandinavia, and we plan to sell chairside-fitted AMPSA Products directly to dentists and/or doctors in many countries, particularly Brazil.  (There are almost three times as many dentists in Brazil as there are in the United States.)


Employees


As of December 31, 2012, we had seven full-time employees, all non-union.  As of March 1, 2013, we had four full-time employees.  We believe that our relations with our employees are good.  


ITEM 1A

RISK FACTORS


This Annual Report on Form 10-K contains forward-looking statements concerning our future programs, expenses, revenue, liquidity and cash needs as well as our plans and strategies. These forward-looking statements are based on current expectations and we assume no obligation to update this information, except as required by applicable laws and regulations.  Numerous factors could cause actual results to differ significantly from the results described in these forward-looking statements, including the following risk factors.


Factors affecting future operating results


Because we need additional capital and our auditors have issued a going concern opinion, there is a risk that we will become unable to continue activities.


We urgently need additional capital.  Our auditors have issued a going concern opinion.  This means that there is substantial doubt that we can continue as an ongoing business for the next twelve months.  


If we are able to complete financing through the sale of additional shares of our common stock in the future, then stockholders will experience dilution.  


The most likely source of future financing is through the sale of shares of our common stock.  Any sale of common stock will result in dilution of equity ownership to existing stockholders.  This means that if we sell shares of our common stock, more shares will be outstanding and each existing stockholder will own a smaller percentage of the shares then outstanding.  In addition, our stock price is low and so we would have to sell many new shares in order to raise the capital we need.  Alternatively, if we were able to borrow money, we would have to assume debt obligations that require us to make interest and principal payments.   


Because there is currently a limited public trading market for our common stock, you may not be able to resell your stock.


Our stock is now traded in OTC Markets Group Inc.’s OTCQB marketplace, which results in a very illiquid and limited market for our common stock.  There is no assurance we will be able to retain this listing or obtain or retain any listing on any other market or exchange.



6




We have identified material weaknesses in our internal control over financial reporting.


We are required to comply with the provisions of Section 404 of the Sarbanes-Oxley Act of 2002, which require us to maintain an ongoing evaluation and integration of the internal controls of our business.


We evaluated our existing controls as of December 31, 2012.  Our Chief Executive Officer and Chief Financial Officer identified material weaknesses in our internal control over financial reporting.  A “material weakness” is a control deficiency, or combination of control deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected.  Readers are directed to review that portion of this Form 10-K entitled Item 9A Controls and Procedures for a detailed disclosure.


Under Section 404 and the SEC’s rules, a company cannot find that its internal control over financial reporting is effective if any “material weaknesses” exist in its controls over financial reporting.


Our business changed materially on January 1, 2013 when we lost the right to sell AMPSA Products to the United States market.  


Sales of chairside AMPSA Products in the U.S. market accounted for over 80% of our business through December 31, 2012.  As a result, when we lost the right to sell AMPSA Products to the United States market on January 1, 2013, it became incumbent on us to increase sales of our existing AMPSA Products to non-US markets, develop sublicensees for laboratory-produced AMPSA Products to non-US markets and/or successfully introduce into the US and non-US markets new (non-AMPSA) products.  


If we fail to create these sales and/or introduce new products successfully, it will likely harm our operating results.  We do not have demonstrated high-volume experience selling AMPSA Products to non-US markets, developing sublicensees for laboratory-produced AMPSA Products to non-US markets and/or successfully introducing into the US and non-US markets new products, and no assurances can be given that we will be successful doing so.  


Beginning on January 1, 2013, we are subject to competition from Boyd Research, and any of its distributors and licensees, in the AMPSA Products business in foreign markets.  


Beginning on January 1, 2013, we are subject to competition from Boyd Research, and any of its distributors and licensees, in the AMPSA Products business in foreign markets.  They have the right to sell AMPSA Products which are physically the same as ours, and they also have the right to sell new and different AMPSA Products.  We do not know how active Boyd Research will be in pursuing non-US markets.  Boyd Research, and any of its distributors and licensees, may have greater financial and other resources, and more effective marketing organizations than we do.  If we are unable to compete successfully, we may not be able to sell enough products at a price sufficient to permit us to generate profits.  


If our patent license from Boyd Research were to be terminated, our AMPSA Products business would be materially adversely affected.


Since April 1, 2011, essentially our entire active business has consisted of the manufacture and sale of AMPSA Products.  If we were to materially breach our agreements with the Boyd Parties, and if such breaches resulted in the termination of the New License Agreement, pursuant to which we are permitted to manufacture and sell patented AMPSA Products, such termination would have a material adverse effect upon our revenues and cash flow.


If we do not engage and retain additional foreign distributors, our foreign sales of chairside AMPSA Products will not grow sufficiently.


For foreign markets (with certain exceptions, among which is Brazil), we distribute our products primarily through distributors.  As a result, we are dependent upon these distributors to sell our products and to assist us in promoting and creating a demand for our products.  Our future growth depends on our ability to engage distributors for foreign sales of our chairside AMPSA products and the efforts of these distributors.  If we are not successful in engaging such additional distributors, or those that we do engage are not successful in selling our products, our financial position and results of operations will be adversely affected.




7




If we do not establish foreign sublicensees for laboratory-produced AMPSA Products, we will not be able to grow that portion of our business sufficiently.


Pursuant to the New License Agreement, we have the right to manufacture and distribute the laboratory fabricated semi-custom versions of the AMPSA Products outside the US market.  However, we ourselves do not have the expertise, capabilities or resources necessary to do so.  As a result, we must establish foreign sublicensees for these products in order to grow this portion of our business.  We do not have a track record in doing so, and no assurances can be made that we will be successful.


We rely on a sole-source contract manufacturer for our AMPSA Products.


We only use one contract manufacturer for the manufacture of AMPSA Products.  If this manufacturer became unable or unwilling to supply us, we may not be able to replace them quickly, and our financial position and results of operations would likely be adversely affected.


Beginning January 1, 2014, we will no longer be able to use the in-licensed “NTI” trademark for AMPSA Products, and will have to rely on our own new trademarks.


Until 2013 we sold our AMPSA Products in conjunction with the in-licensed “NTI” trademark.  Beginning January 1, 2014, we will no longer be able to use the in-licensed “NTI” trademark for our AMPSA Products.  Although we have introduced our own trademarks and are working to phase out our and our distributors’ use of the “NTI” trademark, we believe that this trademark is valuable, and selling AMPSA Products without it may lead to reduced sales and/or additional price pressure.


Our international activities are subject to the risks of doing business abroad, which could affect our ability to sell our products profitably in international markets.


Beginning January 1, 2013, all sales of our AMPSA Products will be done internationally, and subject to the risks of doing business abroad.  These risks include:  


·

regulations and requirements of national agencies with jurisdiction over medical and/or dental devices;

·

the difficulty and expenses of enforcing patents in foreign courts against infringers;

·

fluctuations in currency exchange rates;

·

political instability;

·

limitations on conversion of foreign currencies into U.S. Dollars;

·

restrictions on transfers of funds to or from foreign countries;

·

export and import duties, tariffs, regulations, quotas and other restrictions on free trade; and

·

investment regulation and other restrictions by foreign governments.


If these risks limit or prevent us from selling products in any significant international market or significantly increase the cost of doing business internationally, our financial position and cash flow could suffer.


We may not be able to identify, procure and introduce new (non-AMPSA) products in the US and foreign markets.


Beginning January 1, 2013, we lost all rights to sell AMPSA Products in the US and our rights to sell our current AMPSA Products in the non-US market changed from exclusive to non-exclusive.  As a result, we will face increased competition for sales of current AMPSA Products and will not have rights to new products related to patents held by the Boyd Parties.  Over time we must introduce successful new products, independently and/or in conjunction with third parties.  We do not have a history of developing and introducing new products.  If new products fail to gain acceptance, we likely will fail to generate sufficient revenue or operating margin, and our business will be adversely affected.  


Our success significantly depends on key personnel and our ability to attract and retain additional personnel.


Our future success is dependent on the efforts, performance and abilities of our key management.  The loss of the services of our executive officers, particularly Timothy G. Dixon or Gerry Berg, would deprive us of the strategic direction and daily operational efforts they provide and would have a significant adverse impact on our business.




8




Our personnel and physical infrastructure may not be adequate to manage any growth that might occur in our business, especially if we introduce new (non-AMPSA) products.


We must rapidly and significantly expand our operations, including increasing our product offerings and scaling our infrastructure to support international sales.  This expansion increases the complexity of our business and places significant strain on our management, personnel, operations, systems, technical performance, financial resources, and internal financial control and reporting functions. We may not be able to manage growth effectively, which could damage our reputation, limit our growth and negatively affect our operating results.


Risks Related to Our Common Stock.


Our stock price will likely be volatile.


The market price of our common stock will likely be highly volatile and could fluctuate widely in price in response to various factors, many of which are beyond our control, including the following:


Additions or departures of key personnel;

Limited “public float” – many of our shares are in the hands of a small number of persons whose sales or lack of sales could result in positive or negative pricing pressure on the market price for the common stock;

Sales of the common stock;

Our ability to execute our business plan;

Operating results that fall below expectations;

Loss of any strategic relationship;

Industry developments;

Economic and other external factors; and

Period-to-period fluctuations in our financial results.


In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies.  These market fluctuations may also materially and adversely affect the market price of our common stock.


There is currently no liquid trading market for our common stock and we cannot ensure that one will ever develop or be sustained.


The trading market for our common stock is currently not liquid.  We cannot predict how liquid the market for our common stock might become.  Our common stock is quoted in OTC Markets Group Inc.’s OTCQB marketplace under the symbol TSOI. We currently do not satisfy the initial listing standards, and cannot ensure that we will be able to satisfy the listing standards of, a national securities exchange such as NASDAQ, or that our common stock will be accepted for listing on any such exchange.  Should we fail to satisfy the initial listing standards of such exchanges, or our common stock not be able to remain on the OTCQB marketplace or be suspended from the OTCQB marketplace, the trading price of our common stock could suffer, the trading market for our common stock may be less liquid and our common stock price may be subject to increased volatility.


Our common stock may be deemed a “penny stock”, which would make it more difficult for investors to sell their shares.


Our common stock is subject to the “penny stock” rules adopted under the Exchange Act.  The penny stock rules apply to companies whose common stock is not listed on the NASDAQ Stock Market or other national securities exchange and trades at less than $4.00 per share, other than companies that have had average revenue of at least $6,000,000 for the last three years or that have tangible net worth of at least $5,000,000 ($2,000,000 if the company has been operating for three or more years). These rules require, among other things, that brokers who trade penny stock to persons other than “established customers” complete certain documentation, make suitability inquiries of investors and provide investors with certain information concerning trading in the security, including a risk disclosure document and quote information under certain circumstances.  Many brokers have decided not to trade penny stocks because of the requirements of the penny stock rules and, as a result, the number of broker-dealers willing to act as market makers in such securities is limited.  If we remain subject to the penny stock rules for any significant period, it could have an adverse effect on the market, if any, for our securities.  If our securities continue to be subject to the penny stock rules, investors will find it more difficult to dispose of our securities.



9




Offers or availability for sale of a substantial number of shares of our common stock may cause the price of our common stock to decline.


If our stockholders have the right to sell substantial amounts of common stock in the public market, e.g. upon the expiration of any statutory holding period under Rule 144, it could create a circumstance commonly referred to as an “overhang” and in anticipation of which the market price of our common stock could fall.  The existence of an overhang, whether or not sales have occurred or are occurring, also could make our ability to raise additional financing through the sale of equity or equity-related securities in the future, at a time and price that we deem reasonable or appropriate, more difficult.


Provisions of our Articles of Incorporation and Nevada law could deter a change of control, which could discourage or delay offers to acquire us.


We are subject to the Nevada anti-takeover laws regulating corporate takeovers.  These anti-takeover laws prevent Nevada corporations from engaging in a merger, consolidation, sales of its stock or assets, and certain other transactions with any stockholder, including all affiliates and associates of the stockholder, who owns 10% or more of the corporation’s outstanding voting stock, for three years following the date that the stockholder acquired 10% or more of the corporation’s voting stock except in certain situations.  In addition, our Articles of Incorporation and Bylaws include a number of provisions that may deter or impede hostile takeovers or changes of control or management. These provisions include the following:


the authority of our Board of Directors to issue up to 5,000,000 shares of preferred stock and to determine the price, rights, preferences, and privileges of these shares, without stockholder approval;

special meetings of the stockholders may be called only by the Board of Directors or the President of the Company; and

cumulative voting is not allowed in the election of our directors.


These provisions of Nevada law and our Articles of Incorporation and Bylaws could prohibit or delay mergers or other takeover or change of control of the Company and may discourage attempts by other companies to acquire us, even if such a transaction would be beneficial to our stockholders.


Volatility in our common stock price may subject us to securities litigation.


The market for our common stock is characterized by significant price volatility when compared to seasoned issuers, and we expect that our share price will continue to be more volatile than a seasoned issuer for the indefinite future.  In the past, plaintiffs have often initiated securities class action litigation against companies following periods of volatility in the market price of their securities.  We may, in the future, be the target of similar litigation.  Securities litigation could result in substantial costs and liabilities and could divert management’s attention and resources.


The elimination of monetary liability against our directors and officers under the Company’s Articles of Incorporation and Nevada law, and the existence of indemnification rights to our directors, officers and employees, may result in substantial expenditures by the Company.


Article 6 of our Articles of Incorporation exculpates our directors and officers from certain monetary liabilities.  Article 7 of our Articles of Incorporation provides that we shall indemnify all directors (and all persons serving at our request as a director or officer of another corporation) to the fullest extent permitted by Nevada law.  


Further pursuant to Article 7, the expenses of the indemnified person incurred in defending a civil suit or proceeding must be paid by us as incurred and in advance of the final disposition of the action, suit, or proceeding under receipt of an undertaking by or on behalf of the indemnified person to repay the amount if it is ultimately determined by a court of competent jurisdiction that he or she is not entitled to be indemnified by us.


The foregoing indemnification obligations could result in us incurring substantial expenditures, which we may be unable to recoup.  These provisions and resultant costs may also discourage us from bringing a lawsuit against directors and officers for breaches of their fiduciary duties even though such actions, if successful, might otherwise benefit us and our stockholders.


Public company compliance may make it more difficult to attract and retain officers and directors.


The Sarbanes-Oxley Act and related rules implemented by the SEC have required changes in corporate governance practices of public companies.  As a public entity, these rules and regulations increase compliance costs and make certain activities more time consuming and costly.  As a public entity, these rules and regulations also make it more difficult and expensive for us to obtain director and officer liability insurance and we may be required to accept reduced policy limits and coverage.  As a result, it may be more difficult for us to attract and retain qualified persons to serve as directors or as executive officers.




10




ITEM 1B

UNRESOLVED STAFF COMMENTS


No disclosure required.


ITEM 2

PROPERTIES.


We do not own any real-estate property or manufacturing equipment.  Our business is conducted in approximately 1,300 square feet of rented space located at 4093 Oceanside Blvd., Suite B, Oceanside, CA 92056.


ITEM 3 

LEGAL PROCEEDINGS.


None.


ITEM 4

MINE SAFETY DISCLOSURES.


No disclosure required.


PART II


ITEM 5 

MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.


Our stock is traded in OTC Markets Group Inc.’s OTCQB marketplace under the ticker symbol TSOI.  As of the date of this Annual Report on Form 10-K there are approximately 137 stockholders of record of our common stock.


The following table sets forth the quarterly high and low sales prices for our common stock from January 1, 2011 through December 31, 2012.


Quarter Ended

High

Low

December 31, 2012

$0.08

$0.01

September 30, 2012

$0.05

$0.02

June 30, 2012

$0.07

$0.01

March 31, 2012

$0.07

$0.03

December 31, 2011

$0.10

$0.07

September 30, 2011

$0.12

$0.07

June 30, 2011

$0.19

$0.05

March 31, 2011

$0.17

$0.05


Dividends


We did not declare or pay dividends during 2011 and 2012 and do not anticipate declaring or paying dividends in the foreseeable future.


Repurchases/Cancellation of Securities


We made no repurchases of our securities during 2011 or 2012.


Pursuant to the terms of the MDRA, and upon satisfaction of the conditions specified in the Escrow Agreement, on January 18, 2013 James Boyd surrendered 223,991,933 shares of common stock to us for cancellation.  The MDRA did not require us to pay a separate consideration in respect of the surrendered shares.  


ITEM 6

SELECTED FINANCIAL DATA.


No disclosure required.




11




ITEM 7 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.


The following discussion is intended to assist in the understanding and assessment of significant changes and trends related to the results of operations and financial condition of the Company.  The following discussion contains forward-looking statements that involve risks and uncertainties.  See “Forward-Looking Statements” elsewhere in this Annual Report on Form 10-K.  This discussion and analysis should be read in conjunction with our financial statements and notes thereto included elsewhere in this Annual Report on Form 10-K for the fiscal year ended December 31, 2012.


General / 2012 Change in Key Business Rights and Obligations/ Trends and Uncertainties.


We were organized on August 6, 2007 under the name Friendly Auto Dealers, Inc.  Our initial business strategies did not come to fruition, and we had no active business operations until, on April 1, 2011, under one of the Exclusive Agreements, we acquired an exclusive worldwide license to make and sell (i) chairside AMPSA Products; and (ii) the dental laboratory semi-custom version of AMPSA Products outside of the United States; and since then, our business has consisted primarily of the manufacture and sale of AMPSA Products.  


On August 24, 2012, we undertook major changes by entering into (i) a Master Dispute Resolution Agreement (the “MDRA”) with James P. Boyd (“Boyd”), Boyd Research, Inc. (“Boyd Research”) and TMD Courses, Inc. (“TMD” and together with Boyd and Boyd Research, the “Boyd Parties”) and Timothy G. Dixon (“Dixon”) and Gerry B. Berg (“Berg”), (ii) a License Agreement with Boyd Research and TMD (the “New License Agreement”), (iii) an Escrow Agreement with Boyd and with Chicago Title Company as escrow agent (the “Escrow Agreement”), and (iv) a Voting Agreement with Boyd.  


Under the MDRA, Boyd agreed to surrender 223,991,933 shares of our common stock and resigned as a director of the Company.  The MDRA also provided that Boyd’s employment with us would continue throughout 2012, with his salary rate reduced to $100,000 per annum as of the date of the MDRA.  Also, the Boyd Parties agreed never to directly and/or indirectly sell into the public market, in any rolling 90-day period, more than 1% of our then-outstanding common stock; and they agreed to a 10-year standstill prohibiting them from further acquisitions of our stock and from seeking or assisting to acquire or gain control of us.  Further, the Boyd Parties agreed not to, except in conjunction with other stockholders (unaffiliated with them) holding at least 1,000,000 shares of our common stock, exercise any stockholder rights other than the right to vote.  


Before the New License Agreement, we and certain Boyd Parties were party to the Exclusive Agreements, which granted us an exclusive worldwide license to certain Boyd Parties patent rights and related technology (but no license for the US dental-laboratory field).


The Exclusive Agreements provided for a 30% royalty rate and a $3,000,000 license inception fee to be paid by us to Boyd Research.  We did not pay the inception fee and did not have the funds to do so.  The Boyd Parties threatened to sue us for payment of the inception fee and/or seek to terminate the Exclusive Agreements and seek an injunction against us to prevent further sales of products licensed by Boyd Research, all on the ground that the inception fee had not been paid.  We believed that we had valid defenses but determined that it was in our best interest to, instead of putting our defenses to the test, enter into the MDRA and the New License Agreement.


The New License Agreement terminated the Exclusive Agreements.  However, the New Licensee Agreement granted us new licenses under the applicable patent rights and related technology of the Boyd Parties to manufacture and sell our existing chairside AMPSA Products (but not any such products other than our currently existing ones) and laboratory-manufactured semi-custom AMPSA Products.  


The New License Agreement essentially carried forward the Exclusive Agreements’ terms as to sales to the US market for the remainder of 2012, but under the New License Agreement our rights to sell AMPSA Products to the US market expired at the end of 2012.  Specifically, for AMPSA Products sales to the US market, the New License Agreement granted us an exclusive license (but no license for the US dental-laboratory field), carrying a 30% royalty on net sales; but such license for the US market expired on December 31, 2012.


For sales of the existing AMPSA Products to non-US markets, the New License Agreement granted us for the remainder of 2012 an exclusive license, which converted to a non-exclusive license on January 1, 2013.  Under the New License Agreement, we had to pay a 30% royalty on 2012 net sales of the existing AMPSA Products to non-US markets, but, under the New License Agreement, after 2012 our net sales to non-US markets are royalty-free.



12




We had been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.


On January 1, 2013, the Boyd Parties began selling AMPSA Products to the US market, and we ceased doing so.  The Boyd Parties may compete with us in the manufacture and sale to some or all non-US countries, from and after January 1, 2013, of our AMPSA Products, and the Boyd Parties could sell new AMPSA Products there as well.


In the transition from the Exclusive Agreements to the New License Agreement, we gave up our license rights to the “Total Splint System” intraoral devices (which we had not successfully commercialized) and to all potential AMPSA Products which could have been commercialized using our Exclusive Agreements rights but which as of August 2012 we were not selling.


Sales of chairside AMPSA Products to the US market constituted over 80% of our business in 2011 and 2012.  Our challenge will be to counter the loss of our AMPSA Products sales to the US market and the loss of the ability to introduce new products based on Boyd Party technology, by increasing sales of our existing AMPSA Products to non-US markets, by sublicensing the right to manufacture and sell semi-custom laboratory-produced AMPSA Products in non-US markets and/or by successfully introducing into the US and non-US markets new products which do not require licenses from the Boyd Parties.  On the other hand, our business in 2013 and thereafter is free of Boyd Parties royalty obligations and is not subject to any Boyd Parties license inception fee.


The MDRA and New License Agreement contained various provisions pertaining to the transition of US market sales of the existing AMPSA Products from us to a Boyd Party on January 1, 2013, joint access to AMPSA Products production molds, website and toll-free telephone number transition, regulatory matters, etc.  We provided a limited supply of the existing AMPSA Products to the Boyd Parties in November 2012 so they could begin selling and shipping without interruption effective January 1, 2013.


In addition, we agreed under the MDRA to make deferred payments totaling $140,000 to the Boyd Parties.  We agreed to pay $10,000 per month for five months beginning September 1, 2012, and $5,000 per month for 18 months beginning July 1, 2013.  These obligations do not bear interest and are unsecured.


Also, as part of the MDRA, Dixon dismissed litigation he brought against Boyd pertaining to TMD, Dixon transferred his shares of TMD to Boyd (making Boyd the sole stockholder of TMD), and Boyd transferred 5,000,000 shares of our common stock to Dixon.  


All parties to the MDRA granted general releases to each other.


As contemplated by the MDRA, Boyd placed the 223,991,933 shares of Company common stock in escrow pursuant to the Escrow Agreement, to be released to us for cancellation when we finished making timely estimated minimum royalties and other payments, all totaling $351,000, into the escrow for the benefit of Boyd.  $301,000 of the $351,000 consisted of estimated minimum royalties payments which roughly corresponded to the anticipated amount of the 30% royalty on AMPSA Products net sales which we would owe anyway for the remainder of 2012, and the other $50,000 was a portion of the $140,000 of deferred payments referred to above.  All required payments were duly made, and, in January 2013, the 223,991,933 shares of common stock were released from escrow, surrendered to us, and cancelled.


As a result of the MDRA transactions (and our Board of Directors’ decision to accelerate the vesting of all outstanding stock options on December 31, 2012), Boyd’s beneficial ownership percentage of our common stock decreased from 78% to 12%, and Dixon’s beneficial ownership percentage of our common stock increased from 5.5% to 27%.  Also, all of our other stockholders’ beneficial ownership percentage of common stock increased substantially as a result of the MDRA because our outstanding common shares were reduced from 305,458,333 to 81,466,400 on January 18, 2013.  (Our outstanding common stock at March 23, 2013 was 83,466,400 shares.) This increase in Dixon’s beneficial ownership, viewed together with his Board of Directors seat and his positions as our Chief Executive Officer and President, may be considered to constitute a change in control of us, in favor of Dixon.


This summary of the material terms of the MDRA, the New License Agreement, the Escrow Agreement and the Exclusive Agreements does not purport to be exhaustive, and is qualified in its entirety by reference to the complete text of these agreements as filed by us with the SEC.


Boyd resigned as a director of the Company on August 24, 2012 in connection with the MDRA; and on the same date Berg was elected as a director of the Company.  Berg also serves as our Chief Financial Officer.



13




Critical Accounting Policies


The preparation of our consolidated financial statements and notes thereto requires management to make estimates and assumptions that affect the amounts and disclosures reported within those financial statements.  On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, contingencies, litigation and income taxes.  Management bases its estimates and judgments on historical experiences and on various other factors believed to be reasonable under the circumstances.  Actual results under circumstances and conditions different than those assumed could result in differences from the estimated amounts in the financial statements.  There have been no material changes to these policies during fiscal 2012.  


Results of Operations


We had a net loss of approximately $0.8 million in 2012 compared to a net loss of approximately $1.0 million in 2011.    


We did not begin commercial operations until April 1, 2011.  Beginning on April 1, 2011, we began to market and sell AMPSA Products.  Our sales of these products for the 12 months of 2012 was approximately $2.2 million versus sales in the second, third and fourth quarters of 2011 of approximately $1.7 million.   Although total sales actually increased for 2012, on a per-month basis the 2011 sales were slightly better.


Operating expenses for the years ended December 31, 2012 and December 31, 2011 were approximately $3.3 million and $2.7 million, respectively, an increase of approximately $0.6 million in the 2012 period. We did not have any active business for the three months ended March 31, 2011. As a result, expense items of general and administration, salaries/wages/related costs and royalties for the year ended December 31, 2012, which included 12 full months of active operations, were higher than those for 2011.


We paid approximately $656,000 of royalties to Boyd Research for the year ended December 31, 2012 versus approximately $496,000 for 2011, under the Exclusive Agreements and New License Agreement authorizing us to sell AMPSA Products.


Legal and professional fees increased approximately $0.385 million for 2012 as compared to 2011. This increase was primarily due to legal fees for the negotiations during 2012 which resulted in the MDRA and the New License Agreement, and to legal assistance with activities related to the transitions contemplated by those agreements.


Amortization and depreciation was approximately $0.19 million for the year ended December 31, 2012 versus approximately $0.23 million for the year ended December 31, 2011. We owed a $3.0 million license inception fee under the 2011 Agreement, and we were amortizing the $3.0 million over the 10-year term of the 2011 Agreement. When the license inception fee obligation was terminated in August 2012, we reversed the $0.4 million of amortization charges we had recognized during 2011 and 2012, with respect to this obligation, and recognized this amount as other income.


Consulting fees, primarily representing recognition of the pro rata portions of the $1.0 million of common stock we issued to our investor relations consultant in June 2011 as compensation for 12 months of consulting services, decreased by approximately $0.085 million in 2012 versus 2011.  There was about 6.5 months of such recognition in 2011, but only about 5.5 months of such recognition in 2012. The entire $1.0 million was completely recognized as expense by mid June 2012.


Cash constraints and uncertainty about our future business led us to keep our selling expenditures low during the first eight months of 2012 versus 2011. In addition, these uncertainties rendered us unable to gain advantage during 2012 from the investor relations consulting services mentioned above.


Although we have had a high gross profit margin on our AMPSA Products sales since April 1, 2011, our net revenues did not provide enough economies of scale to put us in a position to pay or finance the 2011 Agreement’s $3.0 million license inception fee. To resolve that obligation, we entered into the MDRA, the New License Agreement and the related agreements on August 24, 2012, as noted above.


As noted above, the nature and conditions of our business will change substantially on January 1, 2013, due to contract changes.




14




Liquidity and Capital Resources


Our operations commenced on April 1, 2011 and we financed our operations in 2011 through product sales. As of December 31, 2012, our cash and cash equivalents totaled only about $35,000 and our accounts payable had increased to about $230,000.  Particularly in view of our no longer having the right to sell AMPSA Products in the United States beginning January 1, 2013, our current cash reserves are not adequate for our needs.  Based upon our current plans, we believe that our existing capital resources will be sufficient to meet our operating expenses into mid-2013.  


There is no guarantee we will receive the required financing to complete our business strategies, and it is uncertain whether future financing will be available to us on acceptable terms.  If financing is not available on satisfactory terms, we may be unable to continue, develop or expand our operations.  Our auditor has stated in their opinion that there is substantial doubt about the Company’s ability to continue as a going concern.


In 2012, we had negative cash flow from operations of $46,830, as compared to a positive cash flow from operations of $100,255 in 2011.


Off-Balance Sheet Arrangements.


We currently do not have any off-balance sheet arrangements.


ITEM 7A

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.


No disclosure required.


ITEM 8 

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.


Our financial statements and the accompanying notes that are filed as part of this Annual Report on Form 10-K are listed and set forth beginning on page F-1 immediately following the signature page of this Form 10-K.


ITEM 9 

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.


None.


ITEM 9A.

CONTROLS AND PROCEDURES


A.

Disclosure Controls and Procedures


As required by Rule 13a-15(b) under the Securities Exchange Act,  our principal executive officer and principal financial officer evaluated our  disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act) for the period covered by this Annual Report on Form 10-K as of December 31, 2012. Based on this evaluation, these officers concluded that as of December 31, 2012, these disclosure controls and procedures were adequate to ensure that the information required to be disclosed by us in reports we file or submit under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and include controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.


Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.




15




B.

Management’s Report on Internal Control over Financial Reporting


Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance to management and the board of directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; (iii) provide reasonable assurance that receipts and expenditures of company assets are made in accordance with management authorization; and (iv) provide reasonable assurance that unauthorized acquisition, use or disposition of company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis.


Because of its inherent limitations, internal control over financial reporting may not prevent or detect every misstatement. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because changes in conditions may occur or the degree of compliance with the policies or procedures may deteriorate.


Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2012. This assessment was based on the criteria for effective internal control described in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “COSO”). Based on its assessment, management concluded that our internal control over financial reporting as of December 31, 2012 was not effective and was subject to material weaknesses.


A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.


We identified the following material weaknesses in our internal control over financial reporting using the criteria established in the COSO framework:


There is a significant lack of definition and segregation of duties throughout our financial and financial reporting processes;

Currently we have no written policies or procedures that clearly define roles in the financial close and reporting process. The various roles and responsibilities related to this process need to be defined, assigned, documented, updated and communicated; and

We fail to have an audit committee or other independent committee that is independent of management to assess internal control over financial reporting.


C.

 Changes in Internal Control over Financial Reporting.


There were no changes in our internal control over financial reporting that occurred during our fiscal quarter ended December 31, 2012 that materially affected, or are reasonable likely to materially affect, our internal control over financial reporting.


ITEM 9B

OTHER INFORMATION.


On December 18, 2012, by action of our Board of Directors, we adopted a 2012 Stock Incentive Plan, covering 12,000,000 shares of common stock which may from time to time be issued to, or subjected to stock options in favor of, our service providers.  We registered these shares under the Securities Act of 1933 by filing with the SEC a registration statement on Form S-8.




16




PART III


ITEM 10

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.


The Company’s executive officers and directors and their respective ages as of March 1, 2013 are as follows:


Directors:


  

Name of Director

Age

  

Timothy G. Dixon

Gerry B. Berg

54

66


Executive Officers:


  

Name of Officer

Age

Offices

  

Timothy G. Dixon

Gerry B. Berg

Barry Glassman, D.M.D.

54

66

65

Chief Executive Officer and President

Vice President, Chief Financial Officer and Secretary

Vice President of Training and Education


The term of office for each director is one year, or until the next annual meeting of the stockholders.


Biographical Information


Timothy G. Dixon


Timothy Dixon has served as our President since March 31, 2011, and since September 26, 2012 he has also served as our Chief Executive Officer.  Mr. Dixon served as the President of TMD Courses, Inc., a provider of continuing dental education and at times a maker and seller of AMPSA Products, from 2006 to 2012.  Mr. Dixon has worked in the field of dentistry support since 1995.


Gerry B. Berg


Gerry B. Berg has served as our Vice-President and Chief Financial Officer since April 20, 2011.  Mr. Berg became a director of the Company on August 24, 2012.  Mr. Berg has over 30 years of senior management experience working with private and public companies.  From May 2010 to March 2011, Mr. Berg served as President and Chairman of the Board of Directors of Friendly Auto Dealers, Inc. and also served in a consulting capacity from March 2009 to May 2010.  From June 2008 to March 2009 Mr. Berg served as President of GBB Consulting.  From January 2007 to June 2008 Mr. Berg served as the Chief Financial Officer of Let’s Talk Health, Inc.  Mr. Berg has also been serving, since February 2012, as a member of the Board of Directors of Dakota Territory Resource Corp.


Mr. Berg holds a Bachelors of Science in Accounting from Walsh College where he graduated Cum Laude.  Mr. Berg became a Certified Public Accountant in the State of Michigan in 1979 and in the State of California in 1984.  Mr. Berg does not currently practice as a Certified Public Accountant.


Barry Glassman, D.M.D.


Dr. Glassman became our Vice President of Training and Education in February 2013; he had previously served as our Director of Education from April 2011 until then.  Dr. Glassman maintains, and for well more than the past five years has maintained,  a private practice which is limited to chronic pain management, temporomandibular joint dysfunction and dental sleep medicine, and he is on the staff at the Lehigh Valley Hospital (Allentown, Pennsylvania) where he serves as a resident instructor of Craniofacial Pain and Dysfunction and Dental Sleep Medicine. He is a Diplomate of the American Academy of Craniofacial Pain and the American Academy of Pain Management, as well as a Fellow of the International College of Craniomandibular Orthopedics and the Academy of Dentistry International.




17




Information with Respect to Our Board of Directors


The following is a brief description of the structure and certain functions of our Board of Directors.  Each of the current directors is serving until his respective successor is duly elected, subject to earlier resignation.  We do not have standing audit, compensation or nominating committees of our Board of Directors.  However, the full Board of Directors performs all of the functions of a standing audit committee, compensation committee and nominating committee.


Audit Committee Related Function


We do not have a separately designated standing audit committee in place.  Our full Board of Directors currently serves in that capacity.  This is due to the small number of members of our Board of Directors, the small number of executive officers involved with our company, and the fact that we operate with few employees.  Our Board of Directors will continue to evaluate, from time to time, whether a separately designated standing audit committee should be put in place.  We do not have an audit committee charter.


The Board of Directors reviews with management and the Company's independent public accountants the Company's financial statements, the accounting principles applied in their preparation, the scope of the audit, any comments made by the independent accountants upon the financial condition of the Company and its accounting controls and procedures and such other matters as the Board of Directors deems appropriate.  Because our common stock is traded in OTC Markets Group Inc.’s OTCQB marketplace, we are not subject to the listing requirements of any securities exchange regarding audit committee related matters.


The Board of Directors currently consists of two directors: Mr. Dixon and Mr. Berg.  Because we do not have an audit committee at all, we disclose that we do not have any "audit committee financial expert" serving on an audit committee.


Compensation Committee Related Function


We do not currently have a standing compensation committee, and do not have a compensation committee charter.  The full Board of Directors currently has the responsibility of reviewing and establishing compensation for executive officers and making policy decisions concerning salaries and incentive compensation for executive officers of the Company.


The Company's executive compensation program is administered by the Board of Directors, which determines the compensation of the Chief Executive Officer/President and the Chief Financial Officer of the Company.  In reviewing the compensation of the individual executive officers, the Board of Directors considers the recommendations of the Chief Executive Officer, other market information and current market conditions, as well as any existing employment agreements with them.  


Nominating Committee Related Function


We do not currently have a standing nominating committee.  We have not adopted procedures by which security holders may recommend nominees to serve on our board of directors.


Section 16(a) Beneficial Ownership Reporting Compliance


Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than 10% of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other of our equity securities.  Officers, directors and greater than 10% stockholders are required by SEC regulation to furnish us with copies of all Section 16(a) forms they file.


To our knowledge, based solely on a review of the copies of such reports furnished to us during the fiscal year ended December 31, 2012, all Section 16(a) filing requirements applicable to our officers, directors and greater than 10% beneficial owners were complied with.


Code of Ethics


We have adopted a Code of Ethics for our principal executive and financial officers.  Our Code of Ethics was filed as an Exhibit to our Annual Report on Form 10-K for fiscal year 2010.  We hereby undertake to provide a copy of this Code of Ethics to any person, without charge, upon request.  Requests for a copy of this Code of Ethics may be made in writing addressed to: Therapeutic Solutions International, Inc., 4093 Oceanside Blvd, Suite B, Oceanside, California 92056, Attn:  Corporate Secretary.



18




ITEM 11

EXECUTIVE COMPENSATION.


Summary Compensation Table


The following table summarizes the compensation paid, with respect to fiscal 2012 and 2011 for services rendered to us in all capacities, to each person who served as an executive officer of the Company in 2012 and to one other highly-compensated employee.


Summary Compensation Table


Name and Principal Position

Year

Salary ($)

Bonus ($)

Stock Awards ($)

Option Awards ($)

Nonequity Incentive Plan Compensation ($)

All Other Compensation ($)

Total ($)

Timothy G. Dixon*

President and CEO

2012

112,500

 

 

-0-

 

14,000

126,500

2011

74,167

 

 

144,000

 

1,000

219,167

 

 

 

 

 

 

 

 

Gerry B. Berg**

Vice President, Chief Financial Officer

2012

111,589

 

 

-0-

 

14,000

125,589

2011

51,000

 

 

124,000

 

1,000

176,000

James P. Boyd***

Director of Research and Product Development

2012

108,750

 

 

-0-

 

19,309

128,059

2011

90,000

 

 

144,000

 

27,211

261,211


* Mr. Dixon’s employment with the Company began on April 1, 2011.  

** Mr. Berg’s employment with the Company began on April 20, 2011.  

***Dr. Boyd’s employment with the Company began on April 1, 2011.  Dr. Boyd’s employment with the Company ended on December 31, 2012.


The dollar values of the stock options granted were determined as of the date of grant using the Black-Scholes option-pricing model.  




19




Outstanding Equity Awards at Fiscal Year-End


The following table shows certain information regarding outstanding equity awards at December 31, 2012 for our President, our Chief Financial Officer and Dr. Boyd.  There were no outstanding unvested stock awards at December 31, 2012.


 

Option Awards

 

Number of Securities Underlying Unexercised Options

Equity Incentive Plan Awards:  Number of Securities Underlying Unexercised Unearned Options

Option Exercise Price

Option Expiration Date

Name

Exercisable

Unexercisable

Timothy G. Dixon

1,800,000

 0

 0

 $0.08

8/31/2021

 


 

 

 

 

 


 

 

 

 

Gerry B. Berg

1,500,000

 0

 0

 $0.08

8/31/2021

 


 

 

 

 

 


 

 

 

 

James P. Boyd

1,800,000

 0

 0

 $0.08

8/31/2021

 


 

 

 

 

 


 

 

 

 


We did not grant any stock options in 2012.  On December 31, 2012, we accelerated the vesting of all of our outstanding stock options.


Employment Agreements


We have employment agreements with Timothy G. Dixon and Gerry B. Berg, each dated November 15, 2011.  


The agreement with Mr. Dixon calls for a salary at an annual rate of $120,000 per year for the last one and one-half months of 2011 and for 2012 and at an annual rate of $135,000 for 2013, and an automobile allowance of $1,000 per month.  (Since September 2012 we have in fact been paying Mr. Dixon an automobile allowance of $1,500 per month.)   If his employment is terminated without cause or he resigns for good reason, we must pay his salary and benefits for the remainder of the scheduled term and pay his salary for one year thereafter, and COBRA continuation payments for 18 months.  If his employment is terminated due to death or disability or if his employment ends upon the natural expiration of the contract term, we must pay his salary for one year thereafter, and COBRA continuation payments for 18 months.


The agreement with Mr. Berg calls for a salary at an annual rate of $110,000 per year for the last one and one-half months of 2011 and for 2012, and at an annual rate of $130,000 for 2013, and an automobile allowance of $1,000 per month.  (Since September 2012 we have in fact been paying Mr. Berg an automobile allowance of $1,500 per month.)  If his employment is terminated without cause or he resigns for good reason, we must pay his salary and benefits for the remainder of the scheduled term and pay his salary for one year thereafter, and COBRA continuation payments for 18 months.  If his employment is terminated due to death or disability or if his employment ends upon the natural expiration of the contract term, we must pay his salary for one year thereafter, and COBRA continuation payments for 18 months.  


Director Compensation


When our employees serve on our Board of Directors, we do not give them any additional compensation in respect of such Board service.  In 2012, each person who served as a member of the Board of Directors was an employee of ours.




20




ITEM 12

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.


The following table sets forth, as of March 23, 2013, information regarding the ownership of the Company’s outstanding shares of common stock by (i) each person known to management to own, beneficially or of record, more than 5% of the outstanding shares of our common stock, (ii) each director of the Company, (iii) each executive officer of the Company, and (iv) all directors and executive officers as a group.  As of March 23, 2013, a total of 83,466,400 shares of our common stock were outstanding.


Name and Address of Beneficial Owners

Amount and Nature of Beneficial Ownership (1)

Percent of Shares Outstanding

 

Timothy G. Dixon (2)

23,071,400

26.9

%

Gerry B. Berg (3)

13,210,000

15.5

%

James P. Boyd (4)

10,300,000

12.1

%

Tad Mailander (5)

7,600,000

9.1

%

Gemini Consulting LLC (6)

4,690,000

5.6

%

Barry Glassman (7)

1,233,169

1.5

%

All directors and executive officers

as a group (3 persons) (2)(3)(7)

37,514,569

42.5

%


(1)

Under SEC rules (i) a person is deemed to be the beneficial owner of shares if that person has, either alone or with others, the power to vote or dispose of those shares; and (ii) if a person holds options to purchase shares of our common stock, that person will be deemed to be the beneficial owner of the number of those shares that may be purchased by exercise of those options at any time during a 60 day period which, for purposes of this table, will end on May 22, 2013.  The number of shares subject to options that are exercisable or may become exercisable during that 60-day period is deemed outstanding for purposes of computing the number of shares beneficially owned by, and the percentage ownership of, the person holding such options, but not for computing the percentage ownership of any other stockholder.  Except as otherwise noted below, the persons named in the table have sole voting and dispositive power with respect to all shares shown as beneficially owned by them, subject to community property laws where applicable.

(2)

Includes 3,000 shares owned by Mr. Dixon’s wife; Mr. Dixon disclaims beneficial ownership of those shares.  Includes 1,800,000 shares subject to outstanding stock options.  Also includes 400,000 shares subject to outstanding stock options held by Mr. Dixon’s wife; Mr. Dixon disclaims beneficial ownership of those shares.  

(3)

Includes 1,500,000 shares subject to outstanding stock options.  

(4)

Includes 1,800,000 shares subject to outstanding stock options.  

(5)

Includes 4,600,000 shares owned by Mailander Law Office. The business address of Tad Mailander is 835 5th Avenue, San Diego, CA 92101.  

(6)

Includes 250,000 shares owned by Steve Chu.  The business address of Gemini Consulting LLC is 4132 South Rainbow, Suite 514, Las Vegas, NV 89103.

(7)

Includes 233,169 shares owned by Dr. Glassman’s wife; Dr. Glassman disclaims beneficial ownership of those shares.  Includes 1,000,000 shares subject to outstanding stock options.  


Securities Authorized for Issuance under Equity Compensation Plans


In 2009 we issued 250,000 common stock warrants to a consultant. The warrants have an exercise price of $1.00 per share and expire in 2014.


In March 2009, we adopted a 2009 Stock Incentive Plan (the “2009 Plan”).  Pursuant to the 2009 Plan, we may grant stock options and stock awards to our service providers.  The maximum number of shares that could be issued pursuant to the 2009 Plan as initially adopted was 6,000,000 shares.  We filed a Form S-8 registration statement with the SEC to register 10,000,000 2009 Plan shares on March 13, 2009.  In August 2011, by action of our Board of Directors, we expanded the number of shares authorized under the 2009 Plan from 6,000,000 shares to 10,000,000 shares.  


In December 2012 we adopted a 2012 Stock Incentive Plan (the “2012 Plan”).  Pursuant to the 2012 Plan, we may grant stock options and stock awards to our service providers.  The maximum number of shares that can be issued pursuant to the 2012 Plan is 12,000,000 shares.  We filed a Form S-8 registration statement with the SEC to register the 12,000,000 2012 Plan shares on December 18, 2012.  

The following table provides information as of December 31, 2012 with respect to all of our compensation plans under which we are authorized to issue equity securities.   



21




Equity Compensation Plan Information


Plan Category

Number of securities to

be issued upon exercise

of outstanding options,

warrants and rights

Weighted-average

exercise price of

outstanding options,

warrants and rights

Number of securities

remaining available for

future issuance under

equity compensation

plans (excluding

securities in the first

column)

Equity compensation plans approved by security holders

0

0

0

Equity compensation plans not approved by security holders

7,150,000

$0.11

15,100,000

Total

7,150,000

$0.11

15,100,000


ITEM 13

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.


Our Board of Directors currently consists of two directors, each of whom is an employee director.  Accordingly, we disclose that we have no independent directors.


In general, it is our policy to submit all proposed related party transactions (those of the kind and size that may require disclosure under Regulation S-K, Item 404) to the Board of Directors for approval.  The Board of Directors only approves those transactions that are on terms comparable to, or more beneficial to us than, those that could be obtained in arm’s length dealings with an unrelated third party.  Examples of related party transactions covered by our policy are transactions in which any of the following individuals has or will have a direct or indirect material interest: any of our directors or executive officers, any person who is known to us to be the beneficial owner of more than 5% of our common stock, and any immediate family member of one of our directors or executive officers or person known to us to be the beneficial owner of more than 5% of our common stock.


Boyd had a material interest in the Exclusive Agreements, and Boyd has a material interest in the New License Agreement.


Boyd, Dixon and Berg each have a material interest in the MDRA.


ITEM 14

PRINCIPAL ACCOUNTANT FEES AND SERVICES.


Audit Fees


The aggregate fees billed to us by our principal accountants, PLS CPA A Professional Corporation, for auditing and accounting services for fiscal year 2012 was $40,000 (inclusive of the review of the quarterly reports on Form 10-Q).    


The aggregate fees billed to us by our principal accountants, PLS CPA A Professional Corporation, for auditing and accounting services for fiscal year 2011 was $16,500 (inclusive of the review of the quarterly reports on Form 10-Q).  


Audit-Related Fees, Tax Fees and All Other Fees


There were no fees billed to us by our principal accountant for fiscal year 2012 for assurance and related services (audit-related fees), tax services or other products and services.


There were no fees billed to us by our principal accountant for fiscal year 2011 for assurance and related services (audit-related fees), tax services or other products and services.  


Audit Committee Matters


We do not have an audit committee.  



22




PART IV


ITEM 15

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.


(a)

The following documents have been filed as a part of this Annual Report on Form 10-K.


1.

Financial Statements


  

Page

Report of Independent Registered Public Accounting Firm

F-1

Balance Sheets

F-2

Statements of Operations

F-3

Statements of Stockholders' Equity

F-4

Statements of Cash Flows

F-5

Notes to Financial Statements

F-6


2.

Financial Statement Schedules.


All schedules are omitted because they are not applicable or not required or because the required information is included in the Financial Statements or the Notes thereto.


3.

Exhibits.


The following exhibits are filed as part of, or incorporated by reference into, this Annual Report on Form 10-K:


EXHIBIT

NUMBER

DESCRIPTION

3.1

Articles of Incorporation (incorporated herein by reference to Form 10-K, filed October 31, 2012)

3.1.1

Certificate of Merger, filed February 22, 2011 (incorporated herein by reference to Form 10-K, filed October 31, 2012)

3.1.2

Certificate of Amendment to Articles of Incorporation filed October 15, 2012  (incorporated herein by reference to Form 8-K, filed on October 17, 2012)

3.2

Bylaws (incorporated herein by reference to Form SB-2, filed on November 21, 2007)

3.2.1

Bylaws amendments adopted August 22, 2012, August 24, 2012  and September 26, 2012 (incorporated herein by reference to Form 10-K, filed October 31, 2012)

10.1

2009 Stock Incentive Plan (as amended on August 31, 2011) (incorporated herein by reference to Form 10-K, filed on October 31, 2012)

10.2

Common Stock Share Exchange Agreement dated November 16, 2010 (incorporated herein by reference to Exhibit E to Regulation 14C information statement filed on February 15, 2011)

10.3

Exclusive License Agreement between Boyd Research, Inc. and us, dated April 1, 2011 (incorporated herein by reference to Form 10-K, filed on October 31, 2012)

10.4

Investor Relations Consulting Agreement,  between us and Constellation Asset Advisors, Inc., dated June 17, 2011 (incorporated herein by reference to Form 10-K, filed on October 31, 2012)

10.5

 Employment Agreement between Timothy Dixon and us, dated November 15, 2011 (incorporated herein by reference to Form 10-K, filed on October 31, 2012)

10.6

 Employment Agreement between Gerry Berg and us, dated November 15, 2011 (incorporated herein by reference to Form 10-K, filed on October 31, 2012)

10.7

Master Dispute Resolution Agreement, by and among us, James P. Boyd, Boyd Research, Inc., TMD Courses, Inc., Timothy G. Dixon and Gerry B. Berg, dated August 24, 2012 (incorporated herein by reference to Exhibit 10.1 to Form 8-K filed August 30, 2012)

10.8

License Agreement, by and among us, Boyd Research, Inc. and TMD Courses, Inc., dated August 24, 2012 (incorporated herein by reference to Exhibit 10.2 to Form 8-K filed August 30, 2012)

10.9

Escrow Agreement, by and among us and James P. Boyd and Chicago Title Company (as escrow agent), dated August 24, 2012 (incorporated herein by reference to Exhibit 10.3 to Form 8-K filed August 30, 2012)

10.10

Voting Agreement, by and between us and James P. Boyd, dated August 24, 2012 (incorporated herein by reference to Exhibit 10.4 to Form 8-K filed August 30, 2012)

10.11

2012 Stock Incentive Plan

23.1

Consent of Independent Registered Public Accounting Firm

31.1

Rule 13a-14(a)/Section 302 Certification of Principal Executive Officer

31.2

Rule 13a-14(a)/Section 302 Certification of Principal Financial Officer

32.1

Certification pursuant to 18 U.S.C. Section 1350/Rule 13a-14(b)



23




SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.



By:  /s/ Timothy G. Dixon

Timothy G. Dixon

Chief Executive Officer and President


Date:  March 29, 2013


/s/ Timothy G. Dixon

Timothy G. Dixon

Chief Executive Officer, President and Director (Principal Executive Officer)


Date:  March 29, 2013


/s/ Gerry B. Berg

Gerry B. Berg

Vice President, Chief Financial Officer and Director (Principal Financial and Accounting Officer)


Date:  March 29, 2013






24






[f10k123112_10k002.jpg]





Report of Independent Registered Public Accounting Firm



To the Board of Directors and Stockholders

Therapeutic Solutions International, Inc.

(Formerly Splint Decisions Inc.)


We have audited the accompanying consolidated balance sheets of Therapeutic Solutions International, Inc. (Formerly Splint Decisions Inc.) (the “Company”) as of December 31, 2012 and 2011 and the related consolidated statements of operation, changes in shareholders’ equity and cash flows for the years then ended. These consolidated financial statements are the responsibility of the Company’s management.  Our responsibility is to express an opinion on these consolidated financial statements based on our audit.


We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.  An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.  An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  We believe that our audit provides a reasonable basis for our opinion.  


In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial positions of Therapeutic Solutions International, Inc. (Formerly Splint Decisions Inc.) as of December 31, 2012 and 2011, and the consolidated results of its operation and its cash flows for the years then ended in conformity with U.S. generally accepted accounting principles.


The consolidated financial statements have been prepared assuming that the Company will continue as a going concern.  As discussed in Note 2 to the consolidated financial statements, under the New License Agreement the Company’s rights to sell AMPSA Products to the US market (81% of total revenue) expired at the end of 2012.  This fact raises substantial doubt about its ability to continue as a going concern.  The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.




/s/ PLS CPA

PLS CPA, A Professional Corp.


March 29, 2013

San Diego, CA 92111






Registered with the Public Company Accounting Oversight Board



F-1






THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

(Formerly Splint Decisions Inc.)

Consolidated Balance Sheets

(Audited)

 

 

 

 

 

 

 

December 31,

2012

 

 

December 31,

2011

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

$

35,011

 

$

87,976

 

Accounts receivable, net

 

16,358

 

 

37,416

 

Inventories

 

30,790

 

 

48,198

 

Prepaid expenses and other current assets

 

14,535

 

 

490,037

 

          Total current assets

 

96,694

 

 

663,627

 

 

 

 

 

 

 

Other non-current assets

 

12,410

 

 

12,350

Property and equipment, net

 

92,453

 

 

7,639

Licensing agreement, net

 

-

 

 

2,775,000

 

 

 

 

 

 

 

Total assets

$

201,557

 

$

3,458,616

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' DEFICIT

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

$

230,786

 

$

56,777

 

Accrued expenses and other current liabilities

 

24,814

 

 

39,155

 

Due to related parties

 

30,013

 

 

3,004,090

 

Royalties payable, related party

 

48,842

 

 

56,211

Total current liabilities

 

334,454

 

 

3,156,233

 

 

 

 

 

 

 

Long term liabilities:

 

 

 

 

 

 

Due to related parties

$

60,000

 

$

-

Total long term liabilities

 

60,000

 

 

-

 

 

 

 

 

 

 

Shareholders' Deficit

 

 

 

 

 

 

Preferred stock, $.001 par value; 5,000,000 shares authorized

 

-

 

 

-

 

Common stock, $.001 par value; 699,999,999 shares authorized,  305,458,333 issued and outstanding at December 31, 2012 and 700,000,000 shares authorized, 305,458,333 issued and outstanding at December 31, 2011

 

305,458

 

 

305,458

 

Capital in excess of par

 

1,285,533

 

 

975,281

 

Deficit accumulated

 

(1,783,888)

 

 

(978,356)

 

 

 

 

 

 

 

Total shareholders' deficit

 

(192,897)

 

 

302,383

 

 

 

 

 

 

 

Total liabilities and shareholders' deficit

$

201,557

 

$

3,458,616

 

 

 

 

 

 

 

See accompanying notes to financial statements.




F-2






THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

 (Formerly Splint Decisions Inc.)

 Consolidated Statements of Operations

(Audited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Year End December 31, 2012

 

 

For the Year End December 31, 2011

 

 

 

 

 

 

 

 

 

 

 

Net domestic revenues

 

 

 

 

$

1,837,480

 

$

1,362,006

Net international revenues

 

 

 

 

 

354,155

 

 

325,926

 

Total revenues

 

 

 

 

 

2,191,635

 

 

1,687,932

Cost of goods sold

 

 

 

 

 

80,129

 

 

59,949

Gross profit

 

 

 

 

 

2,111,506

 

 

1,627,984

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

Selling

 

 

 

 

 

106,527

 

 

145,573

 

General and administrative

 

 

 

 

 

138,490

 

 

104,292

 

Salaries, wages, and related costs

 

 

 

 

 

1,188,531

 

 

934,590

 

Royalties

 

 

 

 

 

656,310

 

 

496,037

 

Amortization and depreciation

 

 

 

 

 

186,320

 

 

227,187

 

Consulting fees

 

 

 

 

 

478,068

 

 

563,489

 

Legal and professional fees

 

 

 

 

 

583,023

 

 

198,558

 

          Total operating expenses

 

 

 

 

 

3,337,270

 

 

2,669,727

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

 

 

 

(1,225,763)

 

 

(1,041,743)

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

Expense recapture as result of settlement

 

 

 

 

 

400,000

 

 

 

 

Net other income (expense)

 

 

 

 

 

20,268

 

 

71,404

 

Interest expense

 

 

 

 

 

(36)

 

 

(360)

 

          Total other income (expense)

 

 

 

 

 

420,232

 

 

71,045

Net loss

 

 

 

 

$

(805,532)

 

$

(970,699)

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per common share

 

 

 

 

$

(0.0099)

 

$

(0.0139)

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding*

 

 

 

 

 

81,466,400

 

 

69,771,159

 

 

 

 

 

 

 

 

 

 

 

 See accompanying notes to financial statements.



* Reflects cancellation of 223,991,933 shares in January 2013.



F-3






Therapeutic Solutions International, Inc.

Condensed Consolidated Statement of Changes in Shareholders' (Deficit)

For the Period from December 31, 2010 to December 31, 2012

(Audited)

 

 

Common Stock

 

Common Stock Amount

 

Additional Paid-in Capital

 

Earnings (Deficit) Accumulated

 

Total

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2010

28,710,000

$

28,710

$

(28,708)

$

(7,657)

$

(7,655)

 

 

 

 

 

 

 

 

 

 

Stock issued for service on February 11, 2011

15,500,000

 

15,500

 

1,224,500

 

-

 

1,240,000

Recapitalization

250,523,333

 

250,523

 

(1,525,624)

 

-

 

(1,275,101)

Stock issued for service on May 17, 2011

525,000

 

525

 

41,475

 

-

 

42,000

Stock issued for service on June 3, 2011

200,000

 

200

 

11,800

 

-

 

12,000

Stock issued for service on June 17, 2011

10,000,000

 

10,000

 

990,000

 

-

 

1,000,000

Employee stock options vested during the year

-

 

-

 

261,838

 

-

 

261,838

Net Loss, December 31, 2011

-

 

-

 

-

 

(970,699)

 

(970,699)

 

 

 

 

 

 

 

 

 

 

Balance,  December 31, 2011

305,458,333

$

305,458

$

975,281

$

 (978,356)

$

302,383

 

 

 

 

 

 

 

 

 

 

Employee stock options vested during the year

-

 

-

 

310,252

 

-

 

310,252

Net Loss, December 31, 2012

-

 

-

 

-

 

(805,532)

 

(805,532)

 

 

 

 

 

 

 

 

 

 

Balance,  December 31, 2012

305,458,333

$

305,458

$

1,285,533

$

 (1,783,888)

$

 (192,897)

 

 

 

 

 

 

 

 

 

 

See Accompanying Notes to Financial Statements




F-4






THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

(Formerly Splint Decisions Inc.)

 Consolidated Statements of Cash Flows

(Audited)

 

 

 

 

 

 

 

 

For the Year End

December 31, 2012

 

 

For the Year End

December 31, 2011

Cash flows from operating activities

 

 

 

 

 

Net loss

$

(805,532)

 

$

(970,699)

 

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

 

Non-cash expenses:

 

 

 

 

 

 

 

     Amortization

 

175,000

 

 

225,000

 

 

     Depreciation

 

11,320

 

 

2,187

 

 

     Stock based compensation to officers

 

-

 

 

42,000

 

 

     Stock based compensation to consultants

 

-

 

 

1,012,000

 

 

     Compensation expense - employee stock option plan

 

310,252

 

 

261,838

 

 

     Amortization recapture as result of settlement

 

(400,000)

 

 

-

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

     (Increase) decrease in inventory

 

17,408

 

 

(48,198)

 

 

     (Increase) decrease in accounts receivable

 

21,058

 

 

(37,416)

 

 

     (Increase) decrease in prepaid expenses and other current assets

 

475,502

 

 

(490,037)

 

 

     (Increase) decrease in other assets

 

(60)

 

 

(12,350)

 

 

     Increase (decrease) in accounts payable

 

174,010

 

 

56,777

 

 

     Increase (decrease) in accrued expenses and other current liabilities

 

(14,341)

 

 

39,155

 

 

     Increase (decrease) in other related party liabilities

 

(11,447)

 

 

19,998

Net cash provided by operating activities

 

(46,830)

 

 

100,255

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

Acquisition of fixed assets

 

(6,135)

 

 

(9,826)

 

 

Acquisition of licensing agreement

 

-

 

 

(3,000,000)

Net cash used by  investing activities

 

(6,135)

 

 

(3,009,826)

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

Borrowing and other advances

 

-

 

 

3,000,000

 

 

Repayments

 

-

 

 

(4,819)

Net cash provided by financing activities

 

-

 

 

2,995,181

 

 

 

 

 

 

 

 

 

 

Increase in cash

 

(52,965)

 

 

85,611

 

 

Cash at beginning of period

 

87,976

 

 

2,366

 

 

Cash at end of period

$

35,011

 

$

87,976

 

 

 

 

 

 

 

 

Supplemental disclosure of non-cash investing and financing activities:

 

 

 

 

 

 

Decrease in license agreement and due to related parties due to settlement

$

3,000,000

 

$

-

 

Increase in fixed assets and due to related parties

 

90,000

 

 

-

 

Increase in liabilities from merger

 

-

 

 

35,101

 

Increase in License agreement and due to related party

 

-

 

 

3,000,000

 

 

 

 

 

 

 

 

Supplemental Cash Flow Information:

 

 

 

 

 

 

Cash paid for interest

$

36

 

$

311

 

Cash paid for income taxes

$

800

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to financial statements.




F-5






THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

(Formerly Splint Decisions Inc.)

Notes to Financial Statements

December 31, 2012 and 2011


Note 1 – Nature of Business


Therapeutic Solutions International, Inc. (the “Company”) was organized August 6, 2007 under the name Friendly Auto Dealers, Inc. under the laws of the State of Nevada. In the first quarter of 2011 the Company changed its name from Friendly Auto Dealers, Inc. to Therapeutic Solutions International, Inc., and acquired Splint Decisions Inc., a California corporation organized September 21, 2010 (“Splint”).  Splint is treated as the “accounting acquirer” in the accompanying financial statements.  In the transaction, the Company issued 250,523,333 common shares to the shareholders of Splint; such shares represented, immediately following the transaction, 85% of the outstanding shares of the Company.  The transaction was accounted for as a “reverse merger” and a reverse recapitalization and the issuances of common stock were recorded as a reclassification between paid-in-capital and par value of Common Stock.  


On August 24, 2012, the Company entered into a Master Dispute Resolution Agreement (the “MDRA”) with James P. Boyd (“Boyd”), Boyd Research, Inc. and TMD Courses, Inc. (together with Boyd, the “Boyd Parties”) and Timothy G. Dixon (“Dixon”) and Gerry B. Berg, and on August 24, 2012, the Company also entered into a License Agreement with Boyd Research, Inc. and TMD Courses, Inc. (the “New License Agreement”), an Escrow Agreement with Boyd and with Chicago Title Company as escrow agent, and a Voting Agreement with Boyd.  


Before the New License Agreement, the Company and certain Boyd Parties were party to an Exclusive License Agreement dated April 1, 2011, as amended on November 1, 2011 (the “2011 Agreement”).  Also, the Company’s predecessor Splint Decisions Inc. and certain Boyd Parties were party to an Exclusive License Agreement dated October 22, 2010, as amended on July 8, 2011 (together with the 2011 Agreement, the “Exclusive Agreements”).  The Exclusive Agreements granted the Company an exclusive worldwide license to certain Boyd Parties patent rights and related technology.  Since April 1, 2011, essentially the Company’s entire active business has consisted of the manufacture and sale of Anterior Midpoint Stop Appliance intraoral devices (“AMPSA Products”) as authorized by the Exclusive Agreements and the New License Agreement.  


The New License Agreement terminated the Exclusive Agreements.  However, the New Licensee Agreement grants the Company new licenses under the applicable patent rights and related technology of the Boyd Parties to manufacture and sell the Company’s existing chairside AMPSA Products (but not any such products other than the Company’s currently existing ones) and laboratory-manufactured semi-custom AMPSA Products.  


The New License Agreement essentially carries forward the Exclusive Agreements’ terms as to sales to the US market for the remainder of 2012, but under the New License Agreement the Company’s rights to sell AMPSA Products to the US market will expire at the end of 2012.  Specifically, for AMPSA Products sales to the US market, the New License Agreement grants the Company an exclusive license (but no license for the US dental-laboratory field), carrying a 30% royalty on net sales; but such license expires on December 31, 2012.  


For sales of the existing AMPSA Products to non-US markets, the New License Agreement grants the Company an exclusive license, which converts to a non-exclusive license on January 1, 2013.  Under the New License Agreement, the Company must pay a 30% royalty on 2012 net sales of the existing AMPSA Products to most non-US markets, but, under the New License Agreement, after 2012 the Company’s net sales to non-US markets will be royalty-free.  


The Company had been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.  


The 2011 Agreement required the Company to pay a deferred $3,000,000 license inception fee.  The New License Agreement eliminated this license inception fee.  


The Company expects that the Boyd Parties will manufacture and, beginning on January 1, 2013, sell to the US market the AMPSA Products which the Company had previously sold to the US market (and which, beginning on that date, the Company will no longer be allowed to sell to the US market) and new AMPSA Products as well. The Company also expects that the Boyd Parties may compete with the Company in the manufacture and sale to some or all non-US countries, from and after January 1, 2013, of the AMPSA Products which the Company had previously sold to the US and non-US markets, and the Boyd Parties could sell new AMPSA Products there as well.



F-6






Beginning January 1, 2014, the Company will no longer be able to use the in-licensed “NTI” trademark for its AMPSA Products.  


In the transition from the Exclusive Agreements to the New License Agreement, the Company is giving up its license rights to the “Total Splint System” intraoral devices (which the Company has not successfully commercialized) and to all potential chairside AMPSA Products which could have been commercialized using the Company’s Exclusive Agreements rights but which the Company is not currently selling.


Note 2 – Significant Accounting Policies


Estimates


The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.


Cash


For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of December 31, 2011 and 2012.  Other assets include restricted cash of $10,000 that is used to secure a company credit card.


Inventory


Inventory consists of finished goods, and is stated at the lower of cost or market. The Company records cost of sales using the moving average cost method. There was no excess or obsolete inventory reserve at December 31, 2011 and 2012.


Depreciation and Amortization


Depreciation is calculated using the straight line method over the estimated useful lives of the assets.  Amortization is computed using the straight line method over the term of the agreement.


Intangible Assets


Intangible assets consist primarily of intellectual properties such as regulatory product approvals and patents. The Company does not own any such intangible assets. However, the Company entered into the Exclusive Agreements on October 22, 2010 and April 1, 2011, which gave the Company respectively (i) the exclusive worldwide license to make and sell the “Total Splint System” and (ii) the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. The licensor under the Exclusive Agreements is Boyd Research, Inc., a related party to the Company. The 2011Agreement required a deferred $3,000,000 license inception fee, which the Company amortized over a ten year period using the straight line method of amortization.  On August 24, 2012, the Company entered into the New License Agreement, which terminated the Exclusive Agreements and continued, for the remainder of 2012, the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products.  The primary licensor under the New License Agreement is Boyd Research, Inc., a related party to the Company.  The New License Agreement eliminated the 2011 Agreement’s license inception fee.  Beginning on January 1, 2013, the New License Agreement grants the Company a royalty-free nonexclusive worldwide license to make and sell certain products under certain Boyd Parties patent rights and related technology (but excluding the United States market).   See Note 5 – License Agreements.


Income Taxes


The Company accounts for income taxes under ASC 740 "Income Taxes," which codified SFAS 109, "Accounting for Income Taxes" and FIN 48 “Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.



F-7






Going Concern


The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. Under the New License Agreement the Company’s rights to sell AMPSA Products to the US market (81% of total revenue) expire at the end of 2012.  The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.


Share Based Expenses


ASC 718 "Compensation - Stock Compensation," which codified SFAS 123, prescribes accounting and reporting standards for all stock-based payments awarded to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights.  Such payments may be classified as either equity or liabilities. The Company should determine if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a) the option to settle by issuing equity instruments lacks commercial substance or (b) the present obligation is implied because of an entity's past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity. See also Note 6 – Equity Transactions.


The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50 "Equity-Based Payments to Non-Employees," which codified SFAS 123, and the Emerging Issues Task Force consensus in Issue No. 96-18, "Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services". Measurement of share-based payment transactions with non-employees shall be based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction should be determined at the earlier of the performance commitment date or performance completion date.  See also Note 6 – Equity Transactions.


Recently Implemented Standards


Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.


Note 3 – Restricted Cash


Other non-current asset is a $10,000 certificate of deposit with an annual interest rate of 0.6%.  This certificate matures on June 17, 2013, and is used as collateral for a Company credit card, pursuant to a security agreement dated June 20, 2011.


Note 4 – Equipment


The cost and accumulated depreciation of fixed assets and equipment at December 31, 2012 and 2011 are summarized below:


 

 

December 31, 2012

 

December 31, 2011

Computer Hardware

$

10,747

$

4,612

Office Furniture and Equipment

 

3,639

 

3,639

Shipping and Other Equipment

 

1,575

 

1,575

Molding Equipment Interests

 

90,000

 

0

Total

 

105,961

 

9,826

Accumulated Depreciation

 

(13,508)

 

(2,187)

Property and Equipment, net

$

92,453

$

7,639


Depreciation is calculated using the straight line method over the estimated useful lives of the assets.




F-8






Note 5 – License Agreements


The Exclusive Agreements granted the Company an exclusive worldwide license to make and sell under certain Boyd Parties patent rights and related technology (but excluding the United States market as to the laboratory-products semi-custom field of use), with a 30% royalty on net sales (subject to reduction under certain conditions) and, for the 2011 Agreement, a deferred $3,000,000 license inception fee.  


The New License Agreement granted the Company, for the period from August 24, 2012 to December 31, 2012, an exclusive worldwide license to make and sell under certain Boyd Parties patent rights and related technology (but excluding the United States market as to the laboratory-products semi-custom field of use), with a 30% royalty on net sales (subject to reduction under certain conditions).  Also, the New License Agreement granted the Company, for the period from January 1, 2013 forward, a royalty-free nonexclusive worldwide license to make and sell certain products under certain Boyd Parties patent rights and related technology (but excluding the United States market).  The New License Agreement eliminated the 2011 Agreement’s license inception fee.


From April 1, 2011 through December 31, 2012, essentially the Company’s entire active business consisted of the manufacture and sale of AMPSA Products as authorized by the Exclusive Agreements and the New License Agreement.  The Exclusive Agreements licensor and the New License Agreement licensors are wholly owned by James P. Boyd, a related party of the Company.


Note 6 – Equity Transactions


Preferred Stock


The Company is authorized to issue 5,000,000 shares of $.001 par value preferred stock. The Company has not issued any preferred stock.


Common Stock


The Company is authorized to issue 699,999,999 shares of $.001 par value common stock.  All shares have equal voting rights, are non-assessable, and have one vote per share.  Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they choose to do so, elect all of the directors of the Company.  


In the first quarter of 2011 the Company issued 250,523,333 shares of common stock to James P. Boyd and Timothy G.  Dixon, the shareholders of Splint Decisions Inc., to acquire Splint Decisions Inc.  


On May 17, 2011 the Company issued 525,000 shares of common stock, to Gerry Berg and Timothy G. Dixon to replace shares which they had transferred to third parties at the request of James P. Boyd in the first quarter of 2011.  


On June 3, 2011 the Company issued 200,000 shares of common stock, valued at $0.06 per share, to a broker-dealer for consulting services.  


On June 17, 2011 the Company issued 10,000,000 shares of common stock, valued at $0.10 per share, to an equity markets consulting firm for consulting services.  


Warrants


On February 20, 2009, the Company granted certain compensatory warrants.  The fair value of each compensatory warrant granted is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following table. Expected volatilities are based on volatilities from the Company's traded common stock since February 20, 2009.  


The risk-free rate for the periods within the contractual life of the compensatory warrants is based on the U.S. Treasury bond rate in effect at the time of grant for bonds with maturity dates at the estimated term of the warrants.  




F-9






The following values were used to calculate the intrinsic values of the Company’s outstanding compensatory warrants as of their issuance dates:  


Expected volatility

136.53% - 217.26%

Expected dividends

0

Expected term (in years)

2 - 4

Risk-free rate

1.29% - 1.86%


A summary of these compensatory warrants outstanding at December 31, 2011 and 2012 and changes during the periods then ended is presented below:


Warrants

Shares

Weighted-

Average

Exercise

Price

Weighted-

Average

Remaining

Contractual

Term

Aggregate

Intrinsic

Value

Exercisable at December 31, 2010

450,000

$0.78

3.26

$34,653

Granted

0

 

 

 

Exercised

0

 

 

 

Canceled

0

 

 

 

 

 

 

 

 

Exercisable at

 

 

 

 

December 31, 2011

450,000

$0.78

2.26

$34,653

Granted

0

 

 

 

Exercised

0

 

 

 

Cancelled

200,000

 

 

 

 

 

 

 

 

Exercisable at

 

 

 

 

December 31, 2012

250,000

$1.00

1.25

$    -


Stock Based Compensation


On August 31, 2011, the Company issued options to purchase an aggregate of 7,950,000 shares of the Company’s common stock with an estimated fair value of $636,000 to its officers and employees.  The options have an exercise price of $0.08 per share.  As of December 31, 2011, 1,614,000 options had vested and no options were exercised.  Subject to continuation of service, the remaining option shares were to vest monthly over the next 32 months; and the options expire ten years from the date of grant unless earlier terminated.  Compensation cost, using the graded vesting attribute method in accordance with ASC 718, is recognized over the requisite service period during which each tranche of shares is earned (36 months). The value of each tranche is amortized on a sum of the years digits basis; $261,838 was expensed in the year ended December 31, 2011. 


The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with dividend yield of 0%; expected volatility of 191%; risk-free interest rate of 2.23%; contractual life of ten years; and an exercise price ($0.08) equal to 100% of the grant-date common stock fair market value.  Expected volatility is calculated based on the historic trade day stock market closing price of the preceding 406 trading days.


The expected term of options granted is estimated at half of the contractual term as noted in the individual option agreements and represents the period of time that options granted are expected to be outstanding.




F-10






The following table summarizes information regarding stock options outstanding as of December 31, 2011:


 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise prices

 

 

Number

Outstanding

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

Number

exercisable

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.08

 

 

 

7,950,000

 

 

 

9.67

 

 

$

0.08

 

 

 

1,614,000

 

 

 

9.67 

 

 

$

0.08

 


As of December 31, 2012 (due in part to a December 31, 2012 acceleration of the vesting of all remaining outstanding but unvested options), 6,900,000 options had vested and no options were exercised.  


The following table summarizes information regarding stock options outstanding as of December 31, 2012:


 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise prices

 

 

Number

Outstanding

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

Number

exercisable

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.08

 

 

 

6,900,000

 

 

 

8.67

 

 

$

0.08

 

 

 

6,900,000

 

 

 

8.67 

 

 

$

0.08

 


A summary of the stock options available under the 2009 Stock Incentive Plan and 2012 Stock Incentive Plan at December 31, 2011 and 2012 and changes during the periods then ended is presented below:


Available at December 31, 2010

 

6,000,000

Option shares granted

 

(7,950,000)

Amendment of 2009 Plan to increase the option shares pool

 

4,000,000

Exercised

 

-

Canceled

 

-

 

 

 

Available at December 31, 2011

 

2,050,000

Option shares granted

 

0

Adoption of 2012 Plan

 

12,000,000

Exercised

 

-

Canceled

 

1,050,000

 

 

 

Available at December 31, 2012

 

15,100,000


Note 7 – Related Party Transactions


At December 31, 2011, under the 2011 Agreement, the Company was obligated for a license inception fee to a related party in the amount of $3,000,000.  This license inception fee was amortized over a ten-year period using the straight line method of amortization.  The unamortized balance at December 31, 2011 was $2,775,000.  Amortization ceased as of August 24, 2012 as a result of the New License Agreement’s elimination of the license inception fee.


Under the 2011 Agreement and the New License Agreement, the Company incurred royalty expenses payable to a related party of $656,310 for 2012 and $496,037 for 2011. The royalty accrued but unpaid at December 31, 2012 and 2011 was $48,842 and $56,211, respectively.   Such accrued but unpaid amounts were paid in full in 2012 and 2013.




F-11






On August 24, 2012, the Company entered into the MDRA and the New License Agreement with various related parties.  During 2012, the Company made cash payments totaling $50,000 to James P. Boyd, a related party, as required by the MDRA. The Company also transferred $24,978 of inventory to Boyd Research, Inc., an affiliated person of James P. Boyd, a related party, under the MDRA.


In addition, the Company agreed under the MDRA to make deferred payments of $5,000 per month for 18 months (totaling $90,000; $30,000 is in short-term liabilities and $60,000 is in long-term liabilities) to an affiliated person of James P. Boyd, a related party, beginning July 1, 2013.  This obligation does not bear interest and is unsecured.  


Note 8 – Income Taxes


The Company has net operating losses carried forward of $636,349 (2011 – $640,051) available to offset taxable income in future years which expire beginning in fiscal 2031.


The Company is subject to United States federal and state income taxes at an approximate rate of 45%. The reconciliation of the provision for income taxes at the United States Federal statutory rate compared to the Company’s income tax expense as reported is as follows:


 

December 31, 2012

$

 

December 31, 2011

$

Net loss before income taxes per financial statements

(805,532)

 

(970,699)

Income tax rate

45%

 

45%

Income tax recovery

(362,489)

 

(436,815)

Permanent differences

151,782

 

148,792

Temporary differences

11,172

 

 

Change in valuation allowance

199,534

 

436,815

Provision for income taxes

 


The significant components of deferred income tax assets and liabilities at December 31, 2012 and 2011 are as follows:


 

December 31, 2012

$

 

December 31, 2011

$

Net operating loss carry-forward

636,349

 

436,815

Valuation allowance

(636,349)

 

(436,815)

Net deferred income tax asset

 


Note 9 – Geographic Information


The following table provides information related to our 2012 and 2011 revenues:


2012 :

 

 

 

 

 

Net domestic revenues

$

1,837,480

Net international revenues

 

354,926

Total

$

2,191,635

 

 

 

2011 :

 

 

 

 

 

Net domestic revenues

$

1,362,006

Net international revenues

 

325,926

Total

$

1,687,932


Note 10 – Subsequent Events  


Under the MDRA, which was entered into on August 24, 2012, James P. Boyd agreed to surrender 223,991,933 shares of Company common stock when certain conditions were met.  On January 17, 2013 all the conditions were met, and so the 223,991,933 shares were surrendered to the Company and on January 18, 2013 the Company cancelled such shares.


On November 5, 2012, the Company entered into an Investor Relations Consulting Agreement with Constellation Asset Advisors, Inc. (“CAA”) and issued a Warrant to CAA.  In 2013 the Company and CAA agreed to cancel the Investor Relations Consulting Agreement and the Warrant.  Such cancellation is treated as if it occurred on November 5, 2012.



F-12


EX-10.11 2 f10k123112_ex10z11.htm EXHIBIT 10.11 2012 STOCK INCENTIVE PLAN Exhibit 10.11 2012 Stock Incentive Plan

Exhibit 10.11


THERAPEUTIC SOULUTIONS INTERNATIONAL, INC.

2012 STOCK INCENTIVE PLAN



1. Purpose. The purpose of this 2012 Stock Incentive Plan (the “Plan”) is to enable Therapeutic Solutions International, Inc. (the “Company”) to attract and retain the services of (i) selected employees, officers and directors of the Company or any parent or subsidiary of the Company and (ii) selected nonemployee agents, consultants, advisors and independent contractors of the Company or any parent or subsidiary of the Company. For purposes of this Plan, a person is considered to be employed by or in the service of the Company if the person is employed by or (as a Consultant to or a director of) in the service of any entity (the “Employer”) that is either the Company or a parent or subsidiary of the Company.


2. Definitions. Wherever the following capitalized terms are used in the Plan, they shall have the meanings specified below:


“Affiliate” means (i) any person or entity that would be treated as an “affiliate” of the Company for purposes of Rule 12b-2 under the Exchange Act and (ii) any joint venture or other entity in which the Company has a direct or indirect beneficial ownership interest representing at least one-third (1/3) of the aggregate voting power of the equity interests of such entity or one-third (1/3) of the aggregate fair market value of the equity interests of such entity, as determined by the Committee.


“Award” means an award of a Stock Option, Stock Award, or Restricted Stock Award granted under the Plan.


“Award Agreement” means a written or electronic agreement entered into between the Company and a Participant setting forth the terms and conditions of an Award granted to a Participant.


“Board” means the Board of Directors of the Company.


“Code” means the Internal Revenue Code of 1986, as amended.


“Common Stock” means the Company’s common stock, $0.001par value per share.


“Committee” means the Compensation Committee of the Board, or such other committee of the Board appointed by the Board to administer the Plan, or if no such committee exists, the Board.


“Company” means Therapeutic Solutions International, Inc., a Nevada corporation.


 “Consultant” means any person who is a consultant or advisor to the Company and which is a natural person and who provides bona fide services to the Company which are not in connection with the offer or sale of securities in a capital-raising transaction for the Company, and do not directly or indirectly promote or maintain a market for the Company’s securities.


“Date of Grant” means the date on which the Committee makes an Award under the Plan, or such later date as the Committee may specify to be the effective date of an Award.


 “Eligible Person” means any person who is an employee of the Company, or any Affiliate, or any person to whom an offer of employment with the Company or any Affiliate is extended, as determined by the Committee, or any person who is a Non-Employee Director, or any person who is Consultant to the Company.


“Exchange Act” means the Securities Exchange Act of 1934, as amended.





“Fair Market Value” means the mean between the highest and lowest reported sales prices of the Common Stock on the New York Stock Exchange Composite Tape or, if not listed on such exchange, on any other national securities exchange on which the Company’s common stock is listed, or, if not so listed on any national securities exchange, then the average of the bid price of the Company’s common stock during the last five trading days on the over-the-counter market immediately preceding the last trading day before the date with respect to which the Fair Market Value is to be determined.


“Incentive Stock Option” means a Stock Option granted under Section 6 hereof that is intended to meet the requirements of Section 422 of the Code and the regulations thereunder.


“Non-Employee Director” means any member of the Board who is not an employee of the Company.


“Nonqualified Stock Option” means a Stock Option granted under Section 6 hereof that is not an Incentive Stock Option.


“Participant” means any Eligible Person who holds an outstanding Award under the Plan.


“Plan” means the 2012 Stock Incentive Plan of Therapeutic Solutions International, Inc. as set forth herein, as amended from time to time.


“Restricted Stock Award” means a grant of shares of Common Stock to an Eligible Person under Section 8 hereof that are issued subject to such vesting and transfer restrictions as the Committee shall determine and set forth in an Award Agreement.


“Service” means a Participant’s employment or Consultancy with the Employer or a Participant’s service as a Non-Employee Director with the Employer.


“Stock Award” means a grant of shares of Common Stock to an Eligible Person under Section 7 hereof that are issued free of transfer restrictions and forfeiture conditions.


“Stock Option” means a contractual right granted to an Eligible Person under Section 6 hereof to purchase shares of Common Stock at such time and price, and subject to such conditions, as are set forth in the Plan and the applicable Award Agreement.


3. Administration.


3.1 Committee Members. The Plan shall be administered by a Committee comprised of one or more members of the Board of Directors, or if no such committee exists, the Board of Directors.


3.2 Committee Authority. The Committee shall have such powers and authority as may be necessary or appropriate for the Committee to carry out its functions as described in the Plan.






Subject to the express limitations of the Plan, the Committee shall have authority in its discretion to determine the Eligible Persons to whom, and the time or times at which, Awards may be granted, the number of shares, units or other rights subject to each Award, the exercise, base or purchase price of an Award (if any), the time or times at which an Award will become vested, exercisable or payable, the performance goals and other conditions of an Award, the duration of the Award, and all other terms of the Award. Subject to the terms of the Plan, the Committee shall have the authority to amend the terms of an Award in any manner that is not inconsistent with the Plan, provided that no such action shall adversely affect the rights of a Participant with respect to an outstanding Award without the Participant’s consent. The Committee shall also have discretionary authority to interpret the Plan, to make factual determinations under the Plan, and to make all other determinations necessary or advisable for Plan administration, including, without limitation, to (i) correct any defect, to (ii) supply any omission or to (iii) reconcile any inconsistency in the Plan or any Award Agreement hereunder. The Committee may prescribe, amend, and rescind rules and regulations relating to the Plan. The Committee’s determinations under the Plan need not be uniform and may be made by the Committee selectively among Participants and Eligible Persons, whether or not such persons are similarly situated. The Committee shall, in its discretion, consider such factors as it deems relevant in making its interpretations, determinations and actions under the Plan including, without limitation, the recommendations or advice of any officer or employee of the Company or such attorneys, consultants, accountants or other advisors as it may select. All interpretations, determinations and actions by the Committee shall be final, conclusive, and binding upon all parties.


3.3 Delegation of Authority. The Committee shall have the right, from time to time, to delegate to one or more officers of the Company the authority of the Committee to grant and determine the terms and conditions of Awards granted under the Plan, subject to the requirements of state law and such other limitations as the Committee shall determine. In no event shall any such delegation of authority be permitted with respect to Awards to any members of the Board or to any Eligible Person who is subject to Rule 16b-3 under the Exchange Act or Section 162(m) of the Code. The Committee shall also be permitted to delegate, to any appropriate officer or employee of the Company, responsibility for performing certain ministerial functions under the Plan.


In the event that the Committee’s authority is delegated to officers or employees in accordance with the foregoing, all provisions of the Plan relating to the Committee shall be interpreted in a manner consistent with the foregoing by treating any such reference as a reference to such officer or employee for such purpose. Any action undertaken in accordance with the Committee’s delegation of authority hereunder shall have the same force and effect as if such action was undertaken directly by the Committee and shall be deemed for all purposes of the Plan to have been taken by the Committee.


4. Shares Subject to the Plan.


4.1 Maximum Share Limitations. Subject to appropriate adjustments for stock splits or reverse stock splits, the maximum aggregate number of shares of Common Stock that may be issued and sold under all Awards granted under the Plan shall be 12,000,000; and the maximum number of shares of Common Stock with respect to which Awards may be granted under the Plan to any one Participant shall be 4,000,000 in any one calendar year and 6,000,000 overall. Shares of Common Stock issued and sold under the Plan may be either authorized but unissued shares or shares held in the Company’s treasury. To the extent that any Award involving the issuance of shares of Common Stock is forfeited, cancelled, returned to the Company for failure to satisfy vesting requirements or other conditions of the Award, or otherwise terminates without an issuance of shares of Common Stock being made thereunder, the shares of Common Stock covered thereby will no longer be counted against the foregoing maximum share limitations and may again be made subject to Awards under the Plan pursuant to such limitations.






4.2 Adjustments. If there shall occur any change with respect to the outstanding shares of Common Stock by reason of any recapitalization, reclassification, stock dividend, extraordinary dividend, stock split, reverse stock split or other distribution with respect to the shares of Common Stock, or any merger, reorganization, consolidation, combination, spin-off or other similar corporate change, or any other change affecting the Common Stock, the Committee may, in the manner and to the extent that it deems appropriate and equitable to the Participants and consistent with the terms of the Plan, cause an adjustment to be made in (i) the maximum number and kind of shares provided in Section 4.1 hereof, (ii) the number and kind of shares of Common Stock, or other rights subject to then outstanding Awards, (iii) the exercise or base price for each share or other right subject to then outstanding Awards, and (iv) any other terms of an Award that are affected by the event. Notwithstanding the foregoing, in the case of Incentive Stock Options, any such adjustments shall, to the extent practicable, be made in a manner consistent with the requirements of Section 424(a) of the Code.


5. Participation and Awards.


5.1 Designations of Participants. All Eligible Persons are eligible to be designated by the Committee to receive Awards and become Participants under the Plan. The Committee has the authority, in its discretion, to determine and designate from time to time those Eligible Persons who are to be granted Awards, the types of Awards to be granted and the number of shares of Common Stock or units subject to Awards granted under the Plan. In selecting Eligible Persons to be Participants and in determining the type and amount of Awards to be granted under the Plan, the Committee shall consider any and all factors that it deems relevant or appropriate.


5.2 Determination of Awards. The Committee shall determine the terms and conditions of all Awards granted to Participants in accordance with its authority under Section 3.2 hereof. An Award may consist of one type of right or benefit hereunder, or of two or more such rights or benefits granted in tandem or in the alternative. In the case of any fractional share or unit resulting from the grant, vesting, payment or crediting of dividends or dividend equivalents under an Award, the Committee shall have the discretionary authority to (i) disregard such fractional share or unit, (ii) round such fractional share or unit to the nearest lower or higher whole share or unit, or (iii) convert such fractional share or unit into a right to receive a cash payment. To the extent deemed necessary by the Committee, an Award Agreement as described in Section 10.1 shall evidence an Award hereunder.


6. Stock Options.


6.1 Grant of Stock Options. A Stock Option may be granted to any Eligible Person selected by the Committee. Subject to the provisions of Section 6.8 hereof and Section 422 of the Code, each Stock Option shall be designated, in the discretion of the Committee, as an Incentive Stock Option or as a Nonqualified Stock Option.


6.2 Exercise Price. The exercise price per share of a Stock Option shall not be less than 100% of the Fair Market Value of the shares of Common Stock on the Date of Grant, provided that the Committee may in its discretion specify for any Stock Option an exercise price per share that is higher than the Fair Market Value on the Date of Grant.


6.3 Vesting of Stock Options. The Committee shall in its discretion prescribe the time or times at which, or the conditions upon which, a Stock Option or portion thereof shall become vested and/or exercisable, and may accelerate the vesting or exercisability of any Stock Option at any time. The requirements for vesting and exercisability of a Stock Option may be based on the continued Service of the Participant with the Company or its Affiliates for a specified time period (or periods) or on the attainment of specified performance goals established by the Committee in its discretion.


6.4 Term of Stock Options. The Committee shall in its discretion prescribe in an Award Agreement the period during which a vested Stock Option may be exercised, provided that the maximum term of a Stock Option shall be ten years from the Date of Grant.





6.5 Termination of Service. Subject to Section 6.8 hereof with respect to Incentive Stock Options, the Stock Option of any Participant whose Service with the Company or one of its Affiliates terminates for any reason shall terminate on the earlier of (A) the date that the Stock Option expires in accordance with its terms or (B) as otherwise provided in an Award Agreement. Unless otherwise provided by the Committee, if an entity ceases to be an Affiliate of the Company or otherwise ceases to be qualified under the Plan or if all or substantially all of the assets of an Affiliate of the Company are conveyed (other than by encumbrance), such cessation or action, as the case may be, shall be deemed for purposes hereof to be a termination of the Service.


6.6 Stock Option Exercise; Tax Withholding. Subject to such terms and conditions as shall be specified in an Award Agreement, a Stock Option may be exercised in whole or in part at any time during the term thereof by notice in the form required by the Company, together with payment of the aggregate exercise price therefor and applicable withholding tax. Payment of the exercise price shall be made in the manner set forth in the Award Agreement, unless otherwise provided by the Committee: (i) in cash or by cash equivalent acceptable to the Committee, (ii) by payment in shares of Common Stock that have been held by the Participant for at least six months (or such period as the Committee may deem appropriate, for accounting purposes or otherwise) valued at the Fair Market Value of such shares on the date of exercise, (iii) through an open-market, broker-assisted sales transaction pursuant to which the Company is promptly delivered the amount of proceeds necessary to satisfy the exercise price, (iv) by a combination of the methods described above or (v) by such other method as may be approved by the Committee and set forth in the Award Agreement. In addition to and at the time of payment of the exercise price, the Participant shall as a condition of exercise pay to the Company the full amount of any and all applicable income tax, employment tax and other amounts required to be withheld in connection with such exercise, payable in cash or in any other manner as may be expressly approved therefor by the Committee and set forth in the Award Agreement.


6.7 Limited Transferability of Nonqualified Stock Options. All Stock Options shall be nontransferable except (i) upon the Participant’s death, in accordance with Section 10.2 hereof or (ii) in the case of Nonqualified Stock Options only, for the transfer of all or part of the Stock Option to a Participant’s “family member” (as defined for purposes of the Form S-8 registration statement under the Securities Act of 1933), as may be approved by the Committee in its discretion at the time of proposed transfer. The transfer of a Nonqualified Stock Option may be subject to such terms and conditions as the Committee may in its discretion impose from time to time. Subsequent transfers of a Nonqualified Stock Option shall be prohibited other than in accordance with Section 10.2 hereof.


6.8 Additional Rules for Incentive Stock Options.


(a)

Eligibility. An Incentive Stock Option may only be granted to an Eligible Person who is considered an employee for purposes of Treasury Regulation Sec.1.421-7(h) with respect to the Company or any Affiliate that qualifies as a “subsidiary corporation” with respect to the Company for purposes of Section 424(f) of the Code.


(b)

Termination of Employment. An Award of an Incentive Stock Option may provide that such Stock Option may be exercised not later than 3 months following termination of employment of the Participant with the Company and all Subsidiaries, or not later than one year following a permanent and total disability within the meaning of Section 22(e)(3) of the Code, as and to the extent determined by the Committee to comply with the requirements of Section 422 of the Code.


(c)

Other Terms and Conditions; Nontransferability. Any Incentive Stock Option granted hereunder shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as are deemed necessary or desirable by the Committee, which terms, together with the terms of the Plan, shall be intended and interpreted to cause such Incentive Stock Option to qualify as an “incentive stock option” under Section 422 of the Code. An Award Agreement for an Incentive Stock Option may provide that such Stock Option shall be treated as a Nonqualified Stock Option to the extent that certain requirements applicable to “incentive stock options” under the Code shall not be satisfied. An Incentive Stock Option shall by its terms be nontransferable other than by will or by the laws of descent and distribution, and shall be exercisable during the lifetime of a Participant only by such Participant.





(d)

Disqualifying Dispositions. If shares of Common Stock acquired by exercise of an Incentive Stock Option are disposed of within two years following the Date of Grant or one year following the transfer of such shares to the Participant upon exercise, the Participant shall, promptly following such disposition, notify the Company in writing of the date and terms of such disposition and provide such other information regarding the disposition as the Company may reasonably require.


7. Stock Awards.


7.1 Grant of Stock Awards. A Stock Award may be granted to any Eligible Person selected by the Committee. A Stock Award may be granted for past services, in lieu of bonus or other cash compensation, as directors’ compensation or for any other valid purpose as determined by the Committee. A Stock Award granted to an Eligible Person represents shares of Common Stock that are issued without restrictions on transfer and other incidents of ownership and free of forfeiture conditions, except as otherwise provided in the Plan and the Award Agreement. The deemed issuance price of shares of Common Stock subject to each Stock Award shall not be less than 100% of the Fair Market Value of the Common Stock on the Date of Grant. The Committee may, in connection with any Stock Award, require the payment of a specified purchase price.


7.2 Rights as Stockholder. Subject to the foregoing provisions of this Section 7 and the applicable Award Agreement, upon the issuance of the Common Stock under a Stock Award the Participant shall have all rights of a stockholder with respect to the shares of Common Stock, including the right to vote the shares and receive all dividends and other distributions paid or made with respect thereto.


8. Restricted Stock Awards.


8.1 Grant of Restricted Stock Awards. A Restricted Stock Award may be granted to any Eligible Person selected by the Committee. The deemed issuance price of shares of Common Stock subject to each Restricted Stock Award shall not be less than 100% of the Fair Market Value of the Common Stock on the Date of Grant. The Committee may require the payment by the Participant of a specified purchase price in connection with any Restricted Stock Award.


8.2 Vesting Requirements. The restrictions imposed on shares granted under a Restricted Stock Award shall lapse in accordance with the vesting requirements specified by the Committee in the Award Agreement, provided that the Committee may accelerate the vesting of a Restricted Stock Award at any time. Such vesting requirements may be based on the continued Service of the Participant with the Company or its Affiliates for a specified time period (or periods) or on the attainment of specified performance goals established by the Committee in its discretion. If the vesting requirements of a Restricted Stock Award shall not be satisfied, the Award shall be forfeited and the shares of Common Stock subject to the Award shall be returned to the Company.


8.3 Restrictions. Shares granted under any Restricted Stock Award may not be transferred, assigned or subject to any encumbrance, pledge, or charge until all applicable restrictions are removed or have expired, unless otherwise allowed by the Committee. Failure to satisfy any applicable restrictions shall result in the subject shares of the Restricted Stock Award being forfeited and returned to the Company. The Committee may require in an Award Agreement that certificates representing the shares granted under a Restricted Stock Award bear a legend making appropriate reference to the restrictions imposed, and that certificates representing the shares granted or sold under a Restricted Stock Award will remain in the physical custody of an escrow holder until all restrictions are removed or have expired.


8.4 Rights as Stockholder. Subject to the foregoing provisions of this Section 8 and the applicable Award Agreement, the Participant shall have all rights of a stockholder with respect to the shares granted to the Participant under a Restricted Stock Award, including the right to vote the shares and receive all dividends and other distributions paid or made with respect thereto.


The Committee may provide in an Award Agreement for the payment of dividends and distributions to the Participant at such times as paid to stockholders generally or at the times of vesting or other payment of the Restricted Stock Award.





8.5 Section 83(b) Election. If a Participant makes an election pursuant to Section 83(b) of the Code with respect to a Restricted Stock Award, the Participant shall file, within 30 days following the Date of Grant, a copy of such election with the Company and with the Internal Revenue Service, in accordance with the regulations under Section 83 of the Code. The Committee may provide in an Award Agreement that the Restricted Stock Award is conditioned upon the Participant’s making or refraining from making an election with respect to the Award under Section 83(b) of the Code.


9. Forfeiture Events.


9.1 General. The Committee may specify in an Award Agreement at the time of the Award that the Participant’s rights, payments and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events shall include, but shall not be limited to, termination of Service for cause, violation of material Company policies, breach of noncompetition, confidentiality or other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is detrimental to the business or reputation of the Company.


9.2 Termination for Cause. Unless otherwise provided by the Committee and set forth in an Award Agreement, if a Participant’s employment with the Company or any Affiliate shall be terminated for cause, the Company may, in its sole discretion, immediately terminate such Participant’s right to any further payments, vesting or exercisability with respect to any Award in its entirety. In the event a Participant is party to an employment (or similar) agreement with the Company or any Affiliate that defines the term “cause,” such definition shall apply for purposes of the Plan. The Company shall have the power to determine whether the Participant has been terminated for cause and the date upon which such termination for cause occurs.


Any such determination shall be final, conclusive and binding upon the Participant. In addition, if the Company shall reasonably determine that a Participant has committed or may have committed any act which could constitute the basis for a termination of such Participant’s employment for cause, the Company may suspend the Participant’s rights to exercise any option, receive any payment or vest in any right with respect to any Award pending a determination by the Company of whether an act has been committed which could constitute the basis for a termination for “cause” as provided in this Section 9.2.


10. General Provisions.


10.1 Award Agreement. To the extent deemed necessary by the Committee, an Award under the Plan shall be evidenced by an Award Agreement in a written or electronic form approved by the Committee setting forth the number of shares of Common Stock or units subject to the Award, the exercise price, base price, or purchase price of the Award, the time or times at which an Award will become vested, exercisable or payable and the term of the Award. The Award Agreement may also set forth the effect on an Award of termination of Service under certain circumstances. The Award Agreement shall be subject to and incorporate, by reference or otherwise, all of the applicable terms and conditions of the Plan, and may also set forth other terms and conditions applicable to the Award as determined by the Committee consistent with the limitations of the Plan. Award Agreements evidencing Incentive Stock Options shall contain such terms and conditions as may be necessary to meet the applicable provisions of Section 422 of the Code. The grant of an Award under the Plan shall not confer any rights upon the Participant holding such Award other than such terms, and subject to such conditions, as are specified in the Plan as being applicable to such type of Award (or to all Awards) or as are expressly set forth in the Award Agreement. The Committee need not require the execution of an Award Agreement by a Participant, in which case, acceptance of the Award by the Participant shall constitute agreement by the Participant to the terms, conditions, restrictions and limitations set forth in the Plan and the Award Agreement as well as the administrative guidelines of the Company in effect from time to time.





10.2 No Assignment or Transfer; Beneficiaries. Except as provided in Section 6.7 hereof, Awards under the Plan shall not be assignable or transferable by the Participant, except by will or by the laws of descent and distribution, and shall not be subject in any manner to assignment, alienation, pledge, encumbrance or charge. Notwithstanding the foregoing, the Committee may provide in the terms of an Award Agreement that the Participant shall have the right to designate a beneficiary or beneficiaries who shall be entitled to any rights, payments or other benefits specified under an Award following the Participant’s death.


During the lifetime of a Participant, an Award shall be exercised only by such Participant or such Participant’s guardian or legal representative. In the event of a Participant’s death, an Award may to the extent permitted by the Award Agreement be exercised by the Participant’s beneficiary as designated by the Participant in the manner prescribed by the Committee or, in the absence of an authorized beneficiary designation, by the legatee of such Award under the Participant’s will or by the Participant’s estate in accordance with the Participant’s will or the laws of descent and distribution, in each case in the same manner and to the same extent that such Award was exercisable by the Participant on the date of the Participant’s death.


10.3 Deferrals of Payment. The Committee may in its discretion permit a Participant to defer the receipt of payment of cash or delivery of shares of Common Stock that would otherwise be due to the Participant by virtue of the exercise of a right or the satisfaction of vesting or other conditions with respect to an Award. If any such deferral is to be permitted by the Committee, the Committee shall establish rules and procedures relating to such deferral in a manner intended to comply with the requirements of Section 409A of the Code, including, without limitation, the time when an election to defer may be made, the time period of the deferral and the events that would result in payment of the deferred amount, the interest or other earnings attributable to the deferral and the method of funding, if any, attributable to the deferred amount.


10.4 Rights as Stockholder. A Participant shall have no rights as a holder of shares of Common Stock with respect to any unissued securities covered by an Award until the date the Participant becomes the holder of record of such securities. Except as provided in Section 4.2 hereof, no adjustment or other provision shall be made for dividends or other stockholder rights, except to the extent that the Award Agreement provides for dividend payments or dividend equivalent rights.


10.5 Employment or Service. Nothing in the Plan, in the grant of any Award or in any Award Agreement shall confer upon any Eligible Person any right to continue in the Service of the Company or any of its Affiliates, or interfere in any way with the right of the Company or any of its Affiliates to terminate the Participant’s employment or other service relationship for any reason at any time.


10.6 Securities Laws. No shares of Common Stock will be issued or transferred pursuant to an Award unless and until all then applicable requirements imposed by Federal and state securities and other laws, rules and regulations and by any regulatory agencies having jurisdiction, and by any exchanges upon which the shares of Common Stock may be listed, have been fully met.


As a condition precedent to the issuance of shares pursuant to the grant or exercise of an Award, the Company may require the Participant to take any reasonable action to meet such requirements. The Committee may impose such conditions on any shares of Common Stock issuable under the Plan as it may deem advisable, including, without limitation, restrictions under the Securities Act of 1933, as amended, under the requirements of any exchange upon which such shares of the same class are then listed, and under any blue sky or other securities laws applicable to such shares. The Committee may also require the Participant to represent and warrant at the time of issuance or transfer that the shares of Common Stock are being acquired only for investment purposes and without any current intention to sell or distribute such shares.


10.7 Tax Withholding. The Participant shall be responsible for payment of any taxes or similar charges required by law to be withheld from an Award or an amount paid in satisfaction of an Award, which shall be paid by the Participant on or before the payment or other event that results in taxable income in respect of an Award. The Award Agreement may specify the manner in which the withholding obligation shall be satisfied with respect to the particular type of Award.





10.8 Unfunded Plan. The adoption of the Plan and any reservation of shares of Common Stock or cash amounts by the Company to discharge its obligations hereunder shall not be deemed to create a trust or other funded arrangement. Except upon the issuance of Common Stock pursuant to an Award, any rights of a Participant under the Plan shall be those of a general unsecured creditor of the Company, and neither a Participant nor the Participant’s permitted transferees or estate shall have any other interest in any assets of the Company by virtue of the Plan. Notwithstanding the foregoing, the Company shall have the right to implement or set aside funds in a grantor trust, subject to the claims of the Company’s creditors or otherwise, to discharge its obligations under the Plan.


10.9 Other Compensation and Benefit Plans. The adoption of the Plan shall not affect any other share incentive or other compensation plans in effect for the Company or any Affiliate, nor shall the Plan preclude the Company from establishing any other forms of share incentive or other compensation or benefit program for employees of the Company or any Affiliate. The amount of any compensation deemed to be received by a Participant pursuant to an Award shall not constitute includable compensation for purposes of determining the amount of benefits to which a Participant is entitled under any other compensation or benefit plan or program of the Company or an Affiliate, including, without limitation, under any pension or severance benefits plan, except to the extent specifically provided by the terms of any such plan.


10.10 Plan Binding on Transferees. The Plan shall be binding upon the Company, its transferees and assigns, and the Participant, the Participant’s executor, administrator and permitted transferees and beneficiaries.


10.11 Severability. If any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction.


10.12 Foreign Jurisdictions. The Committee may adopt, amend and terminate such arrangements and grant such Awards, not inconsistent with the intent of the Plan, as it may deem necessary or desirable to comply with any tax, securities, regulatory or other laws of other jurisdictions with respect to Awards that may be subject to such laws. The terms and conditions of such Awards may vary from the terms and conditions that would otherwise be required by the Plan solely to the extent the Committee deems necessary for such purpose. Moreover, the Board may approve such supplements to or amendments, restatements or alternative versions of the Plan, not inconsistent with the intent of the Plan, as it may consider necessary or appropriate for such purposes, without thereby affecting the terms of the Plan as in effect for any other purpose.


10.13 Substitute Awards in Corporate Transactions. Nothing contained in the Plan shall be construed to limit the right of the Committee to grant Awards under the Plan in connection with the acquisition, whether by purchase, merger, consolidation or other corporate transaction, of the business or assets of any corporation or other entity. Without limiting the foregoing, the Committee may grant Awards under the Plan to an employee or director of another corporation who becomes an Eligible Person by reason of any such corporate transaction in substitution for awards previously granted by such corporation or entity to such person. The terms and conditions of the substitute Awards may vary from the terms and conditions that would otherwise be required by the Plan solely to the extent the Committee deems necessary for such purpose.


10.14 Governing Law. The Plan and all rights hereunder shall be subject to and interpreted in accordance with the laws of the State of Nevada, without reference to the principles of conflicts of laws, and to applicable Federal securities laws.


10.15 Financial Statements. All Participants shall be entitled to receive the financial statements of the Company at least annually.


10.16 Performance Based Awards. For purposes of Stock Awards and Restricted Stock Awards granted under the Plan that are intended to qualify as “performance-based” compensation under Section 162(m) of the Code, such Awards shall be granted to the extent necessary in such manner as to satisfy the requirements of Section 162(m) of the Code.





10.17 Stockholder Approval. The Plan must be approved by the stockholders by a majority of all shares entitled to vote within 12 months after the date the Plan was adopted by the Board. Any Incentive Stock Options granted before stockholder approval is obtained shall be converted into Nonqualified Stock Options if stockholder approval is not obtained within 12 months before or after the Plan was adopted.


11. Effective Date; Amendment and Termination.


11.1 Effective Date. The Plan shall become effective on December 18, 2012, the date of its adoption by the Board.


11.2 Amendment. The Board may at any time and from time to time and in any respect, amend, modify or terminate the Plan. The Board may seek the approval of any amendment or modification by the Company’s stockholders to the extent it deems necessary or advisable in its discretion for purposes of compliance with Section 162(m) or Section 422 of the Code, or exchange or securities market requirements or for any other purpose. No amendment or modification of the Plan shall adversely affect any Award theretofore granted without the consent of the Participant or the permitted transferee of the Award.


11.3 Termination. The Plan shall terminate on December 18, 2022, the tenth anniversary of the date of its adoption by the Board. The Board may, in its discretion and at any earlier date, terminate the Plan. Notwithstanding the foregoing, no termination of the Plan shall adversely affect any Award theretofore granted without the consent of the Participant or the permitted transferee of the Award.




EX-23.1 3 f10k123112_ex23z1.htm EXHIBIT 23.1 LETTER OF CONSENT Exhibit 23.1 Letter of Consent

Exhibit 23.1



[f10k123112_ex23z1001.jpg]




March 29, 2013






To Whom It May Concern:



We consent to the incorporation by reference in the registration statements on Form S-8 (File Nos. 333-157968 and 333-185712)  of Therapeutic Solutions International, Inc. (formerly Splint Decisions Inc.) of our report dated on March 29, 2013, with respect to the audited consolidated financial statements of Therapeutic Solutions International, Inc. (formerly Splint Decisions Inc.), for the years ended December 31, 2012 and 2011, included in the Annual Report on Form 10-K for the year ended December 31, 2012.



Very truly yours,




/s/ PLS CPA          

PLS CPA, A Professional Corp.





Registered with the Public Company Accounting Oversight Board


EX-31.1 4 f10k123112_ex31z1.htm EXHIBIT 31.1 SECTION 302 CERTIFICATION Exhibit 31.1 Section 302 Certification

Exhibit 31.1


Section 302 Certification of Principal Executive Officer

  

I, Timothy G. Dixon, certify that:

 

1. I have reviewed this annual report on Form 10-K of Therapeutic Solutions International, Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

  

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:


(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.  The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

  

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Dated:  March 29, 2013

 

/s/ Timothy G. Dixon

Timothy G. Dixon

President and

Chief Executive Officer

(Principal Executive Officer)



EX-31.2 5 f10k123112_ex31z2.htm EXHIBIT 31.2 SECTION 302 CERTIFICATION Exhibit 31.2 Section 302 Certification

Exhibit 31.2


Section 302 Certification of Principal Financial Officer

  

I, Gerry Berg, certify that:

 

1. I have reviewed this annual report on Form 10-K of Therapeutic Solutions International, Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

  

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.  The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:


(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.  The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

  

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal financial reporting.

 

 

Dated:  March 29, 2013

 

/s/ Gerry Berg

Gerry Berg

Chief Financial Officer

(Principal Financial Officer)



EX-32.1 6 f10k123112_ex32z1.htm EXHIBIT 32.1 SECTION 906 CERTIFICATION Exhibit 32.1 Section 906 Certification

Exhibit 32.1


SARBANES-OXLEY SECTION 906 CERTIFICATION


In connection with the Annual Report on Form 10-K of Therapeutic Solutions International, Inc. (the "Company") for the year ending December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Timothy G. Dixon, Chief Executive Officer and President of the Company,  and I, Gerry Berg, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:


(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: March 29, 2013


By: /s/ Timothy G. Dixon

Timothy G. Dixon

Chief Executive Officer

and President

(Principal Executive Officer)



By: /s/ Gerry Berg

Gerry Berg

Chief Financial Officer

(Principal Financial Officer)



EX-101.INS 7 tsoi-20121231.xml XBRL INSTANCE DOCUMENT 10-K 2012-12-31 false THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. 0001419051 --12-31 83466400 2019250 Smaller Reporting Company Yes No No 2012 FY 35011 87976 16358 37416 30790 48198 14535 490037 96694 663627 12410 12350 92453 7639 0 2775000 201557 3458616 230786 56777 24814 39155 30013 3004090 48842 56211 334454 3156233 60000 0 60000 0 0 0 305458 305458 1285533 975281 -1783888 -978356 -192897 302383 201557 3458616 0.001 0.001 5000000 5000000 0.001 0.001 699999999 700000000 305458333 305458333 305458333 305458333 1837480 1362006 354155 325926 2191635 1687932 80129 59949 2111506 1627984 106527 145573 138490 104292 1188531 934590 656310 496037 186320 227187 478068 563489 583023 198558 3337270 2669727 -1225763 -1041743 -400000 0 20268 71404 -36 -360 420232 71045 -805532 -970699 0.0009 -0.0139 81466400 69771159 400000 0 -805532 -970699 175000 225000 11320 2187 0 42000 0 1012000 310252 261838 17408 -48198 21058 -37416 475502 -490037 -60 -12350 174010 56777 -14341 39155 -11447 19998 -46830 100255 -6135 -9826 0 -3000000 -6135 -3009826 0 3000000 0 -4819 0 2995181 -52965 85611 2366 3000000 0 90000 0 0 35101 0 3000000 36 311 800 0 28710000 28710 -28708 -7657 -7655 15500000 15500 1224500 0 1240000 250523333 250523 -1525624 0 -1275101 525000 525 41475 0 42000 200000 200 11800 0 12000 10000000 10000 990000 0 1000000 0 261838 0 261838 0 0 -970699 -970699 305458333 305458 975281 -978356 302383 0 310252 0 310252 0 0 -805532 -805532 305458333 305458 1285533 -1783888 -192897 <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note&nbsp;1 &#150; Nature of Business</b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Therapeutic Solutions International, Inc. (the &#147;Company&#148;) was organized August&nbsp;6, 2007 under the name Friendly Auto Dealers, Inc. under the laws of the State of Nevada. In the first quarter of 2011 the Company changed its name from Friendly Auto Dealers, Inc. to Therapeutic Solutions International, Inc., and acquired Splint Decisions Inc., a California corporation organized September&nbsp;21, 2010 (&#147;Splint&#148;). &nbsp;Splint is treated as the &#147;accounting acquirer&#148; in the accompanying financial statements. &nbsp;In the transaction, the Company issued 250,523,333 common shares to the shareholders of Splint; such shares represented, immediately following the transaction, 85% of the outstanding shares of the Company. &nbsp;The transaction was accounted for as a &#147;reverse merger&#148; and a reverse recapitalization and the issuances of common stock were recorded as a reclassification between paid-in-capital and par value of Common Stock. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">On August&nbsp;24, 2012, the Company entered into a Master Dispute Resolution Agreement (the &#147;MDRA&#148;) with James P. Boyd (&#147;Boyd&#148;), Boyd Research, Inc. and TMD Courses, Inc. (together with Boyd, the &#147;Boyd Parties&#148;) and Timothy G. Dixon (&#147;Dixon&#148;) and Gerry B. Berg, and on August&nbsp;24, 2012, the Company also entered into a License Agreement with Boyd Research, Inc. and TMD Courses, Inc. (the &#147;New License Agreement&#148;), an Escrow Agreement with Boyd and with Chicago Title Company as escrow agent, and a Voting Agreement with Boyd. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Before the New License Agreement, the Company and certain Boyd Parties were party to an Exclusive License Agreement dated April&nbsp;1, 2011, as amended on November&nbsp;1, 2011 (the &#147;2011 Agreement&#148;). &nbsp;Also, the Company&#146;s predecessor Splint Decisions Inc. and certain Boyd Parties were party to an Exclusive License Agreement dated October&nbsp;22, 2010, as amended on July&nbsp;8, 2011 (together with the 2011 Agreement, the &#147;Exclusive Agreements&#148;). &nbsp;The Exclusive Agreements granted the Company an exclusive worldwide license to certain Boyd Parties patent rights and related technology. &nbsp;Since April&nbsp;1, 2011, essentially the Company&#146;s entire active business has consisted of the manufacture and sale of Anterior Midpoint Stop Appliance intraoral devices (&#147;AMPSA Products&#148;) as authorized by the Exclusive Agreements and the New License Agreement. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The New License Agreement terminated the Exclusive Agreements. &nbsp;However, the New Licensee Agreement grants the Company new licenses under the applicable patent rights and related technology of the Boyd Parties to manufacture and sell the Company&#146;s existing chairside AMPSA Products (but not any such products other than the Company&#146;s currently existing ones) and laboratory-manufactured semi-custom AMPSA Products. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The New License Agreement essentially carries forward the Exclusive Agreements&#146; terms as to sales to the US market for the remainder of 2012, but under the New License Agreement the Company&#146;s rights to sell AMPSA Products to the US market will expire at the end of 2012. &nbsp;Specifically, for AMPSA Products sales to the US market, the New License Agreement grants the Company an exclusive license (but no license for the US dental-laboratory field), carrying a 30% royalty on net sales; but such license expires on December&nbsp;31, 2012. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">For sales of the existing AMPSA Products to non-US markets, the New License Agreement grants the Company an exclusive license, which converts to a non-exclusive license on January&nbsp;1, 2013. &nbsp;Under the New License Agreement, the Company must pay a 30% royalty on 2012 net sales of the existing AMPSA Products to most non-US markets, but, under the New License Agreement, after 2012 the Company&#146;s net sales to non-US markets will be royalty-free. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company had been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The 2011 Agreement required the Company to pay a deferred $3,000,000 license inception fee. &nbsp;The New License Agreement eliminated this license inception fee. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company expects that the Boyd Parties will manufacture and, beginning on January&nbsp;1, 2013, sell to the US market the AMPSA Products which the Company had previously sold to the US market (and which, beginning on that date, the Company will no longer be allowed to sell to the US market) and new AMPSA Products as well. The Company also expects that the Boyd Parties may compete with the Company in the manufacture and sale to some or all non-US countries, from and after January&nbsp;1, 2013, of the AMPSA Products which the Company had previously sold to the US and non-US markets, and the Boyd Parties could sell new AMPSA Products there as well.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Beginning January&nbsp;1, 2014, the Company will no longer be able to use the in-licensed &#147;NTI&#148; trademark for its AMPSA Products. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">In the transition from the Exclusive Agreements to the New License Agreement, the Company is giving up its license rights to the &#147;Total Splint System&#148; intraoral devices (which the Company has not successfully commercialized) and to all potential chairside AMPSA Products which could have been commercialized using the Company&#146;s Exclusive Agreements rights but which the Company is not currently selling.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note&nbsp;2 &#150; Significant Accounting Policies </b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Estimates</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Cash</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of December&nbsp;31, 2011 and 2012. &nbsp;Other assets include restricted cash of $10,000 that is used to secure a company credit card.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Inventory</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Inventory consists of finished goods, and is stated at the lower of cost or market. The Company records cost of sales using the moving average cost method. There was no excess or obsolete inventory reserve at December&nbsp;31, 2011 and 2012.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Depreciation and Amortization</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Depreciation is calculated using the straight line method over the estimated useful lives of the assets. &nbsp;Amortization is computed using the straight line method over the term of the agreement.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Intangible Assets</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Intangible assets consist primarily of intellectual properties such as regulatory product approvals and patents. The Company does not own any such intangible assets. However, the Company entered into the Exclusive Agreements on October&nbsp;22, 2010 and April&nbsp;1, 2011, which gave the Company respectively (i)&nbsp;the exclusive worldwide license to make and sell the &#147;Total Splint System&#148; and (ii)&nbsp;the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. The licensor under the Exclusive Agreements is Boyd Research, Inc., a related party to the Company. The 2011Agreement required a deferred $3,000,000 license inception fee, which the Company amortized over a ten year period using the straight line method of amortization. &nbsp;On August&nbsp;24, 2012, the Company entered into the New License Agreement, which terminated the Exclusive Agreements and continued, for the remainder of 2012, the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. &nbsp;The primary licensor under the New License Agreement is Boyd Research, Inc., a related party to the Company. &nbsp;The New License Agreement eliminated the 2011 Agreement&#146;s license inception fee. &nbsp;Beginning on January&nbsp;1, 2013, the New License Agreement grants the Company a royalty-free nonexclusive worldwide license to make and sell certain products under certain Boyd Parties patent rights and related technology (but excluding the United States market). &nbsp;&nbsp;See Note&nbsp;5 &#150; License Agreements.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Income Taxes</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company accounts for income taxes under ASC 740 <i>"Income Taxes," </i>which codified SFAS 109, <i>"Accounting for Income Taxes" </i>and FIN 48 <i>&#147;Accounting for Uncertainty in Income Taxes &#150; an Interpretation of FASB Statement No. 109.&#148; </i>Under the asset and<i> </i>liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to<i> </i>differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred<i> </i>tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Going Concern</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. Under the New License Agreement the Company&#146;s rights to sell AMPSA Products to the US market (81% of total revenue) expire at the end of 2012. &nbsp;The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Share Based Expenses</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">ASC 718 <i>"Compensation - Stock Compensation,"</i> which codified SFAS 123, prescribes accounting and reporting standards for all stock-based payments awarded to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights. &nbsp;Such payments may be classified as either equity or liabilities. The Company should determine if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a)&nbsp;the option to settle by issuing equity instruments lacks commercial substance or (b)&nbsp;the present obligation is implied because of an entity's past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity. See also Note&nbsp;6 &#150; Equity Transactions.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50 <i>"Equity-Based Payments to Non-Employees,"</i> which codified SFAS 123, and the Emerging Issues Task Force consensus in Issue No. 96-18, <i>"Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services".</i> Measurement of share-based payment transactions with non-employees shall be based on the fair value of whichever is more reliably measurable: (a)&nbsp;the goods or services received; or (b)&nbsp;the equity instruments issued. The fair value of the share-based payment transaction should be determined at the earlier of the performance commitment date or performance completion date. &nbsp;See also Note&nbsp;6 &#150; Equity Transactions.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Recently Implemented Standards</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company&#146;s consolidated financial statements upon adoption.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note&nbsp;3 &#150; Restricted Cash</b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Other non-current asset is a $10,000 certificate of deposit with an annual interest rate of 0.6%. &nbsp;This certificate matures on June&nbsp;17, 2013, and is used as collateral for a Company credit card, pursuant to a security agreement dated June&nbsp;20, 2011.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note&nbsp;4 &#150; Equipment</b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The cost and accumulated depreciation of fixed assets and equipment at December&nbsp;31, 2012 and 2011 are summarized below:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2012</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2011</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Computer Hardware</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">10,747</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">4,612</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Office Furniture and Equipment</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">3,639</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">3,639</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Shipping and Other Equipment</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,575</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,575</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Molding Equipment Interests</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">90,000</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Total</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">105,961</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">9,826</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Accumulated Depreciation</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">(13,508)</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">(2,187)</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Property and Equipment, net</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="123" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">92,453</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="117" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">7,639</p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Depreciation is calculated using the straight line method over the estimated useful lives of the assets.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note&nbsp;5 &#150; License Agreements</b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Exclusive Agreements granted the Company an exclusive worldwide license to make and sell under certain Boyd Parties patent rights and related technology (but excluding the United States market as to the laboratory-products semi-custom field of use), with a 30% royalty on net sales (subject to reduction under certain conditions) and, for the 2011 Agreement, a deferred $3,000,000 license inception fee. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The New License Agreement granted the Company, for the period from August 24, 2012 to December 31, 2012, an exclusive worldwide license to make and sell under certain Boyd Parties patent rights and related technology (but excluding the United States market as to the laboratory-products semi-custom field of use), with a 30% royalty on net sales (subject to reduction under certain conditions). &nbsp;Also, the New License Agreement granted the Company, for the period from January 1, 2013 forward, a royalty-free nonexclusive worldwide license to make and sell certain products under certain Boyd Parties patent rights and related technology (but excluding the United States market). &nbsp;The New License Agreement eliminated the 2011 Agreement&#146;s license inception fee.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">From April&nbsp;1, 2011 through December 31, 2012, essentially the Company&#146;s entire active business consisted of the manufacture and sale of AMPSA Products as authorized by the Exclusive Agreements and the New License Agreement. &nbsp;The Exclusive Agreements licensor and the New License Agreement licensors are wholly owned by James P. Boyd, a related party of the Company.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note&nbsp;6 &#150;</b>&nbsp;<b>Equity Transactions</b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Preferred Stock</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company is authorized to issue 5,000,000 shares of $.001 par value preferred stock. The Company has not issued any preferred stock.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Common Stock</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company is authorized to issue 699,999,999 shares of $.001 par value common stock. &nbsp;All shares have equal voting rights, are non-assessable, and have one vote per share. &nbsp;Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they choose to do so, elect all of the directors of the Company. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">In the first quarter of 2011 the Company issued 250,523,333 shares of common stock to James P. Boyd and Timothy G. &nbsp;Dixon, the shareholders of Splint Decisions Inc., to acquire Splint Decisions Inc. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">On May&nbsp;17, 2011 the Company issued 525,000 shares of common stock, to Gerry Berg and Timothy G. Dixon to replace shares which they had transferred to third parties at the request of James P. Boyd in the first quarter of 2011. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">On June&nbsp;3, 2011 the Company issued 200,000 shares of common stock, valued at $0.06 per share, to a broker-dealer for consulting services. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">On June&nbsp;17, 2011 the Company issued 10,000,000 shares of common stock, valued at $0.10 per share, to an equity markets consulting firm for consulting services. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Warrants</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">On February 20, 2009, the Company granted certain compensatory warrants. &nbsp;The fair value of each compensatory warrant granted is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following table. Expected volatilities are based on volatilities from the Company's traded common stock since February 20, 2009. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The risk-free rate for the periods within the contractual life of the compensatory warrants is based on the U.S. Treasury bond rate in effect at the time of grant for bonds with maturity dates at the estimated term of the warrants. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The following values were used to calculate the intrinsic values of the Company&#146;s outstanding compensatory warrants as of their issuance dates: &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Expected volatility</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">136.53% - 217.26%</p></td></tr> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Expected dividends</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">0</p></td></tr> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Expected term (in years)</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">2 - 4</p></td></tr> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Risk-free rate</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">1.29% - 1.86%</p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">A summary of these compensatory warrants outstanding at December&nbsp;31, 2011 and 2012 and changes during the periods then ended is presented below:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Warrants</p></td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Shares</p></td> <td width="76" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Weighted- </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Average </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Exercise </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Price</p></td> <td width="82" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Weighted-</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Average </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Remaining </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Contractual</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Term</p></td> <td width="75" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Aggregate </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Intrinsic </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Value</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercisable at December&nbsp;31, 2010</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">450,000</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$0.78</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">3.26</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$34,653</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Granted</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercised</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Canceled</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercisable at</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">December&nbsp;31, 2011</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">450,000</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$0.78</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">2.26</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$34,653</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Granted</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercised</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Cancelled</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">200,000</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercisable at</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">December&nbsp;31, 2012</p></td> <td width="70" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">250,000</p></td> <td width="76" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$1.00</p></td> <td width="82" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">1.25</p></td> <td width="75" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$ &nbsp;&nbsp;&nbsp;-</p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt"><u>Stock Based Compensation</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">On August&nbsp;31, 2011, the Company issued options to purchase an aggregate of 7,950,000 shares of the Company&#146;s common stock with an estimated fair value of $636,000 to its officers and employees.&nbsp; The options have an exercise price of $0.08 per share. &nbsp;As of December&nbsp;31, 2011, 1,614,000 options had vested and no options were exercised.&nbsp; Subject to continuation of service, the remaining option shares were to vest monthly over the next 32 months; and the options expire ten years from the date of grant unless earlier terminated. &nbsp;Compensation cost, using the graded vesting attribute method in accordance with ASC 718, is recognized over the requisite service period during which each tranche of shares is earned (36 months). The value of each tranche is amortized on a sum of the years digits basis; $261,838 was expensed in the year ended December&nbsp;31, 2011.&nbsp; </p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with dividend yield of 0%; expected volatility of 191%; risk-free interest rate of 2.23%; contractual life of ten years; and an exercise price ($0.08) equal to 100% of the grant-date common stock fair market value.&nbsp; Expected volatility is calculated based on the historic trade day stock market closing price of the preceding 406 trading days.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The expected term of options granted is estimated at half of the contractual term as noted in the individual option agreements and represents the period of time that options granted are expected to be outstanding.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The following table summarizes information regarding stock options outstanding as of December&nbsp;31, 2011:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="250" colspan="10" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:187.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Options Outstanding</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="250" colspan="10" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:187.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Options Exercisable</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Exercise prices</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Number</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Outstanding</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>remaining</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>contractual</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>life (years)</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercise</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>price</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Number</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercisable</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>remaining</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>contractual</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>life (years)</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercise</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>price</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">7,950,000</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">9.67</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,614,000</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">9.67&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">As of December 31, 2012 (due in part to a December 31, 2012 acceleration of the vesting of all remaining outstanding but unvested options), 6,900,000 options had vested and no options were exercised. &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The following table summarizes information regarding stock options outstanding as of December&nbsp;31, 2012:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="250" colspan="10" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:187.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Options Outstanding</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="250" colspan="10" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:187.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Options Exercisable</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Exercise prices</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Number</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Outstanding</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>remaining</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>contractual</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>life (years)</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercise</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>price</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Number</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercisable</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>remaining</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>contractual</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>life (years)</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercise</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>price</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">6,900,000</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">8.67</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">6,900,000</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">8.67&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">A summary of the stock options available under the 2009 Stock Incentive Plan and 2012 Stock Incentive Plan at December&nbsp;31, 2011 and 2012 and changes during the periods then ended is presented below: </p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Available at December&nbsp;31, 2010</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">6,000,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Option shares granted</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">(7,950,000)</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Amendment of 2009 Plan to increase the option shares pool</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">4,000,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Exercised</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">-</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Canceled</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">-</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Available at December&nbsp;31, 2011</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">2,050,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Option shares granted</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Adoption of 2012 Plan</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">12,000,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Exercised</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">-</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Canceled</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,050,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Available at December&nbsp;31, 2012</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">15,100,000</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note&nbsp;7 &#150; Related Party Transactions</b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">At December&nbsp;31, 2011, under the 2011 Agreement, the Company was obligated for a license inception fee to a related party in the amount of $3,000,000. &nbsp;This license inception fee was amortized over a ten-year period using the straight line method of amortization. &nbsp;The unamortized balance at December&nbsp;31, 2011 was $2,775,000. &nbsp;Amortization ceased as of August 24, 2012 as a result of the New License Agreement&#146;s elimination of the license inception fee.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Under the 2011 Agreement and the New License Agreement, the Company incurred royalty expenses payable to a related party of $656,310 for 2012 and $496,037 for 2011. The royalty accrued but unpaid at December&nbsp;31, 2012 and 2011 was $48,842 and $56,211, respectively. &nbsp;&nbsp;Such accrued but unpaid amounts were paid in full in 2012 and 2013.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">On August 24, 2012, the Company entered into the MDRA and the New License Agreement with various related parties. &nbsp;During 2012, the Company made cash payments totaling $50,000 to James P. Boyd, a related party, as required by the MDRA. The Company also transferred $24,978 of inventory to Boyd Research, Inc., an affiliated person of James P. Boyd, a related party, under the MDRA.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">In addition, the Company agreed under the MDRA to make deferred payments of $5,000 per month for 18 months (totaling $90,000; $30,000 is in short-term liabilities and $60,000 is in long-term liabilities) to an affiliated person of James P. Boyd, a related party, beginning July 1, 2013. &nbsp;This obligation does not bear interest and is unsecured. &nbsp;</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note 9 &#150; Geographic Information</b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The following table provides information related to our 2012 and 2011 revenues:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">2012&nbsp;:</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Net domestic revenues</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,837,480</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Net international revenues</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">354,926</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Total</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="100" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">2,191,635</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">2011&nbsp;:</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Net domestic revenues</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,362,006</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Net international revenues</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">325,926</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Total</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="100" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,687,932</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note&nbsp;10 &#150; Subsequent Events &nbsp;</b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Under the MDRA, which was entered into on August 24, 2012, James P. Boyd agreed to surrender 223,991,933 shares of Company common stock when certain conditions were met. &nbsp;On January&nbsp;17, 2013 all the conditions were met, and so the 223,991,933 shares were surrendered to the Company and on January&nbsp;18, 2013 the Company cancelled such shares.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">On November 5, 2012, the Company entered into an Investor Relations Consulting Agreement with Constellation Asset Advisors, Inc. (&#147;CAA&#148;) and issued a Warrant to CAA. &nbsp;In 2013 the Company and CAA agreed to cancel the Investor Relations Consulting Agreement and the Warrant. &nbsp;Such cancellation is treated as if it occurred on November 5, 2012.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b>Note 8 &#150; Income Taxes</b></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company has net operating losses carried forward of $636,349 (2011 &#150; $640,051) available to offset taxable income in future years which expire beginning in fiscal 2031.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company is subject to United States federal and state income taxes at an approximate rate of 45%. The reconciliation of the provision for income taxes at the United States Federal statutory rate compared to the Company&#146;s income tax expense as reported is as follows:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2012</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2011</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Net loss before income taxes per financial statements</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(805,532)</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(970,699)</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Income tax rate</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">45%</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">45%</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Income tax recovery</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(362,489)</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(436,815)</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Permanent differences</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">151,782</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">148,792</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Temporary differences</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">11,172</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Change in valuation allowance</p></td> <td width="138" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">199,534</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">436,815</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Provision for income taxes </p></td> <td width="138" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">&#150;</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">&#150;</p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The significant components of deferred income tax assets and liabilities at December&nbsp;31, 2012 and 2011 are as follows:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="153" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="146" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="153" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2012</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$</p></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="146" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2011</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$</p></td></tr> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Net operating loss carry-forward</p></td> <td width="153" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">636,349</p></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="146" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">436,815</p></td></tr> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Valuation allowance</p></td> <td width="153" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(636,349)</p></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="146" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(436,815)</p></td></tr> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Net deferred income tax asset</p></td> <td width="153" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">&#150;</p></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="146" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">&#150;</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt"><u>Estimates</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><u>Cash</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of December&nbsp;31, 2011 and 2012. &nbsp;Other assets include restricted cash of $10,000 that is used to secure a company credit card.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><u>Inventory</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Inventory consists of finished goods, and is stated at the lower of cost or market. The Company records cost of sales using the moving average cost method. There was no excess or obsolete inventory reserve at December&nbsp;31, 2011 and 2012.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><u>Depreciation and Amortization</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Depreciation is calculated using the straight line method over the estimated useful lives of the assets. &nbsp;Amortization is computed using the straight line method over the term of the agreement.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><u>Intangible Assets</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Intangible assets consist primarily of intellectual properties such as regulatory product approvals and patents. The Company does not own any such intangible assets. However, the Company entered into the Exclusive Agreements on October&nbsp;22, 2010 and April&nbsp;1, 2011, which gave the Company respectively (i)&nbsp;the exclusive worldwide license to make and sell the &#147;Total Splint System&#148; and (ii)&nbsp;the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. The licensor under the Exclusive Agreements is Boyd Research, Inc., a related party to the Company. The 2011Agreement required a deferred $3,000,000 license inception fee, which the Company amortized over a ten year period using the straight line method of amortization. &nbsp;On August&nbsp;24, 2012, the Company entered into the New License Agreement, which terminated the Exclusive Agreements and continued, for the remainder of 2012, the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. &nbsp;The primary licensor under the New License Agreement is Boyd Research, Inc., a related party to the Company. &nbsp;The New License Agreement eliminated the 2011 Agreement&#146;s license inception fee. &nbsp;Beginning on January&nbsp;1, 2013, the New License Agreement grants the Company a royalty-free nonexclusive worldwide license to make and sell certain products under certain Boyd Parties patent rights and related technology (but excluding the United States market). &nbsp;&nbsp;See Note&nbsp;5 &#150; License Agreements.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><u>Income Taxes</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company accounts for income taxes under ASC 740 <i>"Income Taxes," </i>which codified SFAS 109, <i>"Accounting for Income Taxes" </i>and FIN 48 <i>&#147;Accounting for Uncertainty in Income Taxes &#150; an Interpretation of FASB Statement No. 109.&#148; </i>Under the asset and<i> </i>liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to<i> </i>differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred<i> </i>tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><u>Going Concern</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. Under the New License Agreement the Company&#146;s rights to sell AMPSA Products to the US market (81% of total revenue) expire at the end of 2012. &nbsp;The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><u>Share Based Expenses</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">ASC 718 <i>"Compensation - Stock Compensation,"</i> which codified SFAS 123, prescribes accounting and reporting standards for all stock-based payments awarded to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights. &nbsp;Such payments may be classified as either equity or liabilities. The Company should determine if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a)&nbsp;the option to settle by issuing equity instruments lacks commercial substance or (b)&nbsp;the present obligation is implied because of an entity's past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity. See also Note&nbsp;6 &#150; Equity Transactions.</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50 <i>"Equity-Based Payments to Non-Employees,"</i> which codified SFAS 123, and the Emerging Issues Task Force consensus in Issue No. 96-18, <i>"Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services".</i> Measurement of share-based payment transactions with non-employees shall be based on the fair value of whichever is more reliably measurable: (a)&nbsp;the goods or services received; or (b)&nbsp;the equity instruments issued. The fair value of the share-based payment transaction should be determined at the earlier of the performance commitment date or performance completion date. &nbsp;See also Note&nbsp;6 &#150; Equity Transactions.</p> <!--egx--><p style="MARGIN:0in 0in 0pt"><u>Recently Implemented Standards</u></p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <p style="MARGIN:0in 0in 0pt">Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company&#146;s consolidated financial statements upon adoption.</p> <!--egx--><p style="MARGIN:0in 0in 0pt">The cost and accumulated depreciation of fixed assets and equipment at December&nbsp;31, 2012 and 2011 are summarized below:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2012</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2011</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Computer Hardware</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">10,747</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">4,612</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Office Furniture and Equipment</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">3,639</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">3,639</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Shipping and Other Equipment</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,575</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,575</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Molding Equipment Interests</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">90,000</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Total</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">105,961</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">9,826</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Accumulated Depreciation</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="123" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">(13,508)</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="117" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">(2,187)</p></td></tr> <tr> <td width="212" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:159pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Property and Equipment, net</p></td> <td width="21" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="123" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:92.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">92,453</p></td> <td width="23" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:17.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="117" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:87.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">7,639</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt">The following values were used to calculate the intrinsic values of the Company&#146;s outstanding compensatory warrants as of their issuance dates: &nbsp;</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Expected volatility</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">136.53% - 217.26%</p></td></tr> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Expected dividends</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">0</p></td></tr> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Expected term (in years)</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">2 - 4</p></td></tr> <tr> <td width="197" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:147.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Risk-free rate</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">1.29% - 1.86%</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt">A summary of these compensatory warrants outstanding at December&nbsp;31, 2011 and 2012 and changes during the periods then ended is presented below:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Warrants</p></td> <td width="70" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Shares</p></td> <td width="76" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Weighted- </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Average </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Exercise </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Price</p></td> <td width="82" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Weighted-</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Average </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Remaining </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Contractual</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Term</p></td> <td width="75" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Aggregate </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Intrinsic </p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">Value</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercisable at December&nbsp;31, 2010</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">450,000</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$0.78</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">3.26</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$34,653</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Granted</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercised</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Canceled</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercisable at</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">December&nbsp;31, 2011</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">450,000</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$0.78</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">2.26</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$34,653</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Granted</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercised</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">0</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Cancelled</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">200,000</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Exercisable at</p></td> <td width="70" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="76" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="82" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="75" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="154" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:115.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">December&nbsp;31, 2012</p></td> <td width="70" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:52.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">250,000</p></td> <td width="76" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:57pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$1.00</p></td> <td width="82" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:61.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">1.25</p></td> <td width="75" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:56.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$ &nbsp;&nbsp;&nbsp;-</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt">The following table summarizes information regarding stock options outstanding as of December&nbsp;31, 2011:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="250" colspan="10" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:187.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Options Outstanding</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="250" colspan="10" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:187.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Options Exercisable</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Exercise prices</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Number</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Outstanding</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>remaining</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>contractual</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>life (years)</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercise</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>price</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Number</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercisable</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>remaining</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>contractual</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>life (years)</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercise</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>price</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">7,950,000</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">9.67</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,614,000</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">9.67&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt">A summary of the stock options available under the 2009 Stock Incentive Plan and 2012 Stock Incentive Plan at December&nbsp;31, 2011 and 2012 and changes during the periods then ended is presented below: </p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Available at December&nbsp;31, 2010</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">6,000,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Option shares granted</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">(7,950,000)</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Amendment of 2009 Plan to increase the option shares pool</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">4,000,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Exercised</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">-</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Canceled</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">-</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Available at December&nbsp;31, 2011</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">2,050,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Option shares granted</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Adoption of 2012 Plan</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">12,000,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Exercised</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">-</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Canceled</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,050,000</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="228" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:171pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Available at December&nbsp;31, 2012</p></td> <td width="36" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:27pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="128" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:96pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">15,100,000</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt">The following table provides information related to our 2012 and 2011 revenues:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">2012&nbsp;:</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Net domestic revenues</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,837,480</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Net international revenues</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">354,926</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Total</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="100" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">2,191,635</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">2011&nbsp;:</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Net domestic revenues</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="100" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,362,006</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Net international revenues</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="100" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">325,926</p></td></tr> <tr> <td width="194" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:145.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">Total</p></td> <td width="20" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:15pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">$</p></td> <td width="100" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">1,687,932</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt">The Company is subject to United States federal and state income taxes at an approximate rate of 45%. The reconciliation of the provision for income taxes at the United States Federal statutory rate compared to the Company&#146;s income tax expense as reported is as follows:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2012</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2011</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Net loss before income taxes per financial statements</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(805,532)</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(970,699)</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Income tax rate</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">45%</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">45%</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Income tax recovery</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(362,489)</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(436,815)</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Permanent differences</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">151,782</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">148,792</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Temporary differences</p></td> <td width="138" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">11,172</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Change in valuation allowance</p></td> <td width="138" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">199,534</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">436,815</p></td></tr> <tr> <td width="300" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:225pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Provision for income taxes </p></td> <td width="138" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:103.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">&#150;</p></td> <td width="15" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:11.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="134" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:100.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">&#150;</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt">The significant components of deferred income tax assets and liabilities at December&nbsp;31, 2012 and 2011 are as follows:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="153" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="146" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="153" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2012</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$</p></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="146" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">December&nbsp;31, 2011</p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">$</p></td></tr> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Net operating loss carry-forward</p></td> <td width="153" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">636,349</p></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="146" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">436,815</p></td></tr> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Valuation allowance</p></td> <td width="153" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(636,349)</p></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="146" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">(436,815)</p></td></tr> <tr> <td width="251" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:188.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">Net deferred income tax asset</p></td> <td width="153" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:114.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">&#150;</p></td> <td width="18" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:13.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="146" style="BORDER-BOTTOM:black 2.25pt double; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:109.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center">&#150;</p></td></tr></table></div> <!--egx--><p style="MARGIN:0in 0in 0pt">The following table summarizes information regarding stock options outstanding as of December&nbsp;31, 2012:</p> <p style="MARGIN:0in 0in 0pt">&nbsp;</p> <div align="center"> <table cellpadding="0" cellspacing="0"> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in"></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="250" colspan="10" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:187.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Options Outstanding</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="250" colspan="10" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:187.5pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Options Exercisable</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Exercise prices</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Number</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Outstanding</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>remaining</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>contractual</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>life (years)</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercise</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>price</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Number</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercisable</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>remaining</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>contractual</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>life (years)</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>Weighted</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>average</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>exercise</b></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b>price</b></p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="73" colspan="2" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:54.75pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr> <tr> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">6,900,000</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">8.67</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">6,900,000</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">8.67&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">$</p></td> <td width="66" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:49.5pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right">0.08</p></td> <td width="7" style="BORDER-BOTTOM:#ece9d8; BORDER-LEFT:#ece9d8; PADDING-BOTTOM:0in; PADDING-LEFT:0in; WIDTH:5.25pt; PADDING-RIGHT:0in; BACKGROUND:white; BORDER-TOP:#ece9d8; BORDER-RIGHT:#ece9d8; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt">&nbsp;</p></td></tr></table></div> 250523333 3000000 10000 0.6 10747 4612 3639 3639 1575 1575 90000 0 105961 9826 -13508 -2187 92453 7639 3000000 3000000 5000000 0.001 699999999 250523333 525000 200000 10000000 0.001 0.5 0.06 0.10 1.3653 2.1726 0 2 4 0.0129 0.0186 450000 0.78 3.26 34653 0 0 200000 450000 0.78 2.26 34653 0 0 200000 250000 1.00 1.25 7950000 636000 0.08 1614000 6900000 261838 0.00 1.91 2.23 10 0.08 0.08 0.08 7950000 6900000 9.67 8.67 0.08 0.08 1614000 6900000 9.67 8.67 0.08 0.08 6000000 -7950000 4000000 0 2050000 0 12000000 1050000 15100000 0 0 3000000 2775000 496037 656310 56211 48842 50000 24978 30000 60000 5000 90000 1837480 1362006 354926 325926 2191635 1687932 223991933 223991933 -805532 -970699 0.45 0.45 -362489 -436815 151782 148792 11172 0 0 0 636349 436815 0 0 199534 436815 -636349 -436815 0001419051 2012-01-01 2012-12-31 0001419051 2013-03-26 0001419051 2012-06-28 0001419051 2012-12-31 0001419051 2011-12-31 0001419051 2011-01-01 2011-12-31 0001419051 2010-12-31 0001419051 us-gaap:CapitalUnitsMember 2010-12-31 0001419051 us-gaap:CommonStockMember 2010-12-31 0001419051 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0001419051 us-gaap:RetainedEarningsMember 2010-12-31 0001419051 us-gaap:ParentMember 2010-12-31 0001419051 us-gaap:CapitalUnitsMember 2011-01-01 2011-12-31 0001419051 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0001419051 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0001419051 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0001419051 us-gaap:ParentMember 2011-01-01 2011-12-31 0001419051 us-gaap:CapitalUnitsMember 2011-12-31 0001419051 us-gaap:CommonStockMember 2011-12-31 0001419051 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001419051 us-gaap:RetainedEarningsMember 2011-12-31 0001419051 us-gaap:ParentMember 2011-12-31 0001419051 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001419051 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0001419051 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0001419051 us-gaap:ParentMember 2012-01-01 2012-12-31 0001419051 us-gaap:CapitalUnitsMember 2012-12-31 0001419051 us-gaap:CommonStockMember 2012-12-31 0001419051 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001419051 us-gaap:RetainedEarningsMember 2012-12-31 0001419051 us-gaap:ParentMember 2012-12-31 0001419051 2010-09-21 0001419051 2011-03-31 0001419051 2011-05-17 0001419051 2011-06-03 0001419051 2011-06-17 0001419051 fil:SharesMember 2010-12-31 0001419051 fil:WeightedAverageExercisePriceMember 2010-12-31 0001419051 fil:WeightedAverageRemainingContractualTermMember 2010-12-31 0001419051 fil:AggregateIntrinsicValueMember 2010-12-31 0001419051 fil:SharesMember 2011-01-01 2011-12-31 0001419051 fil:SharesMember 2011-12-31 0001419051 fil:WeightedAverageExercisePriceMember 2011-12-31 0001419051 fil:WeightedAverageRemainingContractualTermMember 2011-12-31 0001419051 fil:AggregateIntrinsicValueMember 2011-12-31 0001419051 fil:SharesMember 2012-01-01 2012-12-31 0001419051 fil:SharesMember 2012-12-31 0001419051 fil:WeightedAverageExercisePriceMember 2012-12-31 0001419051 fil:WeightedAverageRemainingContractualTermMember 2012-12-31 0001419051 fil:StockIncentivePlanMember 2010-12-31 0001419051 fil:StockIncentivePlanMember 2011-01-01 2011-12-31 0001419051 fil:StockIncentivePlanMember 2011-12-31 0001419051 fil:StockIncentivePlanMember 2012-01-01 2012-12-31 0001419051 fil:StockIncentivePlanMember 2012-12-31 0001419051 2012-08-24 0001419051 2013-01-17 iso4217:USD shares iso4217:USD shares pure Reflects cancellation of 223,991,933 shares in January 2013 EX-101.CAL 8 tsoi-20121231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 tsoi-20121231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 tsoi-20121231_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Geographic Information During The Period: Net loss before income taxes per financial statements Exercisable Exercisable Exercisable Exercisable Weighted-Average Remaining Contractual Term Shares License Agreements Consists Of the Following: Cost And Accumulated Depreciation of Fixed Assets {1} Cost And Accumulated Depreciation of Fixed Assets Intangible Assets Policy License Agreements Restricted Cash {1} Restricted Cash Nature of Business Cash flows from operating activities Earnings (Deficit) Accumulated Additional Paid in Capital {1} Additional Paid in Capital Loss from operations Loss from operations Operating expenses: Net domestic revenues Common Stock, shares authorized LIABILITIES AND SHAREHOLDERS' DEFICIT Entity Registrant Name Net deferred income tax asset Net deferred income tax asset Related Party Payable in short term liabilities Related Party Payable in short term liabilities Stock Incentive Plan Options Outstanding: Expected term (in years) maximum Expected term (in years) maximum Components of Income Tax Expense As Follows Cost And Accumulated Depreciation of Fixed Assets Related Party Transactions {1} Related Party Transactions Net cash provided by operating activities Net cash provided by operating activities (Increase) decrease in accounts receivable Stock issued for service on February 11, 2011 Amortization and depreciation Net Revenues Total Net Revenues Total Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Net domestic revenues. Issued shares of common stock Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Components of deferred income tax assets and liabilities Changes in operating assets and liabilities: Net loss {1} Net loss Entity Voluntary Filers Significant components of deferred income tax assets and liabilities: Issued options to purchase shares Issued options to purchase shares Restricted Cash Consists Of: Increase in License agreement and due to related party Increase in License agreement and due to related party Decrease in license agreement and due to related parties due to settlement Decrease in license agreement and due to related parties due to settlement during the reporting period. Amortization recapture as result of settlement Stock based compensation to officers Statement, Equity Components [Axis] Long term liabilities: Royalties payable, related party Accrued expenses and other current liabilities Other non-current assets Statement [Line Items] Valuation allowance. Provision for income taxes Related Party Payable in equal monthly payments per month Payment of a borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Related Party Transactions Agreement: Options Exercisable: Weighted average exercise price (number exercisable) Expected volatility of Expected volatility of percent Cancelled Cancelled Risk-free rate minimum The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. Office Furniture and Equipment A summary of the stock options available {1} A summary of the stock options available The Following Values Were Used to Calculate The Intrinsic Values ACCOUNTING POLICIES Nature of Business {1} Nature of Business Amortization Net loss Net loss Salaries, wages, and related costs Gross profit Gross profit Prepaid expenses and other current assets Entity Central Index Key Amendment Flag Net international revenues. Revenues from external customers attributed to all foreign countries in total from which the entity derives revenues. Temporary differences The cumulative amount of the temporary difference for which a deferred tax liability has not been provided because of the exceptions to comprehensive recognition of deferred taxes. Exercised. Exercised. Number exercisable Options exercise price per share Outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. Compensatory Warrants Outstanding Presented STOCKHOLDERS EQUITY Voting rights Voting rights The Following Table Provides Geographic Information Cash Policy Cash paid for income taxes Increase in liabilities from merger The increase (decrease) during the reporting period in liabilities from merger Repayments Non-cash expenses: Total long term liabilities Total long term liabilities Current Fiscal Year End Date Reconciliation of the provision for income taxes : Weighted average exercise price (number exercisable) Weighted average exercise price (number exercisable) Contractual life of years Contractual life of years Stock Based Compensation Consists Of The Following: COMMON STOCK: Issued shares of preferred stock par value The following table summarizes information regarding stock options outstanding {1} The following table summarizes information regarding stock options outstanding Income Tax Disclosure [Text Block] Acquisition of licensing agreement Acquisition of licensing agreement during the reporting period. (Increase) decrease in inventory Stock based compensation to consultants Employee stock options vested during the year Weighted average shares outstanding The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS. Total other income (expense) Total other income (expense) Consulting fees A fee charged for consulting services during the period. Common Stock, shares outstanding Total assets Total assets Document Fiscal Period Focus Entity Filer Category Permanent differences Permanent differences Related Party Payable in long term liabilities Related Party Payable in long term liabilities Canceled Canceled Amendment of 2009 Plan to increase the option shares pool Amendment of 2009 Plan to increase the option shares pool Weighted average exercise price (options outstanding) Number Outstanding Number of shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding. Weighted-Average Exercise Price Expected volatility maximum The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Recently Implemented Standards Entire Policy Disclosure for Recently Implemented Standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company's consolidated financial statements that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company's consolidated financial statements upon adoption. Stock issued for service on June 17, 2011 Stock issued for service on June 17, 2011 Balance Balance Balance Revenue: Common stock, $.001 par value; 699,999,999 shares authorized, 305,458,333 issued and outstanding at December 31, 2012 And 700,000,000 shares authorized, 305,458,333 issued and outstanding at December 31, 2011, respectively Statement [Table] Document and Entity Information Related Party Payable in equal monthly payments totaling Related Party Payable in equal monthly payments totaling Inception fee unamortized value Inception fee unamortized value License inception fee to a related party License inception fee to a related party Weighted average remaining contractual life (in years) Weighted average remaining contractual life (in years) Expected term (in years) minimum Expected term (in years) minimum Issued shares of preferred stock Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Deferred License inception fee. Equipment Consists Of the Following: Issued common shares to the shareholders of Splint Issued common shares to the shareholders of Splint Share Based Expenses Policy Equipment {1} Equipment Increase in cash Increase in cash Cash flows from financing activities Acquisition of fixed assets Increase (decrease) in accrued expenses and other current liabilities Compensation expense - employee stock option plan Stock issued for service on May 17, 2011 Stock issued for service on May 17, 2011 Common Stock Shares Other income (expense): Total shareholders' deficit Total shareholders' deficit Shareholders' deficit Conditions were met shares were surrendered Conditions were met shares were surrendered Net operating loss carry-forward Income tax recovery Income tax recovery Incurred royalty expenses payable to a related party Incurred royalty expenses payable to a related party Available Available Available Available Property and Equipment, net. Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. A summary of the stock options available Information regarding stock options outstanding summary {1} Information regarding stock options outstanding summary Tabular disclosure for information regarding stock options outstanding Subsequent Events License Agreements {1} License Agreements (Increase) decrease in prepaid expenses and other current assets Common Stock, shares issued Due to related parties. Due to related parties Accounts payable Current liabilities: Inventories Change in valuation allowance Weighted average remaining contractual life (years) Weighted average remaining contractual life (years) Options expensed in the year Options expensed in the year Granted Granted. Shipping and Other Equipment The gross amount of long-lived, depreciable assets owned by the entity and used in the entity's principle business operations. Equipment Restricted Cash Supplemental Cash Flow Information: Net cash provided by financing activities Net cash provided by financing activities Common Stock Amount Additional paid-in capital Current assets: ASSETS Document Fiscal Year Focus Subsequent Event Transactions: Transferredof inventory to Boyd Research, Inc., Transferredof inventory to Boyd Research, Inc., Adoption of 2012 Plan Adoption of 2012 Plan Option-pricing model with dividend yield Option-pricing model with dividend yield Common stock with an estimated fair value Common stock with an estimated fair value PREFERRED STOCK: Organization and Presentation: The Following Table Provides Geographic Information {1} The Following Table Provides Geographic Information A summary of Compensatory Warrants Outstanding {1} A summary of Compensatory Warrants Outstanding A summary of Compensatory Warrants Outstanding Inventory Policy Geographic Information Net cash used by investing activities Net cash used by investing activities Total Interest expense Legal and professional fees Total revenues Total revenues Net international revenues Preferred Stock, par value Total current liabilities Total current liabilities Entity Well-known Seasoned Issuer Document Type Stock options available under Incentive Plan STOCKHOLDERS EQUITY: Outstanding Compensatory Warrants: Issued shares of common stock par value Issued shares of common stock par value Information regarding stock options outstanding summary Cash paid for interest Increase (decrease) in other related party liabilities Selling Common Stock, par value Total liabilities and shareholders' deficit Total liabilities and shareholders' deficit Deficit accumulated Licensing agreement, net Total current assets Total current assets James P. Boyd agreed to surrender shares James P. Boyd agreed to surrender shares Risk-free interest rate of Risk-free interest rate of percent Options vested and no options were exercised Options vested and no options were exercised Risk-free rate maximum The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. Components Of Income Tax Expense Benefit The Following Values Were Used to Calculate The Intrinsic Values {1} The Following Values Were Used to Calculate The Intrinsic Values Depreciation and Amortization Policy Geographic Information {1} Geographic Information Related Party Transactions Depreciation Net other income (expense) Total operating expenses Total operating expenses Cost of goods sold Property and equipment, net Document Period End Date Option shares granted Exercised Exercised. Expected volatility minimum The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Issued shares of preferred stock par value Issued shares of preferred stock par value Accumulated Depreciation Molding Equipment Interests Molding Equipment Interests Computer Hardware Other non-current asset certificate of deposit The following table summarizes information regarding stock options outstanding Income Taxes Policy Equity Transactions {1} Equity Transactions Equity Transactions Significant Accounting Policies Basic and diluted loss per common share General and administrative Parentheticals Exercise price equal to 100% of the grant-date common stock fair market value Exercise price equal to 100% of the grant-date common stock fair market value. Aggregate Intrinsic Value Issuedshares of common stock, valued per share for consulting services Issuedshares of common stock, valued per share for consulting services Total Equipment Annual interest rate Annual interest rate Deferred license inception fee Deferred license inception fee Going Concern Increase in fixed assets and due to related parties The increase (decrease) during the reporting period in fixed assets and due to related parties Supplemental disclosure of non-cash investing and financing activities: Cash flows from investing activities Adjustments to reconcile net loss to net cash provided by operating activities: Net Loss, December 31, 2011 Recapitalization Recapitalization associated with restructuring a company's debt and equity mixture that do not qualify for capitalization. Expense recapture as result of settlement Preferred Stock, shares authorized Cash and cash equivalents Cash at beginning of period Cash at end of period Income tax rate New License Agreement with related parties made cash payments totaling New License Agreement with related parties made cash payments totaling Royalty expenses accrued but unpaid Royalty expenses accrued but unpaid Exercise Prices Exercise Prices Expected dividends The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee. Estimates Subsequent Events {1} Subsequent Events Income Taxes Significant Accounting Policies {1} Significant Accounting Policies Borrowing and other advances Increase (decrease) in accounts payable (Increase) decrease in other assets Net Loss, December 31, 2012 The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Stock issued for service on June 3, 2011 Stock issued for service on June 3, 2011 CHANGES IN STOCKHOLDERS EQUITY The increase (decrease) during the reporting period in liabilities from merger Royalties Amount of royalties paid during the period. Preferred stock, $.001 par value; 5,000,000 shares authorized Accounts receivable, net Entity Current Reporting Status Entity Public Float Entity Common Stock, Shares Outstanding EX-101.PRE 11 tsoi-20121231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 12 tsoi-20121231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000280 - Statement - Equipment Consists Of the Following (Details) link:presentationLink link:definitionLink link:calculationLink 000370 - Statement - Reconciliation of the provision for income taxes (Details) link:presentationLink link:definitionLink link:calculationLink 000080 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 000180 - Disclosure - Cost And Accumulated Depreciation of Fixed Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 000120 - Disclosure - Equity Transactions link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 000330 - Statement - Stock Based Compensation Consists Of The Following (Details) link:presentationLink link:definitionLink link:calculationLink 000390 - Statement - Geographic Information During The Period (Details) link:presentationLink link:definitionLink link:calculationLink 000360 - Statement - Related Party Transactions Agreement (Details) link:presentationLink link:definitionLink link:calculationLink 000200 - Disclosure - A summary of Compensatory Warrants Outstanding (Tables) link:presentationLink link:definitionLink link:calculationLink 000110 - Disclosure - License Agreements link:presentationLink link:definitionLink link:calculationLink 000300 - Statement - CAPITAL STOCK TRANSACTIONS (Details) link:presentationLink link:definitionLink link:calculationLink 000310 - Statement - Outstanding Compensatory Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 000070 - Disclosure - Nature of Business link:presentationLink link:definitionLink link:calculationLink 000400 - Statement - Subsequent Event Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 000350 - Statement - Stock options available under Incentive Plan (Details) {Stockholders'Equity} link:presentationLink link:definitionLink link:calculationLink 000270 - Statement - Restricted Cash Consists Of (Details) link:presentationLink link:definitionLink link:calculationLink 000060 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 000100 - Disclosure - Equipment link:presentationLink link:definitionLink link:calculationLink 000030 - Statement - Consolidated Balance Sheets Parentheticals link:presentationLink link:definitionLink link:calculationLink 000210 - Disclosure - The following table summarizes information regarding stock options outstanding (Tables) link:presentationLink link:definitionLink link:calculationLink 000240 - Disclosure - Components Of Income Tax Expense Benefit (Tables) link:presentationLink link:definitionLink link:calculationLink 000250 - Disclosure - The Following Table Provides Geographic Information (Tables) link:presentationLink link:definitionLink link:calculationLink 000090 - Disclosure - Restricted Cash link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000230 - Disclosure - A summary of the stock options available (Tables) link:presentationLink link:definitionLink link:calculationLink 000380 - Statement - Significant components of deferred income tax assets and liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 000130 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 000290 - Statement - License Agreements Consists Of the Following (Details) link:presentationLink link:definitionLink link:calculationLink 000190 - Disclosure - The Following Values Were Used to Calculate The Intrinsic Values (Tables) link:presentationLink link:definitionLink link:calculationLink 000320 - Statement - Compensatory Warrants Outstanding Presented (Details) {Stockholders'Equity} link:presentationLink link:definitionLink link:calculationLink 000150 - Disclosure - Geographic Information link:presentationLink link:definitionLink link:calculationLink 000340 - Statement - Information regarding stock options outstanding (Details) link:presentationLink link:definitionLink link:calculationLink 000050 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 000170 - Disclosure - ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 000260 - Statement - Organization and Presentation (Details) link:presentationLink link:definitionLink link:calculationLink 000160 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 000220 - Disclosure - Information regarding stock options outstanding summary (Tables) link:presentationLink link:definitionLink link:calculationLink 000140 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink GRAPHIC 13 f10k123112_10k001.jpg IMAGE begin 644 f10k123112_10k001.jpg M_]C_X``02D9)1@`!`0```0`!``#__@`\0U)%051/4CH@9V0M:G!E9R!V,2XP M("AUH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U M]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`" M`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2 M\!5B7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2U MMK>XN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`, M`P$``A$#$0`_`/[7/VD/VE_"7[/6A:`;[1-<\<>.?'>IW.A_#SX;^%?L46O> M*]3L+5K_`%.>2^U6XLM(\.^&]`L$-_XD\4:W=V^G:7;/;V\0O]8U'2-)U+X\ MA_;5_:7D7S4^`WP?LO.59!:3_&3Q9=RP+)G:CW,7PKMHIW4@HTT=M`C[-ZQH M#L7F?VP79OVSOA9;2$206/[,_C^\LXF53':W-W\4?!-K=SP*<>7-<06MM'+( MK`ND*(P8``@ZY..>7/?>[$D@C'H8?#TYTU*2;;;6ZZ63Z=T MS]SX!\/<@SO(*6;YK#$XBOBJV(A"$,1+#TJ-*A6=)**I-5)3G*#E.O3'_``K+IV)[?K1_PVI^TSC(^"'P9^O_ M``MSQ?\`B?\`DF1Z>_%>3'@'@$8SC^?7/7^?7.2:8I)&54A0>N"V.O!*9R.> M@S^/-;_5*/9_>O\`(^W_`.(5<&_]`6+_`/#AB_\`Y9Y?GW9ZY_PVG^TU_P!$ M0^#.?3_A;GB_U_[)C]<>H'XT?\-I_M-9'_%C_@SS_P!5<\7^W_5,OKW_`/K> M2@\=..Q!(SS[@$`>_..@-.S_`)P3W.1^F/Y=0*/JE'L_O7^0?\0JX-_Z`L7_ M`.'#%_\`RSR_/NSU?_AM/]IKM\$/@SW/_)7/%_'''_-,3P>O/X9`Q2_\-I_M M-?\`1$/@SW_YJ[XO_P#G9?GQQT'%>2]@`<]>I&">G3OU!(_')/50/0\\\]<< M_3'U&.3U/>CZI1[/\/\`(/\`B%7!O_0%B_\`PX8O_P"6>7Y]V>LC]M/]IK_H MB'P9Z?\`17/%Y.GQ<\7]<'C_`))E MV]\=!7DW4\=,=\L/J.Q_F>S^]?Y!_Q"G@W_ M`*`L5_X<,5Y?]//+\^[/6?\`AM3]IK(_XL?\&>F?^2N>,/Y?\*R'X$_@*3_A MM3]IGC_BR'P9Z?\`17/%^>W'/PQR>N1W/H:\GP#C\3T^AXP>/0'G'`SZIP<' M.!@],DCITZX^N!P0/2CZI1[/[U_D'_$*N#?^@+%_^'#%_P#RSR_/NSUG_AM3 M]IK_`*(A\&NF<_\`"V_%_3'/_-,<=1D?X'!/^&U/VFN/^+(?!GL<_P#"W/%Y MSQT_Y)CR3Z=3UXZ5Y,!C/3C\/;//08ZD')QV((H.`._0=#SP2YSVR`2. M*/JE'L_O7^0?\0JX-_Z`L5_X<,7Y:_Q.MM?F>L_\-I_M-!1_PVG^TT,9^"'P:Z#_`)JYXO\`?C'_``K$#/;UQV'?R;CC M)/3(Y[8['H3GN<'\.IGH.N0><\C`/U`..XZ\\4?5*/9_>O\`(/\`B%7!O_0% MBO\`PX8OR_Z>>7Y]V>L_\-J?M-=/^%(?!GM_S5SQ?Q^?PQ]L\\GGIBE'[:G[ M3/'_`!8_X,XQG/\`PMSQA^/)^&7;WYZ]._D@Z=?8@=_?G)/H<<'IT%*3V.>/ MKSW//)[9!P.G'&:/JE'L_O7^0?\`$*N#?^@+%_\`APQ?_P`L\OS[L]9/[:O[ M3/(_X4A\&>@S_P`7<\7]_3_BV..,\>O?I1_PVI^TU_T1#X,GIG'Q<\7^X."/ MACS^?8],&O)N#GCOR2.,GCH#ZCKD\YYYY,9/Y#G/!].0.,'H1SGDYQ1]4H]G M]Z_R#_B%7!G_`$!8O_PX8OR_Z>>7]7=_6?\`AM3]IK_HB'P9.,9'_"W/%_OV M_P"%8_C_`(`8H_X;3_::Z_\`"D/@R>F?^+N>+SZYQCX8\_A^.,5Y/@9^F/?H M1V'`S@8`Z^G6D'?DXSSSGU.1@#`.S^]?Y!_Q"K@W_`*`L7_X< M,7_\L\OS[L]9_P"&T_VFL?\`)$/@UVZ?%SQAZ]C_`,*Q!/X>O;K1_P`-J?M, M_P#1$/@S^'Q<\7G)YX'_`!;'''J/3GW\FR!WZ`'!;CCTYS^&,'VHSS[$`@9Z M8Z^@'''/4GT)%'U2CV?WK_(/^(4\&_\`0%B__#AB_+_IYZ?TV>L_\-J?M-?] M$/\`@SW/'Q<\7G@^G_%L3GKTXZ>E'_#:G[3(_P":(?!GU'_%W/%Y_$_\6RR! MZ'IC\*\G&.>N,$'&#\V?^+N>+\=1T_P"+ M8\__`%SSZ02_ML_M,6F^Z?\`9^^%&KI&8WETW3?C1XCL;V[A5X_-ALKK4?AE M]@AO3#YQMQ>!+2:98(+F[LXII+JV\MQD9`&3Z9`XS_GG'./:C``R!GUZYX./ M3.3W'3KT'4^J4>S^]?Y"?A3P:TTL)C(MJRE',,2Y+;5>$K+7=$>VU?5?#'BKP?XKLHM-\5>"/&.@3_`&;7?"WB"TMI M[VR^W:?-Y;Q7VFZA?Z/J^FW6GZQHU_>Z9?VUQ+[T>3UQCMNQ[^A]?Z=!7Y?? M\$_HOL7Q3_:WL+9C%8W6O_!KQ/-:C)B_MO5?A[<:%?WL:YVQM0G]0"V.F>1GJ/UR#SVZ]J\RK%0J2C%MI.R;WMYZ+\C^;<_RV&3YU MFF5TZDJU/`XRK0IU))1G.FFI4G-*ZYU3E%3:TM\-?^S7?&__`*MGPA7' M2$'J%X()SG(^8`E<'E@.`>F<'!&37J87^"O\4_\`TIG]+>%G_)%Y6NKK8V*\ MW+&UDE\VTCFM?UG6$U3PYX-\&Z*WBCXA^.;Y]*\(>'1(UO;S3Q()=0U;6;L8 M.F^'=$MRM]J^H,RGR%:"W#7,T2GZK\/?L!7NJ:3'?_$OXZ_$P^*KF-)+FS^' M;^&/"_A/1IRH9K72K34O#7B#4KQ+9FVF^O[YSL?$ M?]H#6;83S:CK-U\-/AU),JN+#PCX2O9;?7-0L7*C:WB/Q1)?P]^V#G)/'88&!D8Q7'7Q,W4:@VE'332]FM;I]UW]3\>'PT<%B*V&>)G2E*G5Q-6K1G"555)1?LE?DC3Y9)-N MY^)WQ<^%OQ%_9FU#3[WQ1X@E^(WP=UO4;?2+;X@76GVFG>)O`^JWKK;Z=:^. MK?3EBTZ_T?4)W%M;>(]/L;2*UNA&-3MXTF#TBLI`8-P>0?4$GMD@9!!QVX)S M7Z_?$'P7H/Q%\(>(O`_B>PAU'P_XHT6_T/5;2:-6$EKJ%N]NSQEP?+F@9Q/; MRJ1)!<1Q31LKQAA^(G@6WUC0(?$/P[\3RO/XI^%OB?5O`VLW$[9GO(=(D']A M:JZ[F8_VQH-SIFH"0%ED:20HSA0S=.%K.HG"3O):Z[O;S;MY?@?=^%7&..S2 MM7R#-\3/%5Z5#ZUE^*KRTA)R?*UWW M4`X`[<\X`!)R.,\CIVQGCD4<\Y`[X&`>XSWQUX'()/.,TQYHHD>2:6.*.-2\ MDDAQ'&BGEWE_U85#DLV_RU&/G!P#YUD>WMD$,=>,CU_IV[XST%<_H/BOPSX MIMS<^&]?TG7;=3M>72[^WO1&V&(#B"1G0D!CEE'0J<=!O@DD8&2=N#\O(;ID MYQ@]_1L.`<\#@XR.0!M M&<]OO+DD<9`[UB>#;+XG?&._OK'X(^!X/%&E:5=2:?JOC_Q%JW_"->`+:_@< M+/8:=J/V:]U+Q+?6SEDN%T#3;ZSMY%:*YOXI%9!7;PSJOQ4\>>#/@GH-W@_#;0G@;Q/>VLPP(+_53<6_AW2YE8&&YU`W/WK6-3^U/ M@WP?X>\">&]$\)>$M'LM!\-Z!906&E:7IL26]M;VT4>,>7&JB21W9I996W2S M3N\\KM,S,>+$XEP?)3^*RYI/H]-%WOK^!^-^(OB%CU@IT\/AX5%*DJKIS4ZM2I3JN?LY_M7^&[0ZC#X:^ M&?CV*&%I9]&\+^*=0T372,!F2P/BG3[?2+Z=!N"1W&I:0DSA5$P+!*\F\.^* M=/\`$B:C#%!J&D:OHE[)I?B+PWK=I)IWB'P[J<2DRV.KZ=<)&\$P!\R*13)9 M7**)[:>2!T8_NG*C$+M53R02Q(QD8R%QSD@+C7^H>2JR7&J^#))H]:L+Z4RS#38M M1LV)A,*KE1Q<^91J>\G9722:>WW>7?S/D.%_%+.L-F%"AG^+6/R[$584ZU>I M0H4\1@^>45'$4YX>G1YJ=)J]6G*,N:#D]TD_G+L.`>G)P"21VQW/KD\^PS7, M^)?%.G>&HK%)XKW4-6UB\32_#WA[2+234==\0ZM-D0Z9H^FVY$UU=G)D9B8K M:WA1[F\GB@1B=QKVU%DU^TT8L5MOM3W)D3R!;>5YYE:09Q&8LN[CY5C)?;;?":UOK=2/"OPYCD=+75[.*;?Y&L>.& M#ZM?7J+'3=DGMTZ]TKO[C]>XZXO7"F5TJV'C3 MKYECI.&`IU+RI1C%1=3%5$FG.G24X*,$_?J3A&7N<[7D?A_]G']J_P`5V2:I M)H7PP^&UO.'FM=(\8:QJ_B7Q"L3J#$FJ1>%1%I&EW*@#S;6'4=4$3,%:5'1X M4X'Q_P"&/C'\$$34?C'X(TX>"Y;B*U;XD_#_`%&YU[PSI4TY5(3XHTNZ@MM? M\.6LDC*@U$V^I:4CR!9K^)AY0_;U1A0.O//3!RW/3CG/.!@].N:S]7TVPUG3 M+[2-4LK34M.U.UGL-0L+Z"*[LKVSNXGAN;6ZMY@8I[>XAD:*6)P4='*L`#BO M/CBZRDG*2<;JZM;32ZOJ^F_YZW_!,-XF<94,6L54S9XN/,G/"5\-@_JLX\UW M#DIX>G.&EXQG&?/!:IN21^+<,L=Q$D\,D4L,ZK+!+$WF1R1.JF-HW7(>-OX9 M%)5QADX88D_+G'0]0>I'4')Y`ZD#'3BLSQ+X"F^`_P`6O$WP;_TB?P=1I5T6ZTV)AY<:!=7&TQX)/'J0FJD5*.J?Y]C^F>'L\PO$6483-L+%TXXB%JM";3EA\332 MCB*#DM)*E4NHST4X.,UI(3')[]/0D9/3&"`!U/;@8Q0._&>?4'KGK@'&1U/< MX[5A:[XI\.>&+47OB36]+T.T8@+/JEY#:(Q/01^ZY;1UNK7/0,>H`''(.!U!X/ M;'IGDDD&D[XZ],$`'DX"\9XRQ`P/O;L<9!`&5@"I#*V"K*PVMP#W`.&4\$@A ML$`YQGB/']UK1TJP\->&1CQ;\0/$&B_#WPNQW'[/K'BZ^ATB/4V5"6:'1K:> MYUB8C(2&PD=L*FXC:2*[6%7CLOB5;>$_$GA+5Y5!?R+ZTT'PWX;U;3OM#8@%Y8WSM;1Y;[',?F MK[M^$WP[\/\`PH^'7A/X=>&+=;?1?"FD6^E6^$"R7:G?23Z MA>3,6DEN;F5W=B=U>A2+N5@#R1TZ#C'!]!ZC@C)]:\B>)JRES*3BELD]+>?W M?T]3^1\TXVXDS/,)X_\`M;'8->TO0PV#Q%7#X?#TXM>+666-9K/5=*NU&S4 MO#VLP$W.DZG'Q/'YD4JI-!*E=4,'GY<'C@@@^QQU(YXZ=,=S7T!^WAX`C\-Z MA\/OVB=)A\F;1M5L/AQ\2&B4*U_X*\67GV31-4NS&H$LGAKQ7<:?%!)*KM'9 MZQ=*&CA1B/G\;2HVC"$94`@_*0"BC&0<(0N0>2">N#7HX>JZL+NUT[.S^Z^B MU?X^I_1'A[Q14XGR-U,5)2S++ZL<)CI)*/M7*FJE'%**LHJO#F4E%4]T_8'/_%W?VKO^Z$^O_0J^+?3^7?I7Z>''?J/=3_Z%S7YA_L#_P#)7/VK M_I\">O3_`)%3Q;U[?Y^M?I^!C_/3VKRZW\6IZK_TE'\Z<;_\E=Q#_P!C&?\` MZ:I'X\_M?_\`)ZWPV_[-=\;_`/JV?"%>1^/]<'ACP5XK\0AB&TC0-6OH0H_> M>=!8S/"T>>6D\Y45%&2[.H&6(QZY^U__`,GK?#;_`+-=\;_^K9\(>M>%?%*U M;4_#FG^'4`>3Q7XW^'GACRS_`!P:QXX\/VU_&!@Y!TQKT#C!8*I`!Y]&@[8= MOJO:6M;?F=MVC]PX(Q;P'AC4QR:3PF"SS$Q;_FHSQ=2-O[W-%:UM3]B/ MV;/`2?#?X"_"+P<8Q'>:/X!\-?VQ@$";7[[3XM4\0W!!Y+7.MWNH3DR;I,2` M.[.I8^X]SQU].N>W7@X`_#/'0FJ]I%';VMO!&-L<,44,:]PD8"(.,9^50>_< M\BI^I(Z_SP,9&3V/.>>N>ISCR;\WO=]?OU/YFUZMM]6]V^K?FQ&3<023P,]. MAYZ=#CM@\<#C))K\>_VDM$A\(?M;^);A%6"T^*'PMT#QA*54(LVM^!K]?!^I MW3/PIF;1KOPU'M[):R2'Y@&7]AN^><8SZYQC!PE,)8R)%%M>V$]SA'5EVF160P[A MMAYNG44KM+JEU6FG_#:]4>_PMFZR+/\`+LTE_#PU2HJT6VE*E5HU*4XRMK;W MT_EWL5_V;_V=[/\`:0+?%#XI1W<_P,_&/V M>6)M4T&:XBGMO#V@3*;*[MX/[4NUGAFM`_ZF:+X`\#^&["+2?#_@_P`,:)I= MO$(;;3=)\/Z1IMA;PH"HBAM+*RAMXH\`?NXXPIZ[:F\'>%=(\$^&/#WA'0+1 M;+1/#6BZ=H6EVZ#:(K'3;6*SMD88YD,<*M*Y.9)F>1OF9F/3XP.!S@`\@<=R M#^@[#''3!FK4E5GSR;TV5[67RMV.+.,VQN>8_$9CF%:=:MB*LYVE)N%*$FW& MC2B](4Z::A",4O=BF]6SY/\`C3^R#\+?BG:7.LZ/IMK\.?B9;0R2Z'\1O!ME M9Z+K4-V%!AAU[[##"GB;19"/(N],UA;J-K62=;9[>5Q*/S5T*]\16NI>)O`O MCC3X],\?^`-5;0_%-K:AA9Z@90LNF>)M%#;6_L/Q59H-3TQ?WGD;Y;*2:6:U MED;]V7^XW`QMSD#KCT`Y)QT`ZYP#Z_EO^W5X6B\'?$/X3_&2P@%K;>(8=9^% M?CAD4QQW:+:R>)?`M]<$#RQ/8WFGZ[I,4K(]S,NLVMI&WEP;#T86M)5%!NZG M)*[>S>B>I]CX;\35LASW"X2K5:RK,JM/!XBA)OV5*K5G&.&Q%.-^6$HUE"$V MDE*G.?,[I,V_V%/#$>L^*OCG\6+J+S&EU[3?A3X:G<*WV?2?!=N=0\11VDA4 MM"M[XEUAX-1CC;9<'2+#S-S6^6_2Y3INH6,22GF9(8Y%RC`5 M]>#&.G'4\_0`C';T/&,9/K7/6ESU9R[R=O))V2/CLYQT\SS;,LPJ-REC,;B, M0F^D:E1^SBK[*--0BELE%!@^IZ=N/0`G.2._KZ]:Q/$/A_2_%&BZOX=UJV2\ MTC7=-O\`2=3LY%5TN[#4;66SNX'#!N)(96&0"1\I'`(K;S[=.?RP>X_R.1R, M4F>HZ8.>A(]?QZ\YQZCG%9['FM7/YS;?2M?N/!5I\$GN9CXLF^)B_L\MG>&="TGP[I-O': MZ7H6EV&CZ=;1($@MK#3+6.SL[>)$PL<4-O!'&B*,``8ZD5^0V@^%HO\`AY[J M/@Q82;'1M;UOX_/;F(BWGFUSX36'A.WE59&*1_9=>U%+Z.2%"?ML4DHVS%GK M]DXQM!&/4DD')RQ/(Z=SV&?U'3B*CG[.[O:"?JVWK;I=)'TW$N?U<]>2NI/F M_L[(\!@)*[LZ]*$G7J.^\YMQ4Y=5"/8DQQT'/&<\$'`]?0`XSSQSFFE2RX!P M.,=SP#@^G.>,9Y]:3\<'VY&>_;`SC/4&$@\*?"_P"*UL@2_P#AW\1]*T[5+D+^\E\'>/U?PMJ]K,5PS6\> ML7/AS4#YA,<*V+R%0V&'Q;XNUR_T:PL;70M,;Q!XM\2:M9>%O"'A^*79)K/B M;5Y#'96AD);R[9%\R\O[DX2UL;6YN)'50H7]2/VO_#7_``EG[,_QMTI0QN(_ MA[X@UBT\L%IH[OP[:GQ!:O`1AUG$VF*(&3$BR.-OS8S\%_L<:)%\4OCV/'E[ M&ESHGPF^'>BW>EPLBRV\?CSXG6OVD7B#!$=SI/A"WECA(4C_`(G[SH4>$$]] M"JZ>&JO1VDDDW9J]E=:/9O?MY)'ZGP;Q=4X?X2XIITIKZW3Q.!GED9W:ABU"WCGUSQ MQX@TZWU%-+G)/AOX` M\9:3C7D1@N=+UK0=+U&RGB(SAK:ZM9(MR'YXY%&^-U22)TD4 M,.S5$0@JBKCY1M`R!UP,#A?;KCG`IX]/Z=.A'U/." M?#TP!!4202:EK$J;LL%W/&%VEJ_1;]IWX<)\5/@3\3?!Z1D:G<>'+[5O#ER$ MQ)8>*O#ZKKGAN_@<`.DD&L:?:%FB997A>:$,%D8'X9_X)OW7_";>-/C-\2I5 MYN/!GP;\-6Z.G[RUNI=+\0>)_$%N[$!DD>YU;35F@.UH6M52100H7L5:4L-4 M4G[T7&*:>K4G;\%O_3/T"CQ?BJW`6:9#BZ\JM:GBLOH82=24I5'@:M6=:K2E M-R-?M#>`8?BA\%/B;X"EB,LGB/P9KUE8JHRR:JEB]SI$D>TATFBU2WM)(GB97 M1E#(P<`C\@/ASK[>*?`?A+7W(:XU70=/N;S&`%OS;I'J"@``;4ODN%4`#:J[ M1TP?WAD4%<;=V,C')SG!.1[GGKT!_#\$/`&G#0?^$Y\(K^[@\&?%7XF^&K5` M`FS3;+Q?J\VD*8Q@(&TN:S"O:.,RV%5)O1SP>(@DTMN;EQ;3>[5DM%8^MOV!_P#DKO[5_../@5^'_%*> M+>N/@2>#_P!2IXMX[Y^N/YU^GXY_ MSU_S[URU_P"+/U7Y(^)XX_Y*[B#_`+&,_P#TU2/S(^.OPJUKXG_MQ^"K'1]0 MTNQDTG]E+Q==SMJ37:I)'=?%WPE$BQ&UM;EMZLN6W*HQ@ACSCC?B?\`?$G@? MQA^SG/J^KZ!?6NK?M&?#>U>VL3J,DTL6GOJFO3@M<6$$:`1:2Q0[SE]B@$$N MOU3-@?M[:1_V:'XA_,_&7PM_C5K]I20GQ[^R?:,J/#/^T!:32(Z*_P"\L_`G MC.:V=6(RK1R-Y@(.2P&>!@N->HH>S37*[]%?WG=Z^OYD8?C#/,)D-7ARA6HQ MRRM2KT9TY8>G*JZ>)G*=5*LUSIN4FTUJEHCZQ08502`<#OGN>AXR.<#*@9'( M(Q3CCZ?J>`Q&><\=?K@@FD7)53[+_/UQCTP.H]1SE<,9]?4D`=,Y[XSU(., M?&O[9>H#2-`^!FH>:8#%^U)\%(%E4A607VJ:A8.-Q`^61;N6)^F8Y&!(YJH? M$OZZ,FI\#]8_^E(^RNF3D\<_H.IXR3@9'')YSV"2!D\@]LGKCUSR#W_K@FF* MV<9&3USUR!R#GOP...AQD4_@YQU([DXQSG&1VST[#TY%26'([@9P>2>ISQST M'7G@\8/)S7PC_P`%)=+-W^R-\0M;B0M?>"M1\'^,-/<$H\-QIOBO2+62:-L$ MKY=CJ-V7/0Q[U)P:^['?@?\`"+041432/AMX(TY$`9`JVOAS38E0(V&` M4*``P!`P""5P?7,XXX'3J2,9_//J>H!.3G!-G7'Y`@#.>#P!U/'(I2^*7J_S%%6C%7;M%*[W M>BW%X/MG'MTR>^#G'Y9!'3-'X0@\X[XY'7TZCDX]3TR> MN,4=.>G0?T_GTX(Z\\\(9\):3X6@C_X*,>*_$(1/.;]E3P?=&3(+F2^^(WBK M1FSE2VYHO#\0X./*B3/0X^[>F>S.<#`P`"#CGZSSG/4\?F,XR!R.0,@<_KD MMMO5DQM;2]K]?1!S_7@DYSVS_@0!P3PL>'-+_'M^B3O@ MNVD>$M`\/>%=-@WK&J,MM-IVH!=F57S''#AEK]-M0`^Q7A/3[+<@#L/W,@&/ MR]>^"/7X'_X)@6D5E^Q5\(5C)Q/+XVO'++@^9<^/O$OK[]!_]?D<_P"T/2COGC/3 M\,X/'UQUSC)YQUD".9%>*2-PK(Z.C*W*NKY#*X(&5()!&>03SC)K\S?^":/A M-O"6A?M(6#2/)]E_:,\"%8D'],W MY1@1NX.0#GOT//<<`?IZ?$O[%$ME+;_M+&Q:$P_\-9?')U2-DRL;>(T\HN@) M>,.BAXO,`+I\Z_)5K^'-=W#\)7?_``"6VI1L[)WNKZ/;==6NGFS[=Y'KW/4# MICKD=/4C\.,`!YZ9/7N..G&.QQD#/XYR:.NF>`003UQGWK\I?!WP*U_P`>?%C]J671 M]3T33;32_CU?JD&HM?Q2!-7\"^!]8,L8@L;A/+DN;Z[R_3G'>OE'X#PR1?&G]K=9&5DE^)?@BYC5&#*%N/ACX<8;@,!9B MJJ)%(R"HSR*TIU)4G*<+Q]/,ZI\-_CQ^U7H6KWNGWUS)8_`2^$VG-<-`(I MO#'C*-4)N;>WDW@Q$L!&5P1@GD5^@&/<_F?Z8KY<^&(Q^U#^U-TX\/?L]_\` MJ/\`CKG/'(YYXR?2OJ(9`''YG_ZQJ)24(*$74<8Q;C".D5:*T6A\@S9_X;VTCC_FT/Q%^7_"Y?"V#_`"_,UVG[ M1?PW\9>.-'\$^(_AQ'M0N[ M1C/IB:EI^JW$=OJB6UT+.[2%Y(&@,N.+FY_;VTCG_FT/Q#Z]OC+X6R/T/7@_ MK7UTZ%R.0%P=RD'YO3!SC!&[`?!GX^^&_BL-1 M\/WFGZAX%^)GA?RH/&WPO\5/!;>)M!NN1)=VH5O*U_P],RR/IWB/2GELKN,Q MM*+:=S;I[_O4GAACCGMGE=H(R!R3QDE3@$#I7A?Q?^`/A+XM'3-9FNM1\(?$ M'PPLLW@SXE^%)5T[Q=X7NW`^6*[(:'5-'E8,NH>']8AO=)O8I'$EO'+MF3RG M3O''[6GP_B/ASQ9\&M&^-\EH=FG?$3X?>,=`\%QZY9*&6.7Q%X2\4K"=&UQU M$9O(]$NK[1YI&DEM)+>+;"I:[5MWT>EOFWMVN&D5Y)>NWH?6^KZOI>BZ=>ZQ MJVH6FFZ5IEI<7^HZA?7$=K8V-E:1R3W-S M(/!WB3]O!+S4KS4=>^&_[/WAZ[;4_A%=V(:P\7>/_B!I0FAT3XI72SQ^?8^# MO#MV;BZ\+:09(Y/$;N-5OO+M4M%KK;CX3_&O]H_Q0]S^T#"OPR^">C7]A=Z3 M\#_#^O:7KFH^.;BSEBN3/\3_`!)I<4MK<:&;B&(1^%M*O#974:G[>'8@+]SV MFGV]G;VUK:0P6UK:P0P6MK;Q1QP6T-O&L,,$"*JB.&.%1$B#Y(T540*.#7P/ MI?JNBVMKU^^Q/Q?X>CV;]4_U70^1[#QW^V-X5LK71=;_`&??!GQ/U.QA2VN/ M&GA3XRZ1X.TC7?+&T7__``COB7PU+J.F75UCSI[19[FVA=RMO.4`%73\7_VL M",?\,=Z?CC_FXWP/UQ_V*V.F.!C]:^NLXSQUX&,\]!P>``.!Q@\<\XH/'0Y( M'/.>/<=`0?3/OG-+F7\L7_X$ORDD'(^DY+RT\O+LNM_T/D7_`(6_^UBP(_X8 M\L!VR/VCO!/`YY./"^?J00>/:O&?V@--_:[^/GP?^('P]'PH\(_!G2=2\-:G M)J6I7WQ&M?B-XAU^/3(3JEIX>\/:;X?T?3;2SN-9O+*VL+B_U2\VVUK-.T<< MTK)&?T@./?\`/N,Y(SCIW/3G/49ICIO4`$=3G&3G/?/!'(^]G(`X)HYETA%/ MH_>T^^30G:[HFKV=C;VFI:7K>D75Y#>Z9J5C>PSP75G5G3ZGG3AC\OYBG[CU?-KO:V]]=_G;Y`^9:))I62[_`)G2'XJ_#!06 M/Q(\!J!CEO%_AX#)X^\VH>I.,X[]J8_Q:^%<2L\OQ+\`1QHID9W\8>'D141< ML[.VHA5C7NS,%!&,]AS;_L_?`I2I'P=^&@'.2O@KPZ.V1@_V>-V<[0`"<]!W MK#_X9H_9X\QYE^"7PR$WF>:7_P"$.T/.\DOGYK)E.3@8,>`"5VX%+W'>W-=6 MNK+RVWN]=E_PS3DW9JW]+S>FNKV75GR+HO[1?@V#]KCQ'\490;7X$>(_`/A_ MX*6'QMGD,7@*]^(OA35M?\730'6Y"+*'2;NV\0?V);:ZS)HESK&F-9PWK3&7 M'WU%\6?A;/</Q*\`R12HLD4L7C+P[+'+&X#I)&ZZB4>-PB22O M=:6^>MODOE.L=(JZW;?1Z+7:W3[SK/\`A:GPQYS\1O`G8?\`(W^'^!)[`?\`$P`Y[`]#QTKFU_9\^!)&?^%. M?#'IQ_Q1/AW\S_Q+O;/;G(Z`&HY?V=O@-/')#+\&_ADR2*5=#X)\.C?\J_KY_B9_Q&^/WPB\$^#?$7B*_^(?@Z MY33=*O9+;3=/\2Z-?:IK.H&WD%EHVE:=:7DEW?ZGJ=T8K2QL[:.2:::5`JE0 M735\1Z#JGA_QIX?\,^(?#C>)UBU[ M4?"'B?0O$OV!9+G2-9U#4TAU.RU*:"6V,-M-:Q20U]J:'^SQ\#?#>I6FL^'_ M`(2?#O1M5T]Q+9:AI_A+1;:[M9004DMYTM`\$JGE9499D."CH<&O95&U0,_7'4L>>N1S2YK)Q5FF[ZK7;]-=@Y>9J3NFE;3UW_``/E.[^,W[02,@L/ MV2?$]RA7+O>?%7X5AQ@Y^K,X_K]3R>Y'7KW'T.0<\#OR<=L9SU]N!Q MGZ$5(7D_+7[_D#4_B)^USK(N-*\._LV^&/"-S>PM!9>+O%_P`: M]!U?2M%N)$V"_O?#_AO0;O5-1AM682+:VERC7+1[)71'W5XEIWPH\8?L5P67 MQ4\-7NK_`!$\)ZO$UW^T_ID%M+-JVIZK<7U]J>H?&CPKI:O(8[K0I=1O(M>T M")E>]\*6]JZSR7FDKN_2P^ON>X&.&?$FA> M+-`TGQ+X;U2SUK0==LK?5-'U2PF6YM+ZQO(UE@G@E3<"KJ>YR'W!P&#*N[YB M#DL#V'?CC(SU/!/7G`)[FOB0?#?XO_LZ^*=9O/@1X8TKXC?!SQ1>SZS>?"&Z M\2P>%-:\!>)+V02ZG??#W5-4MY])?P]K,Q:]OO"]]=64-C>F6327BBF:$7]2 M\4?M:_$_RO#/AOX9:7^SS972[=9^(OC#Q7X=\?:S8V3G:T/@_P`*^'EN+2XU MET.^*_\`$%U#I]DZ;VM;ARH82VVMIU5[???]2F_)M^C_`#M8](^,?[0GA[X: M7VG^#]!TO4/B1\6M?B:3PQ\+?"C17&O7<;$JNKZW/A?XK\!:#XJ\0?$._P!.U#XG?%/Q?>>//'+:,99-$TN\ MNK.QTS2?#6BR2K')+IWAW0]-LM.2Y9$:\NUN[W+"8,W0?"+X#^"/@U8ZB/#T M5]J_B;Q!.MYXP\>>)KR76O&/B_4MJ[[S6=:NF:8J'13;Z?;?9],L5"Q6EI$H M);VM1@`=>/;G/7IU&<9)'XXH=M4MN_7T]+^0*]M=_P"O-GR]\,?^3H?VINW_ M`!3W[/?_`*CWCH=?7T(R#U`/%?48(P,D`_6OEWX9'_C*']J;W\/?L]_^H]XZ M^HQ[\CW]?J(8QQTI#/D";C]O;2./^;0_$/Z_&7PKS_G&?J:^OAU_KQSUXZ=1 MQU]#QUKY!FX_;VTC)_YM#\1?^KD\+W!S48B0$,`0<8R2>G/'3';))R>.1FL?6/$GAWP]` MEWK^NZ/HEJ[^7'SP([*I!*HS,`1N!SP_2/$&A>(;8WV M@ZQIFN662GVS2-0M=2M2Z]5^TV`>3UY['`/3J.<9''!R#Q3P,`\=`1[X`SSN'()ZG'7VZ-\Q",@GH>5S@G( MSM/.>3V&&($1QMLYY;G69V.RVTM\-(@,^GAWY&!S_D<@`XSQSSV[A/' M.0".<8R..AX[YX]">V<#X<\4?M#_`!R^$7V/Q+\;?@5INF_"TRRP^(?&/PR\ M;S>/+WP'[2R?49]2CFAW&6)+6%Y-B*)FV&)4, MNZ.K4)2E&$8NH/7/`Z?@>1@9`[49R,Y!)/3V&2!D#/'!Z M>@QDG/Y/Z#\3/VN/VD[2V^)'A#QUX<_9G^%.N*-2^'>DQ^`=)^(WQ0\2>&+D MPRZ'XH\7S>*[QO#GAY-=LC_:&G:%I6E3W=E9W,4EYJ,DDP\N_/\`L]?$/Q$D M@^(7[7O[37BNQ2(GRK M)D9K[>/!$Z-XYEGN58.O!J%?`T*6:X_&8:IISTJTJ.7QRUU:=[35',JT8R]V M4TU*WP$O$"G73GEG#^;XW#RN\/CJU7+,#@\3"_NU:4:V.GF4:4U[T)5LMI2E M%IJ#O%/]2Y91'O+ML106+$JJA5!9FRV`NS!=R6)"CG%>#^+_`-J+]G?P"ETW MC'XY_"KP_)9'%W9ZAXX\-1ZC`,,=LFF)J$FH+@([8^SD[=W`P*^&)/V'?V<] M4N%N?&'A;Q+\2YT4"-_BE\1/'_Q&$6T%]T,?B[Q+JMO"=X+%;>&-%+?*@'30 M\,^$/V;/!%PUKX`^!6@C^P[R6S76?"GPJL;M+>_MFVS0VOB`67VJXFB=`OF) M=2Q!U=%/R';TQX7X`>FKCO%< MLN+>)\0OW&49'@=&XUJV;9AFC2E;EY\'#*\GCS)7O'Z^KN\8S7Q/V*Z_X*.? MLH7,FSPKX^UOXDR+&[F/X5_#OX@?$8H5**?.?PMX9U&"W&\HOF7$D<`:2/?* MH8&OSC^"V@?&;]M'4/BY\7?$'[57[1GPZ\,6/QM\>^"O!_P\\)W&G^!TT/PW MX??3)=+AO+&6SNIK/5#;7ZK=6D]FMQ&]M(]P3,1.0>,!0.?'OA)9^#O@Y8^,=,\+^$?C1>6WCCXB^) M?B7JTFO>'+*[EM]>\6/;-JD%D;)=/$>EQFTA-K!)'/,BM(LDTS'S#]+E%3), M@PF:3R;`XRAFV(6"IX?%YI4R_.W3H0JU98Q8=3R?"T\'4J1=!RG3A.I4Y/9J M4$FI_*YSAN(N(L;E"SK&X:OE.%ECZF(PN4PS+)%4K5:&'A@WB)4LXQ-7%0IR M^LQ4)SC3I.:J2A.<5)<*/V+/$I.%_;-_;!)]_B=IA^O'_"+CMWSP:\<\60_% M_P#8E^*OP(\<_P##1_[1?QJ^'7C+XDW7A#QK\+=?@L?'FK:EI5UX5UR^BGT* MSBCLY[O5+.\LX;A4MX;>;R(I6B+N/*D^U]0\>?\`">:MX8\)^!_$%SH9U)M< MNO$M[]C,/B'1[3P_#:%]/73M5MB;&^O;W4+)7GGM7B,!=HF+@,N#XP_9OMO' M.K^`]=UWXJ?$R2_^&WBL>,/##PW?AA(XM9_LN^TE99Q+X7E>2(V6I7"%$,)# MX8M(""OI8/B2O7JU*&=K#X[*L3A,=AL7AGE>6N555L%B*=!4ZL,&JF'J+$SH MRAB:353#RBJ\/>IHX,9PS1PU&E7R66+P6;8?%X#%8/$?VIFBA2='&X:I6=6E M+'*EB*;P].LIX:K%T\1%NC/W*ECTBV_X*0?LIVSQV_BSQOXD^&LLD8EC'Q2^ M&GQ"^'L4G'SI%>>*?#.GV5RT;?*QM;F:('&R1TVL?<_!_P"U+^SMX^BM'\&_ M'3X4^(&OG\NUMK+QSX;&H7#L<*D6F2WT=^SL<#;]FW'H%Y(KY^/PUUT@C_A: MWQ#`((VF3PT1@\89CX?Y)`Y/0GIQBO`?BI^S+\/(-"U;Q;K>@^'/'C:>8]1U MK3O&/@CP/?G6=/6XB_M&'^T[+P]IVJV]X86FF@N(KW&V@?=967B#Q7X2^(N@VX9LF.?3_%7@V74M00#"J+K72RKG,CL68\LN#\KF MDL+Q%4C+2[S/):^&IJ][^_EN,SJMHZ6.VGQMF].WUOAFE-)6?]F9 M[2Q51M6O[F9Y?DL==7_%:6BYFV?JH.V?7/\`AV].O3'3H0*,\9YQG^1QR0,] M.YXXP3Z_E#XA^)7[8/[.6GW?Q$\5^.-`_:=^%VA*FH^/M!E^'VA_#SXH:%X= MA93JVN^";KPE=6_AO7AH]J7U&[T36M,2_P!1M[>Z2SOXYE@AN/T/3XE^"+;X M<0?%>[\1Z=:^`+SPQ9^,X?$MQ<>38MX>U+3[74K#4%DWY9+JUN;=X8\F:9Y4 MBC#NZI7S^<\/8S)HX>O.O@\PP6*E.G0Q^75,1.@ZU*,95:%:EC,+@L9AJT(5 M*(P]/#XW+\=A8TZE?`9E##PQ,:%7F5/ M$4YX3$XS!XBA.<)TU4P^*JJ$X2A6]E-PA/T_GU[]\<_-VY/3Z#L,9Q@[_G@C M'7'\QC'4=L^WQ7H'CK]JGXN6,?C;X<:)\*?AGX!U0_:_"=K\5M)\7>(?&?B; M0&.ZQUK4M+\/:UX=M?"":Q:^7>6-E0VTT;7D$4H,;:^E_M&Z]\/=>MO M"/[37A6P^&]YJ=[%8>&?B1H-Y=ZM\)/%,MU(J06LFN7,,5[X.UAW*(NF^*X+ M2VN6WK8:E=E0'\/ETNFGMI=7N^EKW?R^9]&G=7:M\_QN?731JQR03G@XS@XS MV!P#R>H^N<9)L4$8)[D=<=1SQ_3D]L9%10W,-Q$LT,BRPS*LD,L15XY$O'!Y&2>1GH/J>_0&.`.P'<# M`/J>WKGG/3GDDXFC>)?#GB*![OP_KVC:]:H^R2YT;4['5($<`#RWEL9YXU?G M&TMDYQC.#6LLJ,!@CG@G'&0,X(R"#CL<<=1@\,#YC^&(_P",H?VIO;P]^SW[ M?\R]XZ/MCI[8[8KZBP>.3^``_H:^7/AC_P`G0?M3?]B]^SW]>?#_`(ZQ^'J, M$=@#BOJ'>``#G\1^'^?\O_P!?T&<" MH[;XD_&/X\3:@?@W!X?^'?PSM]7UGP^?BQXHMSXB\3>(7T:^FTK4=0^'_@V* MYM=*AT\ZA;75KI^O^*KV:"Z6![NTT.YA>WE/.^/-=A\.?MDWNN/<10OI7[$G MCO4H/,E2,O-IWQ3\/7:I'N*[W#1+A5R3QP<\^T?LLZ-%HG[.GP3T\+AO^%9^ M#]3D#*0XN=--'D^,GBV\3;J'C#XP"T\=:O<$DF2.SL]4M#H6A6(D M.^'3=`TC3;.WQ@1NX,C9'B_]FG1=#N&\T8QR!D`<'(( M]/8\X/`'IG--D`92&&%.!C!P><@=N#C!&,$,588S3NUI?1DVM[[O<_.# MP[\3O&?[6_B^_P#A/%JNN?!O2/AEH5J/VA=.\,3B'QE<^.[_`%K7-$3P!H?B MN2*8:5X;>V\/W^M76OZ1'_;&HZ3J6DK97]D\TDB?';;PMX!\ M.:;X9T6V9I6M;"W_`'EW=.=TU[J-V[-=ZGJ%P^7GO[Z:>\G?#33/@`_-_P`` M?"UGI/[1G[:.L6T<:-K7CWX7-(%C565E^$OAN]E)8+@F2^O;FZ)/)FGEE.7= MB?LQ>5&>X..G4+@<]^_.0<^HYIS24FEM9?BD_P!0@VX1;U;1!<6D-U"\%PB3 M0RH\4L,T:212Q2H8WCEBD#1R(Z2%71T9""0P9^F>!M#CE%MIOPR\::EK,&@?$!=$A1E73O#%]H.I:9K.EZ M);*;>+7_`+>L:QVSNK_NUCG/.`1@<=ASZY(Z>O!Y)K\7O^"OMA!':?LU>()@ MOE:-\1[RXN\6XN)GT^!M#N;I5C;*LNQ-T@X*(A6&BZ190?$^>W@L]-L;>*U@\%>%TMH$@MH8TA@B,+;((57 M9`B,-@$99G"8.J/"WQ!.1_PM2\_\([PP>>I`(AQ].1^%>CQ,DD< M1@[67<\GOQW/?GN!R<$$U]FX*;N[MKWU M;>K>KOH?$1:@E""C&,$HPCRP5H)))))62225EI='BGBBU^)?A70=7\26WCJ# MQ$-!T^\U6ZT35/"VF6,%_96=NUQ=)%?:28+JTNQ;P3-;R$R*7P-E=%\'4*?# M+P=+Y:QF\T>*](7!S+J4T^H3.Q.27EEGDD<[ADR#<6QD[OC[_D1O&0YS_P`( MMXA(&3U32+S:0,GD9Z]3GWK#^$#H_P`+O`.TGCPSI08?,3NCM1%@GGY@5!/. M$F[7C*UTE'7EC*/PI)I72U]-3TG)P"/7%:V5[]7^2MT=_Z^\R;>[;OIM=:Z=%Z+^KGSR]A:P_M.17,4*)/<_" M07%Q(H"M/<-XDOK-II=H`>4V]G;Q%V!=HXD5BVT&OH89X]@><\8.,8./;Z@# M)SD9^>;B[(_:=TZ$!201T/('2IA]I;6G:V]M(NWXES;:@V[MPC=]]7=Z?@+Z@]P!C/)[>N1^ M9'.>N:\X^+Y*_#'QO@$M_P`(]?L`"REBL8;;O!!7Y]']?7CN3R?4 M?_6X'?T\Q^,UP+7X6^-)254-H[6XW`E?])N;>VQCIG,I'(Z=<`$45-(2?D%/ M^)#_`!Q_]*16\,0_$+6/#NB:F?$OA[25OM+LKF'38O"UWJ(M+:6WC:WB:\E\ M1V+7$OE%3)(+:-2Y(`XR=S^Q_B#W\:^'SSC)\$7!_P#=O'0<=.O8#FMCP>V[ MPGX8.,C_`(1[1U[D8&GP8P/[N<\8`&<#`XKHQCUXZ]3WZ=3^![9]\@)4X-)V MW2=[OLNS\D#DTVE;1O[,7U[M7Z'FFJ>%_&VKZ=?Z3>^,O#LMEJEC?:;>H?`\ MYWVE_97%KKZ,LSSZ9X]\36WBB[TGX;RZU:R2S13Z=X5TZPN-1&CW&;1M7M[ M:=HS!:105^HK$@<`-D#@$XP"#VX`&.6P<#@C%?GK_P`$>M/@GM?VA?$\5G]E MAU#Q)X*&UBU;Q[?M!;S999+98K^TVEF+-Y:.22S MSSA^5)[\LI8+B6%2/O-M*:<)-1^-TH\VD(VVR%WXRR_57GP[Q%&<4E&\:>8\ M+2A/W4N;DE.4(J3]SVD^5+GE?]JD@5$0*3A0F-H4<``8P%`VD#:N!E5`"GTS M=>\.:+XGTG4/#_B'3+#6M$U:WFM=3TO5+."^L+^UN$:.:WO+6Y62">.13@H\ M9'0XR`1LC`4=#P,>@'!R?YG'&,=,BG?4=R,<]"2#@\=3S[#GTQ^8JZMW5OO/ MU:RM;IL?FSXRU[5_V)/&'A[PMX)MM:\ZA'9K"ZN;.6*Q*6Z>Z>$_V:M*\0WP M\G1AYRNT1W_`,,_B3"4 M`96WEKN*R(7C30?B;\+8]1 MTK2;GXH>%K1O#?C'PS'J]_;:/I^H>.O!DD]UI6IV*7]W:1ZKKOA.ZLQ9QSF\ ME\.I:0SR)]BLJD#(!*XQZC.![D#(&<$YP.M>&_M*Z0-;^`7QETI=P>Z^&WBX M1F,,76>'1[JYCE4CD21R0Q21L#E2,@_*#2BDVDU>[2WMN]QR]V/N]-;+5_B< M=\+V5_VGOVI'0@J_AW]GIE8$$$'P[XZ8,"."".>P/?';ZEZ=C^G<_6OB?]G' M78?$7QJ^.>MPS),NK?#;]EO4&V.K%9+WP3XPO&1@A.'43*&4X9>`0.I^UM@] M^_0]LG'6I+::=FFFMTU9_`3M8$$GJ/S7_`&Q(XY?VT?AU%*NZ*7]EGQU'*I&X-&_Q7\(K("O= M2A.X=2,XYK[%_88\4+K?[/OASPW/J:;PU)VVG5YK;:S=FO)_FS[/.,)/_`%+X-QT: M?[MU<^PU6HHZ*H\92JTE.75SC&MRK?W&?87/89[X/<$YX/J.,D<=R23PR3`4 MDTET=FM!>64EF. M78["34(\S]E6PM6-9\NKM&BZDI-)\L4Y6:3/H'X:>*;'QM\.OA_XPT_=_9_B M[P9X8\260=E,BVVMZ'::G"C[6QYJ13JDBKTD#+@'@=N!CGCGZ]`<'(P!T]0` M#R3SQ\A_L?O=>$_"OCG]G_6)B^O?LZ?$3Q'\/H?.\M;F_P#`MW=R^(OAEKKQ MB9R+75O!^J62Q21D6ZW5A?Z=;HYL':OKP)J8O+L'7K0]G MB/81I8RDW=T[O+16))33=?CCU2$1KD;8A=O=QACD@Q/SN M!8^8U^]37>S^5DOR^X]U8:?]GSQ>O(\7"BVT[)RI72T6E^1VD]+(]_\`7G`S MVZG`P1TSV[9/IBD'X'KGG/I[8S[$<^O7+E&3C.,>P]/0>I^GH!ZL=MI*]QEB M M%59>0DJ^%]3UUHVSC#27"A5[LQ`QRIKZR#9!.,,"0<]>,9/(`[@^^!7P%+K0 M?6W^(R2,88OBA%X@25LO1IRV_E>MQV,].G&<8]<^GXD9Z'OGGQ#]H.Y(^&UY8J2)-9U?0=*"# MAV2XU:W>!?# M*@R>7>ZGXKO8U8_+::;9_8;')4-N$M]J;%,C!>U+@!5.74>B726GG?2UO,Y\ M#AY8K&86A&_[VO3@[*[2S^`K@7?@CPC<]?/\,Z,^><$_P!G M6ZN%7J`K*00"#D'J1D==^6!+&R9@;C0;S5-"G3 M+`I_9^H7/V,A2%=4ETZ:SF3@AUDW(0I45ZMVX.3T'0GC.!UYSZ#GGL2350:< M4^EGY;.WZ&->#I5JM-JSIU)P:_PR*;?P/X&\8^,KIH!!X5\+Z[ MX@D^TN(X6_LK2[J\17[.&W;,%F%?)7_``1YTJ?0OAA\4M*NIO-N MHM7^&U]<+AP;>Y\0_#C2/%%U8LK@,DEA<:W+92)C"2VTJ=5)KHOVSM2&M?#K M0/@A9WJ6VL_M`^+M(^'TTJN0^F^`;9SXF^+/B*9A#(8+/1?A]HNMK<7:C-B^ MI6-[\R1O'5'_`()H:NS^,_VC?.C>R'Q#O?"/Q>T/3)BJO9Z'K]]XQT^V@A08 M7R++3+;0K>$QHB+$T28("XXN)ZBH<.8/#W7/F>:2QTHO1K#Y32KX'#54MW&O MB(483`SK15Z<<5GF*6*KT9RZ5J M6'RW*:W(MZ6.I2>J?+^N_5><8&,YSQ_(YQ^9_5>"<\9Y`/4=R/TZ]_PQE.H& M#S@=>G7';W]>#[XX7^7)/7J"2?;K^?TK\VW/TL^2_P!J..2;7OV7(XU+R?\` M#3/A-\`$_+#X+\?SR'/3"QH['..`>G0?6?/7@`\\\<<8!P"..W.?U!_,[_@H MC\0=1\$ZK^S%=Z/'+=7GA?XO3_%W4;2`YN)_"WPYT&XM/$L*;<%6N-*\77$< M+-E#*H4))C;7Z/:3J]AK6F:9K&E74%[I>JV5I?V%Y`ZR075E>P1W-I-ESE74GH:IQM&,K.TN;5^3M_GZ[C=&I",*TH35*M*I&E4:?).5+V;J MQC*UFX>UIW2VYE?Y^A]NG6O+?C3=PV/PA^*MU<-MBB^'7C1Y M&`&0/^$;U!>A*C.3W(Z$\8->I'IUXXQVXZC'?/&.W7@9%?(?[;WBQ/#_`.SU MXVT2"8?VY\2/[+^&GAVT1RES:0@HD-@X8C>H M*BKR2[M+3M?4NE2J5ZM*A2BYU:U2%&E!;SJ5)*$(+NY2:27=GRE_P3,BDA\1 M?'J">25YX/"_[-,+^:26/E?#_P`0QD-N:0J%;("9P".F>OZS_-V53U'Y$^N* M_+S_`()_VT=M\5/VI[=`%2VA^`T*`#`")X2\5HB@<8554*HXP.2PXFSJAI:AC/9+ELE:G2I13LMKI*5 MNE['X]?M@C/[:GPW&,_\8N>-\?4?%GP@0?7@X.!R<8[UR_@CQQXU^"'CJ[\? M^!+`^(]&\1PV-G\1?AXU]'I9\116(>#3?$WA^^E5[&T\5Z/:RO"T6H1I!K6G MQ1Z;/?6?DVLT/4_M?_\`)ZWPV_[-=\;^O_16?"'IS7*<<\]^V<\\$]^_`Z@$ M8SD\>C0A&=#EDKIRG_Z6S]RX)R/+^(O#G!99F5-U,/4K8V<)0G*G6P]>.+KJ M%>A4BUR5(IM.ZE&<6X3C*#:?VOI_[>/P.ELD;68?B5XUU&2VGQYD4A4\?,OQQ_:)\4_'_`$V;X?>$/#_B M+P'\*]14)XS\0>)@VD>+O&FE&3$_A?2/#ZL+S0-(U!(_+UG4=3N(K^]LY7T^ M#3$AGG9_/R@)W$J,'C`89/\`M;65B?QZ=B!R[`].F<#)SG'H/;)'.3QR!BB& M#I0FIIR;3NKNZOI_DA9;X/Y'@\;3Q6+QV-S"C2G&<,)4IX:C2DX2C**JRI\\ MYP323C'V*E9W25E'I?V<_$MK\,?VF/#T,GEV/A_XO>#)OAX%'[FUA\4^$KF; MQ'X1BSM5=]YI4_B33[&$;,NSYR^%/[$*R[1R.5)).>!C[W/.,#U''!&>GX5^ M*_#D?B?3!:I?7.D:I87MEK7AWQ!8[1J7AWQ)I,XO-&UJQ]TK4;!H;69WM[>\ND57;#%T9N:G&-TTD[;[::=;[W/A MO$[A#'X;.JV=X#"5,1E^81C4K?5:52;PN*A"G3JQJP@I.,*O*JU.HER7G4IN MSAK^D4C(`26`.<@9VDD#&,Y&`20*/$#:>)H2WG'1VMVE+6NR/WKXJ_MJZY MX[T6\\(?`#PGXPT&_P!71[*[^*GCWP_=^$]-\+6TPD6ZOO#F@ZQ&FN:]KZ`? M\2PR6EGI<#LEQ)75U(3+>7M M_<.S27%]>W,LEU>7,F9)[B6220L[$L\)0DI.Z\/3^"?VK98W.J>!]%T?X`?MJ:!8P%]071M(D:+P'\>?L6\7-SI^EW-TMU? MWP@G7_A%-;U",7,4/A^=T_2BQU"TU2QLM3TV[M[[3]0L[6_LKVTD2XM+NQN[ M=9[2[M9D+QSV]U&?-@FW.DZ.NQF`!K\TM;\)#4+V76]'UG4?"OB"73+C0[O5 MM(^R21:SH-VCI=:#XFT?5+:]T'Q/H5RLDBR:5KNF:C;J7>2)HS(/+^?]$\6_ M%G]EC2['P5XA\7^*/%/[-K330VVN^'=*C37_`(2P7=Q*PT;5H;2&\U.3X:@2 M&*QOM)NHYO#L;M9.'M/(C/Z1DE1YU@\/EO-"6=Y?25#+X3J*"S;+H3O2P,)R MWS++54<<+"3?UW`J.#HN.(PF&HXO\.\2/"#/^!LWS/B#+Z"QO`^8UY8S'8VC M+GJ\.8F;I0K8_,XC?-M>^)KV(V\\44N6$O]C6*RVLTV62&\O98@8WB=:Q/ M#/B*/P+XULM>O'\O0M>MXO#WB&?YPEDZRF?2=9N%7E8K6=KBUN')5(;>_,A= M8HR#R_A74_#6M:!IFI^#-3TO6/#UU;QS:?J.BWMOJ5A=PRE7\V*[MI)UG:1I M'EFE=V8R>:9F#\5NS017,3P3PQ303QM#-!*JR1R(ZD2*RNI!#IN&.P.05.#4 MU*4X.=.:<*U.;4XRBXSA4@[2A*+]Z+C-6DFKQ:::33-L-DN%J9$L!&K"K"O3 M6(ABJ=JE*=><5*G7I3CI4I)-J#C)J5.=T_A/M6*0.`\;J\;HLB-&V]=K`C(< M9#H^`Z,"20PZC%>/?&7QH=!\/2>'])N%/BOQ5')I>E6\;C[39VTX*:AKLR1D MRQ6MC:>>$D*IYER8T60,JUX-IDGBW0+9;'P[XWUW2=-3S/(TTIINJV]F)"7* M6,VKV-[5;Q2B--P*X[5[;2Q%7=]J^LW0"7FL:K.;O4+A!@K` MLN$2VM%P-EO`B0JV"R-R3*4Y)*6G>VS[?U^&Q\UA.$<9]:C];=)86G43E*%1 M2E5A&4;QC"UXN<>9>\TDKZWT(SHME_8K:'M/V%]-732NT,P@,*0^82&HM%U:8+XI\+PPZ9K5O)*'GN8H`8K#6U#'+V^IV\2 MR&159%NEN(VD+AJ\/P2`!@'IS@CK@\@9SCGZXX/-9UWI[27T&J6-[J&CZU9I MY4&KZ1=-97@CRA,$K+NBN;=R@+P7,4T;%1\F,TVDK22V222V:OY>K_K?Z7/L MF_M3#TE1Y8XC#1Y:3DW&$JVFG6=U?:A<16EE9P MO/=75PZQ0011*6DD>1RJ*%`)RQ7D=>F/BJXUF;QAXGUOQG(DD-E?_9],\.V\ MRE9H_#FF^9Y=PP<`J=7N7FOF0J'\N:*-]WD@U'J,&N^(%A@\5^+-=\2V,$HE M&FW4ME9:;,58&,W=CI-GI\-\5!;/VXW".>J`&KRJ(P`%C"*@1-N(T15R`-HP MJH%XX/8=.I-7K)6M9K2]]GMOT_'R=_.X?X15H1:HTZ)*^II[RVL[6>\O+F"VM;:"2YN;F:>.&WMX(XV MGFFFN)&$<4,,2-(\SL(TB4R9V=/ASQ!K?A_0-&O]6\4:GI6BZ#:6LLFIZCKM MY:V&EPVH!\TW5Y>R)9H@'S;7;YMK!`^TJ/BW5-;\7_M/[_"?A?5O'7@K]F5! M)#KNISZIJ^F7WQ=*R2*=%\):9J!6XT;P(=T4^IZPH237-BV=M;16"E&6*Q]:*<<-@Z7[RI*2G4E2P\*M>G MQ9WPWC,SSK#Y?PU1AF/$&<-_5,E@Y0E%\RA6S+&UU&K3P&4864JZK8,MC+,;_Z&^#_B:R^#_P"T M-\+/$$QBTSP?XPT*\^"VN7&%M[+39[MX-4^'\MT2%5+===LI-`B"E(5FUU)G M81QD-QG@SP)X5\`Z6FC>$]#L]'LD2)7\GS)KFX\B%((#5.']/\`!?@O1X5X`S/AZMBZ.-XCSJ2S+,\V49JC M6SA3C7IQIJ`A0I:JA%O]R4D4HI#`@JI+`Y_A!.#R.1R. M>^<@8R.^.`X!ZMS@A6&`2,#&!SGV/(P*_*'X;?M>_%GX8:59^$_B9X`U3XQZ M?I-O#8Z-X_\`!.J:)9^++RPMPEM;KXL\->(;C2K&YU:-$07FKZ;KJI?NLMTV MG132[!8^(_[8?Q7^(NDW7A?X7?#K4_A);ZA"]MJ7Q!\?:AH-]K^E6KT?3U/RU\%\5_7/ MJ"R+,'B.90O*A4CAO>=E.6+<70C3UNZCG91U:OH<)\>_&%M\5/VF/%4]F\>H M^&/A%X6C^&=E/')'/87_`(IURXM->\&?#VG^%M%LM%TQ9C!:&>2 M:>[F-S>W][>3R7FH:EJ%[(3/=ZA?W<\UW=3RDEYYG*B./9&F_@'WSZ$#//7@ M\\<^F0>AS7H_5XNE&E+IK=6NGI=>FA_0%'PVRJOPKEN0YCS1Q>$=7%/'X9VK M4<;BW&>)Y'*\*E#W:=)TYP:E&C&490EJ?:]_^WG\#8K0R:3%\2O$&J+@#P_I MOPP\;0:HDI!VQW#ZMI.G:;:9;Y'DNKY(H\[WFV-= M,/A?0?#$-Y;?#_X?)?KJ,NCR7\4<&H>*?$M[:^797?BC4;3-A#:V*S6FAV'G MP6U[>R7=U+(QE))P<$G)Y`W=,Y4#[V.^XYXYQT\+C5C;V=94X M04YU:=N:+G4<8S=U'1'NG[`__)7/VKN^/^%$>_\`S*GBWKZ]/KZ MO52>I/M7YA?L$?\`)7/VK_3_`(L1G_PE?%O;Z9S_`"-?IYM/]XCK_,X[CM7F MUOXM3_$O_24?@O''_)7\0_\`8QG>_?V5(_'O]K__`)/6^&W_`&:[XW_]6SX0 MX[]>EZL['7O&GPW\77FD:E.?".H:E6%AXA MTVYUO3?[0M-4;2IA\4IXN\2@8N/@=^T9:S@#S[:X^!WC^6:"7^*-WLM(N+5F M7`!>*9Q(07)8L9)/0PU2FJ24IQ4KR=FULW?5MJVY^T>&7$N1X;AC#9?C,SP> M#Q6$Q&*C5I8K$4L/)QJUYUJ=2'MITU.$HRLW&3<9*S2NCO^.OMCN.N/?/0XR>%_P"$PU__`*(M^T3^'P*^)6/P'_"/GC]/ MPIQ\8:\.GP7_`&AS[?\`"AOB./U702?Z5T>UI_\`/R'_`(''R\_3\#]"_P!: M.'+V>>Y2NW_"C@G?5=%7=M'?7T.Y]>V1C/4X&3R3GCH>,8)QFESCKSD\YW#( M`'!P!D9/0CDXP>H/"+XOUX\GX+_M$#MQ\"_B2O3V_P"$=.:4^+]>P1_PI?\` M:(Z'C_A1'Q'S_P!]_P!@!L_[0&1U`S1[6FO^7D/_``*/=6Z][!_K3PVK-9]E M*:V:S'")IZ;/VVF[7G;S.X4;=N"WR@?>.['RA22<=<#O\IX:@#''S#ZEFV]3 MGG.T9Z@$+RQVC)K@O^$NUX*,?!;]HDG/1O@9\3)`!SV?0`/QSD=,4Y?%^OXY M^"O[1'7M\"/B,/T.@_K_`(4>UIWUJ0_\#CLM.XUQ/PVTKY]E,=_=688*RU5V MK8BR;NV[*[MK<[T<'AL$$8.>1U/3&/S_`*"HWBCD0I)'')$\;1/$\:/#(CDB M6.2)D9)$EW,)$=71]S#:`>>)_P"$PUW_`*(O^T1_X83XC']?[`Y^O>C_`(3# M7?\`HB_[1'_AA/B-_P#*&A5::=U4IWV^*-UMMKH]M5KM8'Q+PU)6EGF323TM M+,,#+1\M]Z[M>^MM['F.I?L^:9I>JWOB/X/^+?$?P5\1WTK7.H+X3EM+CP?K M%QM9C/K7@;61=>'+DLY(GDLK32[B4.\@G-QMF6Q#XN_:I\&E(]7\(?#;XRZ< MBR;-2\,Z_>?#?Q)<1C#"XN-&UZUUW1`Z`%%@T_59EG?:QEMPQ5/1O^$QUW_H MB_[1'_AA/B-_\H:/^$PUWI_PI?\`:(QUQ_PH3XC=?7_D`U]10XSS!1A3S!X# M.Z4(QA!9M3]OB(PC&,80_M'#U<)FSITTDJ5%YA[*$>6,(Q@N5_DF;^'?A-F% M>MB\ISJCPAC,1)U*M7A;/L!@\'4K3:E5KSR#&O'\,RQ%:3YJV)_L58JI)2E4 MKSE)R.+A_:;N++9'XM^!'QZ\-NRY,MAX+MO'-L9,D&*%O`NK:[.Z9`VS2V]L M2.3$I+`3Q_M>?!F.=8-7N?&_AB4LX>#Q/\-O'>D/`(T21WF670W=$7?Y9D*G M$@)`(`SUO_"8:[U_X4O^T1D]3_PH3XC<_P#E!H_X3'7>/^++_M$<*+1KKQMXIF8J( MX_"OPT\>ZVT@=`R&%8/#Z&0,`PZ+C/`-=>?&&N'C_A2_[1!SZ_`7XBD>O.=` M'\^M(?&&OYX^#'[1.<=1\"/B0G`Z`E=`.<=@>G;K37$O#45IDN9REO%U>)L) M**>F\*7#M"4U;I[6*3::[/GAX>5Y2BJOBWP7&-[OV'"7LZC6E[2K>(6)@M&[ M7@[/I>QQ:OX=N_)$K* MCRVEG=%!O?80J[\N3QC^U1XS*1:-X,^&_P`';"41A]2\4Z]?_$/Q#&LF]6N+ M31?#]MH>CF6,[,VEYJX5'/\`Q\3("#Z./&&NX.?@O^T1SDG/P%^([$DDG)8Z M`"#\%_VB"/0_`/XC?3_`*`'IQ64N+\'32^I9'E-.:5HU\;B M,9F-5/1W]G4Q-/+YN]G%5=^*./S*"=YX++L?PYP M_@ZJ;BU&5?!T*V?4;;O:?-] MHL[?Q3);6'@G2+I#E)-)\`Z*EIX&PE%0PV'IRFU*4*%*E"<[3<%*UOU3AO#^''".'JX;AW$UI?\_*?_`(''_/S7WGTG^LW#G_0^R?I_S,L% MY?\`3_S?W,[@KG!)(.,9!P!UX`X`/?.T,.?FSR`+@DC()(&>ORC!"@'=A>#@ MCYADC/)KA_\`A,-=_P"B+_M$?^&$^(W_`,H:/^$PUW_HB_[1'_AA/B-_\H:/ M:TO^?E/_`,#CY>?I]_F'^LW#EDO[>R=+LLQP*WM?:OYN_HSN5&T!1T&,`]AN M)P,YZ$]1Z9Z=`3!YQSGGK_+TSU'/!)_'A?^$P MUW_HB_[1'_AA/B-_\H:0>*?&5VPMM%^`7[1FMZG,RQVFFQ_!OQ1HC7,I.44Z MIXIAT#0+"/=GS;B_U6UMX5'G32HGS4O:TNM2'RE%[VZ)^:U\UW(GQ3PU"+G+ M/LI22N[9AA)M:+[,*TIO=KW8R>FW;ZN_8(_Y*Y^U?W_Y(1Q_W*OBWG\.O;ZB MOT[R?[K?]]'U/I_G\,5\0?L4?`CQ]\)M`^(7C/XK0V&G_$?XT>,;/QAK'AK2 MKZ+5;+P)X;T;PUIGA?P7X%DUB!([75M8TG2M-DU/Q-?Z='+I+^*M=UJ'2+_5 M-*@LM0N?N'/^[_WU[_3_`":\:K)2J3E%W3?Z+_A_F?R7Q3CL/F7$6N.Y[#_`!/XZ=Z3!P?F/!8?D#_`/J]J**```YSGD;>W][_``]*09QG/3(Z>@+? MK_GCBBB@!X!/\6.`>@]^/P_STHVG&-W'7@`444`-RV"<]`O8=_Y8I5R> M?0=!_>('Y8R***`%P<#V./IST[8I`"0.>H/&`>A_Q-%%` M!@C`SZ?PCU'^.:7#8^]U..@]: -7:O<>OMW]O2BB@#_V3\_ ` end GRAPHIC 14 f10k123112_10k002.jpg IMAGE begin 644 f10k123112_10k002.jpg M_]C_X``02D9)1@`!`0$`R`#(``#_VP!#``,"`@,"`@,#`P,$`P,$!0@%!00$ M!0H'!P8(#`H,#`L*"PL-#A(0#0X1#@L+$!80$1,4%145#`\7&!84&!(4%13_ MVP!#`0,$!`4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P``1"`"U`ID#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]4Z***`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/$_C1^V9\(/V?/%4'A MOQ[XM&@ZU/9K?Q6QTZ\N-T)9U#;H87`YC;@G/%,^$W[:OP6^..L2Z3X+\>6. MJZNI7983Q2V4\X*LY,23HC2A41W?8&V*N6V\5^?W_!3?3?#VL_\`!0WX,Z?X MM:`>%[K3-'AU9KNY^S1+9-JMT)RTNY=B^7O)8,"/7I7EG[9W@_X.?"7XO_"N M[_9BU*VO_%:7"W1LO#E^VNQQ7D<\1LC&SM+OF9_,!B#./W47[M=Y,@!^OOQE M_:"\"?L^^%+/Q)X_UL:#HMW=K8Q70MIKD-,R.ZJ%A1VY6-CG&,#M77^$?%6E M^.O"NC^(]$N?MNC:O9Q7]E<[&3S894#HVU@",JP."`>:^$O^"T(W_LK^%I"6 M^?QC9G:3T/V&^]R/RKZO_90P?V6_@Z0"%/@W1R`3G`^Q0X%`$_QN_:3^'/[. M>G:;>_$3Q)#X<@U*9K>R$D4D\EPRJ&TW$,+M',/BQH-[XW^%VJV=NUOIUO?W$&VUCMQ!+;Q2Y4+)'<%KDPQL`1.A M9E\XD?8/[('[&'P?\!>.S\;/A-XKUG5_#NO:L;.%)9"TRG;M>14"I M$L-SN:*2)C)OD5#&`?9L4HFC5US@^HP13)9BCA0%/3.6Q_3Z_E1:%S;IYB[7 M'!&<]_7O]3S[#I7Y??\`!1_QYX\_:#_:2T#]F+X=ZI;I:W%M!<:M;%VME:[( M:Y(NI3]Z"*V2&<(@.6.?G=450#ZR\3_\%'_V<_"&N7.D7_Q,L;B[MBBR2:59 MW6H6WS(K_+<01/$X`89VL=IR#@@@>G_"/]H3X?\`Q[T-]5^'WB>P\2V\1`N( M89#%ZC<6:[]BJRQ0VTD:I'N5F"MYC#?@R.`#7#?\.GK3P-^T#X=\9?"_XD MZSX%T*QFDOIH4VW%[;2&5LZ/<> M*7U)XKFPT379=7B-D(F=I9@TDHB9)/+"CVCCXA^(#H`U<3&Q/V*YN/.\HQB3_`%,;A0OFIDL1]X8S M6]\$M7\0:W\'/`E_XJCN$\4W6A6$^K)=V_V:=;I[=#-OBP`C>86RH``.1@8Q M7Y5_M9:1XK_;\_;<\7^`_!]Z;W2?`>BWD5E#`3&OGVT7^D*4N)43S9+YX[4R M)M7R_*<[ECRP!^NGA3Q9I_C?PMI/B/1IOM>C:O:0W]C=%2@GMY8UDC?:P#+E M6!PP!&>16NK;AG&.U?"/_!(WXW7OQ,_9]O/#.KZE_:&K^"[Q;.-',CS)ITRE M[8O*Y*LH9;B-44YC2W1<`;:^[++_`?@^]-[I/@/1;R*RA@)C7S[:+_`$A2EQ*B>;)?/':F1-J^ M7Y3G6^G?^"1OQNO?B9^S[>>&=7U+^T-7\%WBV<:.9'F33IE+VQ>5R590R MW$:HIS&ENBX`VT`?=RMN&<8[5RGQ2^*GAGX+^!]2\8>,-1.D^'=.,8NKSR7F M\OS)$C3Y8U9CEY%'`[UU-N28$W8)QR5&!7RQ_P`%10!^PO\`$QNX_LSD?]A. MTH`N:3_P4P_9LUK4[.QMOB9`DMU*D*27>E7]O$I9@H+R20*D:Y/+N0JC))`! MKZ.TG7+/7]+LM3TJYM]2TV]B2>UO+68213Q,`1(CC*LA4[@P.&&,<'-?B]X# M^%O[,&H_\$_9_$_B77]'TSXS1Z9J+Q+%XB83@QG0]2)![C*VY!XSTR/?FO>/AS\7O"/Q@\*1 M>)/!&O:?XGT>0+BXL;A6\MS&L@CE7[T4@5TS&X#KNPRBOQB_X)U?#;]G_P`? M1>/_`/A>MQX?L_LCV']D'7O$#Z5DM]I\]8ML\7F8VQ;A\V"R<#//LO\`P28N M3I7[4WQET/P;?7^K?"E;"8V^H75OE;CRKT1Z:TLAC4H[0271"$)N^<[/D&T` M_4[Q5XTT3P-HUUK'B'5;'0](M%5KC4-1N4M[>+I^GO;#CWKX@D\)Z__P`%5_VN/$LZ^()M-^#'@R98 M(YTE^:"S8E0UM$Z+MFO&@DE+R(QC`"N7$4:/]D1?\$J?V`NT`4`?5'ACQ?HWC;1X=7\/ZG9ZYI$Y M=8-0TZX2X@F*,5?;(A*G:RLIYR&4CM7)_&+X_P#@C]G[PI:^(_B%K`\.Z1<7 M:V"3_9I[K,Y1G"A8(W;E8W.2!TYP37Y>1^"]?_X)2?M<>&+BY\0S:G\'/%\S M6TL[S!&DLP0DAN8E1SYMHURDH:-1YH.$*>9(B_0G_!9O)_97\+LS>8\GC&T( M96^0G[#>C(Y.![9QSZT`>LC_`(*B_LRMC'Q*'OG0M3X_\EJ]2^-_[4_PT_9P M713\1O$7_".?VR)S8`V-S=>?Y.SS?]3$^W;YL?WL9W>QK\W?A8W_``3T;X9^ M#CXU*GQE_8]E_;G_`",.T7GDIYX_=?N^)-P^7Y?2NF_X+>NT>+'/?Z^]`'U6?\`@J)^S-NVCXE`\\G^PM3P/_):O MMP>'=#CFCMOM$ZO(TDKGY8XXT5GD;`8[54D*K,9MVDMC.00-[XL?&WP9\#?!L-(LV8_\` M"+C47!LKT1)'Y$K%C,NT,YDC:21)O,7#&`E)/(O^"NWAG6M$^,'PH\15`A>YA\M5D4F0_9W//EK0!^@_P:_:I^%G M[0:W"_#_`,7V7B"[M][2Z?MDM;P(OE[I1!.J2&/,T8\S;M);&<@@-^-W[5/P MS_9Q71&^(OB(^'!K7GBPW6%U<&8P^7YO$43E<>;'RV,[N*^5_P!E7]D']GGQ MOXW\+?'OX/Z_KUAI%FS'_A%QJ+@V5Z(DC\B5BQF7:&#? M$']O7X#?"[Q1-X=\0_$2PBU>`,)[?3[>XU#R'5W22.1K>.01NAC;);Q+:X\AIK*60VT-JSD`;;B M/#OBBZP?$%GG2];`P2;^)4W2C"(H\V-UF*J,)YNWG;F@#H?@O^V!\)OVAM0U M33_A_P"+(==U+3H4N)[-[>:UE\MFV[T29$,BJ M,;3XJ^%4G?2]%U*TTO5[>.ZCB6_BN/,E^Q."&)66.RG^<(^QHT;APF?T2_X* ME?$72/C+^PY\./&>@7!N-$U[Q-87MLWFI(\1:QOM\+B-F421$-&ZAL*Z,,D@ MX`/T6\(^*M+\=>%='\1Z)<_;=&U>SBO[*YV,GFPRH'1MK`$95@<$`\UR?QI^ M/W@7]GGPU;>(?B!K1T'1KB]33XKG['/<;IVC>0+LA1VQLC<[L8X(SFL?]E.Z M0?LP_!Y%5BH\':1V)*C[#$0.G/`_SFO@;_@HEJFK_M4?MA?#S]G3PYJZ6UC9 M^5<:H%60"UNY4,LTLJ2.D<_D6*+*@7#?OI4#;F*@`_27X8_%CPO\9/!.E^+_ M``?J7]K^'=3,@M+P6\T)E\N1XG/ER(KKAXY!\P&=N1D$4?$[XK>&?@UX$U#Q MEXPU'^R/#NG^5]JO!#),(_,D2-/E12QR\BCIWKX#_P""2?Q(US0[WXD?`7QE M</"M\]Y:::WF3O`5F:'4(_-0M$$CG$1`!^9YY&4L,X]\_X*?;/^&$OB4Z M$,"-,8,F.]`'T)\+?BEX8^-/@33/&7@W4_P"V/#>I^;]DO?(E@\SR MY7B?Y)55QAXW'*CID<$&NKKY6_X)=?\`)BOPSZG_`)"?7_L)W=?5-`$,ER(F MPP`&0H;<`,G&`<]R3TKP7X@?M[?`;X7^)YO#WB'XB6$>K0AO.M]/M[C4/)97 M='CD:WCD$;H4;WNUC78&E%O,J2M&#*@\P(5W-MSN!`]26[4DYPJAMN2<=@?\]O M>OSM^+W_``2&\-R^.-`U[X0>+[[X;-#>">YCE=[L:?LB4P36;EUF5_.B4DO* MQ!E+*R^6$:7_`(*=_&?Q-HND>`?V?O!>L7][XY\9M!!J%V9H[:>^M'8VL4,I M2..,?:IR^[RRBJ(75EV2XH`^E/B#^WK\!OA=XHF\.^(?B)81:O`&$]OI]O<: MAY#J[I)'(UO'((W0QMN1B&`P2,$&NG^"_P"U5\*_VA1=+\/_`!E8:_=VN6FL M<26UTJ`H#)Y$RI(4S(HWA=N3C.<@?,OP,_X)%_"?PKX*@7XD07/CGQ1=1(]\ M8]1N+6QM9@S$I;K"T3LH#!"\I8MLW`1[BH\@_;-_X)D:9\*/#MY\5/@9?7_A MRY\.*=4OM(DU%L6EM#&&-U9W#'SHY(S$TC*SN7!;8RE0C@'ZE_:>,[">^,'( M'/.,9[=*^7$_X*A?LTR;0GQ&+.3C9_86I'GN.+8YXSTX]^:Z/]A_]HIOVE_V M>/#OBBZP?$%GG2];`P2;^)4W2C"(H\V-UF*J,)YNWG;FORW_`."=7PV_9^\? M1>/Q\=+KP_:BT;3QH[:]XA;2BP60X&>0#]G?AS\7O"/ MQ@\*1>)/!&O:?XGT>0+BXL;A6\MS&L@CE7[T4@5TS&X#KNPRBO,/BC^WI\#? M@QXXU3P=XP\;C2?$NF+$;JQ_LJ^G\OS(DE3]Y%`R'*2(>"<;N>017PQ_P28G M;2OVI?C'HG@R^U#6/A2+*;R+^Y@!$XBO0FG/-(44H[027)"$+NRYV?)\O)?' M'PU\/_%O_!7#7-'^*UO%C39NE\B=8Y#$#(@\P+LR< M9R"!Z3J>NV6B:?>:AJ5U;Z=IUG&\UQ>7U.__`&I[KQ9_P4(_;*N/@CX&UE=-\$^#@PU.65V$`FCD$=[?-;LJ M&62)Y!;(A8@E=Z.J2NP`/LC4/^"E_P"S;INHWME+\2X))+.1HI9+72K^XAR& M*DK+'`R.N1@.K%3D8)!!/MOPU^+O@_XP>&(?$'@SQ#I_B+2I-BF6QG#F*1D5 M_*D7K'(%=,HP#*3@@&OF[PI_P2D_9TT'0K*UNO"VHZ_>0!C_`&MJ.MW27,N6 M8J6^SR11?*&`&V,<*,D\D_&GQX_9[\2?\$P/C!X1^*OP[UW4-4^'=Q?PV%U! M"&2;R]\JQ(=J*6.7=1P._XUX?I/_!3#]FS6M3L[&V^)D"2W4J0 MI)=Z5?V\2EF"@O))`J1KD\NY"J,DD`&N<_X**^)=+\9_\$Z_&7B/1)Q=:/JU MEHVH6-PJLGFP2ZA9R1-M8`KE64X(!'2O@_P-\+/V8K__`()^3^)_$6M:59?& M>/2M1ECBMO$+'5&NDO)A:1BQ\U@%95B5OW7^KD=\CEZ`/VATK7[#7=*L]4TV M\@U#3+R%+BVO+242Q3QN`5DC9%?@WX*U3Q=XPU0: M1X>TOR_MEWY$LYBWRI$O[N)66,<*<;@3QS7R7_P`$B-4\0:E^R.EOK$

8S,02<-!&S;!@D`^YO@Q\??!'[0OA MBX\1?#_6?^$@T2VO7TZ:Z%K/;[9UC20IMFC1ONR(=V`/F')-9?QN_:G^&7[. M1T0?$/Q)_P`(_P#VT)S88L+J[\X0[#*?W$4FW`EC/S8SN]CC\_\`_@G9?:W^ MR[^V-\1?V>/$NHKR9Y7WG=B.-&;(`/W MY\:?V7?AE^TA!H3?$;PU_P`)&-'\XV`:]N;4P><8_-_U$D>[/E1_>!QM[9-` M'EZ?\%1?V:6!+?$4H%^\?[#U(X['I;'H2.>ASQ7J?CW]JGX8_#+XG^'?AWXE M\2#3O&/B#[/_`&;IOV*YD\_SYFAB_>)&47,BL/F8=*_+'_@E3^R_\,OVDO\` MA9X^(WA@>(O[&&E?8/\`3KFU\GSOMGF?ZB1-V?)C^]G[O&,G/J?[>P`_X*D_ MLY!LLV?#IW9Q_P`QNXP/P.?SH`_4T72Y.["@-MSGC.`?\_3\*\&^(/[>OP&^ M%WBB;P[XA^(EA%J\`83V^GV]QJ'D.KNDD`KRYC\9>.IXEO5M[GR6GLI9#;PVK.P'RW$Y<';(N%@96!24 MBMCX&?\`!(OX3^%?!4"_$B"Y\<^*+J)'OC'J-Q:V-K,&8E+=86B=E`8(7E+% MMFX"/<5`!]-?!?\`:J^%?[0HNE^'_C*PU^[MTFO[V?8[F*WB0N[[%4L<*K'`&>*_ M,K]LW_@F1IGPH\.WGQ4^!E]?^'+GPXIU2^TB346Q:6T,88W5G<,?.CDC,32, MK.Y<%MC*5"/[OX(_:%_X:7_X)L_$/Q1<[/\`A(K7P7K6EZ\`1EKZ*PDS)\J( MH\U&6;:HPGF[>=N:`/HWX+?M*_#?]HG2=2U'X=>)X/$D&FS+!>*L,MO+`S+E M"\)/^$>763.+`FQN;GSC#Y?F MC]S&^W'FQ_>QG/M7XF?L<_'SQ-^R1XUT'XAM#J-Q\.]:O+C1M6TZPN8O^)@; M>*)I2(V)_>P"]AD0MMW;F0.H:3'U9_P6MU>RUS3O@1J>G7T%_IE]#J]Q;WUG M,LT5Q"XL&21&4X=64@@@X((QQ0!^KR,67)&#Z9IU-0`+@9X]:=0`4444`%%% M%`'Y'?\`!3CP?9_$;_@H9\&_!^I37$&F^(=+T;2;J2U8+*D4^K7<3%"00"`Y M(R#7U]\"O^"9/P8^`WC"V\4V%MJWBG7;*XCNM/NO$MS',MC*@8;XXXHXHRQW M9#.K%61&7:RYJS\?/V&?^%X_M3_#GXR_\)M_8O\`PA_]F_\`$E_LG[1]K^R7 MTEU_KO/79O\`,V?<;&,\YQ7U50!^?G_!:,"/]ECPK#N9BOC&TP7;)/\`H5[^ M/?O7U3^RK*8/V7/@ZA7E?!^CQMST864(P?QX]JYG]M+]E+_AK[X7Z7X._P"$ MH'A,6.M1:Q]L.G?;=^R">'R]GFQXSY^[.?X<8YR/EGX6?\$AQB@#Z"^)7[0G[.'QC^ M)3?`KQ?J.E>)M3NY);9[>ZMG^R6UX$54C6[(`CN6$LBQM$^58.F]9&17^$/A MYHVH_P#!/O\`X**Z#\._#GBD^*O"?B>ZL]/NM-2Z6.5;:[=HH%O1L*K<0-)Y MP*!?,0J08Q.R#[3_`&QO^";WA']JS7;+Q-9:S_P@OC!,1WVJV^GB[348@I"" M6+S(\R)P%DW9VC:0P5-F%^R__P`$KO`W[/WBZU\7ZYKT_C_Q1ITQFTQKNR%M M86;#84E%OYDA>9"K;7:3:N4(0.BO0!]L6S,T"%V5G(Y9>A]Q[5^3W[8VM_\` M#)7_``4U\,?&35;#5-;\.ZQ8K?2+9VPC\K%FVFRQ0NY*321A8IRI*?ZZ-3LR M)#^LB((U"J``.@%<3\6_@MX-^.OA*;PSXZT.W\0Z)),MPMO.61H95!`>*1"K M1M@L-RD':[J42BN$D3[T M4@1T+1R!67<`P!XKS_5/VQ/A%9?&W2?A4WC*P?Q=J*S1J+:19(+>Y20(+2:8 M$I'.[!PL9.)O^"(&BW>LW$GA[XM7VE:.2K06FHZ$EY<1_(H? M=,D\0;+!BO[L;00#N(+'W3]F3_@E_P##+]GW5M-\2ZK--X]\:V,XN;?4]0A$ M%I:2*TNU[>T5F53MD3F5I_:OM/D'_MA?'"W_9\_9]\9^+#?M9:K%:-9Z.42&20ZC,"MMLCE.V0HV)& M7#81&;:0I%?D_P#LC_$3]I']F'PMJ(;'Q2+:_?6K[POK%T+J!8B M8!$T4B1&,"61@RKEO,)W,H3;^G?[;'[(.I_MA>'?#6@)X_\`^$/T32KN6^N+ M/^QEOA>3%`D+[O.C9#&K3C`)#";D`J#7O?A'P?I7@7PIHWAO1;;['HVCV4.G MV5OO:3RH(D"1IN.2:`/Q4_9Z^.'B?X&_M\6?C7XH>&KOX70^.9 MI8=>TRYL9K.,0WC$+='[.+[9$LSR!QM$<@3Y1Y=?MU'<;$(VA<`'YCC+' M)/M^OZV:`Q":)<.R M0-O))'E$#`=J\>_;C?QSXLO/@!^S[H7B+61XU\0:G;W^K^-=,A>P0BRBW2W/ ME*R1.P?=>&%)=T9MHL#,D34`?>,4@EB1QR&`(Q7B?[8GQRM_V?OV?O&?BTW[ M66JQ6AL]',:0R2'49@5MBD=&R&-6G&`2&$W(!4&@#\Q/V1_B)^TC^S#X6U. M;X;?`?4/$-CXI%M?OK5]X7UBZ%U`L1,`B:*1(C&!+(P95RWF$[F4)MM_L]?' M#Q/\#?V^+/QK\4/#5W\+H?',TL.O:9RAT^RM][2>5!$@2--SEF;"J!EB3Q MR37@W[:W[%>E_MB^&?#5E-KY\+:QH-Y)/;:H+-KL>1+'MF@,0FB7#LD#;R21 MY1`P':@#Z/@&(5XP2-Q'N>3TKY8_X*C_`/)BOQ-_[AG_`*=+2OI7PEINI:-X M6T>PUK5AKVL6MG##>ZJ+9;;[;.J`23^4I*Q[V#-L!(7=@'BO/_VH_@7_`,-* M?`KQ/\./[;_X1S^VOLO_`!,_LGVKR?)NHI_]5O3=GRMOWAC=GG&"`?GQ^P]_ MP31^%OQV^`?@3XE^*]4\33WNHRW+WFD6U[#%93)!?SQ"(XA\U4=84W;9`V2Y M5ER-OZ;>!?AUX>^%_@K3O"?A;38M%\/:;%Y%G96N0(4)R?F)+,Q8LS,Q+,S$ MDDDUR/[+OP,_X9L^!7AGX==2S_ZK>^W'F[?O M'.W/&<#U1AN&*`/YTO@K^S?-\:/@-\9_&FFW-X->^']OI^HQV:-'Y-S9R?:C M=[RQ4J42$R@@G(C==K,ZD?J5_P`$H]>^&>O?L^S2^"/#<7ASQ5;316OBI#=B MXN;VZCB39=;RV]89^>*_P`&?V#I_@%^TAXC^(?@KXARZ1X,U^>::^\! MPZ-&ENRNLA1%E60*@AEE9HRL0*)^[R06)`/C?]BCX@Z)^P+^U-\3?@[\29#; M0:M>VFGVGB5]@MD\OS7M7G16;RX[B.[C?[[>46428&YX_P!7F\9Z%;^$T\2+ MJ^GCPS]B74!K#7D8L_LQ7>LHFSL*%>0V[;C!S@YKR?\`:4_8N^&7[5-O`_C+ M3)X-:M;?[+::]I3K#?6\7FK(4W,K)(ORL`LB.%$DA7:SEJ^)_P#AQUEU)^-9 M(!R0?"N;V@#D_P!MGXD:1^W[^U/\,_A!\-;@7EII%[>6=SXECD2:WF\U M87NI($+*)(X(K1W#;P)B&"9`5G]X_P""T0V_LL>%F&1_Q6EK@,`,?Z%??Y]Z M^BOV:_V*_AC^RM;RR^#-+FFUZY@^S7GB#59?/OKB+S"^S.`D:YVC;$B!@B%M MS*&JK^VA^R?_`,->_"G2?!?_``E(\)"PUF+5A>C3OMF\)!/$(_+\V/&?/SNS M_#C'/`!XQ^SY_P`$Y?V>?'7P%^&GB76OAZ+S6=8\,Z9J%]6UBDD M;:MP%7+,3@``>E>*?\%PD(/P51I)^P=,]?YU^E/PG\"_\*O^%G@W MP;]N_M/_`(1W1;+2/MOE>5]H^SP)%YFS1_P!-HMNWR/\`:SN[8Y`(!_P3$_9C\M91\.%9 M"-Q8Z[J>"O7/_'S]/:M_X]_M2?`;P=XQL?A/\3-6TK4KW6)+:&_TO4K);O3[ M)7W2P27[2`Q1IO2,X8[EWQ2,!'F0?(0_X(=R"<3?\+O;S0VX/_PBG(;.<_\` M'[7UQ^V#^PMX/_:TT.Q>>X3PQXPTW9'8^)(K);EU@!^:WFC+)YL7)95+#8^2 M#AI$D`/SO_:*\"?\.S_VI?"?B[X9^)&?0=7SJ#>%1?NMZE@)4\ZRG+*X-O+A M_*ED4L#&V07@$C?HK\>_VI?@'X/\967PH^(^JZ5J-UK$EM#>Z5J-BMUIUBC; MI8)+YI`8HDWQQD!CN7?%(56/,@\,^!?_``1X\"?#?QE#X@\;>*KCXC+9SQW% MII;%R65=PV.20<-(D@!^=_[17@3_`(=G_M2^$_%W MPS\2,^@ZOG4&\*B_=;U+`2IYUE.65P;>7#^5+(I8&-L@O`)&]0_X+D!5C^"0 M3`4#6\8Z?\N'3VKU+X%_\$>/`GPW\90^(/&WBJX^(RV<\=Q::7+IJ6=FS+YF MX7*&24SJ2R-LRBDH0XD5BM>L?MQ_L+?\-FQ^!U_X38>#O^$9%Z.-(^VBY^T? M9^WGQ;-OV?WSN[8Y`/F__@JGX:U7X6?M`?!G]H2*W75M$T2[L-.N-/9T@/VB MUNI;Z)?,;51?:>6+*([F`$M&^Y&`ZJV,HS*58];X_P#AWX?^*/A#5_"WBK38=;\/:M%Y M-YI]UDHX!!!!!!5@55@RD%64,"",U\`_$7_@BKX0UWQ/<7O@WXA:AX4T6?<_ M]DZCIHU/R7+L<1S>=$WEJA1563>PVDEV+<`'JW_!0_\`:W\!_"SX->+_``.U MY;>(/&_B73+C1$T&SG#3:>+BW"FXN]NXPJJ3HZ(PW2$J%&-SQW?^"6_P=U3X M1_LE:5/JEQNO/%U])XH2$HO[B&>*&.#YE=M^^*&.;)VD>=M905-<7\`?^"0? MPQ^%VK+J_CC5)OB?J$$WF6MK=6OV/3H\&-E9[<22&5P48$.YC97(:(D!J^[T MBV1*F>![8_2@#\@/^"27PYT?XN_#O]H?P;X@M5OM(UNQTJQE@R@=2XOBLL>] M6021LJNC%259`PY7!^8OC-K7CKX+>"/$'[-OC:Z1R/US_8A_837]C9?&:GQJ/&(\1FQ)SI/V+[/] MF\_!'[^3<6\\<\8V=\\/_;7_`&!]$_;"?PWJ(\0CP;XDT4R1?VG%I<=V+NV? M#&&5=\;MM==R'S,+YDWRDOE0#H/A/\2=%^%'[#OP]\7^(92FEZ'\/],U"X/R MAV*V$11$,C*ID=@$0$_,[``Y-?E)^S+\3_VB/A[XS\4?%[P/\(-2^(.K>-/M M`N/$ESX?8S.4\R5Y'V;B%W[1P!0!^+OBCXZ_ M%+P3^U]X.^//Q,^&]_\`#?5GOK?[<(="N[9=2MHT6WN?*COY&4R?97$6$=`, MHWRL2]?I9_P4KU>S\0?\$^_'VJ:=>6^HZ?>V^D7%O>6DHEAGC?4K1E=''#*0 M001P017I7[7/[+VF?M8_".?P7?ZF-$N$NX+[3]3^S&X%I.C89S$)(]^Z)I8\ M%@!YA;D@8YGQ1^R'JOC/]BB/X!:S\03>WL=G::>OBLZ,J$06UW'-`OV590#M MBACAR9,G;O)))!`,?_@E]*L7["GPT+$!1_:F2>@']J7=?58R0,\'OBORPC_X M(<-%(LB?&TJZD%2/"G((.>/]-K]3HXUBC5$&%4!0/0"@#\O?^"JNE7WPJ_:5 M^!WQRCM9]6TW3);:VN+(6[)$LEC=F]C4W.'"M,LLP4;,J+=V&X9V_>?P'_:- M\`?M#>"[/7?!&NV]]&;>.2YTR25!?Z>6+*([F$$F-MR,!U5MNY&92K'J_B%\ M-_#OQ5\)ZKX8\5:='K.@:I#Y%W87'W)$R",$72'%Q:W4M]$ MOF-N;]\K3+N6-@GDDGEE4^F?`'_@D+\,?A=JJ:OXXU.?XG:C;SB6TMKFV-CI MT>UHW5GMUE M51?:>6+*([F`$M&^Y&`ZJV,HS*58^"?\%#_VM_`?PL^#7B_P.UY;>(/&_B73 M+C1$T&SG#3:>+BW"FXN]NXPJJ3HZ(PW2$J%&-SQ^4_$7_@BKX0UWQ/<7O@WX MA:AX4T6?<_\`9.HZ:-3\ER['$9:VMU:_8].CP8V5GMQ)(97!1@0[F-E*$A*+^XAGBAC@^97;?OBACFR=I'G;64%37Y(? M!3]F^;XS_`7XS^,]-N;P:[\/[?3]0CLXS'Y%S92?:C=[MQ7:8XX3*""-%/C4>,?^$D^PYSI/V'[/]G\_P#Z M;R;MWG^V-O?/`!P__!*+Q#\--=^`,C>"/#D/AWQ-!/#9^*8VNA<7%Y=I"-MU MN9MXBE7>R1D!$$WXED7<5;;7Q./%%C^P!_P4P\:ZSXZCGU'PKX MW@N;J+58(\R6=M?W*W!N/*0R-(L4UM+`X)61E1Y`C?*C_K>.!7E'[0?[+_P] M_:>\-1Z-X]T87_V82'3]1MW,-YI\CH4+PRC_`("VQPT;,B%D;:``#N_#/C30 M?%N@VVL:#K6G:YHTZL8=3TVZ2>UEV,ROLD0E3M9'!&>"I!Z&OS`_X*;_`+2_ MA;]HN_\`!GP-^&,]MXQUZXU^SN7U73[N%[(W#QR06]K%(Q"2.QNB6<.$C(52 M2Q<1;-__`,$/[%M4O9=/^,,]M8O,[6T5SX=\Z>*,L2H:5;M`[@8!<(H/)VC. M!]2?LN?\$]?AC^R[=6>NZ?%<^)?',,3H?$>JGYH3)&J2BV@7$<*$AR/O2`2N MID93B@#AOVZ/!#?#+_@EYK/@][P:@_A[1/#^D->"(Q"(M3N;/7]"ENEM0\UO?3A((IE_>HM MQ;P2KN56*/&QW9=%'[?_`+3_`,!_^&D/@/XF^&W]NMX?_MK[-_Q-&M?M9A\J MZBN/]7O3=GRMOWAC=GMBN6^%O['VB>#/V3H?@1XEU7_A+M#-E?65Q??8EMF8 M7%S+.LD<3-*J21-(I1CN(>-7&.E`'1?`7Q'\-K+]G/PMX@\"K9>'_AQ#HHO+ M=/M$:II]NJ%YEGE\QE$D;>8)F+DB19-S%@37Y">%_C#\8/%W[5/C#]HCX;_# M/5/B"TVHW<.F7EWH-[M>3:A?:L;9K<7<[G:'$/F.(]L2Q1X4\^7N M/+&@#\?/VI?B_P#'KQEXT\$_%?Q_\,)/AOKWAN>"VTO6QH%_9Q/-'(UQ;(ZW MCR1.RNLCJ,98!MX=0HK]OOA7\3M#^,'PV\/>-/#TWFZ+K5G'=VX+H\D6[AHI M`C,%EC8&-U#':Z.N3BLWX]?!C3/C[\(?%/@+6)?)M=;LC"EQAV%M<*RR03A% M="WERI&^S<`VW:3@G/*_LD?L[ZG^S'\'8/A_?^,1XSL[2\GFLK@:6+`6\$IW MM#L$LF?WK2ONW?\`+3&!CD`^&?\`@AP"K_&@$$$?V(,'_N(4?M\_\I3?V-!XN'B3[%P-)-B+;[/\`:/6>7?N^T>V-G?/" M?'S]AG_A>/[4_P`.?C+_`,)M_8O_``A_]F_\27^R?M'VO[)?277^N\]=F_S- MGW&QC/.<4`?-G_!5+PUJOPL^/_P9_:$BMUU;1-$N[#3KC3V=(#]HM;J6^B7S M&W-^^5IEW+&PC\DDDEE4_=GP'_:-\`?M#>"[/7?!&NVU_&8(Y+G37E47VGEB MRB.Y@!+1ON1@.JMC*,RE6/6^/_AWX?\`BCX0U?PMXJTV'6_#VK1>3>:?=9*. M`0000058%58,I!5E#`@C-?`/Q%_X(J^$-=\3W%[X-^(6H>%-%GW/_9.HZ:-3 M\ER['$(/&_B7 M3+C1$T&SG#3:>+BW"FXN]NXPJJ3HZ(PW2$J%&-SQ^1!/IA2`;E=@^^*".;)VD>=M90R'/0?`'_`()!_#'X M7:LNK^.-4F^)^H03>9:VMU:_8].CP8V5GMQ)(97!1@0[F-E7N7=MWYVY&<8R.M`'YE_L( M?`6T_:2_X)T?$CP9.MK'J4OBN[GT>]GVJ+._CLK)H)=^QS&"WR2%1N,;NHY8 M&OB'XS_$CQA?>"O#'PG\;1S7&J_#74M5L8YKF\6;[/$YMXFL1@;)R/( MSNW#J.!C)\Q_;#_X)HZ+^U3\1K/QM8^+_P#A!];^Q"SU$QZ0MXE]L)\J0_O8 MR)`IV%B6W(J`;=O(!]G0?ZL<]SWSCGIUJ2FHH10HR0/4DG\S3J`"BBB@`HHH MH`****`"BBF/($H`?12`YJ.:<1'&`202%&QZ MW7%`$M%1-<"-2SC8!T)X_P`FCSFVN2FW!P,GKSB@"6BH?/*JS,N`#CK^OTHD MN0F.C$@D!223^0H`FHJ$3-N9=@X(&<]>O3CKC!I%N0T7F8&WCD'U^N.*`)Z* MB6;<$JW?KZ=/UH`GHJ(3,P8[,#.`2PP1Z\4"4L< M;>^.3W]J`):*@-R5<*T>S/38K'!(49-- M:5@$`L02%!))_2G&0AE7"Y)/`;M^5`$E%-C8N@ M8C;GH/;M3?,^U$=P9"!LVG`)#'!ZG/ M;MB@">BHEF+]%XSCG(/ZBD\\A69TV@-CJ/SH`FHJ&2Y"8Z,2"0%))/Y"G&0J MC,5^[D\'/'^-`$E%(K;E!P1D9P:C>8Q[R5.Q?XN?3/I_+-`$M%-1MZ@X*Y[' MK3)IQ$<8!)!(49R?P`H`EHJ,R%49BOW>@.#P3^'ZT`345#YY M.=J%N<#GKUI?.R0`,$DC!X/'>@"6BH!<%NB@GT!/&>F>...OI0;G'.W*X)W@ M_*/7^5`$]%(#FFF3]Z$VG.,Y[4`/HJ(S'LA)]#QV-*9L(S;&`7.?8&A[@Q M9+JH'.""2..F>./\]:`)Z*B>;:.@SQU/&":>CAU!''MZ'TH`=1110`4444`% M%%%`!1110`4444`037!A=05!#$*#N`P3G&?Y<9_G7Y<_\%'/^"A6I^#OBQX8 M\&?"_5+=SX5U*#5]:OK6\G5;F[B9Q_9DRQLBO"!_KEW-N9@AV-$P;]1Y+99) M`Q)XZKG@\8Q]/;V%?@O_`,%'/V6K_P#9O^.EUJ%O++>>$/&$TVI:5>WU\;N[ M,OR->1S,P\PLDLH(+[]R21Y>1Q)@`_9_]GCX]^'OVB?A+H/C7P_-"5O8%%]9 M1S-(=.N@JF:VD9E4ED+<,57>NUP-K`U-\<_C)IOP4^'FI^([O9=ZCA;71M($ MC>;JVIR!A;6,2JK,SRN`!M5L+N<@*I->7_\`!/W]FG5OV9?V==/\/>()?*\3 MZI>3:UJMK%,DT5I<2JD:Q1LJ@';#%$&Y=?,WE69=N>,_:'^`GQW^('[1^B^/ M]$_X53K'A?P?`P\+:=XP-^'L;B586N+R18$`:^`+;P#I_C?6+J[-];Z_'>)IL=M%=W$(\H1,[^81%'G)P27 M((P!7%^!/VIOCU:ZM\:)O%7@OPWXWTWX?6T-C';?#2TOI)=4UB9HMMO%)(6W M);J76YPH>$D'8X!K!_8F^(_B#X0?\$R+CQ?=6]C=+HMIK-YX=MK.TNKEY`EQ M+M^U1KSG[69MS(0JQ%&8IL=AZ9\%M*TK]A3]CNZ\1?$&\O+O7`6\2^*9U9KF M\OM5N]BE`6E4650CD$GRUDW/VAOVA_BCI'[17@WX. M_"+1O#FH>)-5TBXUS4]2\66UU)IUG;(TD:,SV\F^++0,I)3;NDB`)+G'S3^S MQ^TC\+?VD?C]H_Q&^,7C*&;QL^JKIW@#X;P:=?3V7A]GE"Q3R2"$137+NJ-Y MF=J_([$,(EMM3]KRZ_9@\1_';QG=?''3?B-X=\8V>@+INF6%TTLEOJ:GS/)O M=+,+S(I7!`$K)`7D??$9!-@`_03X877C9/`>G#XBQZ%_PFBB4WR>%O._L\_O MG\OR1,3)_J_+SN_BW8XQ7B_@?]K(:W^VS\2?@9JZ:=9_V79V=WX?N(L12WK? M9(9KJ&1FE/F2+YVY5CC_`-7'*6QY9+=1^QL_CV/]F/P+_P`+0-\/&GV20WHU M<*+L1&64VYN<_"^R^%\6A^!_[(\V7Q;'J"74BWEF)_E:!F4X9)1DHN`4X8YKQ MKPA\,M<^!NL_LE_$?QO!GQ%X@\8ZR_B=(PT=W+K'B&`K;2M`RH(C'''&DZ)M M5&CPJORQY3XMK^S._P"W-\?O^&BM^<^'UT')U)?F_LV/[1_QY<<9M_O^O'>@ M#ZU_:=^,_P`4/`_Q4^$/P^^&-MX1NM:\;'5P\_B]+HVT;V<$,X*F&3/;!=)U+X=:C?Z#XE&G2*UK=7]GMW_8C*48B8 MR1"-)0C;Y/+YP&;RO]N7X6>&OCS^TI^S?X#\31W$VA:S%XJAG-I+Y,\3C3X) M(G1ON[E=(W4,"I9`"&&Y:Y?X;?"BX^.?_!-CQA\+-$TK1O#GQ$T>XGT+7-.T MBQCABN-9TRY1E29F81RW%Q';VH>XWD;I=Q.$V4`>C3?%/]L+7_#UGXZT7X6> M`M.T&X2*Z7P)JFIW)\1"`[59))V$=NDC#=*`0&12$93(I4]5)^TAXON?BC^S M9H=WX/'@]/B/9ZS<:UH^N+YVH::]I9I,B1R(X"[F;G>@?:1N2-]R+SVF_P#! M23X7VNEVEGXIT_Q)X5^*$ELHG^'=QX?O9M56[=`T5HF(51VE+(8BQ7]_;4^+OAR3XH>.]6T7P7=_!CX>>.+SPIJ=G9&[A M\0S0QW<-LDL.]V@=@+J)SN,88QN,IPU7;3XX>&OVM_VV?@CK'PI&H^*/#_P] MM=;NO$.MBPEM;.T%]:>1;QEIU1S(6C8[=O(Y4L%D*?.,OPM\):+XJ^(7QUUG M0=/UF#PS\?=7T?Q0NM0B\T]=`N72*2:2U89DDADN0T>P%MTA)5PJ[0#[=^(7 M[6"_`KXO^-]%^)BV&D^#(O#(\1^$K^T8PRZCY"[;ZP:6>9(YKXR-$T,$7/ER M*7*EAGUWX`:_XU\5_!KPIK7Q$L-.TGQCJ-F+N_T_2X)X(K7>Q:.)HY\R)*L9 MC616Z2!P.`*^>_\`@H5X8T3Q./V>SK&D:?JHE^*^C:6_VZUBGW6TYF^T0'<# M^[?RHPZ=&\M=P.!C[#C)*`M][O0!\R?M`_M`>--.^.7A_P"#GPNC\)P>.[_1 MW\1->>.IY8K*:V$C1"VM5A^>2X+1O,>RQP.']WQ M%^%VH^*HO`?Q9MO$'PVN[&S36_`_Q2L[5YC#J"G]Z+5K;=(/+86Q>-S'NP6/ MEE;:5\G]I_7_`(A>)O\`@E!K5]\5-..G>/[JRTQ]1MS`MNY_XFT`B>2($A)' MB6-W0!=KNPV1XV*`>H_';XS_`!L^#7P@^&'G1>`9/BEXK\86OA:X$<-Z^BK] MJDG\B2/+B50$2+?G/+.1T`)X=_:H\9V?P_\`CQIOB_2]`@^)WPHTC^T[R71' ME?1;U9K&6]M#$92LH.U/+=3D97<&(?:N;_P43\-:=XTT'X'^'M9M/[1TG5/B MOH5C>V[%@9K>5+J.12RX(!#/R,$9X(X->4_"/PEI/PJ_9<_:Z^$T>C6>G^)? M!5IKMJ]W#;)_:&HZ/<6,]SID][<(-L\K)),HP`45578G<`^AOV5?%OQZ^(FD M:+XI^(\?P\A\&Z]H,.JZ>GA:.^CU))9UBDB$ZS,8UQ&\FX(3A@,$@YKC/A'\ M8_VA/C)\3?&46A67PRMOAUX3\>WOA6]^W1Z@FL-:VLRJ\D6UVB:0PNN&.T%P MPV@#-/PTW-\8QX0@/B6-SJ6`V+7[6?WX^S[EG"#]UC@G;\M M>7?`I?V:F_:@^)$?Q-CS\7#\8-1;PR&&HX9?MJFT;]R1;L!/YQ)EZ@@'*X%` M'T9WBI;EH[_[0=#-^;9$+E\&[Q@D;`A.?F`KZ M3^*'Q2\._!SP1J?BWQ9J7]BZ!IZHUS?-!-<"`R2K#%NCB4NP+NH('3G)`&:\ M$B#1_P#!3]E^98U^#O&!M&1K?7T/.?058_X*1:MJV@_LE>-=1TCQ/<^&[>*W M\C4A;:;%?MJ%M=![0VA$K+Y*2/<(3.N60)\JL>*`/#_@K_P4]B^(WBWX#:!J M5QX>L]5\3WVIZ=XLM+73+Q6TZ8R>7I26[,Q`\XM$'8;U!+$E.0.V\2?M(_M0 M?\(=XD^*FF?#'PMX>^'&BS3W)\,^+GN;3Q-<:=!@37#`L(8L[9I`K#M*T6_^,/Q5 ML[*XL[/5'FBTVWC^R)=WURP#9,<2LH\L.)")!M#E2I[7XT:IH&N?L/?$"^\( MB*'PU=_#_4+K25LX3;1BU.GNT.R(A3&I39\A4$9*D`@BOF_Q)J`^%_P]_8E^ M->NI>)X'\&>'8]/URZLK62YN+)=1TBWMXKHHBD"%77#LQR-RA%=V"D`]X^`? MQO\`B'=?%_Q3\+OC-8>&;#QQ9:;;Z_I%QX1:X:QU+3G+0RD>=ED,4ZA#YC*6 M9SM7:H9O:_'WCO0_A=X.U?Q-XLU2WT?P_ID'GWE]*"JHHQ\H`RSNY(544%F8 MA1EB`?EGX#^.]'_:4_;3\2_%KP-+>WW@#0?!-OX..K75G-:K?7TM[]L86_F` M$K$FU9`VUPS+A2K*Q]F_:F^!$?[17P,\2>"VNIM-U"[C6?3YXKZ2VB6\C^>W M-QL#!HM^-ZLK\`$?.J,`#\]OV4/^"G&N:Y^U3K$_Q!N8=*\`^.;F*UM[>XU" M8VWAZ6*$I!Y(.55)"465MJ*6<2DH$*G];('V1A!N?;C+L,9SW_SW/UQ_/+^S M=^R7XD^.'[2@^%]];_V?)HES)_PD[I=QA[&VMY5CN0C'<'DW'RUVAEWNI/R! MF']`^N74UEHNHSVVGRZE-!&TT=C&8Q+=,!E8D,K*@9V4`,[!1N!)&#@`^8/V M??VEOBO^T+K=GXV\,>&_!5Y\(-7U673$LWU>:'Q!HR1;PUQ?*(GC+L(@RP)R M!&Y?#FBVOBOQ/JTMU>1Z9/,;8'3+&V-YJ-PLF M&7Y8(]H!..$L=/M?B%X&T>_O=3TX64B:?O6.YFM"F927C98=K#>&WK(<*"F>F_8% MN?%'@?PIXI^"WCK6-/UOQ?\`#*\MK*273I)I(UTZ[M5N;3][,J[@NZ2)4"J( MUA50,!<_%>B?"/6(O^";_@CXP>!H;EO%FF:#KOAK7+>"2=HK_0;N_P!0BF#P M1J=YMWG%R"2JKL9W#^7&%`/U0^!_C"_^(?P6\`^*M52WCU37=`L-4NDM$9(5 MEFMTD<(K$D*&$_&SXR_&A_P!J6'X2_"BV\`$_\(8OBBXN/&L5Z0`; MU[9T5[=Q@<1G:4[$[N<#U?\`9-8/^RS\'6W!L^#M')(]?L46?UKYI^.7QP\# M_L^_\%&+?Q)X^UK^PM%N_A2FGQ7/V6XN2]P=7:14VPH[`%8VYP%SWSP0"S\3 M/VW?'?P\^#7Q7@\1^$-*\,?%WP';Z7=BSO96N]*UVRN;J&W;4+10R2&(NS@K M\PA8QJ\C,65?1?VGOC1\3_!/Q3^$?@+X7VWA"36_'(U8R3>,DN6M;=K*WCF8 M;K>3CZ=J.E>`+'PWI?@?0+[4(C'_; MX77X+FYOHE)#1HC)Y85E.[N5=7B3V;_@I`WPT/QQ_9R7XOL6^'A'B)=57?<` MC_1K81@#Z%\:?&WQ1\!/V>D\3?$W3M%U[XA/.NG6WA_P M0TR0:M?S3NMI:VGGYD9GCV%_E9E"RLJL%"GSV_\`%G[9]AID.OVW@OX4:C:L MZ71\'6^I7*ZNL#E2;8W+E+7S(E?#2`[3M)7=D!N:^('@#P=XN_9"^&GB7]G7 M2+CQ-X3^'_BJU\9:%X?LVN5GU46E[QO([Q3H;62-9XV>02NKN M%2W.T.44$`^K?CO^T9>_"7POX471/!5]XI^(?BV\BL=%\$F_@ANC(4+S/.Z- M(JQ0`8DD4O&K%,NJL7'F'B3XP_M+_L_:-=^-?B/X*\!^,O`MFR'4[7X>7%Y% MJ>GVQ;,EZ4N4VS+&@^904Y.250,Z\1K?PO\`B7\&/`?[,WQ(UJW\1_%;Q=\. MI;\^)M)A)O=7D@U6(K*\;F61IC9EDB"ID2!0VZ)%R-7XT_MQ>`/CI\(_%O@' MX+1:M\4O&_B73)M&@TS1M(O;<65O<(;=KVXEE@58X8C,"23COV7B'1['4]+N[?5=.O(%N+>^LY5DAGB90R2(RDAE8$$$9SFOS^_X*>?MHS_ M``SB7X<>!=<;3_%#S?C4AX>TBSTK[5Y(B$[6T21>8%!.W)CSMR<9QFOR5 M_P""L?[+MS\+O'EC\1=&FFG\&:Y(\$EK>ZBTYT_4))9[J6.&-OFCAF9Y9@%) M`D-QG8'0$`_1O]BS]JK3OVJO@UI_B';8V?BFT/V77M(L9&86=QN<*X#?QUX^\3:DNFZ%X5M;Q+>6Y8*S2S MNQ!*01*`7DVE%+IN958NOBO_``3!_9/U/]GOX/WGB#Q.M]8>+?&8@N+[1+Q% M0:?!`TPMD*@EO,99FD?=@J9`A161B>K_`&O-!\0^%OB#\&OC'H7AW5/&[?#_ M`%&^AU3P]HEOYM]/9ZA;"WENH$W$L82JGRE7YM^2R*A:@#,3XE?M7?#'Q-I4 M_BSX9>#/B'X7U"[BM+B+X;W!L0;&,CQ(-U>H_M/_ M`!IU#X*?#%;_`$.QMM7\<:YJ-IX>\.:5;C_`(*&_#3QS-9:1\)K'7?B_P")KB\MHCHF@:-=0-:6[3(DEW)+D_#'4/!%S!\($MM5U#1O&_VU;:; M5KY)_LSLD*E)C#`D4L3H0T3SOR2Q4`'M5A^TC!XV_8ZU#XU>%;2T-R/"-[K4 M.G3I)-%%=V\,K26TAQ&SJD\,L18!0VTLO!%76^,.MK^Q>/BX;?3I/$8^'_\` MPE#6YA?[(US_`&?]JV;=^[R]^1MW9P>M?*/A2R\7?!;X3?M*?!3X@:CX8^W7 MO@G6/'.AZ1X52Z-CI]E=+>1W4$)E15BABE6(K%C(^T,07P<=!X$_:?\`AK\4 M?V"/$/PX\,>(O[2\9Z%\';@:EIB:==1>08=,6"7#M$L;A96"Y1B,GC(YH`]: M^*W[2?BKP+^P9IOQLT^STJ3Q;/H&B:I);W,,S61EO'M1*!&DF\*//;'S9^4# M)J/4_C;\7O@)\-O%7BOXSV/@;7-4,]E8>%M"^',MTMSJ]_,SH+1A=98L28V` MC#L$69@K;`I\F_:1DS_P1]T90H?;X-\)'8PX<>;8<'G/\/8YKH?C=^Q-X4^# M?PUL_$GP3\"SS:WX9\6:/XSN=`MKZYN)]>_L]YA]G1YY7\IA'=3R!HT9F*A0 MC$K@`Z;5?B)^UWX6TRX\7:I\.OA]KOAZ")[V7P1H.I7G_"0B-@3]G66I\PQ,(P2R9W?CA^UA'X>_8MO/CK\.!87Q:TT^ZLXM5)FB7S[J&&2&98 M91^\C,CJZA\AD(S6#JG_``4B^%TFE76G^%+/Q+XL^)L<31P?#JW\/WD.I_;5 M!$EK(?)*1M'B3S"K/L6%ROF8PWD?QT^$>I_`G_@D)=^!]9D,FLV%EI]Q>QA4 M0PS7.LQ7,D`VNRDQM*T>]20VPM@!L``^A?@M\;OB-)\:=0^$'QH>"GN&TYK(W)M6AE6Y(D659%#`KN5E<_L^?MX3?&G]DSXC>. M!9:=;_$/P-HU_>ZGIRV,L>G[ECN9K,H#(2Z,L(1AO#;UDX"E"S?V3OA7X0_9 MQ_:J^+7POL/#UAI23V=MXF\*ZC-"9M2GTN?;'?0F[!)6VANH8DCBD*O\Q;]Y MN+GY5T;X1:O%_P`$X/!'Q@\"Q7,GBO3=!UWPWKD$+SM%?Z#=W^H13!X(U.\V M[SBY5B550C.X?RT"@'V_XQ_:3\5>'O@Q^S3XKBLM'FU3XD>(O#6DZPDMO*88 M8M0MVDG:W7S`R."H"ERP`X(-=_\`M1_&:^^"'PT%]H%E;:OXUUS4K3P_X;TJ MY:E=OLA5GQM7;AY3O**PBV[E)!'S+\1Y`_[+?["3;@?^*S\"-NSP3]B? M/ZYSZ5N?M$V/Q&^//[6&E:3\,=0\$7,'P@BM-5U'1?&_VY;:75[Z.;[,[QQ* M4E,$*1RQ.A#1/,_S$L5`!]/_``!^,^E?'CX.>$?'FE1+;VVNV:S-:H7?[-." M4GAW,BEO+F26/?M`;9N'!%+_$^LVGAKP]IG MF)%"]_#))1>:/J5PN;>.Z29RL MF2"K&(LH",0S'RUDX7]DJVT#]G3X,?$?]J+Q[?>*=3@\2S&32]1\4?Z9KO\` M8:3"'3XY2R`^=<'RR2LAA9!:."%4E?/?V>?VC?A=^T-\?-%^(?QC\7VS>-#J M*:?X!^'$.GW\]CX>=YE5)Y9O)\J:Z=PKF4L%!`=L,L26P!]2_M#_`!M^+?PC M^+/P_2UL/!*]*\(^?.UW<:MYUR7\Z7"F..``)M58[,JQY8DG@`*>N/\]*`/#OV4/C7X MM_:`_9:\._$6^TW24\5ZM#>NEE;-+:V32Q74\,:Y8RNBD1(2,OBG\6O`GQ.L?"-MJO@E](42>#TN!!)]MADF^:29OF*(J@_*OS$@=L MU/\`@E_`T?[#WPU+91U_M1&0]!_Q-+O-1?`&)6_;H_:S5@Q##PD%Z%OAKJD,MQX1U+SM7475QB:\A:UF6-A; ME%:'#7-K)$\C[F:X62*-H;>4_??[/'Q[\/?M$?";0_&GA^XAD6\B`O[..8RG M3KL!3/;2.57)C+8#;5#KM=?E937XX?\`!07]E+6O@;^T!8V^B_;=4\,>*A'! MX4MFNWU"]_RPQ1O!&8RP81K$J%MSAF5G&T$*`#Z,1MZ`^M.I%!"X M)R?7&*6@`HHHH`****`"BBB@`HHHH`*Q?$7@O0O%K:>VMZ/8:N=.O(]1LC?6 MR3?9;J//ESQ[@=DB9.&'(R<&MJB@!J((UVJ,#TICP!BQZ%L`GG./;G@\]:EH MH`@6!@F&D^8]64$=NW/J??%--C&[.S?,7&UP>C#.<$=QU_,^IJS10!!]E!=6 M9V8*#\IY!)(.3[\<>F3338JW#,2AZC`YR,$=.`>#QCD?A5FB@"#[,0RD2'AM MQZGG&,#G@=>/\*3[+AN"H3[VTKG+<\GUYVG\/>K%%`%=[0.26*MD]"O0=P/K MQ[<=*=]G'.3G._K4U%`$/V?)RS9S@\9Z@Y]?K]:06Q&,2OQT)P>.<`Y MZXSUZ\#KSF>B@"N+7#!MYR%(/`R%B.69@,L?Z>O'MV&*<("%(\PD$8Y_G]?\\5-10!$L"I]TD<; MB"-0JC`'0"G44`0RP&7<"5P05Y7)`(Y_7%#VJR)L;EHX]\$C\3ZG*_92N=KX;` M^8CDD=S@C/;T_+BK%%`$"VJ+V!Y)^Z!R1@GTSU_.D^R`KC=M'&-H_`]E6**`*[6[D@B7!P>0N""?3]>#GL>W*+9*J[,GRN/E.2>,8.26`H"X'3_`.MT_P`:FHH`JM8[PVZ0Y==K;1MZ]2,<@_C^?%.6T",[*Q4L M0>!TQTP.G3C..F/2K%%`%?[+DIELA1M'7D=.>>>/\:<+?@!G,@SR'`P?P`'M M^5344`(H(4;B"W<@8J)H&,C.'X(QL(^7Z^__`.JIJ*`*XM2,;9"F!CY0!_\` M6SGU'X4&UW!OG(8Y^8>_\^,?E5BB@"![=GE9_,(R`NT#@#//(YSU[^G%#6Y; MD/@G&["C#?7\.*GHH`K/9EE(#!,GYB`>1V[_`$SGKSZTIM3YHDW*2%P,IG:? M4'J/<>P]\V**`&JNT8R3[FL3Q?X(T+Q]H]QI'B/2+#7M(N2AFL-4M4N8)-C; MDS&X*G#<\@\UNT4`,BC$480=!P*CFMO-)VMLW?>XZC\_7'X9'>IZ*`(3;!B" M2-PX!QT[=/\`/7ZT?9P#QCD\Y';)/;Z]?KZU-10!%Y+1^=3T4`0 M?9_G!W`#N`N,\Y'ZY_.E%N,`$Y&@_SQ4U%`%,]SWYI3;,0F922H`R5'/OCU^ MF*GHH`K_`&)-@4$J`,84#&,8`QTP,\"A[4D@HP5LG)*`YS_]?GZU8HH`C$(4 MD@D$C!/M2+;J@.W@]N^WZ>E2T4`-C01(J*`JJ,`#L*:859V8A3N`!R.N.GY< M_G4E%`&)KW@O1/%+:\=:1\!O`OQ!O/@D M8M6\;^);#0]`\/#Q5"_VR"]MC-:W7VA8"J;V&SRY%4KD$L.E=+XT_:M\<_"C M]F;QE\4OB#\'SX4UK0+R""'PN?$T%X+R"6>VA$PNH8F"8:X;*[&/[OK\W`!] M,T5Q_P`4_B$OPS^%WC#QD;!]1'A_1KS6!9;C#]H$$#R^7O*G86V8S@XST/2O M*OV*/@O_PK_P`%ZKI$>J:9XA/BJUU`77F>6T4?D*B2)NC= MWW,.-F,?,*`/H6BOC7X*?\%!-:^(-OX'UWQE\(;KP+X#\;:D="T+Q-;Z_#J8 MFU,R21QV\ELL<85(#(N1M8NON?P#^.W_``O$?$4C1/[&'A#QEJ7A M($7GVC[7]D\O_2/N+Y>_S/N?-C'WFS0!ZO17B/PS_:ATSQIX8^+GB'6],_X1 MG1_ASXFU?0;ZY^TFZ$L%@B.]UA8U*EES"AI)8],^9W;AC$@?,R^6RD!Q@`^M:*^= M/''[:7A[2/V1)/C]X6TF;Q)H1A@EATV\G-C*S/>):R1.P27:\;F3.`P/EG!( M(:M3QU^UGH.A>$OA/XI\+6]MXS\._$/Q9IOAFRU"VOC"L2W9D4SX\MB6B:)@ MT+!"""K%64J`#W>BOGW]H[]IKQ+\'?&OPV\(^#_AM_PL7Q#XW&HFULCKL>F& M/['%%*_SO$Z-E)'/WACR^^>/4OAAXI\3>*O`FGZKXP\(_P#"#^)9A*;KP\-3 MCU#[-B5TC'VB,!'WJJOQ]W?M/(H`["BO$?@M^T7J'QL^(OQ%TS3O"*:?X+\( M:O-X>'B.ZU0-/?ZA#L\Z-+58B%12_#F7Y@4(4Y8)Y'YA'!X;M->MM2:]1VAB@E-Q&H6-&FF*ME M69%C+;6R%(!]%45\U?#']J?QS\1[;XJ:`WPA_L/XJ^`_LT$QAG7K0V+M+'=&WN5^U2#8%C*2NK%1O"J"J,Q50#WFBOD#PU^W!XZL_C'-X'^)7 MP47X/_%7P)UWPO\`!'5[SRXO'$NJQ3W$%H[,MO>3Z:-DEDD1MVT$#&,%BLHC[S]G+]H;3/VB?A[_P`)#::/J'AW5;&]FTC7 M-"U2-DFTG4H0IGMG8@;MNX$,`.&&Y4;=?'KXTZ9\`_@]XL\?:M"; MJVT.S:=+5&W;N8"@#Z7HKY!\` M?M^:EKWBGP2_B_X/:_X$^'GCV];3O"GC"[O$N/MD[.!:K$_$3X\_$3PSIGA6R\,_!/5O%WC?4=+35-7T M@:K%9:=HR[5$D+:G(A@FG65MHBCRS(CR$*NS?WWP:^,&@_'?X8Z%X\\+_:&T M/68C);_;$$.=#N626Q^U++->6)95ANSMCC1F MRPCD,2A-X#A8EE2-0#ZUHKR;]I[X\C]G'X&>)?B,-#_X2(:,+0_V;]K^RB;S M[J*#_6['V[?-W?=/0#C.0OP2^)/Q,\%_%W[2'B#X16UE<0W&FPNEKK\L\7 MV'4K^!(Y+ZP@8,=TUO'<6[.@RP/G;E01JTFO\=_V@+GX#:MX(NM3\)7%_P"! MM8U(:9KGBJ*]CBA\.&0HEM-<(X`,#.[!Y2ZK&$Y+,Z*P![#17CG@?]H.X^(G MQT\:>!]#\*377ACPE#';:AXS%]&;5]6;RV>PAC`)D,<<@,C[@8W4HR#--?\`$6O6?AS2-&@O$LUN+NXWE`\S@[%VQO\`-M/S M;0=H+,H!['17B'Q]_:-O_@5\/_"^H-X0'B3QGXCUNP\-6'A^PU18K9]2N0Q\ MLWDD8Q&/+=1(8AEBFY4#%EM?LT?M$O\`M`>#-=U'4/"USX-U_P`.Z_>>&M9T MB6\CO([:\MRF\1W"`+*N)$^;:/FW`94!V`/9:*^0/@O^W#XZ_:$\4W$O@'X) MC7OAO;^)FT&7QI_PEMO;[84="]U]BFA28D02)-Y0Y()7=D&D^.'_``4!NOA# M\1_'&D67PNOO$_A#P`FE/XN\2Q:U;VK6/V\J8?L]M(N;G*NN,.F6W`[5`=@# M[`HKQ#Q#^T;J'A#]IGPC\+=7\'JNB^,;2ZET#Q19ZJLOG3VT*S7$,]LT:M%M M0DAU>0-NBQRSB/U'Q7KNI:1X7UN_T31QXAU>TLYIK+25NEMS>W"H62'S7&U` MS;%WG(&[.#CD`WJ*^0;?]L7XQZ7\7?AYX"\6_LY+X7O/&E[);V<__"QT5POQ=\<>*?!/@V74?!?@2Y M^(OB#S5CAT6#4[?3@R\EY&FG(`55!QM5V+%!C!++A_LP?'7_`(:0^"/AGXA? MV'_PCW]M"Z(T[[4;D1"&ZE@R)?+3=N\K=]P8W8YQD@'JU%>8_M"?'.R^`/PS MOO%,^ESZ]J)N(-/TG0+254NM6OIV"0VT(()9B26(568(DC!6*E:X'X3?M2^* M]?\`BW!\.?BE\*9_A-X@U33)-3T)Y=?MM4M]5$3`3PI)$J@3(&#^6-QV!F;: M-I8`^C**^9K;]LN_L?B/HEAXI^%FO^#OAYXEUE?#GAWQ?JTZ1W-]J+DB*.;2 MBHNK6.4QR;'D7.#$SJBR$IZ#^TU^T3H?[,/PBU?QSKD'VT6VV"QTY)UA>^NG M8+'"K-TZEVVAW6..5PC["*`/6**\;G^.'BG6/V?/"GQ"\%_#>X\9^(?$.F6. MI0^&(-9MK00K/"LS[[F?:"L:L1E$9F8KA0"671_9?^./_#2/P,\-?$;^Q?\` MA'O[9^U8TT71N?*$-U+!GS#''NW>5N^X,;LZ5)"A5AR%SM/.<=,?7]#Z'$J,74$C&>V>U?`/[>7_!0;4/V?_B- MX=\->$D6]FT^Z2?Q%:^=;1NX4VDYLSYB2N$DM9G#2(BC=+%Y\8^'93<:1K5H+U-S(7@9AN>&7:S*LB,61EW':RL,\4`=G17S] M^TA^TQXF^#7CCX<>$/!_PW_X6-XA\;?VE]DL_P"W8],,?V.**5_F>)U;*2.> MJX\OOGCT;P-\0-8O/AA%XH^(?AV#X;ZE!#Q:;%$S_`#O=(!&0 M8E60]-H8@_=)H`[NBO$OV7_VJ-#_`&G_``MJFJ:=HVH>&]1T^\$6.13T)WA&D"AVP%_;,TOPQJ?QBTWXB>')_`NH?#Z%M5MX+ MC48)?^$ATEF9+:\LBQC#M+(HB\OD)+-#&9-[,J@'T917%?!?QMX@^(_PPT#Q M+XH\'W/@'6]2A:>;P[>7/GS6:EV$8D;8A#-&$Y-W& M)@CNB2K&R0AW/WAE-H.67(!]&45X1X0^/WCZR\!^/_%OQ8^#]S\-=,\+::^J M1QVGB*TUF74(XHII;A46/8$95B7;N.'\P_&'QAL-&T>?\` MX1[X>W$,"ZU9S'4&UA6%QYDEO!;H[,NZV;R]C2-*C*P52=E.^&7[5^M>(_B7 MH_A'Q[\+M5^%[^*X;FZ\&S:IJ,%U-J\5O&)9EG@B^:RE6%XW,PE43W M=LLDT"F>+ALRE%D"#?\`20F!)XZ'&0<\]Z`)**^:OB=^UKXETOXS7OPR^%OP MEU'XJ>(M$LH[WQ%+_:D>DVFE^:JO!$)YHV265T;=M!`QC!8K*(\O_AX#X9_X M9U;XB?\`")Z^/%8UG_A$?^$"^S2?V@?$>W/]F[MGMN\S;G;QL\W]S0!]4T5\ M_P#P(_:EU/XC_$;Q#\-_'WP\O_A;\1-)LEU>/2+F]74+:^TYBB&YANXT6-ML MKA&7L3P6*R+'Y;XX_;9^.'PT?PX/%'[+QTP>(-9MM`TX1_$"QG::^GW>5"`D M)P2%8[F(48Y84`?:5%?+WQ?_`&R?$/AGXF:_X%^%WPBU?XNZWX6TQ-4\3&TO MQI\.FK(@D@A1GB?[3,\9WB.,$L.$WL'">V?!CXN^'_CQ\,-`\>>%WN'T/686 ME@%W"8ID97:.1'4_Q*Z.I()4[)(D."=TDR@I@A MON[]JAPO[+7Q@#,H'_"&:R"V>`WV*8'/7OVR37H/A+P9I?@?POHOAW1K86>D M:-:0V%C;J[L8H(HQ'&A9F);"C&6))ZGGFKFHZ'9:SI]Q8:C:6^H6%S`UO<6E MS$)8IHF7:Z.K9#*1P5/![YH`_.W]H>VL+W]B#]CVWU/Q#/X7TR;7?!L5WKEI M=BSET^(Z8X>X2$_BMJ_QATU] M5T^2XUS6?$4>MS13?;=/!MOM$8PJA55@O8R9_BK[?USX1>"O$WA.P\+ZQX3T M+5O#FGB,66CZAI<$]G;^6A2/9"RE%VJS*-H&%8@55M?@=\/K'P=J7A*T\#^& MK/PMJ,XNKO1;;1K9+.XE!0B22'9L=LQ)\S*3\B_W10!YA\<_BKX(^)O[+GQP M/A#QAX?\4&R\'ZL+N30]1AO!;^99SA/,\IFVEO+/!P?E/I7E7_!/CPWX(TW0 M/"-_HOQTU[QQXBNO!MJU_P"!;[Q=#J-II)=+9I?+L@NZ#RW`B&3\HWVF^%]4U-IM!TV\CO;F&.\M[/ M:`LP'F-O8G#R,ZX."*G[.?[-4?QH\3_'O78_BU\3/!*0_%77K,:?X*\2&PM9 M-KQOYKH8GW2$R$;N!M51VK[^\,>#-#\$:%::+X*?V'_VL_`7AZ\OO$.L6/Q)U>."[U*1[J]U` M64MC.VXA2TMQ(MN0,+EY&'3.1]=^'/VY_@7XB^'UIXNF^(N@Z+"]FUW+HNKW ML,6JVACW;XVM-QD,JE6`50V[`,>X,"?;-`\&:-X2:_.A:78:*-1O9-2OQ86D M++&%$;^C_@FE^T!XXN;&ZTK3_'_`(X? MQCHUEJ$+PW<%E<:K8K"TR$X4L(=XV,XV2(0[;J7X_P#@K5_V>OVB/A%\,[": M:]^%_BGXH:-XN\.0R-%%!H-TEU(E]IT,4:Y$3&]@E3A$0$*JLWF25^F7B7P= MHGC+1KK2->TFQUG2KID:>PU"V2>WF*L&7?&P*MAE4\C^$5'X@\$:'XI&EG5M M(T[5)-)NTU#3FO[1)_L=T@(CFBW#Y'7)PRX(R<$4`?%_[?-CHNL?M#_LTVWB M/QU?_#71YO\`A)/.\1Z9K"Z7]@L9SU$A`/S5]3?`S3-%TC MX4Z':^'O'U_\2]'B$_V?Q-JNL1ZO/?@SR,Q>YC`64HP:,8^Z(PO4&MGQQ\(O M!/Q,^Q_\)=X0T'Q2;(NUI_;>F0WOV8N%W^7YJMLSM0G;C.T9Z5I^%O!6A>!] M'MM(\.:/I^@Z3;;A!I^F6D=M;PAG=VV1Q@*N6=R<#DL2>2:`/F'_`()>:;8V M?[%O@>YL;6VM[W49M2N+NXBC'F7,HO[B,2R,,%VV11KN;^%$'``%?G^984^& M/_"S3\0M1;X^+\5?[=/P5$%P;+^UC>8\@:>',_FD$-]IW#/^$Y'C<^$/#Z>,RN#X@&E0'4.8_*/^DE/,)\K]W][[N0.[1$\ZRU29$17. M`C*'F#+$Z`1D3-7@OCGXL^+_`(H?\$]+FP\3ZW/K/@JY^($'A27XDW?A^[>: M7PW#,DD>KO&&#L1<0QQ$DL3M,;%YCO;],?&WP@\$?$P60\8>$-!\6"QW_8_[ MN0PYS]D#]G@_LT_`#P]X&G MN-/O-5A,MWJ=]86@A6YN99&9R3G"?V]?B/+HFO_$?P_P##_P#9[T&]C6XT[4]=@TW5?&UTA#H'B:1)8;-&(9<\ ML<$?O,&V_0W_`(0S11X83PR-)T__`(1<69TXZ)]D069M=@3R/*`">7L!79MV MD'&,<5P8_9/^#'RY^$O@-L+C!\,66#Z_\L\],CKWYS0!XA^V)^V=:?"W6K+X M6^`M7\/V7Q8UH!&U77[V&UTSPQ`R%S=W;OE?-"9>.%@20?J.J:';7%Q+L4(@>1T+,%554` MGHH%;W@[X;^&OAQI3:;X0T#2/"NG/.;F6RT;3H;2"20@*SLD:J-VU5&[K\JY MSC%`'RO^U?#)XI_9?T;P)\>/B3HWPO\`%'BO5HK6XUOPUI%S>Z&9HKGS887> M=-T*&-8I"\DL)#1,PO@O?\`A/S[[6-6 MOI=1FT^\N"MO)8#4XR$D$T!DD&TC:5*IM:.8O]O>)?!FB>--&N=&\0Z38:]H MMT5-QINIVR7-O-M<.F^.0%3M=58<<%5/:J'@WX9>&/ASIDNF^$O#VC^%M-GE M,\UGHNGQ6<,DI4*7*1!5W8"J6QDA0,\#`!^?GP6^"NH>)?VJ]*^'*?%N\^)7 MPD^".S68+:=`@TS5&>=;+3Y98I5-S);JF_S<,B>0\`CA5G0\K\7M7\`6&N?& M[XV^#/VHO$7AWQT;^`VOA(P'3)FO+-%6.QO-.=$DO8B,0(WE*L(+&;S=LQK] M.]"\&Z-X6DU%M%TNPTC^T[N34+\6-JD'VNZ?'F7$FP`/(P'S.P+-A.OC1X$^/O@K3OA)\9?%?BCX%>*#X=TO7M3>.ZC\.6FKKZ1X1I-VX;]P)=GF,[1GH,=#I.AV.@Z1:Z5IEK#IVF6D*6UK9V<2PQ6T2*% M2.-%`"J````,`<#B@#\Y/^"Q/P6\3:_X+T+XCZ=?BZ\.:`B6>MV$TT8^Q^9+ MLAN+="NY?,>8QS!9!YFVURI$.Y/#/^"0GP1\3^)?C+>?$RVU";1O"WAZWFT^ M]01/LUF6>)L6JE0(W6,^7,X)8J1;X7Y@R?L7K.@67B#2;S2]2MX=0TV]@>VN MK.[A66*>%QMDC=2,,K+D$'@@FL'X9?"CPY\'/!>E^$?"%@-'\.:9YOV2R$TL MOE^9(TK_`#R.S'+NQP3CG&.F`#P'_@INT3_L0_$64RA.-,(FQC'_`!,[4Y4@ M$C.!SR.!]:V[7PM8_L5?"?XC>-KWXA>-?B##9Z:+V.U\?>(_M($L"R&."WD\ MK]WY[R1QYPY)V#'&#[QXH\&:)XWT.YT;Q'I&GZ_I%RR--I^IVB7%O(5974M& MX(8AE##/0X/:F^*/!.B>-]$NM$\0Z58Z]H=T$6XTO5+9+FVE"NKINC<%3AER M.."%/\(H`_+B+P1^T'\&O#7AGXA:G\"VM?%_@GQ-JOCOQ-XS/C#3RNK0W:2? MVI%]B5FC@$L$=NF^-6*"#YD\EE23#5]*ZMXJV<&I:= M>0-;7-I=1B2*:)UVR(R'(*LO!7&.3ZUFZ-\-?"_A_4[+4M.\/Z58:E9:>FDV MUY:V$4,L%BC;DM$95!6!3RL8(4=<$\T`?.W['X7X$ZSJ_P"S=J[21WGAHW'B M#PK<(&;^T?#]Q=.8Y)Y5POVE)WECD5HXP<*4#C+"E^T?IEMK/[:_[)$&HQ0W MT"2^)IO+O(@T?FQ6$$D4J@\!UD",C#D,%(P5KZ@OO!.@ZIK^EZY?:/87NM:4 MTK:?J5Q;))9]R)Q M7+_L;>-]%^%ND_M.VL?CK6?$'PMT+7?[2M/B-#83WU]-<74.V]D,@29+IK8Q M6Y:81LARTSKY`LQ=]D:`*H M9F9CCDEB2>:`/S(^#$VE?LZ>)O@!HOP;_:"U'XPS^)=5_LW5O!2(USIL>DW$ MGG37:6*.QTZ2!?G?S'WE][':BSI7`?M"Z7X<\=ZW^UKX@^(GQ8O_`(;>,X-9 MBL].\!6ZRV\6MVEHB+ILTMLYWWOG*D95E(6!B9V&R15'ZK>#?@3\._AUJLNI M^%/`OAGPMJ,L)MWO-#T>WLIS&2"T>^)%;82JMM)QD`]0,6=<^#G@GQ+XGL/$ MNJ^$]$U3Q)IXC%GJ]_IT-Q=VWEN9(O+E=2Z['9G&#PS$]:`/E']IR;5/%W@? M]D;Q7XHTBWT?QIM?._Q&_9^\4?%K]K7X>>-];3PU%X`^'D=UTN9V)Y)-8?CCX1>"/B\6_8`XM?[<_L:_$/Q9\6/V9_`7BSQU;+;^)=0LWDN)#9FU:5%EDC@N MA&W`\V!8Y=R@*WFY4!2%KS+_`()TC7A_P3V\%?\`"/-8MKOV;5?[/.H;_(^T M?VE>8\W;\VW.,X]Z^O)(1(C(2"K=5*@@CN/QY_.LSPQX0T7P3I%MI'AW2;'0 M=(M@XAT[3;9+>WBWN7ZI;_$F/P#H/BCQ!K5IX1NHK]TM9+.."".'8X269Y?D$"DN-ZE@J M%7K[3U?0+'7M,O\`3=1M+;4-/OH6M[FTNX%FBGC9=K)(C`AU()!4C!!([UA> M"OA)X+^&S7I\(^$M!\*_;@@NQHFEP68N=A;9YGEJ-VWS),9Z;V]:`/S9_:8^ M)7PX^(LG@G]H'X8_%*]\2_$TZUI\OASX5:X8-6ACG<1PR6J:8H,MI(S1B1I@ MQ!EC!B;?)!(-[]K3P]\:?$7Q'^*/Q`\0_!:;4/"N@>$=:T/PO?Q^-+6"VTJS MDMKF.ZU:2U!9IYY89"PC`C"H%C8.Z)(OWWIGP,^'VC>+)/%5CX&\+V?BEY9; MEMVN MK.[A62*YC=2LB2(?E965F!!&#DYXXH`\=_8ROM1U/]E/X2SZOI"Z+=)X:L42 MW-RL[>2D*QP7&\``&6$)*5QE/-V')4YXK_@EZ"/V%_AIE@Q_XF>2,]?[3NZ^ MF=,T*PT31[32=-L[;3M+M(4MK>QM8$C@AA0!5B1%`54"C:%`P!TJ'POX4T7P M3H=MHOA[2+#0M'MMYAT_3+9+>"(LY=RL:`*-S,S'`Y+$GDT`:M02VYD9SN&# MC"EO$GP!_:"U:WUF>_UG2M8(NM(\37\,*/JL M>Q`YE9/E:Y1VVRR,%>1OW[*#*"WZP_\`!-S]GC6?V>/V:K"P\0S$:UXANO\` MA(9[%[9X9--$T$"K:N'`;>HBRX*KM=V7G;O;W+XB_!7P9\6-5\*ZEXJT.#5- M0\+:E%J^C7FYXI[*Y1@P9)$96VDK&6C)*,8T+`[5QVL,9CC"EMQY).,?Y_SU MH`^+?VTO`2_$O]JK]F+PP_B77?"9O?\`A*,ZGX8OC9ZBA6QMY/W,NUMF[9L; M/568=ZE_:OT3Q3\-OV8]-^"WP\UC5_B)\0?',ESH5G<^*-=MY-7NK`)/=WTC MO,%6<+!NM^-A59XL-N50WUMJG@W0]:U_2-Y;S)O-O;_95B`4%F1BSNP#,^.W@+7_VM?C3J7CGX8:7HUQ=?!65;#3+ MW4P;:36O$EO?6]S<6$C$[I+6&)'1&=H1]HN&*R%&9T^]==\&Z)XH.G?VUI-C MJZZ;=IJ%D+ZV28VMTF=EQ$6!*2KN;#J0PW'!YH\->#]'\&Z):Z+X?TNPT'1+ M4-Y.FZ7:I;01EGWMM1`%4%BQ(`Y+$T`2QR2>237@_BGX!>)M`_;%TGXR^#(O##:9J7A[_`(1KQ18: MB9+2Z>(3I(MY!+&CB694CB7;(H&RV";AN5HP#Y0_:GTOPU\0_P!KWXM67Q3^ M+&H?!.RT;P#;Z;H%Q81RVO\`PD-E,AFN#*Q)%Y$EP\L36L6'FVA5.Z&0ER:C MX6^-7[+O[+OA#XJ?$K4/@EK5NT.J:?LTF6QM]1M;$RP6TJ7\R;(+C[.L#?#_BO[!YGV0:]I4%[]GW[=_E^8K;`V MQ,XZ[5STJYXY^&_A7XF:5%IGBWPWI'B?3HYA<)9ZS817<*R!6"N$D!`8!V&X M-S^RU^UGX:\-^*-2^,O@[PRL>F>'_%VIPSW5Q=6MXQ74T: MX5O])^QQ2.WG`E,;7P8611/^S#IWA;X:_M@?!^U^&/Q3O/C-8ZWX!N-,U^>[ M62X_X1^RB6.:!HV!Q:1//''&MK-EH"6#$O,M?H_X9\$Z)X+T.+1/#^DV&B:+ M#N\K3=.M$M[>+<[.P6-`%4%F8G`Y)/-9'A#X3>#/AG!J">"O!^A>%)+U4$_] MB:=%8BX*A]@D,*`D+O?&<[=[$RL+6TN-1^$@GN9 M(XE!NI5U9(PTN!\S>5%"F2<[%4=AC2_;QT'XM>.?AO9^"/AEX,NO$UAXAF,7 MB>[L=?MM+NH+!&C+VT+S-M#W"L\93SSGUH`_-#]G+XLZU\!?C!^TIK_`(B^#NK>&?#WAK0?#!O]"T'6 M(-9NM'BMK2.WM85.56X5[4EN^XEB#3_$NM>!K#]K'X/?%#X2?%B?X MM^,?&>O/87GAK598]:DTK1;HM-.UN$5)M,6V227$;E6"NP)$:3H_Z,V7@O1= M-U[5=:L])T^TU?5O*_M'4(;54N+WRD*0B>08:4(K,%#YV@X&,5@^"/@7\._A MKJLNI^$O`GACPOJ4L36\EYHNC6UG,\)*DQEXT5BN54D9P2H/84`?GS^UY\3/ M@]^TW\*M7^(,GQ.\1^"_&'@XM;6OPO\`%/D&(:M:32%!=:*ZOYTLGFF(RJ71 M%8"0;8YD'UOJNO\`[0WBOX6_#36_`.G^`])\1:EH<%YXGL/'4&H0?9[J2"%A M';QP\H5++_XK:?KZSO9^)(XE:3499%F*H51QF,OD1X;>)2) MJ^F/%/[.WPM\$O#6H>'=%\):#H_A_4#*;S2=.TN"WM+GS(Q')YD2*%;-PD"SSQJ?*:,.AA9OF\YF._P"';?5?V@/V^=3\2F39X#^#-B^BZ<]M<+)% M>ZU>P`W1#"+&(H9#%(GF;D>*!O\`EHZCZRT3P]8^&]*L]+TNTMM.TRQ@2UM+ M2TA$4=O$BA41%'"J%"@````<8IUKH5G83WEQ:6UO:7-[,MS=RV\"HUS*$6,/ M(<98[(XUR>=L:C.`*`/@W]O/P-J?PP\37GC_`.%OQ)U+P5\3?B1]F\*OX3M5 M68^*)V>&")X6=\6>``ORA6B:5FD^P_@%\'],^`?P=\*^`-)<36NB6G MDO9*\C[`Q5=^U<*`!TFI>"]$UG6](UG4-(T^^U?1Q*N MFZA<6J/<60E4+,(I#ED\Q`%;:1D<'(XK9AC\F)4W%MHQN/4^Y]Z`'T444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`QX]ZL,D!A@TY5VJ!DG` MQDTM%`!1110!&T19R=Q`(Q@=Q_/UZ>M/484#.<=Z6HC-^]*``D8SDXQG/M0! M+13(G\R-6*E21R#V-/H`****`"BBB@`HHHH`**0FF[CGI1N`^BF;\=:7=^5* MX[#J*:&SC%`;)QBDY);A8=132V!FDWG/(Q0Y)=1#ZC:(LY.X@$8P.X_GZ]/6 MG;N?:ESQ3NEH`*,*!G..]+3=^3TH#YIH"/'O5AD@,, M&G*NU0,DX&,FD+8S34D+#D#\Z7,M@)**;NIOF9Z#BFW8%J244W=THW<]*$[@ M.HII;%(),GVIE&:H0M%1&4ARH7(&.3QG/7'KBG12"6-7&,,,\4`/HHHH`*8T6 M[/S,,L&X..F./IQ_.GT4`(.!US2T44`%130"4YR`0"`PSD?B#4M%`$0C?YLN M&RV0-O`'84]5VC&<]Z=10`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%?+?[??[7D?[* M/PSM9]-CM;[QKKLWE:+87MJ\]O((Y(C_X M+!_"'Q?H?Q^B\>WAU#5?!OB"RM;2QO'!^SZ;/$A5[!3O;&\H;@`JNXRR;0WE MR&@#]1/V:/VC-"_:4^$&A^-](2.QDO`T%]I9NTFDL+Q&*R0N5/3C>A(4M&R/ MM7=BL[]J+]HO4OV??"_A*^T7P8?&^M^)O$EIX9L-';4UTTO<7"3,A\UXW7[T M2KR`/WF=PQS\@_\`!'OX->)?!7A#Q-XXN[G[%H&OE+46:7$5U#J.Q(98+B-D M7]UY(ENX7`D?=)*T;K$]L=_KO_!3.WT^]\`_"?$$_A/3IOB=H\-WK=I>" MSETZ)HKL27"3D$1,@)?>>%,>3TH`^B_@QXX\=>-_"UW??$#X<-\--9BO&ABT MD:W!JQEMQ&C+/YL*A1EFD79@D;,YYXU?BE\0!\-/AAXP\8&P.HCP]I%YJOV/ MSUB$Y@A>3R_,PP3.S&X@XSG!Z5Y;\#M#L="^#OBF#X6_%B?XPZB;FX>TUSQ? MXB37(H=0^S1K';S30`%8%81N8U^<;R0?F`'C?[5NL_%S_AC;Q!X6^(-WX9M/ MB5XWUVP\+^'(O`4EW':W@N98O]'>2XP5:1([M7W$1["H)RV*`/HKX7_M)>&O MB1^SQI/Q@9O[+\.3:1+JNH@^9*;'R%?[7&,1AIO)>*5=RH-P3&/BYXQ_9%T+PX8?!WQ3\8Z7XKLY[5+>.:VT=U\[5?*8NJ0M#)IX6"-H2=D, MV=S&,GW/X!_$O3_V[2UL[33+R(7&EVUN^ MUH85G<,%C0$J\IRFY@&`/:?"O[7OA;Q;^TCXA^$5K9W$=QID,D=KK\DT?V'4 MK^!8Y+ZQ@8'YIK>.XMV=!EE/G;U01JTG0_\`"]B/VI%^#AT/!/@W_A+?[9^U M]/\`33:_9_)V>V_?O]MO>OSNL_`_[0/P9\*^%_B%J/P*^R>+?!7B75?'?B3Q MD/&-@Z:K;W:2?VG#]C5W2$2V\=NGF(K%/L^Y%#,Q/U;H>I66M?\`!2W3]1TR M\CU+3;OX+)<6MW!(LB3POK!:-U8'#*RL"#SD8)]:`/9/@-\=?^%W_P#"Q?\` MB2?V+_PB'C+4?"7_`!]^?]K^R^7_`*1]Q=F_S/N?-C'WCFO3VNEC.#C/H>O_ M`-?O^5?%_P"Q5\5O!?A?Q5\=O#6K^,/#^E>(M3^,&O/9:/?:K!#>W/F20HGE MPLX9]SH5&!R<@=!GU;]MH^(C^S#\2$\+-*FK-IN)'1HEQ9>8@O2IDP"1;"7G ME@3\F6P*TH4E7Q$:5[7M^(I.RN>C:?\`&WP#J?BZ;PO:^,_#]QXDBF>W?2(M M5@>Z$B;BZ&(-N#*%8LN,C'-Z3X"&A>*]1\,VS:OJT< M8OQ:",M<*7"8SYH&P;L''S'->+N_[$TOACP1YQ\!S6<5W;?V>+=0]PDS(?*% M[L_>A,;C(+OY-PS)@@55_9F_9]^'7Q5OOVA;WQCX0TW7KVX^(NN:9]KU"W\R M6.V!5AY#]8F!ED.^/#YV_-\BX^LAE>`HT:E6O&I%*WV5NW9M:_??;YW6/M&? M;.IZY::1IUQ?WT\-I8V\+3S7$TH1(T52S,6/`4`++K3;; M0O&OAS6I-0EG@M1IVKV\_G/#&)943:QWLD;([*N2JMD\8)_/KP#J-IJWP%_9 M&F^)=W!>?"A-;U:'5Y-:D$D"W<;W<>E1REN?)0JR`']T%4!P%"BN_NI/@PO[ M//#-[=:KC^S MX+;6+>1[S,C1KY*ALR9>.1:_/'X0_L]_#GQ+_P`$TM<\5ZGX0TN^\32Z)K>I M'6+J)C=)<6TMQY)29CYD<:_9XOD4@,`VX'>^[9MM4\/>(/B!^SW>_'+4M)U' MP7??"Z*XTRX\4RQ/;3ZVR6[7LLYD^^6MS&P,^4WCY?GZXXC(L+#$U:-*BN^3^57\GZ+778<:LG%.Q]R^&?BQX,\:7D=IH'BW1=;NIK9KV*WT[4(;B M22W64PM,JHQ)C$H,98(6( MU@3Q*ABW'[/C:MJ&V?N\[@_S[@<)H_V9%_8+W2+X.7QDGA7+`H@UL:P8PI)4 M@7'_`!\X`X\OR\`#R<"KCP]352$%[1J?)9:5W@+D+C#[*]Q^`S^%F_:Y^(G_``IY M-$7P#_PBUD=='AOR?LG]N&=_LWE[/EQY'F[O+^3=NW_/FL,9D5/#TVXRE?EY MKM6C\7+9._X]]+=2U4;Z'T_KOQ9\%^%_$=EX?UKQ7HND:_?>6;72K[4(H;JX M$DACC,<;,&?TN&U.`)<);@M<-& MV[#B((Y<@D+M.>AKX@^"7_#/!^$OBP_'!?!Q^)W]J:T/%O\`;R6YU;[5]HF\ MS[/Y?[S_`%>S9]DXW[]GSYKAO@AX,T+XAZ)^Q5H7B33K?5](N9?&4LMC.!Y4 MOE2O(BNB_*XW*I*D[2%P006![8<.4%3JSJSG^[;5^7225.I-N/=?NU;R=Q.L MUT/N?P%^TQH_CGXA?$W1HH[*W\.^#+73+X>)4U-)+6^M[NU:X\\-M$:1(@SO M\QLC)^7C.GKWQ^TA8O#4/@Z`>/M3\4"Y;1QHMRCV31V^U9KBXNAE(H(Y)(D= ME$C@R`)'(P*U^>_Q]\(ZA;_M%?&4KI5_JWP6\.WWAN?QAX5\.2K:RO8IIZB% ME4+D00B,LR*5X"$%`GG0^U_M#W]CXM^'6H_\*VU:VLM.^)OA?2="\(7U@\EE M9M-I]Y6"&D$<9,@]S\5_$/PYX"TN+4?$VN:9X;L9)E@6YU M:[2VC+L"P3/5O$7P:\*_!3PSXD\/+X&C!UG3 M?*,MS.3<20>6R,+M[)KJ&+9&[;]@<&,OL])UQ/AL?VR_B1%\=D\+-$^A:4?! MT?B=8/LYL@9_M93S`(]_VK?@O^]P6V_)7#B\EPB:C2E=J'-)0:FW[R5O=;5T MGKKLGIWT4V?5$'QO^'MU<6]O!XV\.RSSS6D$42:K`6>2Z0O:Q@!N6F16:-1R MX4E<@$BKH?[0?PV\3"\.C^/?#.J&PMY+R]^Q:S;S"UMTQOFE*N=D:Y&6;`&1 MG%?F!XDT'X>^+OC/XNT+P?%;7OP_U;XJ>$-->UT^5UM)(Y(-02\CB;*D1F0S MA/+(4+C9\I7'TI\=/V:?A;;_`+7'[/&DQ>!=$M=+UM-8%_86UJ(8;K[';+-` M'C7",0\C$Y^^,!MP``[L7PY@,+6C0JU9IR@Y_"E:U-5+-:3/^R[%^PIL_XHY?&0\,N,8C_MH:QY?.[)\_/VC'4E/+[F'FO,HY'0 MJ5(\LIRA/ELE&\ES+JK[)IVUU\A^U:Z'W7IGQHAUWXLV'A;3;?2]0T&^\-+X MAMM[[HZX[5\M?LRR-)^TA\+1,Y$P^`6EF4,5W$_; M(\G!&<`YYSC'0=Z[S_@GEXRT>P_91^%>DWFK65IJ>L?VLUG8SW2+/=LFH7#2 M"&-FW2!0;3_MV(HS*O$VC^&C>[OLRZMJ,-JTQ7&[8'8;L`@G'0$9K;T_7;'5M)M=2L+J"_TZ[A M2>WN[:42121L,JX9<@J00=PR,'/3FOB/P!_PJ/\`X7)\<1\=4\&?\)Q_PE?[ M@^+!;%?[)\B'[!Y7V@F//EXWB([A^[WX.VL[XL#X2-^R;X?/PJ^P#X,_\)I8 M?\)F+W;\E92R.E.5.FN>\N5-\ONM2 M5[+75_RK[7D6ZC6EC[)T+XU>!/%-AJ][HOC'P_JUEH\0GU*XL=5MYH[*/:S; MIF5R(QM1SEB!A&/:JD'[0/PUN]:L=(B\>^&6U*^$#6MJ-8MO-G\]5>#RTW[G M\Q64H5!#`\$U\"?MM'X1KX2\/M\"AX,/CE?[2)/A%;5F_L<:=<'4?-,0\O\` MU6S:'_>8W^6W\TO,,NZL)Y`$8LB_*``$7;ZU/AS`2IT*M2K./MY)?$.H:!I'BK0]4UW3BPO=,LM3AFN+;8ZI)OC1BZ[6=5( M8#!(!QD5THOU"Y==ISMY;@MR,`]^1CZD<5\6?M$_!3P5\"M6^`.M>!?#]EX/ MU"#Q]H^A_;M)4P32V]?S7_`!>^".O_``Q^-6J>!AHMQ)JO]IRV MEAI,=ZM_=SJ9WB@1O+2-V>4*K(#%$\J21NJ!9$K]]?V1OAOXA^$7[-?P]\(^ M*]0N=1\0Z;I:+>-=,&>W9V:06NY7<,L"N(%*L05B!&`0!YYJ>O4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5PGQ@^#/ACXX>$I?#W MBG3;34+/SDN[9[BTBG:UNH\F&=%D5E+(2?E=61U9XW5T=E/=T4`8GA7P=I?@ MKPUHWA_1X#:Z1H]K#8V,'F.YB@BC$<2;F)9MJ@#+$D]R3DFMXS^'/AGXC:/' MI7BOP]I'B;3HY%F2RUFPBO(%D52JN(Y0P#`,XR,'#$9KI**`.9\(?#CPW\.= M-FT_P=X?T?PI8S3-I"@9JUKO@G0O%*V*ZUI M-EK(L+J._L_[1@6X^S7,?^KGCWYV2)D[77#+DD')-;E%`&?/H&G7.K0ZI)96 M[ZE!!);17C1*9HXI&1I(U?&0K-'&S+T8QH3G:,<]K/P@\%>(CX@.J>$]!U+_ M`(2'[,=:^V:7!+_:GV",=SZUDZ1\,/"F@ZM9ZI8>'M+LM2L], M71;:ZM;**&2"Q1]\=K&54%(D;E47`'7KS74T4`><-^SM\+W\4R>)&^'?A0^( M3>_VDNK_`-AVWVQ;KS/,,PFV;MY?Y]V<[B3G)K-^-$/QA)TI?A6/!?E9E.H_ M\)>;H`C"B,1>1T_BW;@;YG`;U`Y-;4:KI34[)V[Z@MK M'Q=:?!7]H;3O%3>)K/P?^SO9^)S/+<#6H=+OX[OS9`ZR2>:J[]SAVW'=DAB# MG-;VA^$OVIO"Q+.*DW[U.#5K;?\`!,_9IGR!8^`/VGM'\*#PSIVB_`>P\.^3 M+"VE6UMJ26Q64L9%$87:%8NQ(P#?V=]&;3II MY[0:=IE_!Y#31B.5TVH-KNBHK,N-RK@\8Q]I;.,9.*01$#&XXJ?[9K+:E'5Z MZ=][Z_U<'335F?(%C\/OVGM,\(2>%[30?@#:>')(I(&TBVLM2CM#'(29$\D# M;M;_GN)TU;0^`M`_ M9A_:9\)_$2\\8Z!??"30+R70I/#UGI^D07-O8Z9;/,)RUO"+;`D\[S)"9#(I M:0Y4@`!/$?[+/[1_B_0=4CUE?@I?>*]3MI+.[\;G3)8];EADC,+KYR6H4;H3 MY.0@_=\#!PP^_P#9[T;#G[QKM?$V,;C-TZ=XVUY%?39>G=/1[N[)]BNY^>ND M_LB_M"6>NZ1J6H1?!_Q%#IOA2U\'KIFM"_N;.>TMYEFBDEB,6&FWHA+#"_+] MT'D>I>&_!_[5'@G1+;1_#VF_`O1-(MB?(T^P@U.&WB!8L0J(H"Y9BQQP2>F2 M2?KOG]?%6]M2@_+ET_,<:26Y\::_\`"G]H_P`5^([/Q#K/ MA7]GO5M?LC']EU6^T[49KFW"2&2,1R,I9-K'(P1@\]:72?A3^TCH)T-]-\,_ ML^V,NAB<:6]M8:C']B\[/G&+:HV>9D[MN-V3FOLK8<_>-!3W-8?VS6Y>7V<; M=K>37?S?WC=.[/DC3?!O[4FDZOJNJV6E?`FTU/5#$=0O+>VU*.:[\I66(2NJ MY<("`NXD@9`(SQFZ)\+OVD?"OAB]\/:+X5_9XT?0+TR-/- M:GF\6R?!;Q;H3%9(/#.MZ=/=:=9S*H43Q![8RB3&\9:1@/,?Y>F/MP(1WXHV M'U-;4\ZJ0?.J,+VMK%/_`#M\A^S2/S^\%_LJ?M">$/%GB37A:?!C5Y]6N["\ MALM3M[PV6EO91O%:"TBC@3RA%$RQKR2%0O:=K5QI?P*N- M7TOS1I]]<6^IO-:"0;9!&^W*[E`4XQD#FOK:Q]2^"_[0NMZ]=Z]J'@S]G2^UV[0Q7&IW.E7\ES-&T1A='D M*EF4QDI@G&P[3D5]I!/]HT>7SG)K".<5%JJ<4_3\-]@]FCX\TWX=?M,Z-?6- M_8Z#\!+*^L=/32+6Z@M-226"R4Y%LC!-&SW-']L5)*SI0 MU\O^#Z_>"II;'QIXS^%/[27Q#-B/%'AO]G[Q*;,O]F?6-/U"[:`-C=L+H=I. M,''48STYWM/T/]K'2=+M]+L+7X'V6FVL"06]K;1ZI'%$B@!4"@`!```%`'`Q MTKZMV<=:-A_O&I>;U)1472A9?W>OWA[.Y\5^'O@K^T)X9T[6-/TCP=^SKI5C MK$(M]2MK+2K^".^CPR[)E1`)%VNXPP.`[=CBM&\^''[36H>$AX6N]!^`5SX9 M$4<`TB2RU(VHCCV^4@BV[0J;5VC&!@8Q@5]AE">C$4;#ZU;SFJY\[IQWOMU7 MS#V9\CZUX3_:GUX6(U+2O@1J?V"YCOK1;R#4Y!;W48(BECRORN,\,/F!)P>< M#Z=\*0:Q+X9TL^(_L8UX6T7V_P#LWS!;_:`/G\O<=VS=G&[G'7-:[0,68AQR M,8(R,5*JX`&>?6O/Q.+EB$HN$5;LK&EDEH>8>*_V'_B)K6C6VH> M(]"A2.QEN8$D6%HW=K>1=P)5HC/<%0"%+RJ[JS00&+TZ-!&@4``#H%&`/PI] M%<"5E884444P"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB H@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#__V3\_ ` end GRAPHIC 15 f10k123112_ex23z1001.jpg IMAGE begin 644 f10k123112_ex23z1001.jpg M_]C_X``02D9)1@`!`0$`R`#(``#_VP!#``,"`@,"`@,#`P,$`P,$!0@%!00$ M!0H'!P8(#`H,#`L*"PL-#A(0#0X1#@L+$!80$1,4%145#`\7&!84&!(4%13_ MVP!#`0,$!`4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P``1"`"U`ID#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]4Z***`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`/$_C1^V9\(/V?/%4'A MOQ[XM&@ZU/9K?Q6QTZ\N-T)9U#;H87`YC;@G/%,^$W[:OP6^..L2Z3X+\>6. MJZNI7983Q2V4\X*LY,23HC2A41W?8&V*N6V\5^?W_!3?3?#VL_\`!0WX,Z?X MM:`>%[K3-'AU9KNY^S1+9-JMT)RTNY=B^7O)8,"/7I7EG[9W@_X.?"7XO_"N M[_9BU*VO_%:7"W1LO#E^VNQQ7D<\1LC&SM+OF9_,!B#./W47[M=Y,@!^OOQE M_:"\"?L^^%+/Q)X_UL:#HMW=K8Q70MIKD-,R.ZJ%A1VY6-CG&,#M77^$?%6E M^.O"NC^(]$N?MNC:O9Q7]E<[&3S894#HVU@",JP."`>:^$O^"T(W_LK^%I"6 M^?QC9G:3T/V&^]R/RKZO_90P?V6_@Z0"%/@W1R`3G`^Q0X%`$_QN_:3^'/[. M>G:;>_$3Q)#X<@U*9K>R$D4D\EPRJ&TW$,+M',/BQH-[XW^%VJV=NUOIUO?W$&VUCMQ!+;Q2Y4+)'<%KDPQL`1.A M9E\XD?8/[('[&'P?\!>.S\;/A-XKUG5_#NO:L;.%)9"TRG;M>14"I M$L-SN:*2)C)OD5#&`?9L4HFC5US@^HP13)9BCA0%/3.6Q_3Z_E1:%S;IYB[7 M'!&<]_7O]3S[#I7Y??\`!1_QYX\_:#_:2T#]F+X=ZI;I:W%M!<:M;%VME:[( M:Y(NI3]Z"*V2&<(@.6.?G=450#ZR\3_\%'_V<_"&N7.D7_Q,L;B[MBBR2:59 MW6H6WS(K_+<01/$X`89VL=IR#@@@>G_"/]H3X?\`Q[T-]5^'WB>P\2V\1`N( M89#%ZC<6:[]BJRQ0VTD:I'N5F"MYC#?@R.`#7#?\.GK3P-^T#X=\9?"_XD MZSX%T*QFDOIH4VW%[;2&5LZ/<> M*7U)XKFPT379=7B-D(F=I9@TDHB9)/+"CVCCXA^(#H`U<3&Q/V*YN/.\HQB3_`%,;A0OFIDL1]X8S M6]\$M7\0:W\'/`E_XJCN$\4W6A6$^K)=V_V:=;I[=#-OBP`C>86RH``.1@8Q M7Y5_M9:1XK_;\_;<\7^`_!]Z;W2?`>BWD5E#`3&OGVT7^D*4N)43S9+YX[4R M)M7R_*<[ECRP!^NGA3Q9I_C?PMI/B/1IOM>C:O:0W]C=%2@GMY8UDC?:P#+E M6!PP!&>16NK;AG&.U?"/_!(WXW7OQ,_9]O/#.KZE_:&K^"[Q;.-',CS)ITRE M[8O*Y*LH9;B-44YC2W1<`;:^[++_`?@^]-[I/@/1;R*RA@)C7S[:+_`$A2EQ*B>;)?/':F1-J^ M7Y3G6^G?^"1OQNO?B9^S[>>&=7U+^T-7\%WBV<:.9'F33IE+VQ>5R590R MW$:HIS&ENBX`VT`?=RMN&<8[5RGQ2^*GAGX+^!]2\8>,-1.D^'=.,8NKSR7F M\OS)$C3Y8U9CEY%'`[UU-N28$W8)QR5&!7RQ_P`%10!^PO\`$QNX_LSD?]A. MTH`N:3_P4P_9LUK4[.QMOB9`DMU*D*27>E7]O$I9@H+R20*D:Y/+N0JC))`! MKZ.TG7+/7]+LM3TJYM]2TV]B2>UO+68213Q,`1(CC*LA4[@P.&&,<'-?B]X# M^%O[,&H_\$_9_$_B77]'TSXS1Z9J+Q+%XB83@QG0]2)![C*VY!XSTR/?FO>/AS\7O"/Q@\*1 M>)/!&O:?XGT>0+BXL;A6\MS&L@CE7[T4@5TS&X#KNPRBOQB_X)U?#;]G_P`? M1>/_`/A>MQX?L_LCV']D'7O$#Z5DM]I\]8ML\7F8VQ;A\V"R<#//LO\`P28N M3I7[4WQET/P;?7^K?"E;"8V^H75OE;CRKT1Z:TLAC4H[0271"$)N^<[/D&T` M_4[Q5XTT3P-HUUK'B'5;'0](M%5KC4-1N4M[>+I^GO;#CWKX@D\)Z__P`%5_VN/$LZ^()M-^#'@R98 M(YTE^:"S8E0UM$Z+MFO&@DE+R(QC`"N7$4:/]D1?\$J?V`NT`4`?5'ACQ?HWC;1X=7\/ZG9ZYI$Y M=8-0TZX2X@F*,5?;(A*G:RLIYR&4CM7)_&+X_P#@C]G[PI:^(_B%K`\.Z1<7 M:V"3_9I[K,Y1G"A8(W;E8W.2!TYP37Y>1^"]?_X)2?M<>&+BY\0S:G\'/%\S M6TL[S!&DLP0DAN8E1SYMHURDH:-1YH.$*>9(B_0G_!9O)_97\+LS>8\GC&T( M96^0G[#>C(Y.![9QSZT`>LC_`(*B_LRMC'Q*'OG0M3X_\EJ]2^-_[4_PT_9P M713\1O$7_".?VR)S8`V-S=>?Y.SS?]3$^W;YL?WL9W>QK\W?A8W_``3T;X9^ M#CXU*GQE_8]E_;G_`",.T7GDIYX_=?N^)-P^7Y?2NF_X+>NT>+'/?Z^]`'U6?\`@J)^S-NVCXE`\\G^PM3P/_):O MMP>'=#CFCMOM$ZO(TDKGY8XXT5GD;`8[54D*K,9MVDMC.00-[XL?&WP9\#?!L-(LV8_\` M"+C47!LKT1)'Y$K%C,NT,YDC:21)O,7#&`E)/(O^"NWAG6M$^,'PH\15`A>YA\M5D4F0_9W//EK0!^@_P:_:I^%G M[0:W"_#_`,7V7B"[M][2Z?MDM;P(OE[I1!.J2&/,T8\S;M);&<@@-^-W[5/P MS_9Q71&^(OB(^'!K7GBPW6%U<&8P^7YO$43E<>;'RV,[N*^5_P!E7]D']GGQ MOXW\+?'OX/Z_KUAI%FS'_A%QJ+@V5Z(DC\B5BQF7:&#? M$']O7X#?"[Q1-X=\0_$2PBU>`,)[?3[>XU#R'5W22.1K>.01NAC;);Q+:X\AIK*60VT-JSD`;;B M/#OBBZP?$%GG2];`P2;^)4W2C"(H\V-UF*J,)YNWG;F@#H?@O^V!\)OVAM0U M33_A_P"+(==U+3H4N)[-[>:UE\MFV[T29$,BJ M,;3XJ^%4G?2]%U*TTO5[>.ZCB6_BN/,E^Q."&)66.RG^<(^QHT;APF?T2_X* ME?$72/C+^PY\./&>@7!N-$U[Q-87MLWFI(\1:QOM\+B-F421$-&ZAL*Z,,D@ MX`/T6\(^*M+\=>%='\1Z)<_;=&U>SBO[*YV,GFPRH'1MK`$95@<$`\UR?QI^ M/W@7]GGPU;>(?B!K1T'1KB]33XKG['/<;IVC>0+LA1VQLC<[L8X(SFL?]E.Z M0?LP_!Y%5BH\':1V)*C[#$0.G/`_SFO@;_@HEJFK_M4?MA?#S]G3PYJZ6UC9 M^5<:H%60"UNY4,LTLJ2.D<_D6*+*@7#?OI4#;F*@`_27X8_%CPO\9/!.E^+_ M``?J7]K^'=3,@M+P6\T)E\N1XG/ER(KKAXY!\P&=N1D$4?$[XK>&?@UX$U#Q MEXPU'^R/#NG^5]JO!#),(_,D2-/E12QR\BCIWKX#_P""2?Q(US0[WXD?`7QE M</"M\]Y:::WF3O`5F:'4(_-0M$$CG$1`!^9YY&4L,X]\_X*?;/^&$OB4Z M$,"-,8,F.]`'T)\+?BEX8^-/@33/&7@W4_P"V/#>I^;]DO?(E@\SR MY7B?Y)55QAXW'*CID<$&NKKY6_X)=?\`)BOPSZG_`)"?7_L)W=?5-`$,ER(F MPP`&0H;<`,G&`<]R3TKP7X@?M[?`;X7^)YO#WB'XB6$>K0AO.M]/M[C4/)97 M='CD:WCD$;H4;WNUC78&E%O,J2M&#*@\P(5W-MSN!`]26[4DYPJAMN2<=@?\]O M>OSM^+W_``2&\-R^.-`U[X0>+[[X;-#>">YCE=[L:?LB4P36;EUF5_.B4DO* MQ!E+*R^6$:7_`(*=_&?Q-HND>`?V?O!>L7][XY\9M!!J%V9H[:>^M'8VL4,I M2..,?:IR^[RRBJ(75EV2XH`^E/B#^WK\!OA=XHF\.^(?B)81:O`&$]OI]O<: MAY#J[I)'(UO'((W0QMN1B&`P2,$&NG^"_P"U5\*_VA1=+\/_`!E8:_=VN6FL M<26UTJ`H#)Y$RI(4S(HWA=N3C.<@?,OP,_X)%_"?PKX*@7XD07/CGQ1=1(]\ M8]1N+6QM9@S$I;K"T3LH#!"\I8MLW`1[BH\@_;-_X)D:9\*/#MY\5/@9?7_A MRY\.*=4OM(DU%L6EM#&&-U9W#'SHY(S$TC*SN7!;8RE0C@'ZE_:>,[">^,'( M'/.,9[=*^7$_X*A?LTR;0GQ&+.3C9_86I'GN.+8YXSTX]^:Z/]A_]HIOVE_V M>/#OBBZP?$%GG2];`P2;^)4W2C"(H\V-UF*J,)YNWG;FORW_`."=7PV_9^\? M1>/Q\=+KP_:BT;3QH[:]XA;2BP60X&>0#]G?AS\7O"/ MQ@\*1>)/!&O:?XGT>0+BXL;A6\MS&L@CE7[T4@5TS&X#KNPRBO,/BC^WI\#? M@QXXU3P=XP\;C2?$NF+$;JQ_LJ^G\OS(DE3]Y%`R'*2(>"<;N>017PQ_P28G M;2OVI?C'HG@R^U#6/A2+*;R+^Y@!$XBO0FG/-(44H[027)"$+NRYV?)\O)?' M'PU\/_%O_!7#7-'^*UO%C39NE\B=8Y#$#(@\P+LR< M9R"!Z3J>NV6B:?>:AJ5U;Z=IUG&\UQ>7U.__`&I[KQ9_P4(_;*N/@CX&UE=-\$^#@PU.65V$`FCD$=[?-;LJ M&62)Y!;(A8@E=Z.J2NP`/LC4/^"E_P"S;INHWME+\2X))+.1HI9+72K^XAR& M*DK+'`R.N1@.K%3D8)!!/MOPU^+O@_XP>&(?$'@SQ#I_B+2I-BF6QG#F*1D5 M_*D7K'(%=,HP#*3@@&OF[PI_P2D_9TT'0K*UNO"VHZ_>0!C_`&MJ.MW27,N6 M8J6^SR11?*&`&V,<*,D\D_&GQX_9[\2?\$P/C!X1^*OP[UW4-4^'=Q?PV%U! M"&2;R]\JQ(=J*6.7=1P._XUX?I/_!3#]FS6M3L[&V^)D"2W4J0 MI)=Z5?V\2EF"@O))`J1KD\NY"J,DD`&N<_X**^)=+\9_\$Z_&7B/1)Q=:/JU MEHVH6-PJLGFP2ZA9R1-M8`KE64X(!'2O@_P-\+/V8K__`()^3^)_$6M:59?& M>/2M1ECBMO$+'5&NDO)A:1BQ\U@%95B5OW7^KD=\CEZ`/VATK7[#7=*L]4TV M\@U#3+R%+BVO+242Q3QN`5DC9%?@WX*U3Q=XPU0: M1X>TOR_MEWY$LYBWRI$O[N)66,<*<;@3QS7R7_P`$B-4\0:E^R.EOK$

8S,02<-!&S;!@D`^YO@Q\??!'[0OA MBX\1?#_6?^$@T2VO7TZ:Z%K/;[9UC20IMFC1ONR(=V`/F')-9?QN_:G^&7[. M1T0?$/Q)_P`(_P#VT)S88L+J[\X0[#*?W$4FW`EC/S8SN]CC\_\`_@G9?:W^ MR[^V-\1?V>/$NHKR9Y7WG=B.-&;(`/W MY\:?V7?AE^TA!H3?$;PU_P`)&-'\XV`:]N;4P><8_-_U$D>[/E1_>!QM[9-` M'EZ?\%1?V:6!+?$4H%^\?[#U(X['I;'H2.>ASQ7J?CW]JGX8_#+XG^'?AWXE M\2#3O&/B#[/_`&;IOV*YD\_SYFAB_>)&47,BL/F8=*_+'_@E3^R_\,OVDO\` MA9X^(WA@>(O[&&E?8/\`3KFU\GSOMGF?ZB1-V?)C^]G[O&,G/J?[>P`_X*D_ MLY!LLV?#IW9Q_P`QNXP/P.?SH`_4T72Y.["@-MSGC.`?\_3\*\&^(/[>OP&^ M%WBB;P[XA^(EA%J\`83V^GV]QJ'D.KNDD`KRYC\9>.IXEO5M[GR6GLI9#;PVK.P'RW$Y<';(N%@96!24 MBMCX&?\`!(OX3^%?!4"_$B"Y\<^*+J)'OC'J-Q:V-K,&8E+=86B=E`8(7E+% MMFX"/<5`!]-?!?\`:J^%?[0HNE^'_C*PU^[MTFO[V?8[F*WB0N[[%4L<*K'`&>*_ M,K]LW_@F1IGPH\.WGQ4^!E]?^'+GPXIU2^TB346Q:6T,88W5G<,?.CDC,32, MK.Y<%MC*5"/[OX(_:%_X:7_X)L_$/Q1<[/\`A(K7P7K6EZ\`1EKZ*PDS)\J( MH\U&6;:HPGF[>=N:`/HWX+?M*_#?]HG2=2U'X=>)X/$D&FS+!>*L,MO+`S+E M"\)/^$>763.+`FQN;GSC#Y?F MC]S&^W'FQ_>QG/M7XF?L<_'SQ-^R1XUT'XAM#J-Q\.]:O+C1M6TZPN8O^)@; M>*)I2(V)_>P"]AD0MMW;F0.H:3'U9_P6MU>RUS3O@1J>G7T%_IE]#J]Q;WUG M,LT5Q"XL&21&4X=64@@@X((QQ0!^KR,67)&#Z9IU-0`+@9X]:=0`4444`%%% M%`'Y'?\`!3CP?9_$;_@H9\&_!^I37$&F^(=+T;2;J2U8+*D4^K7<3%"00"`Y M(R#7U]\"O^"9/P8^`WC"V\4V%MJWBG7;*XCNM/NO$MS',MC*@8;XXXHXHRQW M9#.K%61&7:RYJS\?/V&?^%X_M3_#GXR_\)M_8O\`PA_]F_\`$E_LG[1]K^R7 MTEU_KO/79O\`,V?<;&,\YQ7U50!^?G_!:,"/]ECPK#N9BOC&TP7;)/\`H5[^ M/?O7U3^RK*8/V7/@ZA7E?!^CQMST864(P?QX]JYG]M+]E+_AK[X7Z7X._P"$ MH'A,6.M1:Q]L.G?;=^R">'R]GFQXSY^[.?X<8YR/EGX6?\$AQB@#Z"^)7[0G[.'QC^ M)3?`KQ?J.E>)M3NY);9[>ZMG^R6UX$54C6[(`CN6$LBQM$^58.F]9&17^$/A MYHVH_P#!/O\`X**Z#\._#GBD^*O"?B>ZL]/NM-2Z6.5;:[=HH%O1L*K<0-)Y MP*!?,0J08Q.R#[3_`&QO^";WA']JS7;+Q-9:S_P@OC!,1WVJV^GB[348@I"" M6+S(\R)P%DW9VC:0P5-F%^R__P`$KO`W[/WBZU\7ZYKT_C_Q1ITQFTQKNR%M M86;#84E%OYDA>9"K;7:3:N4(0.BO0!]L6S,T"%V5G(Y9>A]Q[5^3W[8VM_\` M#)7_``4U\,?&35;#5-;\.ZQ8K?2+9VPC\K%FVFRQ0NY*321A8IRI*?ZZ-3LR M)#^LB((U"J``.@%<3\6_@MX-^.OA*;PSXZT.W\0Z)),MPMO.61H95!`>*1"K M1M@L-RD':[J42BN$D3[T M4@1T+1R!67<`P!XKS_5/VQ/A%9?&W2?A4WC*P?Q=J*S1J+:19(+>Y20(+2:8 M$I'.[!PL9.)O^"(&BW>LW$GA[XM7VE:.2K06FHZ$EY<1_(H? M=,D\0;+!BO[L;00#N(+'W3]F3_@E_P##+]GW5M-\2ZK--X]\:V,XN;?4]0A$ M%I:2*TNU[>T5F53MD3F5I_:OM/D'_MA?'"W_9\_9]\9^+#?M9:K%:-9Z.42&20ZC,"MMLCE.V0HV)& M7#81&;:0I%?D_P#LC_$3]I']F'PMJ(;'Q2+:_?6K[POK%T+J!8B M8!$T4B1&,"61@RKEO,)W,H3;^G?[;'[(.I_MA>'?#6@)X_\`^$/T32KN6^N+ M/^QEOA>3%`D+[O.C9#&K3C`)#";D`J#7O?A'P?I7@7PIHWAO1;;['HVCV4.G MV5OO:3RH(D"1IN.2:`/Q4_9Z^.'B?X&_M\6?C7XH>&KOX70^.9 MI8=>TRYL9K.,0WC$+='[.+[9$LSR!QM$<@3Y1Y=?MU'<;$(VA<`'YCC+' M)/M^OZV:`Q":)<.R M0-O))'E$#`=J\>_;C?QSXLO/@!^S[H7B+61XU\0:G;W^K^-=,A>P0BRBW2W/ ME*R1.P?=>&%)=T9MHL#,D34`?>,4@EB1QR&`(Q7B?[8GQRM_V?OV?O&?BTW[ M66JQ6AL]',:0R2'49@5MBD=&R&-6G&`2&$W(!4&@#\Q/V1_B)^TC^S#X6U. M;X;?`?4/$-CXI%M?OK5]X7UBZ%U`L1,`B:*1(C&!+(P95RWF$[F4)MM_L]?' M#Q/\#?V^+/QK\4/#5W\+H?',TL.O:9RAT^RM][2>5!$@2--SEF;"J!EB3Q MR37@W[:W[%>E_MB^&?#5E-KY\+:QH-Y)/;:H+-KL>1+'MF@,0FB7#LD#;R21 MY1`P':@#Z/@&(5XP2-Q'N>3TKY8_X*C_`/)BOQ-_[AG_`*=+2OI7PEINI:-X M6T>PUK5AKVL6MG##>ZJ+9;;[;.J`23^4I*Q[V#-L!(7=@'BO/_VH_@7_`,-* M?`KQ/\./[;_X1S^VOLO_`!,_LGVKR?)NHI_]5O3=GRMOWAC=GG&"`?GQ^P]_ MP31^%OQV^`?@3XE^*]4\33WNHRW+WFD6U[#%93)!?SQ"(XA\U4=84W;9`V2Y M5ER-OZ;>!?AUX>^%_@K3O"?A;38M%\/:;%Y%G96N0(4)R?F)+,Q8LS,Q+,S$ MDDDUR/[+OP,_X9L^!7AGX==2S_ZK>^W'F[?O M'.W/&<#U1AN&*`/YTO@K^S?-\:/@-\9_&FFW-X->^']OI^HQV:-'Y-S9R?:C M=[RQ4J42$R@@G(C==K,ZD?J5_P`$H]>^&>O?L^S2^"/#<7ASQ5;316OBI#=B MXN;VZCB39=;RV]89^>*_P`&?V#I_@%^TAXC^(?@KXARZ1X,U^>::^\! MPZ-&ENRNLA1%E60*@AEE9HRL0*)^[R06)`/C?]BCX@Z)^P+^U-\3?@[\29#; M0:M>VFGVGB5]@MD\OS7M7G16;RX[B.[C?[[>46428&YX_P!7F\9Z%;^$T\2+ MJ^GCPS]B74!K#7D8L_LQ7>LHFSL*%>0V[;C!S@YKR?\`:4_8N^&7[5-O`_C+ M3)X-:M;?[+::]I3K#?6\7FK(4W,K)(ORL`LB.%$DA7:SEJ^)_P#AQUEU)^-9 M(!R0?"N;V@#D_P!MGXD:1^W[^U/\,_A!\-;@7EII%[>6=SXECD2:WF\U M87NI($+*)(X(K1W#;P)B&"9`5G]X_P""T0V_LL>%F&1_Q6EK@,`,?Z%??Y]Z M^BOV:_V*_AC^RM;RR^#-+FFUZY@^S7GB#59?/OKB+S"^S.`D:YVC;$B!@B%M MS*&JK^VA^R?_`,->_"G2?!?_``E(\)"PUF+5A>C3OMF\)!/$(_+\V/&?/SNS M_#C'/`!XQ^SY_P`$Y?V>?'7P%^&GB76OAZ+S6=8\,Z9J%]6UBDD M;:MP%7+,3@``>E>*?\%PD(/P51I)^P=,]?YU^E/PG\"_\*O^%G@W MP;]N_M/_`(1W1;+2/MOE>5]H^SP)%YFS1_P!-HMNWR/\`:SN[8Y`(!_P3$_9C\M91\.%9 M"-Q8Z[J>"O7/_'S]/:M_X]_M2?`;P=XQL?A/\3-6TK4KW6)+:&_TO4K);O3[ M)7W2P27[2`Q1IO2,X8[EWQ2,!'F0?(0_X(=R"<3?\+O;S0VX/_PBG(;.<_\` M'[7UQ^V#^PMX/_:TT.Q>>X3PQXPTW9'8^)(K);EU@!^:WFC+)YL7)95+#8^2 M#AI$D`/SO_:*\"?\.S_VI?"?B[X9^)&?0=7SJ#>%1?NMZE@)4\ZRG+*X-O+A M_*ED4L#&V07@$C?HK\>_VI?@'X/\967PH^(^JZ5J-UK$EM#>Z5J-BMUIUBC; MI8)+YI`8HDWQQD!CN7?%(56/,@\,^!?_``1X\"?#?QE#X@\;>*KCXC+9SQW% MII;%R65=PV.20<-(D@!^=_[17@3_`(=G_M2^$_%W MPS\2,^@ZOG4&\*B_=;U+`2IYUE.65P;>7#^5+(I8&-L@O`)&]0_X+D!5C^"0 M3`4#6\8Z?\N'3VKU+X%_\$>/`GPW\90^(/&WBJX^(RV<\=Q::7+IJ6=FS+YF MX7*&24SJ2R-LRBDH0XD5BM>L?MQ_L+?\-FQ^!U_X38>#O^$9%Z.-(^VBY^T? M9^WGQ;-OV?WSN[8Y`/F__@JGX:U7X6?M`?!G]H2*W75M$T2[L-.N-/9T@/VB MUNI;Z)?,;51?:>6+*([F`$M&^Y&`ZJV,HS*58];X_P#AWX?^*/A#5_"WBK38=;\/:M%Y M-YI]UDHX!!!!!!5@55@RD%64,"",U\`_$7_@BKX0UWQ/<7O@WXA:AX4T6?<_ M]DZCIHU/R7+L<1S>=$WEJA1563>PVDEV+<`'JW_!0_\`:W\!_"SX->+_``.U MY;>(/&_B73+C1$T&SG#3:>+BW"FXN]NXPJJ3HZ(PW2$J%&-SQW?^"6_P=U3X M1_LE:5/JEQNO/%U])XH2$HO[B&>*&.#YE=M^^*&.;)VD>=M905-<7\`?^"0? MPQ^%VK+J_CC5)OB?J$$WF6MK=6OV/3H\&-E9[<22&5P48$.YC97(:(D!J^[T MBV1*F>![8_2@#\@/^"27PYT?XN_#O]H?P;X@M5OM(UNQTJQE@R@=2XOBLL>] M6021LJNC%259`PY7!^8OC-K7CKX+>"/$'[-OC:Z1R/US_8A_837]C9?&:GQJ/&(\1FQ)SI/V+[/] MF\_!'[^3<6\\<\8V=\\/_;7_`&!]$_;"?PWJ(\0CP;XDT4R1?VG%I<=V+NV? M#&&5=\;MM==R'S,+YDWRDOE0#H/A/\2=%^%'[#OP]\7^(92FEZ'\/],U"X/R MAV*V$11$,C*ID=@$0$_,[``Y-?E)^S+\3_VB/A[XS\4?%[P/\(-2^(.K>-/M M`N/$ESX?8S.4\R5Y'V;B%W[1P!0!^+OBCXZ_ M%+P3^U]X.^//Q,^&]_\`#?5GOK?[<(="N[9=2MHT6WN?*COY&4R?97$6$=`, MHWRL2]?I9_P4KU>S\0?\$^_'VJ:=>6^HZ?>V^D7%O>6DHEAGC?4K1E=''#*0 M001P017I7[7/[+VF?M8_".?P7?ZF-$N$NX+[3]3^S&X%I.C89S$)(]^Z)I8\ M%@!YA;D@8YGQ1^R'JOC/]BB/X!:S\03>WL=G::>OBLZ,J$06UW'-`OV590#M MBACAR9,G;O)))!`,?_@E]*L7["GPT+$!1_:F2>@']J7=?58R0,\'OBORPC_X M(<-%(LB?&TJZD%2/"G((.>/]-K]3HXUBC5$&%4!0/0"@#\O?^"JNE7WPJ_:5 M^!WQRCM9]6TW3);:VN+(6[)$LEC=F]C4W.'"M,LLP4;,J+=V&X9V_>?P'_:- M\`?M#>"[/7?!&NV]]&;>.2YTR25!?Z>6+*([F$$F-MR,!U5MNY&92K'J_B%\ M-_#OQ5\)ZKX8\5:='K.@:I#Y%W87'W)$R",$72'%Q:W4M]$ MOF-N;]\K3+N6-@GDDGEE4^F?`'_@D+\,?A=JJ:OXXU.?XG:C;SB6TMKFV-CI MT>UHW5GMUE M51?:>6+*([F`$M&^Y&`ZJV,HS*58^"?\%#_VM_`?PL^#7B_P.UY;>(/&_B73 M+C1$T&SG#3:>+BW"FXN]NXPJJ3HZ(PW2$J%&-SQ^4_$7_@BKX0UWQ/<7O@WX MA:AX4T6?<_\`9.HZ:-3\ER['$9:VMU:_8].CP8V5GMQ)(97!1@0[F-E*$A*+^XAGBAC@^97;?OBACFR=I'G;64%37Y(? M!3]F^;XS_`7XS^,]-N;P:[\/[?3]0CLXS'Y%S92?:C=[MQ7:8XX3*""-%/C4>,?^$D^PYSI/V'[/]G\_P#Z M;R;MWG^V-O?/`!P__!*+Q#\--=^`,C>"/#D/AWQ-!/#9^*8VNA<7%Y=I"-MU MN9MXBE7>R1D!$$WXED7<5;;7Q./%%C^P!_P4P\:ZSXZCGU'PKX MW@N;J+58(\R6=M?W*W!N/*0R-(L4UM+`X)61E1Y`C?*C_K>.!7E'[0?[+_P] M_:>\-1Z-X]T87_V82'3]1MW,-YI\CH4+PRC_`("VQPT;,B%D;:``#N_#/C30 M?%N@VVL:#K6G:YHTZL8=3TVZ2>UEV,ROLD0E3M9'!&>"I!Z&OS`_X*;_`+2_ MA;]HN_\`!GP-^&,]MXQUZXU^SN7U73[N%[(W#QR06]K%(Q"2.QNB6<.$C(52 M2Q<1;-__`,$/[%M4O9=/^,,]M8O,[6T5SX=\Z>*,L2H:5;M`[@8!<(H/)VC. M!]2?LN?\$]?AC^R[=6>NZ?%<^)?',,3H?$>JGYH3)&J2BV@7$<*$AR/O2`2N MID93B@#AOVZ/!#?#+_@EYK/@][P:@_A[1/#^D->"(Q"(M3N;/7]"ENEM0\UO?3A((IE_>HM MQ;P2KN56*/&QW9=%'[?_`+3_`,!_^&D/@/XF^&W]NMX?_MK[-_Q-&M?M9A\J MZBN/]7O3=GRMOWAC=GMBN6^%O['VB>#/V3H?@1XEU7_A+M#-E?65Q??8EMF8 M7%S+.LD<3-*J21-(I1CN(>-7&.E`'1?`7Q'\-K+]G/PMX@\"K9>'_AQ#HHO+ M=/M$:II]NJ%YEGE\QE$D;>8)F+DB19-S%@37Y">%_C#\8/%W[5/C#]HCX;_# M/5/B"TVHW<.F7EWH-[M>3:A?:L;9K<7<[G:'$/F.(]L2Q1X4\^7N M/+&@#\?/VI?B_P#'KQEXT\$_%?Q_\,)/AOKWAN>"VTO6QH%_9Q/-'(UQ;(ZW MCR1.RNLCJ,98!MX=0HK]OOA7\3M#^,'PV\/>-/#TWFZ+K5G'=VX+H\D6[AHI M`C,%EC8&-U#':Z.N3BLWX]?!C3/C[\(?%/@+6)?)M=;LC"EQAV%M<*RR03A% M="WERI&^S<`VW:3@G/*_LD?L[ZG^S'\'8/A_?^,1XSL[2\GFLK@:6+`6\$IW MM#L$LF?WK2ONW?\`+3&!CD`^&?\`@AP"K_&@$$$?V(,'_N(4?M\_\I3?V-!XN'B3[%P-)-B+;[/\`:/6>7?N^T>V-G?/" M?'S]AG_A>/[4_P`.?C+_`,)M_8O_``A_]F_\27^R?M'VO[)?277^N\]=F_S- MGW&QC/.<4`?-G_!5+PUJOPL^/_P9_:$BMUU;1-$N[#3KC3V=(#]HM;J6^B7S M&W-^^5IEW+&PC\DDDEE4_=GP'_:-\`?M#>"[/7?!&NVU_&8(Y+G37E47VGEB MRB.Y@!+1ON1@.JMC*,RE6/6^/_AWX?\`BCX0U?PMXJTV'6_#VK1>3>:?=9*. M`0000058%58,I!5E#`@C-?`/Q%_X(J^$-=\3W%[X-^(6H>%-%GW/_9.HZ:-3 M\ER['$(/&_B7 M3+C1$T&SG#3:>+BW"FXN]NXPJJ3HZ(PW2$J%&-SQ^1!/IA2`;E=@^^*".;)VD>=M90R'/0?`'_`()!_#'X M7:LNK^.-4F^)^H03>9:VMU:_8].CP8V5GMQ)(97!1@0[F-E7N7=MWYVY&<8R.M`'YE_L( M?`6T_:2_X)T?$CP9.MK'J4OBN[GT>]GVJ+._CLK)H)=^QS&"WR2%1N,;NHY8 M&OB'XS_$CQA?>"O#'PG\;1S7&J_#74M5L8YKF\6;[/$YMXFL1@;)R/( MSNW#J.!C)\Q_;#_X)HZ+^U3\1K/QM8^+_P#A!];^Q"SU$QZ0MXE]L)\J0_O8 MR)`IV%B6W(J`;=O(!]G0?ZL<]SWSCGIUJ2FHH10HR0/4DG\S3J`"BBB@`HHH MH`****`"BBF/($H`?12`YJ.:<1'&`202%&QZ MW7%`$M%1-<"-2SC8!T)X_P`FCSFVN2FW!P,GKSB@"6BH?/*JS,N`#CK^OTHD MN0F.C$@D!223^0H`FHJ$3-N9=@X(&<]>O3CKC!I%N0T7F8&WCD'U^N.*`)Z* MB6;<$JW?KZ=/UH`GHJ(3,P8[,#.`2PP1Z\4"4L< M;>^.3W]J`):*@-R5<*T>S/38K'!(49-- M:5@$`L02%!))_2G&0AE7"Y)/`;M^5`$E%-C8N@ M8C;GH/;M3?,^U$=P9"!LVG`)#'!ZG/ M;MB@">BHEF+]%XSCG(/ZBD\\A69TV@-CJ/SH`FHJ&2Y"8Z,2"0%))/Y"G&0J MC,5^[D\'/'^-`$E%(K;E!P1D9P:C>8Q[R5.Q?XN?3/I_+-`$M%-1MZ@X*Y[' MK3)IQ$<8!)!(49R?P`H`EHJ,R%49BOW>@.#P3^'ZT`345#YY M.=J%N<#GKUI?.R0`,$DC!X/'>@"6BH!<%NB@GT!/&>F>...OI0;G'.W*X)W@ M_*/7^5`$]%(#FFF3]Z$VG.,Y[4`/HJ(S'LA)]#QV-*9L(S;&`7.?8&A[@Q M9+JH'.""2..F>./\]:`)Z*B>;:.@SQU/&":>CAU!''MZ'TH`=1110`4444`% M%%%`!1110`4444`037!A=05!#$*#N`P3G&?Y<9_G7Y<_\%'/^"A6I^#OBQX8 M\&?"_5+=SX5U*#5]:OK6\G5;F[B9Q_9DRQLBO"!_KEW-N9@AV-$P;]1Y+99) M`Q)XZKG@\8Q]/;V%?@O_`,%'/V6K_P#9O^.EUJ%O++>>$/&$TVI:5>WU\;N[ M,OR->1S,P\PLDLH(+[]R21Y>1Q)@`_9_]GCX]^'OVB?A+H/C7P_-"5O8%%]9 M1S-(=.N@JF:VD9E4ED+<,57>NUP-K`U-\<_C)IOP4^'FI^([O9=ZCA;71M($ MC>;JVIR!A;6,2JK,SRN`!M5L+N<@*I->7_\`!/W]FG5OV9?V==/\/>()?*\3 MZI>3:UJMK%,DT5I<2JD:Q1LJ@';#%$&Y=?,WE69=N>,_:'^`GQW^('[1^B^/ M]$_X53K'A?P?`P\+:=XP-^'L;B586N+R18$`:^`+;P#I_C?6+J[-];Z_'>)IL=M%=W$(\H1,[^81%'G)P27 M((P!7%^!/VIOCU:ZM\:)O%7@OPWXWTWX?6T-C';?#2TOI)=4UB9HMMO%)(6W M);J76YPH>$D'8X!K!_8F^(_B#X0?\$R+CQ?=6]C=+HMIK-YX=MK.TNKEY`EQ M+M^U1KSG[69MS(0JQ%&8IL=AZ9\%M*TK]A3]CNZ\1?$&\O+O7`6\2^*9U9KF M\OM5N]BE`6E4650CD$GRUDW/VAOVA_BCI'[17@WX. M_"+1O#FH>)-5TBXUS4]2\66UU)IUG;(TD:,SV\F^++0,I)3;NDB`)+G'S3^S MQ^TC\+?VD?C]H_Q&^,7C*&;QL^JKIW@#X;P:=?3V7A]GE"Q3R2"$137+NJ-Y MF=J_([$,(EMM3]KRZ_9@\1_';QG=?''3?B-X=\8V>@+INF6%TTLEOJ:GS/)O M=+,+S(I7!`$K)`7D??$9!-@`_03X877C9/`>G#XBQZ%_PFBB4WR>%O._L\_O MG\OR1,3)_J_+SN_BW8XQ7B_@?]K(:W^VS\2?@9JZ:=9_V79V=WX?N(L12WK? M9(9KJ&1FE/F2+YVY5CC_`-7'*6QY9+=1^QL_CV/]F/P+_P`+0-\/&GV20WHU M<*+L1&64VYN<_"^R^%\6A^!_[(\V7Q;'J"74BWEF)_E:!F4X9)1DHN`4X8YKQ MKPA\,M<^!NL_LE_$?QO!GQ%X@\8ZR_B=(PT=W+K'B&`K;2M`RH(C'''&DZ)M M5&CPJORQY3XMK^S._P"W-\?O^&BM^<^'UT')U)?F_LV/[1_QY<<9M_O^O'>@ M#ZU_:=^,_P`4/`_Q4^$/P^^&-MX1NM:\;'5P\_B]+HVT;V<$,X*F&3/;!=)U+X=:C?Z#XE&G2*UK=7]GMW_8C*48B8 MR1"-)0C;Y/+YP&;RO]N7X6>&OCS^TI^S?X#\31W$VA:S%XJAG-I+Y,\3C3X) M(G1ON[E=(W4,"I9`"&&Y:Y?X;?"BX^.?_!-CQA\+-$TK1O#GQ$T>XGT+7-.T MBQCABN-9TRY1E29F81RW%Q';VH>XWD;I=Q.$V4`>C3?%/]L+7_#UGXZT7X6> M`M.T&X2*Z7P)JFIW)\1"`[59))V$=NDC#=*`0&12$93(I4]5)^TAXON?BC^S M9H=WX/'@]/B/9ZS<:UH^N+YVH::]I9I,B1R(X"[F;G>@?:1N2-]R+SVF_P#! M23X7VNEVEGXIT_Q)X5^*$ELHG^'=QX?O9M56[=`T5HF(51VE+(8BQ7]_;4^+OAR3XH>.]6T7P7=_!CX>>.+SPIJ=G9&[A M\0S0QW<-LDL.]V@=@+J)SN,88QN,IPU7;3XX>&OVM_VV?@CK'PI&H^*/#_P] MM=;NO$.MBPEM;.T%]:>1;QEIU1S(6C8[=O(Y4L%D*?.,OPM\):+XJ^(7QUUG M0=/UF#PS\?=7T?Q0NM0B\T]=`N72*2:2U89DDADN0T>P%MTA)5PJ[0#[=^(7 M[6"_`KXO^-]%^)BV&D^#(O#(\1^$K^T8PRZCY"[;ZP:6>9(YKXR-$T,$7/ER M*7*EAGUWX`:_XU\5_!KPIK7Q$L-.TGQCJ-F+N_T_2X)X(K7>Q:.)HY\R)*L9 MC616Z2!P.`*^>_\`@H5X8T3Q./V>SK&D:?JHE^*^C:6_VZUBGW6TYF^T0'<# M^[?RHPZ=&\M=P.!C[#C)*`M][O0!\R?M`_M`>--.^.7A_P"#GPNC\)P>.[_1 MW\1->>.IY8K*:V$C1"VM5A^>2X+1O,>RQP.']WQ M%^%VH^*HO`?Q9MO$'PVN[&S36_`_Q2L[5YC#J"G]Z+5K;=(/+86Q>-S'NP6/ MEE;:5\G]I_7_`(A>)O\`@E!K5]\5-..G>/[JRTQ]1MS`MNY_XFT`B>2($A)' MB6-W0!=KNPV1XV*`>H_';XS_`!L^#7P@^&'G1>`9/BEXK\86OA:X$<-Z^BK] MJDG\B2/+B50$2+?G/+.1T`)X=_:H\9V?P_\`CQIOB_2]`@^)WPHTC^T[R71' ME?1;U9K&6]M#$92LH.U/+=3D97<&(?:N;_P43\-:=XTT'X'^'M9M/[1TG5/B MOH5C>V[%@9K>5+J.12RX(!#/R,$9X(X->4_"/PEI/PJ_9<_:Z^$T>C6>G^)? M!5IKMJ]W#;)_:&HZ/<6,]SID][<(-L\K)),HP`45578G<`^AOV5?%OQZ^(FD M:+XI^(\?P\A\&Z]H,.JZ>GA:.^CU))9UBDB$ZS,8UQ&\FX(3A@,$@YKC/A'\ M8_VA/C)\3?&46A67PRMOAUX3\>WOA6]^W1Z@FL-:VLRJ\D6UVB:0PNN&.T%P MPV@#-/PTW-\8QX0@/B6-SJ6`V+7[6?WX^S[EG"#]UC@G;\M M>7?`I?V:F_:@^)$?Q-CS\7#\8-1;PR&&HX9?MJFT;]R1;L!/YQ)EZ@@'*X%` M'T9WBI;EH[_[0=#-^;9$+E\&[Q@D;`A.?F`KZ M3^*'Q2\._!SP1J?BWQ9J7]BZ!IZHUS?-!-<"`R2K#%NCB4NP+NH('3G)`&:\ M$B#1_P#!3]E^98U^#O&!M&1K?7T/.?058_X*1:MJV@_LE>-=1TCQ/<^&[>*W M\C4A;:;%?MJ%M=![0VA$K+Y*2/<(3.N60)\JL>*`/#_@K_P4]B^(WBWX#:!J M5QX>L]5\3WVIZ=XLM+73+Q6TZ8R>7I26[,Q`\XM$'8;U!+$E.0.V\2?M(_M0 M?\(=XD^*FF?#'PMX>^'&BS3W)\,^+GN;3Q-<:=!@37#`L(8L[9I`K#M*T6_^,/Q5 ML[*XL[/5'FBTVWC^R)=WURP#9,<2LH\L.)")!M#E2I[7XT:IH&N?L/?$"^\( MB*'PU=_#_4+K25LX3;1BU.GNT.R(A3&I39\A4$9*D`@BOF_Q)J`^%_P]_8E^ M->NI>)X'\&>'8]/URZLK62YN+)=1TBWMXKHHBD"%77#LQR-RA%=V"D`]X^`? MQO\`B'=?%_Q3\+OC-8>&;#QQ9:;;Z_I%QX1:X:QU+3G+0RD>=ED,4ZA#YC*6 M9SM7:H9O:_'WCO0_A=X.U?Q-XLU2WT?P_ID'GWE]*"JHHQ\H`RSNY(544%F8 MA1EB`?EGX#^.]'_:4_;3\2_%KP-+>WW@#0?!-OX..K75G-:K?7TM[]L86_F` M$K$FU9`VUPS+A2K*Q]F_:F^!$?[17P,\2>"VNIM-U"[C6?3YXKZ2VB6\C^>W M-QL#!HM^-ZLK\`$?.J,`#\]OV4/^"G&N:Y^U3K$_Q!N8=*\`^.;F*UM[>XU" M8VWAZ6*$I!Y(.55)"465MJ*6<2DH$*G];('V1A!N?;C+L,9SW_SW/UQ_/+^S M=^R7XD^.'[2@^%]];_V?)HES)_PD[I=QA[&VMY5CN0C'<'DW'RUVAEWNI/R! MF']`^N74UEHNHSVVGRZE-!&TT=C&8Q+=,!E8D,K*@9V4`,[!1N!)&#@`^8/V M??VEOBO^T+K=GXV\,>&_!5Y\(-7U673$LWU>:'Q!HR1;PUQ?*(GC+L(@RP)R M!&Y?#FBVOBOQ/JTMU>1Z9/,;8'3+&V-YJ-PLF M&7Y8(]H!..$L=/M?B%X&T>_O=3TX64B:?O6.YFM"F927C98=K#>&WK(<*"F>F_8% MN?%'@?PIXI^"WCK6-/UOQ?\`#*\MK*273I)I(UTZ[M5N;3][,J[@NZ2)4"J( MUA50,!<_%>B?"/6(O^";_@CXP>!H;EO%FF:#KOAK7+>"2=HK_0;N_P!0BF#P M1J=YMWG%R"2JKL9W#^7&%`/U0^!_C"_^(?P6\`^*M52WCU37=`L-4NDM$9(5 MEFMTD<(K$D*&$_&SXR_&A_P!J6'X2_"BV\`$_\(8OBBXN/&L5Z0`; MU[9T5[=Q@<1G:4[$[N<#U?\`9-8/^RS\'6W!L^#M')(]?L46?UKYI^.7QP\# M_L^_\%&+?Q)X^UK^PM%N_A2FGQ7/V6XN2]P=7:14VPH[`%8VYP%SWSP0"S\3 M/VW?'?P\^#7Q7@\1^$-*\,?%WP';Z7=BSO96N]*UVRN;J&W;4+10R2&(NS@K M\PA8QJ\C,65?1?VGOC1\3_!/Q3^$?@+X7VWA"36_'(U8R3>,DN6M;=K*WCF8 M;K>3CZ=J.E>`+'PWI?@?0+[4(C'_; MX77X+FYOHE)#1HC)Y85E.[N5=7B3V;_@I`WPT/QQ_9R7XOL6^'A'B)=57?<` MC_1K81@#Z%\:?&WQ1\!/V>D\3?$W3M%U[XA/.NG6WA_P M0TR0:M?S3NMI:VGGYD9GCV%_E9E"RLJL%"GSV_\`%G[9]AID.OVW@OX4:C:L MZ71\'6^I7*ZNL#E2;8W+E+7S(E?#2`[3M)7=D!N:^('@#P=XN_9"^&GB7]G7 M2+CQ-X3^'_BJU\9:%X?LVN5GU46E[QO([Q3H;62-9XV>02NKN M%2W.T.44$`^K?CO^T9>_"7POX471/!5]XI^(?BV\BL=%\$F_@ANC(4+S/.Z- M(JQ0`8DD4O&K%,NJL7'F'B3XP_M+_L_:-=^-?B/X*\!^,O`MFR'4[7X>7%Y% MJ>GVQ;,EZ4N4VS+&@^904Y.250,Z\1K?PO\`B7\&/`?[,WQ(UJW\1_%;Q=\. MI;\^)M)A)O=7D@U6(K*\;F61IC9EDB"ID2!0VZ)%R-7XT_MQ>`/CI\(_%O@' MX+1:M\4O&_B73)M&@TS1M(O;<65O<(;=KVXEE@58X8C,"23COV7B'1['4]+N[?5=.O(%N+>^LY5DAGB90R2(RDAE8$$$9SFOS^_X*>?MHS_ M``SB7X<>!=<;3_%#S?C4AX>TBSTK[5Y(B$[6T21>8%!.W)CSMR<9QFOR5 M_P""L?[+MS\+O'EC\1=&FFG\&:Y(\$EK>ZBTYT_4))9[J6.&-OFCAF9Y9@%) M`D-QG8'0$`_1O]BS]JK3OVJO@UI_B';8V?BFT/V77M(L9&86=QN<*X#?QUX^\3:DNFZ%X5M;Q+>6Y8*S2S MNQ!*01*`7DVE%+IN958NOBO_``3!_9/U/]GOX/WGB#Q.M]8>+?&8@N+[1+Q% M0:?!`TPMD*@EO,99FD?=@J9`A161B>K_`&O-!\0^%OB#\&OC'H7AW5/&[?#_ M`%&^AU3P]HEOYM]/9ZA;"WENH$W$L82JGRE7YM^2R*A:@#,3XE?M7?#'Q-I4 M_BSX9>#/B'X7U"[BM+B+X;W!L0;&,CQ(-U>H_M/_ M`!IU#X*?#%;_`$.QMM7\<:YJ-IX>\.:5;C_`(*&_#3QS-9:1\)K'7?B_P")KB\MHCHF@:-=0-:6[3(DEW)+D_#'4/!%S!\($MM5U#1O&_VU;:; M5KY)_LSLD*E)C#`D4L3H0T3SOR2Q4`'M5A^TC!XV_8ZU#XU>%;2T-R/"-[K4 M.G3I)-%%=V\,K26TAQ&SJD\,L18!0VTLO!%76^,.MK^Q>/BX;?3I/$8^'_\` MPE#6YA?[(US_`&?]JV;=^[R]^1MW9P>M?*/A2R\7?!;X3?M*?!3X@:CX8^W7 MO@G6/'.AZ1X52Z-CI]E=+>1W4$)E15BABE6(K%C(^T,07P<=!X$_:?\`AK\4 M?V"/$/PX\,>(O[2\9Z%\';@:EIB:==1>08=,6"7#M$L;A96"Y1B,GC(YH`]: M^*W[2?BKP+^P9IOQLT^STJ3Q;/H&B:I);W,,S61EO'M1*!&DF\*//;'S9^4# M)J/4_C;\7O@)\-O%7BOXSV/@;7-4,]E8>%M"^',MTMSJ]_,SH+1A=98L28V` MC#L$69@K;`I\F_:1DS_P1]T90H?;X-\)'8PX<>;8<'G/\/8YKH?C=^Q-X4^# M?PUL_$GP3\"SS:WX9\6:/XSN=`MKZYN)]>_L]YA]G1YY7\IA'=3R!HT9F*A0 MC$K@`Z;5?B)^UWX6TRX\7:I\.OA]KOAZ")[V7P1H.I7G_"0B-@3]G66I\PQ,(P2R9W?CA^UA'X>_8MO/CK\.!87Q:TT^ZLXM5)FB7S[J&&2&98 M91^\C,CJZA\AD(S6#JG_``4B^%TFE76G^%+/Q+XL^)L<31P?#JW\/WD.I_;5 M!$EK(?)*1M'B3S"K/L6%ROF8PWD?QT^$>I_`G_@D)=^!]9D,FLV%EI]Q>QA4 M0PS7.LQ7,D`VNRDQM*T>]20VPM@!L``^A?@M\;OB-)\:=0^$'QH>"GN&TYK(W)M6AE6Y(D659%#`KN5E<_L^?MX3?&G]DSXC>. M!9:=;_$/P-HU_>ZGIRV,L>G[ECN9K,H#(2Z,L(1AO#;UDX"E"S?V3OA7X0_9 MQ_:J^+7POL/#UAI23V=MXF\*ZC-"9M2GTN?;'?0F[!)6VANH8DCBD*O\Q;]Y MN+GY5T;X1:O%_P`$X/!'Q@\"Q7,GBO3=!UWPWKD$+SM%?Z#=W^H13!X(U.\V M[SBY5B550C.X?RT"@'V_XQ_:3\5>'O@Q^S3XKBLM'FU3XD>(O#6DZPDMO*88 M8M0MVDG:W7S`R."H"ERP`X(-=_\`M1_&:^^"'PT%]H%E;:OXUUS4K3P_X;TJ MY:E=OLA5GQM7;AY3O**PBV[E)!'S+\1Y`_[+?["3;@?^*S\"-NSP3]B? M/ZYSZ5N?M$V/Q&^//[6&E:3\,=0\$7,'P@BM-5U'1?&_VY;:75[Z.;[,[QQ* M4E,$*1RQ.A#1/,_S$L5`!]/_``!^,^E?'CX.>$?'FE1+;VVNV:S-:H7?[-." M4GAW,BEO+F26/?M`;9N'!%+_$^LVGAKP]IG MF)%"]_#))1>:/J5PN;>.Z29RL MF2"K&(LH",0S'RUDX7]DJVT#]G3X,?$?]J+Q[?>*=3@\2S&32]1\4?Z9KO\` M8:3"'3XY2R`^=<'RR2LAA9!:."%4E?/?V>?VC?A=^T-\?-%^(?QC\7VS>-#J M*:?X!^'$.GW\]CX>=YE5)Y9O)\J:Z=PKF4L%!`=L,L26P!]2_M#_`!M^+?PC M^+/P_2UL/!*]*\(^?.UW<:MYUR7\Z7"F..``)M58[,JQY8DG@`*>N/\]*`/#OV4/C7X MM_:`_9:\._$6^TW24\5ZM#>NEE;-+:V32Q74\,:Y8RNBD1(2,OBG\6O`GQ.L?"-MJO@E](42>#TN!!)]MADF^:29OF*(J@_*OS$@=L MU/\`@E_`T?[#WPU+91U_M1&0]!_Q-+O-1?`&)6_;H_:S5@Q##PD%Z%OAKJD,MQX1U+SM7475QB:\A:UF6-A; ME%:'#7-K)$\C[F:X62*-H;>4_??[/'Q[\/?M$?";0_&GA^XAD6\B`O[..8RG M3KL!3/;2.57)C+8#;5#KM=?E937XX?\`!07]E+6O@;^T!8V^B_;=4\,>*A'! MX4MFNWU"]_RPQ1O!&8RP81K$J%MSAF5G&T$*`#Z,1MZ`^M.I%!"X M)R?7&*6@`HHHH`****`"BBB@`HHHH`*Q?$7@O0O%K:>VMZ/8:N=.O(]1LC?6 MR3?9;J//ESQ[@=DB9.&'(R<&MJB@!J((UVJ,#TICP!BQZ%L`GG./;G@\]:EH MH`@6!@F&D^8]64$=NW/J??%--C&[.S?,7&UP>C#.<$=QU_,^IJS10!!]E!=6 M9V8*#\IY!)(.3[\<>F3338JW#,2AZC`YR,$=.`>#QCD?A5FB@"#[,0RD2'AM MQZGG&,#G@=>/\*3[+AN"H3[VTKG+<\GUYVG\/>K%%`%=[0.26*MD]"O0=P/K MQ[<=*=]G'.3G._K4U%`$/V?)RS9S@\9Z@Y]?K]:06Q&,2OQT)P>.<`Y MZXSUZ\#KSF>B@"N+7#!MYR%(/`R%B.69@,L?Z>O'MV&*<("%(\PD$8Y_G]?\\5-10!$L"I]TD<; MB"-0JC`'0"G44`0RP&7<"5P05Y7)`(Y_7%#VJR)L;EHX]\$C\3ZG*_92N=KX;` M^8CDD=S@C/;T_+BK%%`$"VJ+V!Y)^Z!R1@GTSU_.D^R`KC=M'&-H_`]E6**`*[6[D@B7!P>0N""?3]>#GL>W*+9*J[,GRN/E.2>,8.26`H"X'3_`.MT_P`:FHH`JM8[PVZ0Y==K;1MZ]2,<@_C^?%.6T",[*Q4L M0>!TQTP.G3C..F/2K%%`%?[+DIELA1M'7D=.>>>/\:<+?@!G,@SR'`P?P`'M M^5344`(H(4;B"W<@8J)H&,C.'X(QL(^7Z^__`.JIJ*`*XM2,;9"F!CY0!_\` M6SGU'X4&UW!OG(8Y^8>_\^,?E5BB@"![=GE9_,(R`NT#@#//(YSU[^G%#6Y; MD/@G&["C#?7\.*GHH`K/9EE(#!,GYB`>1V[_`$SGKSZTIM3YHDW*2%P,IG:? M4'J/<>P]\V**`&JNT8R3[FL3Q?X(T+Q]H]QI'B/2+#7M(N2AFL-4M4N8)-C; MDS&X*G#<\@\UNT4`,BC$480=!P*CFMO-)VMLW?>XZC\_7'X9'>IZ*`(3;!B" M2-PX!QT[=/\`/7ZT?9P#QCD\Y';)/;Z]?KZU-10!%Y+1^=3T4`0 M?9_G!W`#N`N,\Y'ZY_.E%N,`$Y&@_SQ4U%`%,]SWYI3;,0F922H`R5'/OCU^ MF*GHH`K_`&)-@4$J`,84#&,8`QTP,\"A[4D@HP5LG)*`YS_]?GZU8HH`C$(4 MD@D$C!/M2+;J@.W@]N^WZ>E2T4`-C01(J*`JJ,`#L*:859V8A3N`!R.N.GY< M_G4E%`&)KW@O1/%+:\=:1\!O`OQ!O/@D M8M6\;^);#0]`\/#Q5"_VR"]MC-:W7VA8"J;V&SRY%4KD$L.E=+XT_:M\<_"C M]F;QE\4OB#\'SX4UK0+R""'PN?$T%X+R"6>VA$PNH8F"8:X;*[&/[OK\W`!] M,T5Q_P`4_B$OPS^%WC#QD;!]1'A_1KS6!9;C#]H$$#R^7O*G86V8S@XST/2O M*OV*/@O_PK_P`%ZKI$>J:9XA/BJUU`77F>6T4?D*B2)NC= MWW,.-F,?,*`/H6BOC7X*?\%!-:^(-OX'UWQE\(;KP+X#\;:D="T+Q-;Z_#J8 MFU,R21QV\ELL<85(#(N1M8NON?P#^.W_``O$?$4C1/[&'A#QEJ7A M($7GVC[7]D\O_2/N+Y>_S/N?-C'WFS0!ZO17B/PS_:ATSQIX8^+GB'6],_X1 MG1_ASXFU?0;ZY^TFZ$L%@B.]UA8U*EES"AI)8],^9W;AC$@?,R^6RD!Q@`^M:*^= M/''[:7A[2/V1)/C]X6TF;Q)H1A@EATV\G-C*S/>):R1.P27:\;F3.`P/EG!( M(:M3QU^UGH.A>$OA/XI\+6]MXS\._$/Q9IOAFRU"VOC"L2W9D4SX\MB6B:)@ MT+!"""K%64J`#W>BOGW]H[]IKQ+\'?&OPV\(^#_AM_PL7Q#XW&HFULCKL>F& M/['%%*_SO$Z-E)'/WACR^^>/4OAAXI\3>*O`FGZKXP\(_P#"#^)9A*;KP\-3 MCU#[-B5TC'VB,!'WJJOQ]W?M/(H`["BO$?@M^T7J'QL^(OQ%TS3O"*:?X+\( M:O-X>'B.ZU0-/?ZA#L\Z-+58B%12_#F7Y@4(4Y8)Y'YA'!X;M->MM2:]1VAB@E-Q&H6-&FF*ME M69%C+;6R%(!]%45\U?#']J?QS\1[;XJ:`WPA_L/XJ^`_LT$QAG7K0V+M+'=&WN5^U2#8%C*2NK%1O"J"J,Q50#WFBOD#PU^W!XZL_C'-X'^)7 MP47X/_%7P)UWPO\`!'5[SRXO'$NJQ3W$%H[,MO>3Z:-DEDD1MVT$#&,%BLHC[S]G+]H;3/VB?A[_P`)#::/J'AW5;&]FTC7 M-"U2-DFTG4H0IGMG8@;MNX$,`.&&Y4;=?'KXTZ9\`_@]XL\?:M"; MJVT.S:=+5&W;N8"@#Z7HKY!\` M?M^:EKWBGP2_B_X/:_X$^'GCV];3O"GC"[O$N/MD[.!:K$_$3X\_$3PSIGA6R\,_!/5O%WC?4=+35-7T M@:K%9:=HR[5$D+:G(A@FG65MHBCRS(CR$*NS?WWP:^,&@_'?X8Z%X\\+_:&T M/68C);_;$$.=#N626Q^U++->6)95ANSMCC1F MRPCD,2A-X#A8EE2-0#ZUHKR;]I[X\C]G'X&>)?B,-#_X2(:,+0_V;]K^RB;S M[J*#_6['V[?-W?=/0#C.0OP2^)/Q,\%_%W[2'B#X16UE<0W&FPNEKK\L\7 MV'4K^!(Y+ZP@8,=TUO'<6[.@RP/G;E01JTFO\=_V@+GX#:MX(NM3\)7%_P"! MM8U(:9KGBJ*]CBA\.&0HEM-<(X`,#.[!Y2ZK&$Y+,Z*P![#17CG@?]H.X^(G MQT\:>!]#\*377ACPE#';:AXS%]&;5]6;RV>PAC`)D,<<@,C[@8W4HR#--?\`$6O6?AS2-&@O$LUN+NXWE`\S@[%VQO\`-M/S M;0=H+,H!['17B'Q]_:-O_@5\/_"^H-X0'B3QGXCUNP\-6'A^PU18K9]2N0Q\ MLWDD8Q&/+=1(8AEBFY4#%EM?LT?M$O\`M`>#-=U'4/"USX-U_P`.Z_>>&M9T MB6\CO([:\MRF\1W"`+*N)$^;:/FW`94!V`/9:*^0/@O^W#XZ_:$\4W$O@'X) MC7OAO;^)FT&7QI_PEMO;[84="]U]BFA28D02)-Y0Y()7=D&D^.'_``4!NOA# M\1_'&D67PNOO$_A#P`FE/XN\2Q:U;VK6/V\J8?L]M(N;G*NN,.F6W`[5`=@# M[`HKQ#Q#^T;J'A#]IGPC\+=7\'JNB^,;2ZET#Q19ZJLOG3VT*S7$,]LT:M%M M0DAU>0-NBQRSB/U'Q7KNI:1X7UN_T31QXAU>TLYIK+25NEMS>W"H62'S7&U` MS;%WG(&[.#CD`WJ*^0;?]L7XQZ7\7?AYX"\6_LY+X7O/&E[);V<__"QT5POQ=\<>*?!/@V74?!?@2Y M^(OB#S5CAT6#4[?3@R\EY&FG(`55!QM5V+%!C!++A_LP?'7_`(:0^"/AGXA? MV'_PCW]M"Z(T[[4;D1"&ZE@R)?+3=N\K=]P8W8YQD@'JU%>8_M"?'.R^`/PS MOO%,^ESZ]J)N(-/TG0+254NM6OIV"0VT(()9B26(568(DC!6*E:X'X3?M2^* M]?\`BW!\.?BE\*9_A-X@U33)-3T)Y=?MM4M]5$3`3PI)$J@3(&#^6-QV!F;: M-I8`^C**^9K;]LN_L?B/HEAXI^%FO^#OAYXEUE?#GAWQ?JTZ1W-]J+DB*.;2 MBHNK6.4QR;'D7.#$SJBR$IZ#^TU^T3H?[,/PBU?QSKD'VT6VV"QTY)UA>^NG M8+'"K-TZEVVAW6..5PC["*`/6**\;G^.'BG6/V?/"GQ"\%_#>X\9^(?$.F6. MI0^&(-9MK00K/"LS[[F?:"L:L1E$9F8KA0"671_9?^./_#2/P,\-?$;^Q?\` MA'O[9^U8TT71N?*$-U+!GS#''NW>5N^X,;LZ5)"A5AR%SM/.<=,?7]#Z'$J,74$C&>V>U?`/[>7_!0;4/V?_B- MX=\->$D6]FT^Z2?Q%:^=;1NX4VDYLSYB2N$DM9G#2(BC=+%Y\8^'93<:1K5H+U-S(7@9AN>&7:S*LB,61EW':RL,\4`=G17S] M^TA^TQXF^#7CCX<>$/!_PW_X6-XA\;?VE]DL_P"W8],,?V.**5_F>)U;*2.> MJX\OOGCT;P-\0-8O/AA%XH^(?AV#X;ZE!#Q:;%$S_`#O=(!&0 M8E60]-H8@_=)H`[NBO$OV7_VJ-#_`&G_``MJFJ:=HVH>&]1T^\$6.13T)WA&D"AVP%_;,TOPQJ?QBTWXB>')_`NH?#Z%M5MX+ MC48)?^$ATEF9+:\LBQC#M+(HB\OD)+-#&9-[,J@'T917%?!?QMX@^(_PPT#Q M+XH\'W/@'6]2A:>;P[>7/GS6:EV$8D;8A#-&$Y-W& M)@CNB2K&R0AW/WAE-H.67(!]&45X1X0^/WCZR\!^/_%OQ8^#]S\-=,\+::^J M1QVGB*TUF74(XHII;A46/8$95B7;N.'\P_&'QAL-&T>?\` MX1[X>W$,"ZU9S'4&UA6%QYDEO!;H[,NZV;R]C2-*C*P52=E.^&7[5^M>(_B7 MH_A'Q[\+M5^%[^*X;FZ\&S:IJ,%U-J\5O&)9EG@B^:RE6%XW,PE43W M=LLDT"F>+ALRE%D"#?\`20F!)XZ'&0<\]Z`)**^:OB=^UKXETOXS7OPR^%OP MEU'XJ>(M$LH[WQ%+_:D>DVFE^:JO!$)YHV265T;=M!`QC!8K*(\O_AX#X9_X M9U;XB?\`")Z^/%8UG_A$?^$"^S2?V@?$>W/]F[MGMN\S;G;QL\W]S0!]4T5\ M_P#P(_:EU/XC_$;Q#\-_'WP\O_A;\1-)LEU>/2+F]74+:^TYBB&YANXT6-ML MKA&7L3P6*R+'Y;XX_;9^.'PT?PX/%'[+QTP>(-9MM`TX1_$"QG::^GW>5"`D M)P2%8[F(48Y84`?:5%?+WQ?_`&R?$/AGXF:_X%^%WPBU?XNZWX6TQ-4\3&TO MQI\.FK(@D@A1GB?[3,\9WB.,$L.$WL'">V?!CXN^'_CQ\,-`\>>%WN'T/686 ME@%W"8ID97:.1'4_Q*Z.I()4[)(D."=TDR@I@A MON[]JAPO[+7Q@#,H'_"&:R"V>`WV*8'/7OVR37H/A+P9I?@?POHOAW1K86>D M:-:0V%C;J[L8H(HQ'&A9F);"C&6))ZGGFKFHZ'9:SI]Q8:C:6^H6%S`UO<6E MS$)8IHF7:Z.K9#*1P5/![YH`_.W]H>VL+W]B#]CVWU/Q#/X7TR;7?!L5WKEI M=BSET^(Z8X>X2$_BMJ_QATU] M5T^2XUS6?$4>MS13?;=/!MOM$8PJA55@O8R9_BK[?USX1>"O$WA.P\+ZQX3T M+5O#FGB,66CZAI<$]G;^6A2/9"RE%VJS*-H&%8@55M?@=\/K'P=J7A*T\#^& MK/PMJ,XNKO1;;1K9+.XE!0B22'9L=LQ)\S*3\B_W10!YA\<_BKX(^)O[+GQP M/A#QAX?\4&R\'ZL+N30]1AO!;^99SA/,\IFVEO+/!P?E/I7E7_!/CPWX(TW0 M/"-_HOQTU[QQXBNO!MJU_P"!;[Q=#J-II)=+9I?+L@NZ#RW`B&3\HWVF^%]4U-IM!TV\CO;F&.\M[/ M:`LP'F-O8G#R,ZX."*G[.?[-4?QH\3_'O78_BU\3/!*0_%77K,:?X*\2&PM9 M-KQOYKH8GW2$R$;N!M51VK[^\,>#-#\$:%::+X*?V'_VL_`7AZ\OO$.L6/Q)U>."[U*1[J]U` M64MC.VXA2TMQ(MN0,+EY&'3.1]=^'/VY_@7XB^'UIXNF^(N@Z+"]FUW+HNKW ML,6JVACW;XVM-QD,JE6`50V[`,>X,"?;-`\&:-X2:_.A:78:*-1O9-2OQ86D M++&%$;^C_@FE^T!XXN;&ZTK3_'_`(X? MQCHUEJ$+PW<%E<:K8K"TR$X4L(=XV,XV2(0[;J7X_P#@K5_V>OVB/A%\,[": M:]^%_BGXH:-XN\.0R-%%!H-TEU(E]IT,4:Y$3&]@E3A$0$*JLWF25^F7B7P= MHGC+1KK2->TFQUG2KID:>PU"V2>WF*L&7?&P*MAE4\C^$5'X@\$:'XI&EG5M M(T[5)-)NTU#3FO[1)_L=T@(CFBW#Y'7)PRX(R<$4`?%_[?-CHNL?M#_LTVWB M/QU?_#71YO\`A)/.\1Z9K"Z7]@L9SU$A`/S5]3?`S3-%TC MX4Z':^'O'U_\2]'B$_V?Q-JNL1ZO/?@SR,Q>YC`64HP:,8^Z(PO4&MGQQ\(O M!/Q,^Q_\)=X0T'Q2;(NUI_;>F0WOV8N%W^7YJMLSM0G;C.T9Z5I^%O!6A>!] M'MM(\.:/I^@Z3;;A!I^F6D=M;PAG=VV1Q@*N6=R<#DL2>2:`/F'_`()>:;8V M?[%O@>YL;6VM[W49M2N+NXBC'F7,HO[B,2R,,%VV11KN;^%$'``%?G^984^& M/_"S3\0M1;X^+\5?[=/P5$%P;+^UC>8\@:>',_FD$-]IW#/^$Y'C<^$/#Z>,RN#X@&E0'4.8_*/^DE/,)\K]W][[N0.[1$\ZRU29$17. M`C*'F#+$Z`1D3-7@OCGXL^+_`(H?\$]+FP\3ZW/K/@JY^($'A27XDW?A^[>: M7PW#,DD>KO&&#L1<0QQ$DL3M,;%YCO;],?&WP@\$?$P60\8>$-!\6"QW_8_[ MN0PYS]D#]G@_LT_`#P]X&G MN-/O-5A,MWJ=]86@A6YN99&9R3G"?V]?B/+HFO_$?P_P##_P#9[T&]C6XT[4]=@TW5?&UTA#H'B:1)8;-&(9<\ ML<$?O,&V_0W_`(0S11X83PR-)T__`(1<69TXZ)]D069M=@3R/*`">7L!79MV MD'&,<5P8_9/^#'RY^$O@-L+C!\,66#Z_\L\],CKWYS0!XA^V)^V=:?"W6K+X M6^`M7\/V7Q8UH!&U77[V&UTSPQ`R%S=W;OE?-"9>.%@20?J.J:';7%Q+L4(@>1T+,%554` MGHH%;W@[X;^&OAQI3:;X0T#2/"NG/.;F6RT;3H;2"20@*SLD:J-VU5&[K\JY MSC%`'RO^U?#)XI_9?T;P)\>/B3HWPO\`%'BO5HK6XUOPUI%S>Z&9HKGS887> M=-T*&-8I"\DL)#1,PO@O?\`A/S[[6-6 MOI=1FT^\N"MO)8#4XR$D$T!DD&TC:5*IM:.8O]O>)?!FB>--&N=&\0Z38:]H MMT5-QINIVR7-O-M<.F^.0%3M=58<<%5/:J'@WX9>&/ASIDNF^$O#VC^%M-GE M,\UGHNGQ6<,DI4*7*1!5W8"J6QDA0,\#`!^?GP6^"NH>)?VJ]*^'*?%N\^)7 MPD^".S68+:=`@TS5&>=;+3Y98I5-S);JF_S<,B>0\`CA5G0\K\7M7\`6&N?& M[XV^#/VHO$7AWQT;^`VOA(P'3)FO+-%6.QO-.=$DO8B,0(WE*L(+&;S=LQK] M.]"\&Z-X6DU%M%TNPTC^T[N34+\6-JD'VNZ?'F7$FP`/(P'S.P+-A.OC1X$^/O@K3OA)\9?%?BCX%>*#X=TO7M3>.ZC\.6FKKZ1X1I-VX;]P)=GF,[1GH,=#I.AV.@Z1:Z5IEK#IVF6D*6UK9V<2PQ6T2*% M2.-%`"J````,`<#B@#\Y/^"Q/P6\3:_X+T+XCZ=?BZ\.:`B6>MV$TT8^Q^9+ MLAN+="NY?,>8QS!9!YFVURI$.Y/#/^"0GP1\3^)?C+>?$RVU";1O"WAZWFT^ M]01/LUF6>)L6JE0(W6,^7,X)8J1;X7Y@R?L7K.@67B#2;S2]2MX=0TV]@>VN MK.[A66*>%QMDC=2,,K+D$'@@FL'X9?"CPY\'/!>E^$?"%@-'\.:9YOV2R$TL MOE^9(TK_`#R.S'+NQP3CG&.F`#P'_@INT3_L0_$64RA.-,(FQC'_`!,[4Y4@ M$C.!SR.!]:V[7PM8_L5?"?XC>-KWXA>-?B##9Z:+V.U\?>(_M($L"R&."WD\ MK]WY[R1QYPY)V#'&#[QXH\&:)XWT.YT;Q'I&GZ_I%RR--I^IVB7%O(5974M& MX(8AE##/0X/:F^*/!.B>-]$NM$\0Z58Z]H=T$6XTO5+9+FVE"NKINC<%3AER M.."%/\(H`_+B+P1^T'\&O#7AGXA:G\"VM?%_@GQ-JOCOQ-XS/C#3RNK0W:2? MVI%]B5FC@$L$=NF^-6*"#YD\EE23#5]*ZMXJV<&I:= M>0-;7-I=1B2*:)UVR(R'(*LO!7&.3ZUFZ-\-?"_A_4[+4M.\/Z58:E9:>FDV MUY:V$4,L%BC;DM$95!6!3RL8(4=<$\T`?.W['X7X$ZSJ_P"S=J[21WGAHW'B M#PK<(&;^T?#]Q=.8Y)Y5POVE)WECD5HXP<*4#C+"E^T?IEMK/[:_[)$&HQ0W MT"2^)IO+O(@T?FQ6$$D4J@\!UD",C#D,%(P5KZ@OO!.@ZIK^EZY?:/87NM:4 MTK:?J5Q;))9]R)Q M7+_L;>-]%^%ND_M.VL?CK6?$'PMT+7?[2M/B-#83WU]-<74.V]D,@29+IK8Q M6Y:81LARTSKY`LQ=]D:`*H M9F9CCDEB2>:`/S(^#$VE?LZ>)O@!HOP;_:"U'XPS^)=5_LW5O!2(USIL>DW$ MGG37:6*.QTZ2!?G?S'WE][':BSI7`?M"Z7X<\=ZW^UKX@^(GQ8O_`(;>,X-9 MBL].\!6ZRV\6MVEHB+ILTMLYWWOG*D95E(6!B9V&R15'ZK>#?@3\._AUJLNI M^%/`OAGPMJ,L)MWO-#T>WLIS&2"T>^)%;82JMM)QD`]0,6=<^#G@GQ+XGL/$ MNJ^$]$U3Q)IXC%GJ]_IT-Q=VWEN9(O+E=2Z['9G&#PS$]:`/E']IR;5/%W@? M]D;Q7XHTBWT?QIM?._Q&_9^\4?%K]K7X>>-];3PU%X`^'D=UTN9V)Y)-8?CCX1>"/B\6_8`XM?[<_L:_$/Q9\6/V9_`7BSQU;+;^)=0LWDN)#9FU:5%EDC@N MA&W`\V!8Y=R@*WFY4!2%KS+_`()TC7A_P3V\%?\`"/-8MKOV;5?[/.H;_(^T M?VE>8\W;\VW.,X]Z^O)(1(C(2"K=5*@@CN/QY_.LSPQX0T7P3I%MI'AW2;'0 M=(M@XAT[3;9+>WBWN7ZI;_$F/P#H/BCQ!K5IX1NHK]TM9+.."".'8X269Y?D$"DN-ZE@J M%7K[3U?0+'7M,O\`3=1M+;4-/OH6M[FTNX%FBGC9=K)(C`AU()!4C!!([UA> M"OA)X+^&S7I\(^$M!\*_;@@NQHFEP68N=A;9YGEJ-VWS),9Z;V]:`/S9_:8^ M)7PX^(LG@G]H'X8_%*]\2_$TZUI\OASX5:X8-6ACG<1PR6J:8H,MI(S1B1I@ MQ!EC!B;?)!(-[]K3P]\:?$7Q'^*/Q`\0_!:;4/"N@>$=:T/PO?Q^-+6"VTJS MDMKF.ZU:2U!9IYY89"PC`C"H%C8.Z)(OWWIGP,^'VC>+)/%5CX&\+V?BEY9; MEMVN MK.[A62*YC=2LB2(?E965F!!&#DYXXH`\=_8ROM1U/]E/X2SZOI"Z+=)X:L42 MW-RL[>2D*QP7&\``&6$)*5QE/-V')4YXK_@EZ"/V%_AIE@Q_XF>2,]?[3NZ^ MF=,T*PT31[32=-L[;3M+M(4MK>QM8$C@AA0!5B1%`54"C:%`P!TJ'POX4T7P M3H=MHOA[2+#0M'MMYAT_3+9+>"(LY=RL:`*-S,S'`Y+$GDT`:M02VYD9SN&# MC"EO$GP!_:"U:WUF>_UG2M8(NM(\37\,*/JL M>Q`YE9/E:Y1VVRR,%>1OW[*#*"WZP_\`!-S]GC6?V>/V:K"P\0S$:UXANO\` MA(9[%[9X9--$T$"K:N'`;>HBRX*KM=V7G;O;W+XB_!7P9\6-5\*ZEXJT.#5- M0\+:E%J^C7FYXI[*Y1@P9)$96VDK&6C)*,8T+`[5QVL,9CC"EMQY).,?Y_SU MH`^+?VTO`2_$O]JK]F+PP_B77?"9O?\`A*,ZGX8OC9ZBA6QMY/W,NUMF[9L; M/568=ZE_:OT3Q3\-OV8]-^"WP\UC5_B)\0?',ESH5G<^*-=MY-7NK`)/=WTC MO,%6<+!NM^-A59XL-N50WUMJG@W0]:U_2-Y;S)O-O;_95B`4%F1BSNP#,^.W@+7_VM?C3J7CGX8:7HUQ=?!65;#3+ MW4P;:36O$EO?6]S<6$C$[I+6&)'1&=H1]HN&*R%&9T^]==\&Z)XH.G?VUI-C MJZZ;=IJ%D+ZV28VMTF=EQ$6!*2KN;#J0PW'!YH\->#]'\&Z):Z+X?TNPT'1+ M4-Y.FZ7:I;01EGWMM1`%4%BQ(`Y+$T`2QR2>237@_BGX!>)M`_;%TGXR^#(O##:9J7A[_`(1KQ18: MB9+2Z>(3I(MY!+&CB694CB7;(H&RV";AN5HP#Y0_:GTOPU\0_P!KWXM67Q3^ M+&H?!.RT;P#;Z;H%Q81RVO\`PD-E,AFN#*Q)%Y$EP\L36L6'FVA5.Z&0ER:C MX6^-7[+O[+OA#XJ?$K4/@EK5NT.J:?LTF6QM]1M;$RP6TJ7\R;(+C[.L#?#_BO[!YGV0:]I4%[]GW[=_E^8K;`V MQ,XZ[5STJYXY^&_A7XF:5%IGBWPWI'B?3HYA<)9ZS817<*R!6"N$D!`8!V&X M-S^RU^UGX:\-^*-2^,O@[PRL>F>'_%VIPSW5Q=6MXQ74T: MX5O])^QQ2.WG`E,;7P8611/^S#IWA;X:_M@?!^U^&/Q3O/C-8ZWX!N-,U^>[ M62X_X1^RB6.:!HV!Q:1//''&MK-EH"6#$O,M?H_X9\$Z)X+T.+1/#^DV&B:+ M#N\K3=.M$M[>+<[.P6-`%4%F8G`Y)/-9'A#X3>#/AG!J">"O!^A>%)+U4$_] MB:=%8BX*A]@D,*`D+O?&<[=[$RL+6TN-1^$@GN9 M(XE!NI5U9(PTN!\S>5%"F2<[%4=AC2_;QT'XM>.?AO9^"/AEX,NO$UAXAF,7 MB>[L=?MM+NH+!&C+VT+S-M#W"L\93SSGUH`_-#]G+XLZU\!?C!^TIK_`(B^#NK>&?#WAK0?#!O]"T'6 M(-9NM'BMK2.WM85.56X5[4EN^XEB#3_$NM>!K#]K'X/?%#X2?%B?X MM^,?&>O/87GAK598]:DTK1;HM-.UN$5)M,6V227$;E6"NP)$:3H_Z,V7@O1= M-U[5=:L])T^TU?5O*_M'4(;54N+WRD*0B>08:4(K,%#YV@X&,5@^"/@7\._A MKJLNI^$O`GACPOJ4L36\EYHNC6UG,\)*DQEXT5BN54D9P2H/84`?GS^UY\3/ M@]^TW\*M7^(,GQ.\1^"_&'@XM;6OPO\`%/D&(:M:32%!=:*ZOYTLGFF(RJ71 M%8"0;8YD'UOJNO\`[0WBOX6_#36_`.G^`])\1:EH<%YXGL/'4&H0?9[J2"%A M';QP\H5++_XK:?KZSO9^)(XE:3499%F*H51QF,OD1X;>)2) MJ^F/%/[.WPM\$O#6H>'=%\):#H_A_4#*;S2=.TN"WM+GS(Q')YD2*%;-PD"SSQJ?*:,.AA9OF\YF._P"';?5?V@/V^=3\2F39X#^#-B^BZ<]M<+)% M>ZU>P`W1#"+&(H9#%(GF;D>*!O\`EHZCZRT3P]8^&]*L]+TNTMM.TRQ@2UM+ M2TA$4=O$BA41%'"J%"@````<8IUKH5G83WEQ:6UO:7-[,MS=RV\"HUS*$6,/ M(<98[(XUR>=L:C.`*`/@W]O/P-J?PP\37GC_`.%OQ)U+P5\3?B1]F\*OX3M5 M68^*)V>&")X6=\6>``ORA6B:5FD^P_@%\'],^`?P=\*^`-)<36NB6G MDO9*\C[`Q5=^U<*`!TFI>"]$UG6](UG4-(T^^U?1Q*N MFZA<6J/<60E4+,(I#ED\Q`%;:1D<'(XK9AC\F)4W%MHQN/4^Y]Z`'T444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`QX]ZL,D!A@TY5VJ!DG` MQDTM%`!1110!&T19R=Q`(Q@=Q_/UZ>M/484#.<=Z6HC-^]*``D8SDXQG/M0! M+13(G\R-6*E21R#V-/H`****`"BBB@`HHHH`**0FF[CGI1N`^BF;\=:7=^5* MX[#J*:&SC%`;)QBDY);A8=132V!FDWG/(Q0Y)=1#ZC:(LY.X@$8P.X_GZ]/6 MG;N?:ESQ3NEH`*,*!G..]+3=^3TH#YIH"/'O5AD@,, M&G*NU0,DX&,FD+8S34D+#D#\Z7,M@)**;NIOF9Z#BFW8%J244W=THW<]*$[@ M.HII;%(),GVIE&:H0M%1&4ARH7(&.3QG/7'KBG12"6-7&,,,\4`/HHHH`*8T6 M[/S,,L&X..F./IQ_.GT4`(.!US2T44`%130"4YR`0"`PSD?B#4M%`$0C?YLN M&RV0-O`'84]5VC&<]Z=10`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%?+?[??[7D?[* M/PSM9]-CM;[QKKLWE:+87MJ\]O((Y(C_X M+!_"'Q?H?Q^B\>WAU#5?!OB"RM;2QO'!^SZ;/$A5[!3O;&\H;@`JNXRR;0WE MR&@#]1/V:/VC-"_:4^$&A^-](2.QDO`T%]I9NTFDL+Q&*R0N5/3C>A(4M&R/ MM7=BL[]J+]HO4OV??"_A*^T7P8?&^M^)O$EIX9L-';4UTTO<7"3,A\UXW7[T M2KR`/WF=PQS\@_\`!'OX->)?!7A#Q-XXN[G[%H&OE+46:7$5U#J.Q(98+B-D M7]UY(ENX7`D?=)*T;K$]L=_KO_!3.WT^]\`_"?$$_A/3IOB=H\-WK=I>" MSETZ)HKL27"3D$1,@)?>>%,>3TH`^B_@QXX\=>-_"UW??$#X<-\--9BO&ABT MD:W!JQEMQ&C+/YL*A1EFD79@D;,YYXU?BE\0!\-/AAXP\8&P.HCP]I%YJOV/ MSUB$Y@A>3R_,PP3.S&X@XSG!Z5Y;\#M#L="^#OBF#X6_%B?XPZB;FX>TUSQ? MXB37(H=0^S1K';S30`%8%81N8U^<;R0?F`'C?[5NL_%S_AC;Q!X6^(-WX9M/ MB5XWUVP\+^'(O`4EW':W@N98O]'>2XP5:1([M7W$1["H)RV*`/HKX7_M)>&O MB1^SQI/Q@9O[+\.3:1+JNH@^9*;'R%?[7&,1AIO)>*5=RH-P3&/BYXQ_9%T+PX8?!WQ3\8Z7XKLY[5+>.:VT=U\[5?*8NJ0M#)IX6"-H2=D, MV=S&,GW/X!_$O3_V[2UL[33+R(7&EVUN^ MUH85G<,%C0$J\IRFY@&`/:?"O[7OA;Q;^TCXA^$5K9W$=QID,D=KK\DT?V'4 MK^!8Y+ZQ@8'YIK>.XMV=!EE/G;U01JTG0_\`"]B/VI%^#AT/!/@W_A+?[9^U M]/\`33:_9_)V>V_?O]MO>OSNL_`_[0/P9\*^%_B%J/P*^R>+?!7B75?'?B3Q MD/&-@Z:K;W:2?VG#]C5W2$2V\=NGF(K%/L^Y%#,Q/U;H>I66M?\`!2W3]1TR M\CU+3;OX+)<6MW!(LB3POK!:-U8'#*RL"#SD8)]:`/9/@-\=?^%W_P#"Q?\` MB2?V+_PB'C+4?"7_`!]^?]K^R^7_`*1]Q=F_S/N?-C'WCFO3VNEC.#C/H>O_ M`-?O^5?%_P"Q5\5O!?A?Q5\=O#6K^,/#^E>(M3^,&O/9:/?:K!#>W/F20HGE MPLX9]SH5&!R<@=!GU;]MH^(C^S#\2$\+-*FK-IN)'1HEQ9>8@O2IDP"1;"7G ME@3\F6P*TH4E7Q$:5[7M^(I.RN>C:?\`&WP#J?BZ;PO:^,_#]QXDBF>W?2(M M5@>Z$B;BZ&(-N#*%8LN,C'-Z3X"&A>*]1\,VS:OJT< M8OQ:",M<*7"8SYH&P;L''S'->+N_[$TOACP1YQ\!S6<5W;?V>+=0]PDS(?*% M[L_>A,;C(+OY-PS)@@55_9F_9]^'7Q5OOVA;WQCX0TW7KVX^(NN:9]KU"W\R M6.V!5AY#]8F!ED.^/#YV_-\BX^LAE>`HT:E6O&I%*WV5NW9M:_??;YW6/M&? M;.IZY::1IUQ?WT\-I8V\+3S7$TH1(T52S,6/`4`++K3;; M0O&OAS6I-0EG@M1IVKV\_G/#&)943:QWLD;([*N2JMD\8)_/KP#J-IJWP%_9 M&F^)=W!>?"A-;U:'5Y-:D$D"W<;W<>E1REN?)0JR`']T%4!P%"BN_NI/@PO[ M//#-[=:KC^S MX+;6+>1[S,C1KY*ALR9>.1:_/'X0_L]_#GQ+_P`$TM<\5ZGX0TN^\32Z)K>I M'6+J)C=)<6TMQY)29CYD<:_9XOD4@,`VX'>^[9MM4\/>(/B!^SW>_'+4M)U' MP7??"Z*XTRX\4RQ/;3ZVR6[7LLYD^^6MS&P,^4WCY?GZXXC(L+#$U:-*BN^3^57\GZ+778<:LG%.Q]R^&?BQX,\:7D=IH'BW1=;NIK9KV*WT[4(;B M22W64PM,JHQ)C$H,98(6( MU@3Q*ABW'[/C:MJ&V?N\[@_S[@<)H_V9%_8+W2+X.7QDGA7+`H@UL:P8PI)4 M@7'_`!\X`X\OR\`#R<"KCP]352$%[1J?)9:5W@+D+C#[*]Q^`S^%F_:Y^(G_``IY M-$7P#_PBUD=='AOR?LG]N&=_LWE[/EQY'F[O+^3=NW_/FL,9D5/#TVXRE?EY MKM6C\7+9._X]]+=2U4;Z'T_KOQ9\%^%_$=EX?UKQ7HND:_?>6;72K[4(H;JX M$DACC,<;,&?TN&U.`)<);@M<-& MV[#B((Y<@D+M.>AKX@^"7_#/!^$OBP_'!?!Q^)W]J:T/%O\`;R6YU;[5]HF\ MS[/Y?[S_`%>S9]DXW[]GSYKAO@AX,T+XAZ)^Q5H7B33K?5](N9?&4LMC.!Y4 MOE2O(BNB_*XW*I*D[2%P006![8<.4%3JSJSG^[;5^7225.I-N/=?NU;R=Q.L MUT/N?P%^TQH_CGXA?$W1HH[*W\.^#+73+X>)4U-)+6^M[NU:X\\-M$:1(@SO M\QLC)^7C.GKWQ^TA8O#4/@Z`>/M3\4"Y;1QHMRCV31V^U9KBXNAE(H(Y)(D= ME$C@R`)'(P*U^>_Q]\(ZA;_M%?&4KI5_JWP6\.WWAN?QAX5\.2K:RO8IIZB% ME4+D00B,LR*5X"$%`GG0^U_M#W]CXM^'6H_\*VU:VLM.^)OA?2="\(7U@\EE M9M-I]Y6"&D$<9,@]S\5_$/PYX"TN+4?$VN:9X;L9)E@6YU M:[2VC+L"P3/5O$7P:\*_!3PSXD\/+X&C!UG3 M?*,MS.3<20>6R,+M[)KJ&+9&[;]@<&,OL])UQ/AL?VR_B1%\=D\+-$^A:4?! MT?B=8/LYL@9_M93S`(]_VK?@O^]P6V_)7#B\EPB:C2E=J'-)0:FW[R5O=;5T MGKKLGIWT4V?5$'QO^'MU<6]O!XV\.RSSS6D$42:K`6>2Z0O:Q@!N6F16:-1R MX4E<@$BKH?[0?PV\3"\.C^/?#.J&PMY+R]^Q:S;S"UMTQOFE*N=D:Y&6;`&1 MG%?F!XDT'X>^+OC/XNT+P?%;7OP_U;XJ>$-->UT^5UM)(Y(-02\CB;*D1F0S MA/+(4+C9\I7'TI\=/V:?A;;_`+7'[/&DQ>!=$M=+UM-8%_86UJ(8;K[';+-` M'C7",0\C$Y^^,!MP``[L7PY@,+6C0JU9IR@Y_"E:U-5+-:3/^R[%^PIL_XHY?&0\,N,8C_MH:QY?.[)\_/VC'4E/+[F'FO,HY'0 MJ5(\LIRA/ELE&\ES+JK[)IVUU\A^U:Z'W7IGQHAUWXLV'A;3;?2]0T&^\-+X MAMM[[HZX[5\M?LRR-)^TA\+1,Y$P^`6EF4,5W$_; M(\G!&<`YYSC'0=Z[S_@GEXRT>P_91^%>DWFK65IJ>L?VLUG8SW2+/=LFH7#2 M"&-FW2!0;3_MV(HS*O$VC^&C>[OLRZMJ,-JTQ7&[8'8;L`@G'0$9K;T_7;'5M)M=2L+J"_TZ[A M2>WN[:42121L,JX9<@J00=PR,'/3FOB/P!_PJ/\`X7)\<1\=4\&?\)Q_PE?[ M@^+!;%?[)\B'[!Y7V@F//EXWB([A^[WX.VL[XL#X2-^R;X?/PJ^P#X,_\)I8 M?\)F+W;\E92R.E.5.FN>\N5-\ONM2 M5[+75_RK[7D6ZC6EC[)T+XU>!/%-AJ][HOC'P_JUEH\0GU*XL=5MYH[*/:S; MIF5R(QM1SEB!A&/:JD'[0/PUN]:L=(B\>^&6U*^$#6MJ-8MO-G\]5>#RTW[G M\Q64H5!#`\$U\"?MM'X1KX2\/M\"AX,/CE?[2)/A%;5F_L<:=<'4?-,0\O\` MU6S:'_>8W^6W\TO,,NZL)Y`$8LB_*``$7;ZU/AS`2IT*M2K./MY)?$.H:!I'BK0]4UW3BPO=,LM3AFN+;8ZI)OC1BZ[6=5( M8#!(!QD5THOU"Y==ISMY;@MR,`]^1CZD<5\6?M$_!3P5\"M6^`.M>!?#]EX/ MU"#Q]H^A_;M)4P32V]?S7_`!>^".O_``Q^-6J>!AHMQ)JO]IRV MEAI,=ZM_=SJ9WB@1O+2-V>4*K(#%$\J21NJ!9$K]]?V1OAOXA^$7[-?P]\(^ M*]0N=1\0Z;I:+>-=,&>W9V:06NY7<,L"N(%*L05B!&`0!YYJ>O4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5PGQ@^#/ACXX>$I?#W MBG3;34+/SDN[9[BTBG:UNH\F&=%D5E+(2?E=61U9XW5T=E/=T4`8GA7P=I?@ MKPUHWA_1X#:Z1H]K#8V,'F.YB@BC$<2;F)9MJ@#+$D]R3DFMXS^'/AGXC:/' MI7BOP]I'B;3HY%F2RUFPBO(%D52JN(Y0P#`,XR,'#$9KI**`.9\(?#CPW\.= M-FT_P=X?T?PI8S3-I"@9JUKO@G0O%*V*ZUI M-EK(L+J._L_[1@6X^S7,?^KGCWYV2)D[77#+DD')-;E%`&?/H&G7.K0ZI)96 M[ZE!!);17C1*9HXI&1I(U?&0K-'&S+T8QH3G:,<]K/P@\%>(CX@.J>$]!U+_ M`(2'[,=:^V:7!+_:GV",=SZUDZ1\,/"F@ZM9ZI8>'M+LM2L], M71;:ZM;**&2"Q1]\=K&54%(D;E47`'7KS74T4`><-^SM\+W\4R>)&^'?A0^( M3>_VDNK_`-AVWVQ;KS/,,PFV;MY?Y]V<[B3G)K-^-$/QA)TI?A6/!?E9E.H_ M\)>;H`C"B,1>1T_BW;@;YG`;U`Y-;4:KI34[)V[Z@MK M'Q=:?!7]H;3O%3>)K/P?^SO9^)S/+<#6H=+OX[OS9`ZR2>:J[]SAVW'=DAB# MG-;VA^$OVIO"Q+.*DW[U.#5K;?\`!,_9IGR!8^`/VGM'\*#PSIVB_`>P\.^3 M+"VE6UMJ26Q64L9%$87:%8NQ(P#?V=]&;3II MY[0:=IE_!Y#31B.5TVH-KNBHK,N-RK@\8Q]I;.,9.*01$#&XXJ?[9K+:E'5Z MZ=][Z_U<'335F?(%C\/OVGM,\(2>%[30?@#:>')(I(&TBVLM2CM#'(29$\D# M;M;_GN)TU;0^`M`_ M9A_:9\)_$2\\8Z!??"30+R70I/#UGI^D07-O8Z9;/,)RUO"+;`D\[S)"9#(I M:0Y4@`!/$?[+/[1_B_0=4CUE?@I?>*]3MI+.[\;G3)8];EADC,+KYR6H4;H3 MY.0@_=\#!PP^_P#9[T;#G[QKM?$V,;C-TZ=XVUY%?39>G=/1[N[)]BNY^>ND M_LB_M"6>NZ1J6H1?!_Q%#IOA2U\'KIFM"_N;.>TMYEFBDEB,6&FWHA+#"_+] MT'D>I>&_!_[5'@G1+;1_#VF_`O1-(MB?(T^P@U.&WB!8L0J(H"Y9BQQP2>F2 M2?KOG]?%6]M2@_+ET_,<:26Y\::_\`"G]H_P`5^([/Q#K/ MA7]GO5M?LC']EU6^T[49KFW"2&2,1R,I9-K'(P1@\]:72?A3^TCH)T-]-\,_ ML^V,NAB<:6]M8:C']B\[/G&+:HV>9D[MN-V3FOLK8<_>-!3W-8?VS6Y>7V<; M=K>37?S?WC=.[/DC3?!O[4FDZOJNJV6E?`FTU/5#$=0O+>VU*.:[\I66(2NJ MY<("`NXD@9`(SQFZ)\+OVD?"OAB]\/:+X5_9XT?0+TR-/- M:GF\6R?!;Q;H3%9(/#.MZ=/=:=9S*H43Q![8RB3&\9:1@/,?Y>F/MP(1WXHV M'U-;4\ZJ0?.J,+VMK%/_`#M\A^S2/S^\%_LJ?M">$/%GB37A:?!C5Y]6N["\ MALM3M[PV6EO91O%:"TBC@3RA%$RQKR2%0O:=K5QI?P*N- M7TOS1I]]<6^IO-:"0;9!&^W*[E`4XQD#FOK:Q]2^"_[0NMZ]=Z]J'@S]G2^UV[0Q7&IW.E7\ES-&T1A='D M*EF4QDI@G&P[3D5]I!/]HT>7SG)K".<5%JJ<4_3\-]@]FCX\TWX=?M,Z-?6- M_8Z#\!+*^L=/32+6Z@M-226"R4Y%LC!-&SW-']L5)*SI0 MU\O^#Z_>"II;'QIXS^%/[27Q#-B/%'AO]G[Q*;,O]F?6-/U"[:`-C=L+H=I. M,''48STYWM/T/]K'2=+M]+L+7X'V6FVL"06]K;1ZI'%$B@!4"@`!```%`'`Q MTKZMV<=:-A_O&I>;U)1472A9?W>OWA[.Y\5^'O@K^T)X9T[6-/TCP=^SKI5C MK$(M]2MK+2K^".^CPR[)E1`)%VNXPP.`[=CBM&\^''[36H>$AX6N]!^`5SX9 M$4<`TB2RU(VHCCV^4@BV[0J;5VC&!@8Q@5]AE">C$4;#ZU;SFJY\[IQWOMU7 MS#V9\CZUX3_:GUX6(U+2O@1J?V"YCOK1;R#4Y!;W48(BECRORN,\,/F!)P>< M#Z=\*0:Q+X9TL^(_L8UX6T7V_P#LWS!;_:`/G\O<=VS=G&[G'7-:[0,68AQR M,8(R,5*JX`&>?6O/Q.+EB$HN$5;LK&EDEH>8>*_V'_B)K6C6VH> M(]"A2.QEN8$D6%HW=K>1=P)5HC/<%0"%+RJ[JS00&+TZ-!&@4``#H%&`/PI] M%<"5E884444P"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB H@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#__V3\_ ` end XML 16 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Geographic Information During The Period (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Net domestic revenues. $ 1,837,480 $ 1,362,006
Net international revenues. 354,926 325,926
Net Revenues Total $ 2,191,635 $ 1,687,932

XML 17 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation Consists Of The Following (Details) (USD $)
Dec. 31, 2012
Dec. 31, 2011
Issued options to purchase shares 7,950,000  
Common stock with an estimated fair value $ 636,000  
Options exercise price per share $ 0.08  
Options vested and no options were exercised 6,900,000 1,614,000
Options expensed in the year $ 261,838  
Option-pricing model with dividend yield 0.00%  
Expected volatility of 191.00%  
Risk-free interest rate of 223.00%  
Contractual life of years   10
Exercise price equal to 100% of the grant-date common stock fair market value   $ 0.08
XML 18 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 19 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
The Following Table Provides Geographic Information (Tables)
12 Months Ended
Dec. 31, 2012
The Following Table Provides Geographic Information  
The Following Table Provides Geographic Information

The following table provides information related to our 2012 and 2011 revenues:

 

2012 :

 

 

 

 

 

Net domestic revenues

$

1,837,480

Net international revenues

 

354,926

Total

$

2,191,635

 

 

 

2011 :

 

 

 

 

 

Net domestic revenues

$

1,362,006

Net international revenues

 

325,926

Total

$

1,687,932

ZIP 20 0001078782-13-000576-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001078782-13-000576-xbrl.zip M4$L#!!0````(`!%X?4(O9W('-&@``*$?!P`1`!P`='-O:2TR,#$R,3(S,2YX M;6Q55`D``]+D55'2Y%51=7@+``$$)0X```0Y`0``Y%WK<^,VDO]\5W7_`[=N M-\Y6638?HAXSF6QI_)AU,F.[+$_V\BE%DY"$#44H`&E;^]=?-TA*?(`22=%C M[UTJR8Q(H/N'1J,?>/&'OSTO?>V1<$%9\.'(.-&/-!*XS*/!_,,1%:PW&MGC MGG'TMQ__ZS]_^%.OIUT3=N8[/!):3Z.7U"?:-*(A26EH_1/3,@Q-Z_6PQO,# M]S5@$8AW'J$?CA9AN'IW>HJ/3P1Q3^;L\11>G)JZ8?1THV<91TGQ&?4WQ9^> MGD["!>'.BD0A=1W_Q&5+K&,:YJ9&KK1DP/@<"NG6*0U$Z`0N26D_"YHK_62E M98W3__GR>>HNR-+IE6KY-/A=5<\8C\>G\FU:M%0RCP=?/SAB2QG>T@;X(]&; M.\YJ4V/FB`=9.GFA$"=T9=\TAKN8Q"72"D&T5!?V0GX:KE?D%$H03MU-!1;4 MJ,."7J$>%O(*JI&`&IS&+X]`E?[C!Y3:.R'[YH[,-"GP=TCUPY&@RY6/XI'/ M%IS,/AR%@M%>JB,GS\([TDXE'="W=^?,!11!>`_5-9<%(7D.[[#6KX9Y]*.A M]W[^X;18KE3Y%IK!O(O`.W="!17DW8-_+2-/*U=M0W0"KSQ\?>D[\S*QF>,+ M$M/)E=S4OPA"&J[OR)R*D#M!>.TL%9CN_WYQ-[F]^'I_=:9-;S[#GS?74^WJ M^O[B[GJ"/R:?C^'GV4G,2D6TP/$,@'#'OPH\\OPS69=9ZC"J^L98MXTLS4*U M#=&SB'-L&A4PS'\E#J\4;R\KVZIJ1;!LN63!-&3N[].%PXFXB4(<6FCNM"B@ M,?GXU5&.Y95AZ98Y.-(\XM(E=`8\NKX\^G%D]0>#OJ[GVK:#2P'0;?3@4_?2 M9TZXY?]U>EYD;NH#B$X"5*C'XE(BA4\@C!@7#=OH*4/Q_J65Y92.Q;EYO1' MQGA4@\4M)RN'>A?/*Q((`GU]@X'C1`@2BL34-.V]OFW96\XU&'0*2"&*,81K MP_:(#A'&>#`8]S-:U0&3<@,'`VM@#NMPR;3TF@5NN_XU^T9&>94D#V1:;B+$ MI'8CIK>)^I M\T!]&E+2TN*:X/GZ.2[@A$60"M`&2$U%7KE20/ M9+JSM?L90C@](_#8DQ,X;3)A/1>;%XD=Q&QGV_8QR\Q+M4KP=;N?S6.+Y-KS M4MG>!KPFG@<=R@+'OX4\Z"HX<#(MK,VH8+LP:S+K1T/;7-D-.-\ M1T*'!L2[<'A`@[D`.QTM(SF*S\F,NK3IR.P9PY$U&F6$OI]%EXC*8NF-`9$] M:`U(JLN"^1[A`G.*<-U8)&-S-,[$?66*AS!4J;UIC:S:_#+&#-*F@YM;S`[V MD>\.2XV,HA&8O"4$KW;#<5Z9>-)XW!(NY^4SD(27/JQAWD\@+JVRNE6\7@J> MPB%T#"]>PIA$X8)Q^B_B[5XG40D,<]RX"@UUO:A$K7'(-:06LHCC(RL;KE30[H)_57QV M./_:ZZ]MA5!<>NT"23MQ5"&9.CX1=^21!!'YQ)BW9Q[Q5U7H.K*&_5%&'U4T M#V.JF,*V!KA%HP'39!V5>N2<"M=G(N+D)OA$V)P[JP5U)YPX*8%+SI87SR'A M$`2?12)D2_#TDS#D]"$"DW//+ADG=!ZVQ.7@-*21$FG:;:8QQ-36;$L1TFA-7:/1@-!Q;YA[B9TR$-S.IX%,(0!LV M8*0;9LZ!Y8BU9J0(=,;C?DU&GS@3XI:SV0[TS)`H1Z'US;+9#`B[&X7$&^`]GWMAZ&,9H9%M&SF7E MZ+5GIIC4@11VK._A-:/^N\W4>L/6#.R!A2O7.1H-J:IV%PSD[H(RU4!OZJM4;JS\:5]+/++G/B!!RCK%%*R#6U=VL"%J/C45M'!9:UM`<9G=F%`D>P$ZA?H/!>)CU.S79704N MA%N?P1$V;%_/,$U[.+`4'+C`N]*VEW!4,R*&'V]WPK&%1"&_#ALV=-6 M)OPLD&K-1J'$UD"OQP?ZG2G;W=130,=FDY%*NAUP5W6GWK<;,R=A>\LTTFT[ MU]XLL99LE&M*^B`[A5C-)EUE2F3!Y!,^:DQCP:]3X<0ORB#J!O@]Q0(%=L/^,1"B/9C!^2,Y4V#):2;<#[JI\J0WW;%;5.&6OS!#; ML5"TJ3(#S(O0]YF+RUVI320>GI`"595EVXW!K"AKT>\:DF("P,SW<'-8ZI+M M):.F=RA+UX?;V=%EB&;MH9&Z4F>BA?5?IIC*Q1([X0 M*^$:`#DG\9]707H4I_D$%B2%>NY,SP[2'8%0V._2R:+V*,J'K!K/I^OV3BQE M#MU"4B4^^8-D'6!*#BR=)QLOE`>7&D^KV;9N[D)9A^E+XU9I7^$PUXL`ER63 M?:(6E]'O[^R_FD=1.L.HFI8?[W:;-2%>DQ"/ M8T/6]$@]XGU*8IYS0EJ(*YF"VD.T$^:J("W=D5@7PQZMPYA7'#;\\NI3G\]+P%-++*]! M+1%">9<03^!VJ.F"\?">\.4Y>6BA/WM)=L!8>+P%-,0,P'MM&]NA12X#JBU7BZV>* MH4%30V*;XT'&DC1A]3(8%=?,V(/]=]^TAMCD"AQ=<61^T.H&'/0DVV@N=B-D MXT1P.:@K*8S] M/%X"VH[XI27`XIX./'+;U'`IMJ`@F7;T5=<5&+48X#:&>^>9"'S7?"?12,]/ M8!6H'<)LYPKP'E:-S^?HO[GQ@6DL)\H.<30T]/(Z3_4!G1;\Y>$?@Z)D_RE=B-!;>$[-1(P[8+.5@]MB^#=(?N2J!O`F5= M+3=,L_]6,.\=$&\#9L6P,EG2>MQHQIZ[9IR2.7*NJ'L-UE MO"77SEG6MMF&;=H#L]\Y@#JJV3'+*NMLF,-M\%O)+Z-\EXQ/"7^$>.\F^.*L MC2'>?GZ@=MG)/JCTE MKS_RNC#DQBMAJJOJX_$K`>Q`V[L'5:7OS55K3]PL9]XS.S#%Q3/A+A5DSVS1 M3EW;'ZY7LWU1T'654;E%]'JS"^>HS@$"#"(@D>UJ@ M'I3P(YQTN<6C`RQ([P_!36GW#(]00B7.Y"4)Z<1G-\/A9;"]?O/K#JS_!Z+8 M/P%9/+OS?U425;GV*[2_^6U;NX,\Q=5;'4\D[S8IQ9MJ.V=>.VPK7"+;.9`Z MPRE_7VOG$"KTN'1M:ILI_9:NU/QWC+_,VEJE/)KT9EKQ[QI_F96:W(FX,2>Y M)O(,ZCEQR?*!<,O`SXX=ILF59`]BVB!@>1D`^^U:>H;X9?A7.>=Z7%M;4_.U M_>IN?7MAOUI?[TKWPG>.9+\"EJYF[QQ#Y6I,\0;TG8ROG3#BY&:VC1=+FTY^ M_,X/W_^IUR/SYU[ONWGX'G^O-!&N??+ANS\B%K[_,KG[='7]3J>!)O];A?'S MM/0#_N6:A>0[9[EZ'SR(U7M#DW__;\/6WVLQ"HW-M(^1`,$*@;5.']+ZIRO\ MF]:0\897:Q+WVT\8:U/F1[&`9)0<.+$J'L-/]T3[/ER0M$7]X?OD2YSI@]'[ MOVI/CM`8GSN!O,-X$LTC$6XA#HXU4]>'T.T>X1H2"_!SL)>1(H//R[O.`9?UR31\=S3J"L?#ZC')*./R*'`WA\+R?3\$V" M57,73C`':&!;8N8SR"AV(H`'M25TK('V:4Y\U,/3IBO(-T*@!SXPJ2++:&>. M3V<,AI4#BLA7+-;*C.2F9!5*D[H5GFF@]`Q=^W[;`S`><:-L*"7?D>]")S]OA4$Q`\RTQC<9"Q4)2>%AL%N^X=GQ0+Z`I-ZUGF28=@9_E M%8Z+K3K.R9_&-SN;MGYLF]8Q&'(M-K>:D$,8Q8WEY:_D)GWLR+@Q[S41N8NT M*,<[$00@(-ZQ1I=+XE&`!+TX@T2//2'<$I:1_9=4B5C&$"44DS<)V&R[[O.$ MI*(GTH/F0%^B<)V,:#G!3X\3;2FW0V:D*C5$2U_SX@(UOD8,*"C\N+8$E8H( M79+V!-DKUF/F\D#")T("#7U(CP:]A(FD#C95>Y0[MH%R M?!^T)H.V;'M?TR#=!"7+8?:E\IMY92(RDX?!'(#6.-H71^"P/Z=B%8%YN",B M&:O:]@!3P81].;^;Y.P7#1?:3V`7A'9[HGUD:R\[W/!WIO1Q7`#X@(MT%XF] M0!'??SD'D!%TL-B83C8G>/8W9H$5CPN#41)+-@]G,4F"=,G"Q5K[=`+->X86 M95#)!\4*GPCG:^TCM`'T+S9+K*Y8P<^RHFR3?:L926[:45<`N<9>DZR$3^.EN`SL_!1M/0SS1!:"2N[,RA8F*7M5^8M'4*@F]%]S\2 ML"5$=H=21(6>@E:YA&.DV2`.I<16(`20!2`91,]$]D`GH'N\F5UTC4T;Y4&7)J M"^I<4@[B^Y5*]TSEH5E,`R!5P(&1UP+M^X>NP^4]1^"_ MGAQ>K5!;@4GU$S(K87),;Z+_KU/H5OX["65DC4\X68+-\C99'1AG[*FM-E4H MN+JC$D5#MJ@M!1TH@7BB4(@\KZ3!BHF2P$N1Y',N\%`8A8-$CB7X`FUU,TLC M:O>`RMGXU+(GFKOYG4H.F'A`Q_%[6PV$-([X'@19;G*^$F(C2_^+QN7-ZFMT M)CE6#,@MD%(OQ*/O@:3@>S.@ M^U:4ZSXCZX4#L4*<=*N'%!B%^A*'@%)[8$DH"=)`%Y(7S%\S@M_GN5];1OE8 M&*QY,D.6U55H<*RI7G*GF/9GZUC7=?QO,T@P[)1K2]HLKP4[G)1/MT$.%?M) MO;:P-M,;S^!-I)%)G$X^Q\%A40A^8$"2.0V"./*H-"?'29!4]'/XJZ"&L?D* M"VH.J=DC99$`MR_P&T`E2M_+_!SK%B#)MF#&E;=3LC'HO%B`IY)AM#LXA4>\ MC8\NLHB#*@PM"X@=3/]\_T3+BC*>TM@ISR7H'DYTDI!L<[C-M&50G8@@0K8$ M^\WC$1X/4C?]OM1Q/,4L)R"D':SNE<0D'-@%94MQO,E3=$4@6J$%U_KS(]Q/T4B7AJA0:]Q`IXV3FI^ZO,/"UDCAY!`XD0!GR8D7CWP,I*";5RR,,Y#J ME"Z-P%#9%PY.-J"3SM/4<\N@,V`0WY/G\*./RP+?9D73S*YH9I!I6VA:BDU[ M&^N;6#K"OUQ`H+4$UQ.ONT:OC0O]TPIO44U7_V;*U37T/="W8(26^+UJZ9J^ MGDQ/M'G\A3)0+L?%2`87@[:=L.(0W]"5+]?)9+2%+BYPYDEBC!,GOT/XFDRNF-S(V7^-O;?*DQ7L"2 MJ)!S59V8BYG'UC$0B3]]I$G=RAE*DGQR`U+)Z"V800, M0#J1'Z8NT:/0;)[:428R8GI51[C19+PGZ6TH\64RRS#=]A"N*@(^[1(".`P] MP$HOP%:"GOH4%!&7E/#NNKBP5.71DM:FZZ`P%:0$.<>?'>AC*E%XFO MWX9&;>"DZP`BL8Q4+$"D<_Q6:!S0@I2E8?!2XX$9`X_-C0A1>>+X-Y\*Q"OG M(BDS2[+QK?]?,AGR./$G3^)B2P)FP/O?]KZV27$C6??SGHCS'W1B[>N>")I! MO#/V.H)Y\_9>>V9.=X]]]].&6BI`.T)B]=+=^-??S*J2D$"`H$$J(!V[-@U2 MO61E/4]65E5FHF#<1D%G#^HF5.,]@`F.ZP8[:3L>3/`?N;NPB,(IH0B99!78 MM'3F##64(]-$&'_3<,Q([!0L1A!3=:)Q!GCC,CEVFO.IQ MX8X1$SVS1YE.2X)5@AY%NU2(7NZD^&1O2(D1OW%#PQW;N#H2H4F#NXY^1[P02!/ MPH0)<23X8'E,&._>D[O8!;*7FU37,KMAN4=2UJ[!0)/6[C>+F;=F8U6L-,:X MB@DSF!:@:P-J`RGI1.VI.R(A%%%IKBYJ7&@R"J81MDO/HR78CPT(JFAMA4.=C#NW=:K]W@ M-=B\?EY,NE,U\95P5?%G8G>A98]L'-R/PSM-;PQJRZ6D'%Y8?492RV6B2GV\ M^:2U^ZE2%@>1LB5]=:62AGS?(5UP6F4,5YQ`G^$]C=B!!(U]NUB+@\;5L>WU M%&I]TKC48[&39I[B#BG8VH+$0.QK/3ORN/)8'&V/47T4\6T4 M?!&M.R!&QH\[&ZFKNS"M\YHD_#/B\?BD\UJ'T>*(P\)1E&RZ;G!@08&VG[*L M>$L?C(`!J,=9C_(:MT424V8$_-R/8&CF&MR-@&_Y'$;$+I5P'N`1*8'MQC.7 MAU1R24Q(^-P_&!L(Z*J"?N.%`B"9M)BPZG3)#V),'CF#XPD)'N49EKA?TS-' M$JUP`H*&%1EN-"WD-0O>SJ1C=I!6`]M=ZHPT7,3A&A`*5V#/-",?!#[D)];E MRA1W!L7Q/CPD*B+"<[6*P3VOF3:L%SB=3O%\K6-_8_QL(LPBM/63+<&E/22T MV/@.0;JH<.)[T7@2:["7N.W5P.Q?/%2L=Q["B"++]A1H_Q]CY@5@4^0[=_W8 M)9Y,D'R7=H[O.\]8XU@U!<4RC?1Q0WX(9\S%9`HQ+8[IX/1Q^+O"]%SN/PP-P*3G;EFP[VE;CPPL?TO+K9D M!DF-Z<6O&FH\_:8FL]XI8AIQT-;[RX9*)O7HM;CJHZ6_E#;0@L*T7!NH"18\ M7K@R@9Y9D)Z8PF*.MU;XI2H#7:PC>22"WUNZ?N`BBS.=:`:>$A5DA%/.FS,\ M*V''@3R2+^6M)T]L2]72OG?^2VWYR5D$ZR1,E@'SV!635?R`SI_$>2CF4N;L M)C_M&S]2,%$["0QL>YEJ/.&)N^K M:=Z#8X]%._AD1NX5BW54KJRD,M?.<"^0;SCX\CBR1"1NT'">W%C%YM>AC6^T M*V/)G2,$GRKD0=SBXV,D!&&[,"21D)MCF-^"U.ZZ%D0/J!$F/R!S];!4>DYS M`0YL&%$4^0,SC4B`)YZN!&T+$P*9&=P?B(+AM^3\>#-@)K>?Z]K-&IF+[M86 MYR:D=.6@/63L58Y#B1'\HQ#.Y,@5M^C$)1^YTN@T M.M>=E56<$-2U`.(XSQK6^@EJ_9`@2G%LBW>6/^"53=1N&9GZW@B^:1\]WQ1[ MD-#/B#>>_\R76(/NM=[?MD"4`WN3FBMBBQW8Y"81F=ANO$>[-.F#.$?.[^=R M%PNN==&^^W?DRLNH*+L[<<*DIOV".V3XE(SX)Y>C]90,?A.+$&%BC[:ACMRE MS8XFO"..Y8K7/+D",^S4Y5(N:O21)W:WSW`F.7.Y#$+2SX&<<=R#0/8`YQ.# M-9CU8RZ(Y,"04$*!R=E&%8'9Q41.`#S99(0U%V"3'Q<%QC\>S>`ZC*AGA\FE M,FSKTL]@O/(*\.<,]YP@,B06$698YH><;K!_4WXA&PUP804H8ALM)N/"/N'S M;W$D3`(7CIKO`5#=R0='&WTXX#[/GRN4:]^WUV_89;U:FR^!D;<6<' M`\"FO/.]V#TOSU3PDRO\&J:#"V$\L,D-^44,C<4)EAI:VQBH(!2+:G[:!5$J MV>B6UVNS=38;8D,S5Q<+*]9RWLG\Q*K5:61[&;UY>]301>1%?K1%!"PQHZD\ M1F&E3UCP@S?/7!T2QP=+,N-N.MO2C,^VZ!SD@FB*^_;\.BUSO*)$_)+S*)IA*,PRTY([EPPWILL=?`L#;E5\6)?B+CQB"P`HG M\LFFWI2EI/OR]O/M^P^WUV\_W]]__NW-7T%>`ZO_HR:__O7#Q_O%EU^&[]_? M?/HE?ACZ#@\.W_W?7VX_?_WT_OK=YU\_W[[A=HJ(B[1X@Y?#G__CYOW]W]_H MG<$L]?/MS2]_E[_+BN\_?UEIC'AJI37X*+R:5??7H;5>#@J)H=[K5"8(6%4H M(XE!L]ZL3A(*"4+O52D(7>\I(XE^KZS)(3[ZA*&R;X]IG@J]V1+%O(P,"9VK M%G$1W']`/ZFFST*-K]U.&?]WD_7]A_]W?SW\]>:73V^$A?:CMD[\&\VY]99G M\:EP$:Q4[50HP'=E3X4C\IYB4T'/'2=BXR/-CW?B9H"O_=WPK2?H#Y'R!DD_ M>&'H38M.$+Y=6W!^\&<7!7]W4.(^@P5;1>.@-VJ]=H_8686QV&%.7,:*M:)Q M:->Z:PQ68NDCL?3GT<@VF?8Q\ET[">22]\]+2I82A,C[XL^K5JW-2!" M5DOCB6\KT7CBVR/Q[=W$GLWB4\+B"`2QK:+8HQ#$GQ_;ZK5.KT-LJY;&$]M6 MHO'$MD=BV]\\A]^>22A6B]/=!D2V:D'/)>\2EP9!`WZJEEA7+=6_Y%WATE0_ M7^N)>8_$O#Q4%G&L6D"C$)Z?'[?JC4YMT,T_9$+DJC*YTI)V;WNRUF]VB5C+ M)-9AZG92.OXK<:U:N$/KV1+PYTIOU3J-_BLB7;64GU:T92A_LZ;W>_FZ3_1[ M)/J-+U9GSTG5,),=,;`*L^*PYYL%2@G>U"PO>G`8T?3NRX1FK=UI$4FK,!:' M/>M631P$1!EE]`FF9@HBSP: M(KM'=:%0M@0[Y[U6(B9*;EX"'IU^*5MM)MMS@7CT)86?E]G4>3:D1<+Y)`A^ M.E,!SP&.Z@?J^*HF(PRM30.N7071P[]Y,C@/VH?%B:A6Z6Z!,ED\!Z7(>;]( MX9#-+5#;-\EOU=JQ(7E!5CT6/9=AK7DN.9%70XO3::`DX[N;6GQ[N4::M46S M,LF9G,#;FE>BR-#(I!6:S%6!SSSQ^%;GD(;B:"E`JIR/'_F,RLV3E$1HSYE= M+,!HL#:/';XFH![^CO>"1-C_.&IWG(.*63%EYV:#QIBE*PFIC0A,`1G^:KXY M_\U:75X>T-P2DKPR&XM*'A,1UY\F'DK#>W)%^_YA3$&/OM2Y=JZFFO$RT;MS M+98"ADAE/K)%8!#];*[>3OZHV&CEHHH[G.DK[Q8,39 M"-QQ)FD9U1._6GY>B0&"]DX!3D]K=+J#06T@_K]A?$S1-3DX:=9VXK=XM%/V M'XQI^>CQ6*J"_FHR-JI[C0NC(,!5H(A0R=\`%L;G.8>+HM+E_YXN*0FR*G<1 M$3&Y;8I741CPO`SD+>$'^\%#%?/<()W&]S'>I3LC\@379"*#N69./$^PO^5I M:)$P3$O(8]_+MRU@%#/T_&`9/A6Q;F_B##H^&*@P''Z8I%O3EY(U\.G4[#1J MG6:KUFJU4@J0D1%((\,D?/3N[:D73N;:+^F.O[>?/;>VB,R<&@J9>A"(7,8$ M%^G/,-BH*0+LYCZAB%0_N]IO1CH36J^V5J*=9F<)[M+2Y%W^!.8;)XE*2S(&(AY:(<1WGQD%;WO8%JZX,T5?LD*G&,8#_O]7:/>Z"Z@1JB?]N![WYA_;3$P^WR1?TA$M^=! MIF7D.8[&(U$J1%`PHT55U<"3O_8?@\-:$:S`RC M^)$]^'RE*F(H8V*Z]`C&"][%NEEF9L`\E4^R,\M+B6R`?&;P_`BK[R6%@U&P M<&;*P.26#$3-GTGY1-^BO_SZ#A@2E_HR%OHBF=?4LY@C`J='@4RZ!(P?346Z M%R3N16ZGD8>IOWC):`_4>?X='N3[T4-F3Z592[(29'[A2_W,JD_D$@%L911LZH> M.+Z9K`Y?ZW=@6_L\9<-<>_#0,V'P=.=Q;CC)':`3*27`]N##,G\$CT".F&!Q M/T6<3B%1I'2>[#Q-K5K:"^WC4P53QH*B\6CIF++Q+?=P#;C9[-6 M7]K;X$4A3R@@$EWE#8<1OV[['*%Y,@DNQ#='%4_E$;7U@3I'6?5V:>%RN=UO?:M=;$`Q;=[U]X MAHW4?6]U!U:S+>9:Q>]#D[;O*.N7WCPD[=Y;N[D1?04_\]S0Q8^)DX[O*/$F M8'F;]+QDJ=]F5KRDW4>S5^K-`5HK>KV_W581']4XIS>4J:;B;>I@G8\CO>S> ME,A*CQ-9B8Q6(K%]H%F1'WNX8G<+?,8<\$KOM-6957JGI#5I MGB1Z#64$T6E6*8>N.G+H52:%OCKWB[IZE=K0448.G6Y96;]VL/X*P&?9=P:/ M"*,ON6GPHO0HF2V\(M9B`30O>UR.A^J5# MF&+6M;;16CU4=<-'YAMC5DYE'YZ9;]I!2;5]\6VS^/*T@,%0MFX?SW"H7KO/ M3[EOV=2P75R0EE+=N\5I@E+JNV?^M#A1;+*XUF?E=RA% M!6Z2`Q6E5/<[GMIXJ7?W,MPC!PV](EF:.ZTV>>6*1W2]"-=,92C0[NP67_<" M'$25C<5WC7JO?TB;\_2=5)6-1:N^)DK@Y?K)JIL7K7:MNR88"['Y,=G\%W%> MG+A:B7E`+*U0P$"BWQ*$3,1Z:"D37Y:P^B7&),8DQB3&),8\`RD38QY3^._P M+J1#A$F$281)A$F$>092)L)43<6),DL0,O$A\>$9")GXD/CPE/@P>^"(.%$I M+"%.)$X\`R$3)Q(GGA(GKK\+3_RHA)N53MVJ,Q9TZE:=L6C2J5MEQH).W=*I M6^)JVA)5:B5&]$O+W1.4,O$EG;HEQB3&),8\3R$38Q)CGA)CBE.W=.Q6%<:4 MFEL.XC8/R955C(!"O'DP)^SA#^56,C*J MD.W!#B+J]1U&I7`JAG)'12%^/M2XZ"#`0[)X)9-%(48_V'S14OR?\^EZFU$@ M/JJ1#A*?CO##7>B!=KPU`F9I[^*$D+;G\I*CI*$'3=!8O(C/KC:,QE$0KEZY MJ?$;%0N8V)-$:,!?5%3[1[J#5N\<1XY$UE<3J>&6;*X>4V MZHT^)M,4[:VGU'#(&[_^6E)-TVM=ON M>8_0)7S+9<^AUFJ*'X(?>;/"E&C8\\S&]YE,WJR-?&_*G[#DD([Q9+<6N0X+ MX''#=VPLFOE3V\6!2HLLK>/0F2"L:5$09RR%;1.TRK\(+QM3S0]$& M:"UF?8T57`C/LL>HG0]&8(.LOVMV]5J_U=>>#"YH$`WC_8Q?D(E;U^M86D^J MA`H42G9"BBRWB79C!Y.I:X1Y"I0HPEODS.L[<^(Y"!"\B&N0OX^*)_KA8NI9;M<=?!W"94&4!2;,DS!C"/L,YDH.4CE4N;%VU/`P@E4 MN-P@PT^WVM,>6#J9<^4"'7F.XSWQ&<8=VR(?-2`5X)P[\ORIP&0D:I^K@5"? MN)>9O-1;>.\I`8B`Q$#B0.I`8 M2`P$#J0.)`82`X$#J0.)@<1`X$#J0&(@,1`XD#J0&$@,!`ZD#N6I0_'3X+U6 MO#WHX>Y@O,.HSB6(3KO>4^4TWZ%O0:@C9'5.3)*,3T[&S4XC%T3THM<<]%FH M!9YC6T/0IXJ??3^+4/A5@H?'(?&.X9 M1EL]JL]2DC$AX44@X86;P^2>(??,*6`ER9CXB/CH_/F(W#,$4(N/=$-%G1$A MK2<9*R/C%.[[R)<%89\_6XV1=(EH4]THJ3,C(FM"']/F?])AFKQ)J$-J<.D41DF=X5!GSA`N MG9Z,"6U(O\]$OW?8W3V"Y/>1;3)8;YXF=LC4DO9WA17Y*#$_U\ES4U3/RN5Y M&'L$\UI6BB)GI\N*H/-)RO6L;.R3'($#:S;!]6%5.TFO3II-F*V&7`FSJQX! MPFRE57M0[_9(J0FN2:Z7*E=R;Y![XUQTF3"B:IVF$5!&LPFN#ZO:>JVKM\F] MH8!FDUQ)KJU;1N;=#@ M6]#Q=]K$L#3Y&+RJN5[RRQ/SF19'Q+'JV@%$<8`B[D$"(\]QO"?L)A]B+8BF M4\.W_V0!R'/D^5,A+Y^-#9]+(P@]\UO2L;2J#B0&$@.!`ZD# MB8'$0.!`ZD!B(#$0.)`ZD!A(#`0.I`XD!A(#@0.I`XF!Q$#@0.I0GCJD]K6W M[>Q1E)ZS.HVDFF*2C,]?QLU.(Q=$],96X9>=BDOO]X[%1-6GXOHL3ZM\7IQ6 MX2-'F:%4FS$D8T*E2T.E#Y1$6Z$94\(*@=)L'G`6R=G#-)[P,:`95/D,(AE7 M)&/"(P7PZ%/$3[_GP%`I-@6M<%2?I21C0L*+0,(+3X">7":KJ@&FYX(2FF%D M.%4UP;%'3+N:,\,/7A$?J8F5)&/B(^*C\^>C^/IQ5?5S_PR1@)H`13(F$K@( M$JC6/<-HJT?U64HR)B2\""2\<'.8W#/DGCD%K"09$Q\1'YT_'Y%[A@!J\9%N MJ*@S(J3U)&-E9%Q=ZA1"FU,8)76&0YTY0[ATSAI/N'0*HZ3.<*@S9PB73D_& MA#:DW^>LWR1CE5B3T.841DF=X5!GSA`NG;/&$RZ=PBBI,QSJS!G"I=.3,:$- MZ?>9Z/<.N[M'D/P^LE4ZBR%EY*2,G.>BRXJ@\TG*]:QL[),<`4ICK[1J)\EJ M2;,)L]60*V%VU2-`F*VT:O?KW1XI-<$UR?52Y4KN#7)OG(LN$T94K=,T`LIH M-L$UN3<4&0#";)+K!(S_LNS'`U6Y8Q%#+8BF4\.?:]Y("R<,7O3,;YHG,X\9CX;M8$NUR+68SY]H M-AH#[8X_=N-BM!C[D6E?',/5#->"7_7FFE]#[3T,!X^NF32\I=?P%7WQ+GXP M)X8[9H%F1;[MCGFM,^;;GA7@9U=CT!A+LP-MYK,`X]58V@-SO*O!+,#/,E5\*G/-K-OM'F'][IMOKZ94E MHVZIDY2[V:M,"KI"VC#H*I:2^R*F2I:U0F^V-V4-$W3?A,W%7687,$,/)_P] MUA27,/=W$_"AG,.-#`ICS!IAK`I8R-?^=X9K,(5PA7"%<(5RI5/,)60A93D;` M!!R5;C3IA"J$*HJBRF'LE6:MT2%'"VTT$=@0V!P=;`ADRK5Q++ESQ'>7]";? M72*0(9`Y:Y#1F[1W1'M'A#"$,.3C/0M@H;VC$\25LM.,GQ.^Z.23.9&90$A3 M/=)TGJR;W87E*34.6$4$78+TU^]5NSO`A&]T(0YD`V3*>F%_/"B(]Y M=\]_>AT%UV/#F+WAM[$C$<=#+ MXSO`VJ:-\5KF^KVN:\.QSQC>9:CQ[]YYTYGASK4G(]"\!]`3WM61YVN&YM@F MS),U:.9>`'$TE"`(VT8C:,@U)KM MFHQ)$'!I!9$3QG$2/K$G[5T:\98`OI,KM7J56O=U MC5KQ*`QKNYE5.NA-Y/L@.]^;&PXH$GN>X?,!Z-6<$W6.LJ%Z=3O=6DMO<#U- M0C]\UQYT:XU6+_Y6KVLX[G'9AFGZ$8Y]%((NS`S;VFP&Q'$EI!ZT^[5^6U8$ MM3=Q:L&XSIB)<2J<>5H]%I_N(G.26S.?*H'VQ'RF\6]`OJ/(UPLP8`PX<38#J8T5&0&5J;!6DAOA<1/%8K MG1H6TTPCF*"68)$!J$D('`=/?R<6Y*@W_S"FH$A?ZMI;;V[5EM6HAC/39\!1 MV/Z'>=)ZH31Q78830,<0\D>,:^IW((A!KX]::+N/4+GGS[$VK`28(@"X,B>XWA/W+K@M#/S MO4?;8JA,26L3E0`U\B)_B2-\!F`0L>#-X;M2>1@A?=!69J&KMSOK(ZR];/E5 M8$7:;*@CB.JD``M&9<1PK.2H>_OD+F2R',XQQ%UN"?:E\)/F8M612"]AHJN9 MH9=0Y/C:30!"`')B,B8`.1J`?&*X?S2%-3HL4N/5'&')"_3\,!M4Q0-]$]@< M\:13O]6KM?LO/>E$J+0'*G'?H=@.,AR"IA,U<\H^:'EF"-3JM&N#9I?PIUS\ MN<FS@R/FC5]H->ZK0XA$CEZ3A"6R-&CM(P)0(ZYWZ33 M?E/E&DXH0BARPBA"9DC5RDT`0@!RP@!"^TUJ+NQIOTF!0=!KK2Z&!R)_+^TW MG0,TT7[3J2%0J]FA_2;:;SH]J%'1"J+]I@-81-U^KS9HY4>G2"&2^+CEFO[V MRV'9RV310\#^$\$K'_#*8U#V=7R]D;Y,MFB-)IJS?(6N\BME7S.7(FO:T\0V M)_P:<>;"K)=SNS9S$3&^9`G/!GA1FA?;;+9J@X$.NM"*XU)[H^1:INE-IQBP M&@,Q0+T,KZ?[H0$MA*$2]SCEK>,I"].7#S^[4+<;&?X\)?>>N.<(BNGP[N24 M4>-WX`)Q_3>G;?RYI/6B,YE[I/"VEU=W7]:=?MCD(>8<*"7`B]6BBJIO2'_R M'OD5&]H?A8_!RE#X\EA[X&W=5 MSO@J/);2/R%Y_E#1'L37P&75Z3KYM7@YF*)O=J"%/N/W*V&:V"/-#C7/E.$! MO%4AIP8]A6OK<"J#9B`V;\KNC>?2[\3VTS`FFJ%!.Y@B@432%]\G,`HN:)LW M8[[!!Q8DA9$93!A-6X0(>3)\2X1C:'5KK?9`N^)785-]_*[;;M0:'1V4,8F] MA,`W&J$FA\8S_\86DN`1$$(8#0V#?@02-=GSS(:O%A>P\3$8.%B:-ALMO=+) MGQ88*'`0/?R;F7R.?75M5.6[$#0ZT$8,H`\:S)$2OXJ['.+@8Q@*O)<^F_G> MLSW%GWW\%TBVW?E>!K%@H)@FO[>>B@K"KRD'/!J(YZ^4B4]DV_%1M@/;$/'( M!;PB$[NP"LWID"2+LN,8'2)^`AH0C-]HAS_%+>JSO`+=4LC7UVQ6>/6WI5#$ MN4:KPJO@>D<=0>CU2E5"(1]'HU&22A3W`5T$=%3N$;T,7'J)\T%P9D'OPS+! M%HF6><3J=W!'700L5QN6\S(`7[VYIE#7J/6'0SRE9[( MXGAD<;/PQ*'SCFA`D1G1[GQ/!$`$<"D$L$[="?K+@7YF8I#\.<&_(O/A"@\L MM_MK#"(B`2*!,R2!JW:K6^OK'5H%E$T%7Y@_-5P\96/9HQ&#+ID['-$G,CCN MO-`[>JW7+YY(C*B`J.#45;[=K_4&6T\G$Q$';^H#!?]GW1LX3[P:#6 M`8`AO#\IO"]?]=7!_8/M!PA/$!%$V8Z@]5=`CD`/Y5[A/4>*6%R.(I8X198H M>P:<'U-LF0$ILA`?\ZZR5W/5+X!.V2/;Q'NT>&?.<^/,MDFZV]0].0-OZXKL MM)ELM<5R3H-BG/F5NF9'5P?7^OU*KU!U6NJ(0F_72TJJF2L*A1R2E5XO;'?5 M$41CH-RMNDM!C\HOUET(-*EWVT>YFW67@,S5KD(N`_/5FVJG<;&.*&^/:?AI M)88-CV`SOY;Q:X@(59F=,H@0\1'QT87PT6'V3(@6]I@-O[]D-[T`$Y2^I7B. MC'`E*6&'.Q7$"0IP0OG[Z>?'#8>Z6D'LL.>B8>V6SA%XHN1-Q7/DBGWVU8DL ME"&+LK?5SX\P#K&MOHBDO"E&`?1Y]"$(>MS8X1OCD"#\D-?#F1DG# M*PS\._,9Z%D2CSVP6)C#Q_:H=S$=+[:_VNKHV9BX%XG;EFF":;\:C7 MINE%+O=2S7S@''OF,(RP^Y_(QC#J4\,UQB*N=NC!7]^8QA*IXZD!X*9H.A/A MN,,)AA0>C7@P8AX]6,;I-:98!S^RL.YX`OQM)6..#^*00JMX1.^U1QJP%DL& M+<;/N=*(`X+G-2=.,\0?DB&&`\V*?!3(XB4N'N;;GE77AF88\01%&'H<52]R M+'D+1AOYWA1>\X*4F')#AF?U-Z/:[XQ@,G0M_,\'&`68V-B++V#2FO.C!@SG MZHW5JJ'L'SV1R^!N,9*8<`#:IWW$PRDUGAY@8H\GH,^.#:)"HPECQ(N'N=J# M>&$L81)P!?$9TZ8@N`D4Y6N@Z`$_\`*R#.PD2\`#?(&5L(7P>3!L>)`G%7"] ME=_QR`Q4L-[1'Q^P:692'T#O_%BY8>HYD87Z%H2^;:*:\EHPSKG>J#4:#3&] M[$"+`IF;@9DX5PP12!O3%$`/[!`=S5:NTA72K*68]1C0WO/G9:E?4J$:.I@T M1^A(('004,8.)C`(8\^S@IK,>"`@QXIA"5041I<#61"BNDT-_QOFODA';\=X M&KX5R&=&6F`@^D9!C#Y3[Q$_&H\`VV,F'ILR`!@K44D,F.\!=)FHS5"-]P"K M7\9CO<=M!YUB_B/;>`8LI:)YJK-.$3+:\L7'+8]P_L4QW!`4#95LAI.Q+.UY MSX`=31FL'OLSG")X_\F_4$.C,DVT<5?(,2.'*\YBV`$"#,S#`[#F,CG@&@9> MX;_&S()OL%'DP%./(AL+_BKP)(TS:2'P*D'YHETJ!(-OFA0?Y]G(59.B&K`$ M,J'ACFTP#'FFD>"CC=D#?H5.6>*U(Z)-7+-(0XU!#S%CKJI)+R"(B*,QJ-`0\SM0+`S4`.4`M(YLI^M7B3SY>D"4^>[UBP M4@1TMDV>32(V:GF*#";3#2U2V_"\<-K=#*9%J-W-`S!$%JEN^$M7]HNK,R>& M[:,!H@U_^W(WU+Z(P4)BP3Q&\!3\]\KCU@+8`"Z:]RM)-EYI%HC6<*X=X\'S MQ:@';&I?FU$`:\&EHL60BU8!9T1)XJC210D M((U)D#(`HER>OD5:Z5NA;107P5%Q*2&5R(Z54LWVU@Q+^,,G]J3]*GN0=#EI M/6`H+$Y06&OEC%HAECT1LVK\9HU8@DP-FX\0-'O1CM/0LX44Q>(5\6N>IWFY MTMM;];+5YI?-'#L])-P(2GY-9Z')5X;'$]=Z0/I*3CK[E0OQB",`0/:#SUG]#"6+@A,R>N MYWAC@-6'*!0Z9\53*YOE1]BWK])R267>@BYDD^MUT@F;5B22OVK>:BGD)]PJ M;_&RE%JKS2TQ.LWM@3JC&\>Z?UV@U>@\WKY\6D.U63#D'>'OZ,`#?3 ML^P19N>Z^SB\T_3&H+9-6N16Y/8/SI*D<:G' M8O_4/,4T4K"U!>5MNJ?CBZQ;8Y?36\P!,D,9OHBV(,\V9W(?6.C;,#-EBK.\ M)J4"M&@/+'QBS%WO*^.'U/B2<^$C8\]@>O+OUOONH$#;3]EAO*4/1L"``M[+ M;N=^,I#X]813+"2X`W[*[*[P1^Q.8%> MNC`OC@VO.EWR`XLC7Z+%X0/"AJ'#8`W^-3US)"T+_R=H6)'A1D,$B5E&6UAT MS`[2:F"[2YV19@ZO$(7"%9@G+@2!#_.B-F")/'&;)=4JIH*\9HI$B/#&%!,# M./8W-*RY38`K`^Z(2G/5DPV,@[_XS'"@P>FBPHGO1>-)K,'R4"3H\!J$S\?L M#+#_RIU],,E*RJ3(8?P7#S7PG8=XHX@O(87N_\>8>0&8*OD.<#_>-DAF4K[; M/V=_(,\&Y*`V!0TT#3[IX+\RPZ*AC;F83"$F+:8'%^>9P]\5%BVJ28+#F;F! M0YO\DIXJLB6NYT^A>]!\/^!^_P?L$0N">#:NM[+6)!F4=@_WJ((>9RW8V++\ M>B<-'.VJKW_/O2%\;2@W$%[%"2/ES&"N%5OKR\8HBIZW@5-8WGA9'I],L4N8 MD[?U[RAV;//I-^5K&@`FEZ'G#Q','F4F)7J*W7A@XF4%FOA+@Y0[#S=-L>QN M!=0&8N8C=BNLQG=>4-Y^Q1WFXM7>&N@3_R#W;]28G9P5]/ZR)906F'8-,PJE MD_Y2&ED+CM1RC:PF+"A@4@4G9Q$LVZ`N M#>:_&\AI/F38TYWYAQ`"N$%#"KM/PT7 M6:=6,!&[=$PLPQG.%8.+C_/F@V./13LX"""Y"]\!*E=64AK?Z0?&Y9>$X%.%/,QYMF4^1D(0M@M#$@FYX2D' M[O$%N!8P$SV@1H`]`+5>/2R5GM-<@!$;1A1%_L!,(Q*@"Y8`/`>UQ<0S,[A[ M$@6#%A0:26([9(9`P`?D9HW,17>%]926KARTAXQ!S/$KL;)_%()[L@-6_'TA MIKJ&:U+#";REA6DWO6[X($1ZORBVVKS?:Q=TZ4EMIB%&IN(.D5/M?\`FCM&[;[!C@2PM`N^:1\]WQ3[MM#/B#>>_\S7<(/N-69QW[P"E0-[ MDYHKXO@"L,E-(C*Q17N/AF_2!_[ZT$1')O?XX&(:[<)_1Z[0.RZ[.S`EX.>: M]@ON$>)3=\Q_Q+DAFE-/R>`WLWL:,([@.R@ZN(U3R[Q#%B4 MX5J`SUDN:G39)X:]SW`F.7.YSD)C(0=RQG$/`MD#G$\,G2X_YH)(#@P))128 MG&U4$9A=3.0$P)-M5EC4`3;Y26IJYN.Q%Z[#B'JV6!F),R+^\L]@]/(*\.<, M][P8&5*;[L4,)&Y4C6SGS2W#(U;._`9;AXUGUEU,X64957$;M%0CM*05BIA7 MB_F\,''X%)[@]M`#NCDD]N'`^Q[P%'+8G.L)=_TDO)L4<(VDBD4^`"`Q69XT MQ^7>!9CBDH.Q=@?82*YLN8X9_(!(F/$>\/88>!0%EDQ`P4"GAO`0K%F0(*[A M"7;.G[DKA&B&2WO9D(S:[:A"Q?;OCZ9QB`?\4`,_2F::T53NA5OI;7)^Y.*9 MDW>R4&1QVW:);!-$4]P^_9/;,H[W=);Q;?2F.N>+.X/*(IDT%;J`T*DTM$U3 MG1O$@V:5\8X4$H3>JS3PD]Y31A+]7EF3(W46G3"TXBL:EX'.U=Z"*0!W95^9 M/"+^[R;K,L,H$2M5/A4*\%W94^&(O*?85-!SQXG8^$CSXYTXWNUK?X?U_A/T MATCY8%B;+6B$2O$`N?'R*U:MU4\ M_J)"0Z$2(5>P8B:^/;S&$]\>B6_O)O9L%I^.%,=ZB&T5Q1Z%(/[\V%:O=7KY ML5^);8EMSY%MUVL\L>V1V/8WS^&W!A**%;%2Y-]?.UGICW2,S+(Q81QZH%-`KA^?EQJ][HU`;=_$,F1*XJ MDRLM:?>V)VO]9I>(M4QB':9N)Z6#>!+7JH4[M)XM`7^N]%:MT^@7SY!$I*L* MZ=**]L7*WZSI_=Z+,R01_>XR&^*[R=ES4C7-W2$S$C'P$6?%8<\W5Y&>Y_QH M>M"LM3LM(FD5QN*P9YVKF!_GQ^2](N>PQ,?->:NV1\[(!-JX,R?,BASV><3# MU_&@23)FTA#CL/&@<)]%B+4D9>QPD6GI'EMSU*`<(P_CAN(6+H_4$XC4-W'F MF21I!8]@8KNA;[N!;<;/>J-UD4V\*.2Q5D3X01D8!T.(0Z]%"&PC?MWV>?@6 M'JH'(Z$$;[0#1(U1-VZ'/E#'8::W2[N4GRN*ED(I$AM'RY&X]]+A4E3E<*N' M#W$XIDAC8<3MM[JUCNM[[5KK8EF7/?[%ZZ42=WW5G=@-=MB MKE7\U!5I^XZR?NGY!M+NO;6;YR6[LD7FGZ"X,YIT?$>)-P'+VZ3G)4O]U@Z^ MB>0_F!*"M/MH]DJ].4!K1:_WM]LJ1;P!AUW>;_48B86L'2/ZRT8 MRJB:,L4N"]B:E7UZ[5\L$ZF(4ZQ_2YCQ])U5E8]&JK[D0>;E^LNKF M1:M=ZZXY=TYL?DPV_P7];LPBKE9B'A!+*W0WDNBW!"$3L1Y:RL27):Q^B3&) M,8DQB3&),<]`RL28QQ3^.[R0Z1!A$F$281)A$F&>@92),%53<:+,$H1,?$A\ M>`9")CXD/CPE/LP>.").5`I+B!.)$\]`R,2)Q(FGQ(GK[\(3/RKA9J53M^J, M!9VZ56Q&T>DBNK&`&%>/-@ M3MC#'\JM9&14(=N#'434ZSN,2N%4#.6.BD+\?*AQT4&`AV3Q2B:+0HQ^L/FB MI?@_Y]/U-J-`?-P])^5NB2-WRD-93N[)^PG31I[C>$\\-21?UHILE/:?+-!L M=^3Y4]X>#5,G^#SW9(`]U3S1U6Q6R@!S6*Z_C'..*2752'O0P]W!>(=1G2.0G7:]I\I>_J'/0*HC M9'7.2Y",3T[&S4XC%T3THH<<]5FH!9YC6TQ('] M*\!"XY'YQCAW355&]3Z;&K:[!HC+:`#>%O,-,XP,IZHF./:(:5=S9OC!*^(C M-;&29$Q\1'QT_GS$I*.DJOJY?X9(0$V`(AD3"5P$"53KGF&TU:/Z+"49$Q)> M!!)>N#E,[AERSYP"5I*,B8^(C\Z?C\@]0P"U^$@W5-09$=)ZDK$R,D[AOH]\ M61#V^;/5&$F7B#;5C9(ZPZ'.G"%<.F>-)UPZA5%29SC4F3.$2Z8,X=+IR9C0AO3[3/1[ MA]W=(TA^']DF@_7F:6*'3"UI?U=8D8\2\W.=/#=%]:QQ1QKU1K]2%#D[ M758$G4]2KF=E8Y_D"!Q8LPFN#ZO:O=I@UW3?I-F$V>HK-HV`,II-F'U8U1[4 MNSU2:H)KDNNERI7<&^3>.!==)HRH6J=I!)31;(+KPZJV7NOJ;7)O**#9)%>2 MZRG)E9#X"$X+4F]5U)OD2G(E]\7%H3"Y+TK&B-2Y+O&1AWB,_[+L1_S\T^LH MN!X;QNS-G3EA5N2PSZ.[B>&SMT;`K'?>=,;5(-' M^DS&K:77\!5]\2Y^,">&.V:!9D6^[8YYK3/FVYX5X&=78]`82[,##2078.P< M2WM@CO?T1EOHP0%4B17EEB[)8Z"<*;OP5.<+ M32^#2C//AIWF1O[BSSF^Q M^^R1N1$+WBS&X6SNH>N#MC)(J;<[Z\.%O&S^%H"T9D,=050G!4`<9<1PK$Q? M>QMU%S)9#F=9<)LMP;XWACN)1*PELCKA5UF_U:NW^2[?*")7V0"4; MW3TN]T$9#D'3B9HY9>_4GQD"M3KMVJ#9)?PI%W_NO=`H'@:'H.8TK*`J=MW. M#(^:-7V@U[JM#B$2.7I.$);(T:.TC`E`CKG?I--^4^4:3BA"*'+"*$)F2-7* M30!"`'+"`$+[36HN[&F_28%!T&NM+MXO)W\O[3>=`S31?M.I(5"KV:'])MIO M.CVH4=$*HOVF`UA$W7ZO-FCE7V],(9+X6/B>URXWK];N M"6N:>^/YPS/>&F-OFV+H+ MC9`%VHA9S`>3!B]M!?@5YG^!YFJA\0P_&Z&&R4IG,]][MJ?XLX__\D9:N_-] M7<-:?`9--VU'7'>+,Z?RVV(!?@'"6RD3G\BVXZ-L![8A"CU_+BHRL0N^N&`6 M+KK$[8._ZNWNCT&J;(T)`6M&`*W"T1-Y4>%/<9GM+&^BM11:#22VQ` MP9D%C*(U>^P*K@(6*XVO,9E`+YZY@\-*$TD06NTZ&FX4G#IUW1`.*S(AVYWLB`"*`2R&`=>I.T%\.]#/3 M>V3^G.!?D?EPA>?&VOTU!A&1`)'`&9+`5;O5K?7U#JT"RJ:"+\R?&GCT0;/L MT8A!E\P=3DH2&1QW7N@=O=;K%P\(3E1`5'#J*M_NUWJ#K8?$B`@.3`3W;#KS M?,.?$Q&H."OTFMXC'B`>4)X'2KFK2?"^J^C?30QWC#O"6&HD#O\:>,H6<^8= M%.;+OK9SEG`_&-0Z`#"$]R>%]^6KOCJX?[#]`.$)(H(HVQ&T_@K($>BAW)M4 MYT@1\E)-I[$#A!%+J,,29<^`\V.*+3,@11;B8]$;A3O?!EQSJ_`]&S'?9Q:\ M/0P"%F+"N5]MX\%V[-!FP?%O%`8@.WMDFX8;\JMYHE-XY\^234M?QS-X&_G5 M0F?1RLV9*A?9XT#_SOSF7K.CJP.?_7ZE-[4Z+75$H;?K):50RQ6%0G[/2F\Q MMM7)1:LW!LI=WKL4]*C\_MZ%0)-ZEXJ4N\!W"N3YF)6($!3BA_&W[\^.&0]W@(';8<]&P M=DOG"#Q1\M[E.7+%/MOW1!;*D$79N_?G1QC'VKW?:=>=[]R/;.=-*FKP+1L; M/NX=WX7PQ.<9?A=\CL(@-%S^=32=&O[\^-OW8B\=W4!B6SO@%=M_,HRBFS17 M\^/V0N'8$D^T6/,63<:=>6^T81__'/?K>\J@9:?*O?JN.CZ1=EG;LJ0.)`82 M`X$#J0.)@<1`X$#J0&(@,1`XD#J0&$@,!`ZD#B0&$@.!`X%#]>I`8B`Q$#B0 M.NQP1J@7GU,Q/=P=C'<8F^K(3*$#*P<^(G$)BDDR/G\9-SN-7!#1B^8"+_&X M:+]W?J=_H.0'_"#/UVBI`S9\Y!Z2,:09H\:,(1D3*ET:*GUX9KYI!_SL(:%2 MU3.FA!5"V;-(I97"P6>1G#U,F_EV'$R<9I!JG$,R+D'&A$<*X-&GB)]^SX&A M4FP*6N&H/DM)QH2$%X&$?S![/`F95146&H_,-\:Y:ZHRJO?9U+#=-4!<1@/P MMIAOF&%D.%4UP;%'3+N:,\,/7A$?J8F5)&/B(^*C\^^84L))D3'Q$?'3^?$3N M&0*HQ4>ZH:+.B)#6DXR5D7$*]WWDRX*PSY^MQDBZ1+2I;I34&0YUY@SATCEK M/.'2*8R2.L.ASIPA7#H]&1/:D'Z?LWZ3C%5B34*;4Q@E=89#G3E#N'3.&D^X M=`JCI,YPJ#-G")=.3\:$-J3?9Z+?.^SN'D'R^\@V&:PW3Q,[9&I)^[O"BGR4 MF)_KY+DIJF?E\CR,/=*H-_J5HLC9Z;(BZ'R2[/5)J@FN2ZZ7*E=P;Y-XX%UTFC*A: MIVD$E-%L@FMR;R@R`(39)-<+EBLA\1&<%J3>JJ@WR97D2NZ+BT-A9#RR5PN,N MFDX-?WZ/A=VSY_"M`X_]_-__]9>?>$%!$#'KG3>=>N[=Q/!9<._=3QC_./$< MB_G!Y]'=S+'=4(M<.[QEH[_](![\09QOT M05]M3*O!_Q%-V5`LKSH*KL>&,8/G9EY@A\$P"%@8?/)<,_+QF.'&NILK=>NB MYFVE)KT>NFYD.#<8:8<%X:T1ICK[)?+9]AH;]:[HZ6I1F0Z^,V9V"&K^)Q^8 M602/W7FC\`F&Y!??"X*=.]IK]Q8=W5;ZX9JR.M[MKM[NC M_8R?@GVDT>JV!HLFK"WU`'7GJ/L.=:.>W$WLV0P@`Q[X'$Z8_^$_D3V;[J'J MG5Y':-[:$E]8YVI?=ZGS-P`:>"#Y(9X9NX[M8`$F:XM\8:6K'2U483SF7WQO MQOQP_L4QW!`$DCR^W\3N#+KZ0J$V%WZH=JQ*8-!O=O=JQ=`THVGD`/Y9`+\^ ME,H9%#X[##_`V\.IYX?VG_S[M27O*+=KO=5I]!E+B6-4V2MO!^\N@.Y#]YS4B5_/*Z]?\M:-L?H?8;':A'[ZUJ M0[.S1AD.7'FWT5KM_%I-/'3E.3W7&^LGPD[5'VL*Y%21-.9W+P3+Y1:]#<'N M:QIIY:4+6>IFL-H&WH"D7Q\]_QTLDB,'B[AC_B,F_2T@@76J`%+HIH6P7P-* M[46.3C7J>N.`O?CP/&,FV`&_>V`.V(X=SG^S77L:37<=ZL;LO;;03=4: MS_M4VZSKO69W;;6BT)5JW]N/ML5<:W?%SM:4E+-2PSWSIS?N/S'>^IX";6:K M6BUP8YW[2;.]OLXE2=[:P;>//F/HIMBS@S`?]::DQ)SB\JO:KU]85;^;4]6* M?B1)6[8Q;>-?@?Q^68:=!>2GRMNOCB<9*5M&K(XC1_,(SCF][/6/4V^202&5 MR0`6LM-5:[.^F(PO;((Q'OML#(-D0Y6V&]CF(^+::I7M%.ZLUOF+#XL69FVN M[Y^ZOFXXY4C*8I:[\O*"DX*2HM\9L`QPG!<4G39ZDM+V&86U-1Q0R?6*E'RE MWL)*WCR4DNLE*WGS6$J^K>`7*/G:H@^FY.MK.)R2-W=3;W;6 M-T'8GG(;Z]X#%C8G1B`VB(*MC5IUQ`PZR^ND-64O%&AA[_YAAY.A^R$(H4CH MZ4?#7EDM%?',=%O=A4)M+SUIB6QIK.-?<$1CXWO_!9L$N4V%+[?@=Q9``X>N M]99S$&%BA<._[298^UAS6;ZO['P#4NNSZ/=%WD# M?=U:Z_-HQ6)/[V7N7AG0;"MKLF?+2T%!`F6_VB/XA:]8-E>7H^S)U,\K;843 M^4S\\!]XZM[3&XW/(QAXSI_OH7$I^$"\^,WPO[&PN`0CIO>CV=3OKH6 M]&EQF`LW1[-FVBVV44[P4/ANT4=&"CUMLNY@FT']D, M%']U4J4W,).B#THGW&@-;EP0D>T5\7EN;_5U8LT=IY$+8<-S%C[[>=1L-`:( M'??>C6OZ#,H!@UR\+7KRQ?.<@_2NG1F3'5NPY(`KY&3>WJ2,&RZUX"ZLC(5J M:38Z:BECLZ!LCJV%EL=_1Q70FZ@"!VFXWLPHVDHE.ZM2L5K3@[R_0A6KJZ.O MA;>,VUH_Y"Q9E+I'1455;DU%.0?-[KWA+>-G`;\8?CA_R5G][:4O',BI9[ZZ MACAMR*SM?MN<\TV]7NJ`T89RTY7C,7[KUIL;3CB7SKL`9AR_?O$B@;0'W4:K MES2F>#U':%V.D=SIMO3&2UJW]/30-/V(66^C\*L[,VQK1VEUNDU=>A2W%'R0 M!N2<>.CWV\W=&O")/4E%'XY]QG$;O:XI:=DL^,VPV#LCF$@4#^X]O-.0]A>M M-.\&`+??;.>?II3NHI=4G73@'H-PBZ./WNC&?82'/']^[[WUYM8M"\`L-R>@ M''LTM=D>Q+NS!2M9#&M*V:0*WH#=`O,73Z'\:AL/Z&6VV:;SK^N:U5I(L'`U MFQOVJ^>.7]ZN[I9VY=2RN5G<'_P;U#QQYO'P@['`O]E3\S8T;U-MN[?S!3-D ML$6.FZK+FH^&PX);!LH:L+VKBK'%=3J@G76W5R5 M0`QQY\3EIJ;AR$=V/D7>:0_B0P_KBGQ9G3FF1;.S4YWQ=WQD=^Q?4Q_HW58G MJ2Q3UGZ5Y/GO^KU!J[FEDG\84R!AA$F.\=:]=\?O'%K2A;#%-;86FINMP4`? MQ*?`M]:2WEVS[&13]3<6BM_QC^25;;;_C=YJZ#F'69<:5:RJS#0""O&F[-YX MEK3]EKEL9(?H;++=".;WYQGSC2678B&5N.XW.IU6ZF+B#E4=I8DYUWH&O49W M,'AY$S^,1LS$Y412P"W?1=S4PE6_8)X4&_5V9]&^XO4V50/L/354`:AL`M4A=]VPZ\WS#G[^@7X!?LJJ\TO:O:NW=T;75 M)#>EQ5WT-9-^Q_ZES);-Y1ZJ";G]WJ,)9@`>KI;VLNHWCO+6Z#%:Y M)JR".`"_FZ#+],9=>1\=/<*KZCC>$[H/=YWG@T&GUGH=E-VD#>^[:)%FP9EM"V?#+O_R$GEOA48,_\*1>:(]LYFN!.6%3 M]K_/Z]=/34SU@9GWL/;Y^=_-_8=XT&GI;'S0Z^D^O%Z^),E^G"OUI MENP/P!]!"&MA/!3V,SKNKQOZ-=X%7'PKG@+;>O$,_*^E8Y%6\L1/KQ>%_O1: M]FNECVCGMYK=2OIINWC2(\0>M*X;K6M<.L;?[=*#9J/;[%?=`QBG[G6SOT\/ M/E2D9YG62PW:I_5ZU:W7]V_]/RMJ?6:.ZP7FN+[_'/^@-ZH>H<9+]*OQ+U-$ M&$(."([7%1@5-N91,GYZ?O`=RW[#GF>.;=KA;PP/;VB6#;\&P!E_^R'QXH4P M%O@.!J$(Y[A+[.&:)A@^V]#4I1!)7[$#HK"?7N?6\3,H@6Q$>=+E9X_Y+N5I M"G=Q=EHYV1J6\(\9#NY(V:[4Y).4\S#IRQ?HRXTKE5HYF?LL-&R76S$!]D)Y:0L<@*?I&R_\*8K)5$\D$(L5ZV=Q,>`N+#B$2#&5'5DB%?5 M&0MBWRK6T<31Q_/$?"#V/:ILB5?+ESDQ9AE2)BX\I$3QQ@+A\$8[X\A[Z4/"G)O]AW(^;N!\\^(I2\D[E3C@U\1X4Q\O>[R:9'W*GBKA3$=)>R2D,P/Z=\D[E1$\L2=E8Y';A3H4Q,]WQR\ MB;N`L6G56VV2E-59A=)8E&$CDI35L1UI+([,I''8Q:.)M7#9C(!_Q[)090>2SG^W`:S?UWAOXY:?7\9>\`'PI^_9= M>G$5/RM67%O?3:?W$`58/`&?[!L^]RF:8BPO3\Z0[6W\BZQIZ45>V'OF>E/; MS2LNI\5Q2*?U@_S6]YRL#N$[*0QCO'`G+_]4/A->/X'[?6Q6J;OW3)] MM67Q@`S];`L-WXSK@(];1D,^\7H$BYCKN,3X]="#]LGO_M71.^W6X&.C\8/F M^1;S__:#7F_$3XY\;_H2*9]L7S:,2Z8C\*(7^9@-^'GJP-B[8Y@X[O77NV5U MR&EB\6F5=/KG6S9RF!D&FBFR)_/X99HWTIK-5FTPT&N#5DL3B*+9KO8/PXT, M?ZXA1O_T.M,-@04K$`!?"W:&#_\?4$L#!!0````(`!%X?4)P%98JUP,``+8> M```5`!P`='-O:2TR,#$R,3(S,5]C86PN>&UL550)``/2Y%51TN15475X"P`! M!"4.```$.0$``-596V^;2A!^3J7^!^H^\(0)=BLU5MS*=9,JDD\2V3WM>:O6 M,#:K+KMT=_'EWY]9##FX!4R.&D%><("Y?#/?S,ZRN?RPBYBU`:FHX&/;ZY_; M%G!?!)2OQS95PGGW[NV%X]D?WK]\IYE.8[18)3_&)G+DBBPT!=7XUZH=3QRW>UVV]\M)>L+N78'Y^=#-Q?L MO7QQ=I8*CW:*'BELA[FXY_[SUVSAAQ`1AW*E"?>1X`V?H]7)B<@I(Q^\A\ M_*:29<2[N+APT[=%:307Z`?QHO6W[N'E+]*T!LY#EI'9LP.U4C"8P\HROW_/ M;QIFP#7B+@WD]ZG@2C`:$`W!1\*,]44(H%7/2F,9Z7T,XYZB4UR&;YP57PE+H(*G9KJ=YZUA"LIY''2$ MQQN^0=1"[JO;ZDBD\ZP_&%'DG\O(28TN-K%P!5@+=V96=)D;6ZBV7FJ M&H5?SN";CC!X`%L[0-N"=DTYREBD'I_CUMUC2N3&?!QA,"K6Z=6I;OT MU$?Z/^9GM\)[5M-D1LF2,JHI*&1BH87_(Q0,(2K#BMY75-Y)M?;#J=_-E`BV M75%-J2C66EF\W9X[!<0GYTZY[#/GZ?E,I,:KP8G^?RXDE4EU^VON4P)?Q!R8 M.>.[)[)14]7K=(BWWR,IDG4B],S5Y'W:WN4NOLC M)\T5EMLZ__=7EY\83(T+5HP"XN+_`]=M'%+,`^2OJX M^.O;=^]O;BXN+B]%"Q=[OWT4?SQ;#%WPL3SVZ<>5[V\^7EU]__[][M3=:\MYMW-UPYJ4:BVY+ZR#6)-7+SX<.'J_"W:6K>G>/OR=.]_W05 M_?*(&FO8V6N9(_M#!*U%;4I<-$6+B_B?7Z>C_'C8\Z\N"CYV8JBA9*/A'$!Q4\"A+^(WJ[.YFG%&:%V\(PN^4^1)R9S MA3S*>C^?YWU?EPY:6('K5\AQON]*^25K"U>IX%S7%7`;=G2Y1NMG1*MD-=-O MBL^$R6,.]?;D*F06._376V('7`M^\O?`<^X\'_N[D;<@=!W:PF(Y?$;P9=)Y MR+!QWRE9^*3!'A8_?>#_S0R*7GSD.N6&X)?9,6\DWZ(UM8[#G\ M+`)VN;2LC1CXY@JY/DM^(M1Q.CDXW@TW+?7!#J(!KYO*WJ?1A0*@R8 MB?J/:5M%03YM\@CD!`0'Q-!B*[Z`B+_N?@_PUG(YOVS@#RU*=SP4^L5R`Y75 M,6L+`"C%/$OC9:@'('F*S_'4'#2.\_M:?WU.1X(IZMU;^<%@`..@`4`H);+R:4;!#U M=Q,>:8:1/'<^-L*_5Z\?VB;`8=&+"VYAN1?Z0P]XBYR1YUO>$G/'(YY52GP* M&@%'J$ADH$N(=NV`KO-$!'#+Q`.VGK'+E848_UAG/K%_6Q&7<\7$A^OO"B)W MX^8=2*F8JP+<&I-BW2SCHFG0*E)EIZ,"/_A9F23:G5@[$>H6^,=R8BA(E0CN MC\6%B`L-D).73@V-@KY;Z*B$!F?J;@,T)U/DBMV;B46+$=(TZ!!$.K'!.=7Q M?)J2G>4:?T(YZ@ZAHQ08G"]M;-BZ;=',31D,W_N0P3!WW"1MH"!TCN\F4T47 M5J'"+)N^#13HU#.Q8#DJ3L*UZ-9)!2SSB74,'X6\X+ZCT@D'J"F&$Z\0BQQ9AX#(BPC.C`T\"BH.X2)4F!P]FJ*?"XZRZW5\^CSF^?KM3YPZO-SQT2:>CU[\.S>D^_2&H>5:$DYA MG*45"AM7?S_AJ'L(MQ6.6.KO+IBRFOL! M4?BE;-R!C7E3-8`+SK*,AURR0>"O",5_(,<(MURCSN&5%QM<^):*,$M^9"8M M.X"8D0+`A78IK@V_+5V+;L%D^E6U&+WEN!TQ%IA#$U-W$99$4'!!7([3<>"+ MN@>B)(8I+NDF700G(W(?L#48L.TY9^/%>,/;BN$JB=44/;<4IBFXZ2.TUQ>A MS2P7L2G:(B]`7PAQ-)<&I*0=,*!R$<'%6E&!C&_80;>8V2YA`45C[PLB2_[M MKK`]H,A*Q+CG:KCC7SWEO`\#YI,UHFS@^Q0_!_S[G9-[0A%>>D-Q9I5BI)J' M]8[9@;E1L]+!!8JQ**KYL/]U!Z`[B`(PKF/^>!':FAEQU0%#EJH#.L\)!BYF M^T()8Q-*%LIMT31%!U2>$0A1YR.*F*__F(ZI M.H9*3DAPVP[I#SPS:Q2`J.D[!HU&<'"A.O^""UVU+$T'_(`CH>1*_]#BWGI\ M:2PY"_K98MCFD^L6NV+K5K4[7M"J`\`4"JY8_Z^KRY)\0WBYXF,-MOP+7:*B M8WM&30!KWDQDA=J/_:[^W%[EY_;RM]ZJ/K\G&0'`.3X)5_UY/E-6(X4-R7I# MO/#1A1=<>+1/VJ:^CUORAEG!QY[1O_1#EXNM#AF+S$!;JW]6C-O0Q*O6?"EM MC>O-T+#"[:/QN:7V^:`2=Z9:].=+@D37Y:,]Y/ MRC'+_+I5)TP[<1(_+"M-A9/?R-.]>^$&&3,TH=A&2I4:-(*O:!/)*\Q:&:E_ MB@2GW-OF'E&8.0@L=X[HVA2)@O:=`Z5('[4?!ADLEQ0MN:D/1W*[:X?U, M)1YZ>OCZ+Y"WPLR4PI8+CW_DV9Q!O$7B.0NU75>1PM>R6DIPAV7C&E-?N1+E M2ZR&$#80.@G!G1])7:C4HY"CZP@(>?G`[98,.$6_FX<,LN2S+3JR$_Y?@"# M>89RP"4,#L?+1!D.D<+&7L!%.90GXA1N(#S!B;@$QB&(*W.(7>XY$8^(B+PW M"2\.)V>>FW0\<`3HP=F.D/BKV^[!"W*0+@"25;S&?0Y]U7 M)IY3WU\[&=@^WD9/!>AOL9W0$6!S>XYZP"6@HK)!FHL&*8)6,3E],AY?FT[$ M!8?%P/F_@/FA:14/#_)5SL8NRER",#=QDLN>]IX\ M,%)YP6UE<7%$ MT7%TBZ*_4PYL?%JPP(\OT<%_A$-?1J'@')8\\R-ORU5&-%7]]6U:Q;S\Y-8C MF5$&.'<_S^_`ML7K`(Q/=X2WFKRV4=-7!:5,-1WX'"<4;2PLWJ`.7PQ,EB'/ M"5>;`6/(-_].C3I[5:B;J0]1DLCYN^-CASJNE`1'0;(!$RN")G-;&H MX#NV+\;(:KIX50CK5`7NE)_Y/M_9AQ%>PX9F&76!>Y=D5+*>ZCKJ[G&K5`PYCSKV-D!/>S9BM"/5%_:9;]*Q.[!7`E!>]*\ND1-"S3>9K0+2,NL"94,$Y M=Z3%7\*9WEJNF)K1A((BGY@.?S1#ON^J4@SG]M@JKE5-]B0A<;9Z:\\A) MD!-M_LJ9DX!=IO6K`K:4VFHOFW3@)K5-***N1T27TG*R12U>*5@*]=1>D2G- M0:$=V!7@9=#!JX7/1'G@_-]9L-E$!MUR$^6,O`6AZ^A9;+VG9-JZ`PZ1L2+` M;7LG=5)$35CE`8842;M@E)MOLB<4(SG!9>FB<^=SZP4QP:'ZN5$)87+)__.5Y\#A@7CYU<4$;38X.59#1<-*K5&5YZ>,%)^2(> MG5<,ZU6YV.8NP?DJUG??BK[U+#6J_"DW\!3;W&,2INA\;1_UUXIZCWAH5)_[ M,Q_GJ_+052M:/`S?J`*/_?H*+$"^RU84FF>C\9GI[^;4\ACW+D1QP&JFZ%&? MK,71): MODS&#Z/AZ&Y67;R@Z;L536OX:53G0\)$DI4'+,$Z")>!=/6@\2*U^1&&]15` M47[(5A`JSV:CP,U7Z)ZX+OF>G"Q@WQ!%XAB0*-C@VB'+G"C[\&%E()XW?"N` MGL=RLY9P%JS7%MV-%_OJ0H3NOEF4>V=^^L6=JN`L.V`[-K,DDZU]C^'X$;/X M#\12;LH4+2TJ6$S7_*\!STJY:?UK/5N"A@,98_;B"5T5ZB>/W%*(="*W+9EB M/B/3[`VV%G;#%QC9-!S@T@8<--6W<[^Y8T2Q^_"E[7B5[?#1RWG1*Q3XI\KXCJ(:R[0&?`BKM")J/WN[1\8PNH@:N=JV@_5F>FA>K M[-$`\9829M%=Q[-6JJ)N&URFBECIURA(:U1E#Q40AGT6Y9C%66MM>2TE.6#3 M62QJ_256/"^PW.14[)1S*ZNJDB<"K%656/TZ5/,ZM#]<=3#0Z?CNS.7(L/<& M5R5#COK%Z?4M3L/DR?OH`8R`VYD96?C?>9CQA:H?NRML!MBLFHL.[E;%?4"Y M(D465]S0>A'_8CJ8U/0=P$_TPWUEBX16UGT'L*].E;57_TC&3@^;OU.IHP2,AU9`LPO&?;![;$2'@\EH/GB8 MS3&A\B"`\7:D\IJ(@;T7'Q9,C>RY%)6JKFIY8 M5%:?U+A9AS5_$+WVS.AP_/C(S7Z!`9%1`;<>4L'J+PB8034^[V5D-]*TK4U= MS6R0S]N,A`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`C+YXX6CST;;J!38'<>@`;.241QNTQ9 MA]\!5U=*B-I#VJ'%`P_7E2KL\#O@"DL)T1\#K7EK,_3*/ULL*JX4;M_Q,6JY M6W[*4`UN7Y["7K]A"=]+BV.Y**%1.]:2/P3\*7_N>PGX:A"^O."./+]/B[*9N MMA^3=D/7$A%K/Y8:#2V^+>[T/!('N<*X)0>\_XV1JY[B^E:=T'F!X+4?8\U? M41@OI)&PA`RX@N6B5;@MH#\8G*[4+=6I@A"X5E7B59C&5_E]^RW\![S@8X;G MYZ6NGI00N%Y5XE68B]HCPSXW3"2`TFG$[@KL\WP<\W92R0_&)G MAJ!+!K6)%-)3(-A-37Z)"O,TP+4H$0K"\5/AS*@\M5+-@:N_G"HJ3!Y59-5$ M4BNW-3$05ZR6H>"?=P>2B;43/QI\YRM*?B71'8Q6F]L4&RK!EL+NX+IT.IEKK=47O7@['&;/C5T#J]]2J>O M>:`U%7W-@[[F`7!H^IH'?=#7/.AK'O0U#_J:!WW- M@[[F05_SH*]YT-<\@*/^ON9!L?^ M!%%,CF^GU#0(8+CK4FOMB80!Y\`17(P7[ZZO/XB88DYXB$$1YW"^BO?0H^32 MA!!7]CV6[0(PCJ>II('W-^*K?C<2_:=^"5RS:3%J3PE$Y2TT)3K@7_\\B%#[ M%<2!$_4NYOS-.S'G95]ZG@BX!F5BF07I_8&&DP\T3)$K;N1S-]??S?F"QBP[ MVKA?4A1R=^9]$^/^&SR@8,Q3?Q`!?O3Q@&UQ!UQD6L/OYAZA.1FD(9881X-& MP(VEB=CU/U*<&OVK9ZT)]<4I4.7[Q#IRX/K6BUK_8]N>'8@WTZ=D9[G^+BY\ MP'A4(C[_X@E?KCU\+,HHHW:/_XB/@6W3`#F?`_^KM[&PS*DM:@$<@$*!:P\8 MGM#WV`+N%VU1C2(%/$;LT7+0T&*K.'9G<^);KN+VW%G]`8?K3&75'L^$/M@" MB4^:+$;>E@]/Z&Y./I.=,T4,<66L^#TB'%(5U%[3176,\)HN%/3&'1]M%%?/1*J;U(C#%/&I^@?!^O!:BBM;\O_5)E M`HXS8W,39D6YS_D*32C98G&\^YZ(*S-DC>;6"V)G9^+*#M1H2JXL5GY/%YYXN#P=@+N$$:;_A4TMW8+M,#8&M]DD+`G5NX6RR0+4Z_ M[L68AI7&C-$LT4$'P"RCCB82BC$/W/)N$54D#8]H`&M9(53MR3_NU*ZM\`P9 MYOA2Y,DK7$G)@*M3+EKMN;TY6F\(M>A.KU$I&7"-RD4#=R$@\QT=W++A2IR, M&GFW*,I5<8(!8\AG8A+["(U'@ M7="H`U@6B6V6`.SCX],K;N"EAQ>

" MH9NLNU$!NWU4_?JBZCBN\)8/A+&A1>EN0:@XQZQB7=.@`Q9;)RZX$/ET5^J5 M^$IG.$,G1<,UP?:$5"Z0E+2+P(0BFH73O;MSLKOS!9$E)UIA.U4+_3:@W)Z) MG'AXU>1,MZ;,$`VZ+V78ZMV4U^>FS"P7L2G:(B]`:G-Z3-4!2YH3K/YZ\<@/ MG[OQK&B,>'!9%DU)"EBQ>A%K3YWSH9/1PHURN5:S)/"U>212O]#7G=<(GAGZ M/1#5V<1YO_0]E'/3%L4]-YF5*.:F7\TAK>9RH_=/:XW81!Q(#<\0.W,R"S.C M3OR^J&QM*6X#W"P:"-W`\\%>5)HE?$?T$?G1R.(_>V;D%V?-&@*'P%1\LU7_ M/W&]BG\N_GBV&.(_^7]02P,$%`````@`$7A]0D8B,,@H0@``E`0#`!4`'`!T M;GW8C]#SCORW1'2-TMSWJ],V/OAEHO,UIWMV1)[3F'X\)! MD:@J[+#(&KZH5;ZX_WY(`&2111(`F2@6YNZ#/6H)S$PD$D`">#+S=__YLH[) M,\UREB:__^KLS;NO"$W"-&+)\O=?L3P]_?=__\TWIV=?_>=__,/?_^Y_G)Z2 M3S2]B(.LS,DI8=]_M2J*S;=OWW[Y\N7-RU,6OTFSY=M?OWOW]=NJX:_^X>__[N]$XV]?'<$77P2E+\B)(0O5ASK[-Q>\_I&%00,?,+,E@"_C7:=7L M%'YU>O;KTZ_/WKSD44/0!8M;;(H5S8(-+0L6!O&;,%US:F>_/N/*:7P$9$?J MH_.)TLC9-]]\\U;\M=F:DXN*NGF3^F_>RC_NM68:<6HM\Y']N]]E:4SOZ8(( MGM\6VPW]_:]RMM[$]%?J=ZN,+OK)Q5GV%KY_F]!E4-`(U/H-J/7LWT"M_ZA^ M_2%XHO&O"+3\?'\S*-DW+5KRH[=SR7A',Y9&5\DT8?>^GEGJAR+("H3]G MD_R1KS-TDLR-+^>3-BV">)JTNR^EM'(IA5]\X#^UA*8O!4TB&E5B`QW-/!9L MQ$H!A"O*:=BD^54,:V>:?=74Q%=%GK+3:AT3_>3+WE^_I^F2KW4K%MXDBS1; MBS7WLLSX'O*XHM)4SI_R(@O"HJ(G.O+[KT9__K8I,M!H"9W1/"VSD.YQX?_Y MZU1!A2Z_,N@2V'P%VQOG"!LG34X_/WSU'SM^I,&02(Z$LR22Y[>_>[L3=[^# MYUE(TBRBF=J>F_T-LK#Z!?_1(*IJ\39,^1J^*4XKJ<7GBRQ=3QB.2IITHI+? MCK7`YDZV"/(GT;TR/UT&P09VV+.W-"[RZC=@JV>G[\[4=OV/ZM=_O>$NSIH^ M!B]7+QN:Y/0]3>B"%1=I4K"DY)+>;OCN#8+G>Z8TA<)DFT6(BS';3[0@<9KG MY(GR`:2$"?:D"%YH3C@GLF`)]P-8$!/N$!1T39,B]\6$$3JKK!@]QM.7TJL7 MFH4L#Y[B?7O8_RMJ(>QA@S&8!CF=&?>RWIZV]RJ!N?3]`G\(V7+%7??SOEY.%AR]W(=L(0O%;!HP(Y7!C'W0]*HXDIHE:?`DP-0G(YJDIZ:9(<9TNB$^K`(^ M_H-VUOHSRHSZ&&&L1-+SR0#Z>M@Y+<+ M[D5?IW&!TY7%A^A#E;UP&"N] M2/."<.KD/.0>5!G#U0ZYI)N,\O.3N`U(%^2:O?#?GN=51\#%BW,65.K_FKD=!/[!G&MVE,0NW@Q<< MIN\<7&M8BH:9@#LFU023M'VS/6ME=&\I1@V40Y=DC/-Q(#?CL`Z%+S9BU76M M?W!L3^`BR%=\683_P-+X',0@U27+PSC-RXR:'`+[[]&KTFA1,39W3_FXL!`V M2F#H>O,_2%^T/L!>AWR909,5LK_:3C3$Z:ONIZ#@9&\7[\N<)337+;J#35%K MKDD`U$N#H`UN847=%X.QZ7ESQ;73_7P+[B=:@(URO_29131ZO_VH_7> MKGU/9UW1^IO#_?%MIECI8W_"C#"W^>9-O2=(@,2'-!]"R?2U1,\1#7O4\1\0 M+\V-/TVTV_W,8AP?TW_]ZW>:#9'L'6%`3*YR\/MW=G]D"@8ZZ^) M$ZJH>_-F9MW_03/2C\5\QO00Q#2_I\\T*>GW:1KEW.D>L*/>IF@3T@F`10Q& M?*;F!0M))NE[MP#I.K]O.F;USWAWFJ[7:?)0I.%/$FEP7A:K-&-_H]'0;:GF M"_S]J%D"_@G)!0<2U"Q\,RH+;72N$&U'9SX3^\"")Q;+TWT2"=%6 M:;QYNK!W+^Z9(\_'!^?_7#[8?+ MJ_N'?PDV:?X=N;RZOKFX>?3-*,=J:=]"IXWG6'/-:?AFF3Z_C2B3ELI_V#=0 M_JN_7B4%YWE/EPRX)L6G8+UO(H/-)AN]3=%KDTX`M'.E:#=B,4@`3%R>4+$=T!Y1)_?B M&`NH3A/[BZ79F*8__MU3<>E[%P"T*-@"4/TF>>#.0@&`X<8RW?,::/\MZGEP MM(BXYW()*A/GMV4!>0XB/;Q>TQAE#&8A<-=\@CIID/?FGL^N]TV#L!T#3#SFAH8R M=\#Z)ODS#;+\8_#"UN6ZQR0TC9'1FB8A<,&;DKK<45[Q#68+'%Z3M>3A+O+0 M12_,@8C3>S-_=*))(^U@13OKFO$Z.US1J(SI[>(B76_2!)!PMXN!J.E'V,A- M,$\,1?SE.+X[R(M/Q13P<)(MX7R)8DS.V'<);S M)&J`;YJQ++<+$ZSE!=+M3UF,6 M)#E@'+DO90_)'T/!`=QNM+CN[AF:#%VCI`[4,0-&?ZAWOLQ)A':ZD,.)9NHC M5GM@*HX@,",VV]7==PBX[(WB1YZVHX'9?G31>#N.[J??`/2A"3K5>&?-%I;1 M(*>75/[W)N$[?%IRC_2>AI0]]V1K&O6IB_Q@U@)B9N.KBM%K$BE6<"$=*&8D MJ[GY9J9C--23!FSD&,YX!!=7HGE>IJ7-@GC"8B3@9^*HP<\WL[/01??)VW)L M$&&OM%#PRUQDPNVY6>DTP86Y#C#$>J\542*HNKI,QTAK=$3]$]ETZW^^7&8B M;7(%/@97)%TF@*DDD4RW"PFA9,9%\HK/,,B/(4,FEH#O)7D:1R?5?@&N3,(; M4?XKEO!#(J0]Y[XY7;-RG9_P.4I22/#><,PY_8#[\/QD6;"BY)($":$"'B6Q M@CFA,N@-7'S.(7_]AERGK5RJ%>\P76^"A-,\(4&_"&U^6'9TIM`*JM;/[.)A].[B^ M,Z@+Y#P)5TH*33))X>*J1VS_XSW!:U$1E%0&5#DJZQ@M6G M"UAK`&Z?`P-7*[V3'IB6?+$HD*0$`$BS(W7/ZO57KLRKX)F2)TH3L=+#"KX$ MQ"J\%*?R*P5QAD=CM=ZV:0HR7R@DQ!8=/.&3:,/5L.)GPDBLN)G([`E'8MAL M"C@MEMF6+_2/*\J/RHI.!MY3#HMXJ")OY;HN+WW@RP7+UM6NT1(-F*1?$OZC M7.S7P9;WB>\2L=B2DGA+`K(!;TR^MP"QG8HZP11OB!RDZL2D.EXK<8>KD%N+ M_/6*QM%^'[U91JSLK[G/6,[B8[RJ=Y"EW-=NX-]&OJB/H^;P-7U2-]R]I`^" MCN5T\A!"Z4B%PT_J"%,XYJUK?26LHN`-44DC"!S@!M8D+,K`5_Q?XCS0?"/H MM6EOT'W3-66^C[4;UUGSWBY8H;+&]PW_8"+H_I7')_>EL"U7[LGW3'&[G((9N@+6#(+J:,I&D?3$& M8]^[871:O2/"&]@R80L6\L-.$TI7^0`UI*[/$]#@VIR0Q85-..P8ZM%I)X>X MNIOB>GJS3;M6;"M^P[G)8"]Z5`#!8WJGSO'R'#AXV3/4WL&%CT$4!Y<^J8K] M*%)275NH([W;BQ\'/3%=_J!Z=)SK"(-6NE<25K:&"2VM$O4"^F97/T*SY!L_ M00:2V@F$PW6VTRTW"H9XM0+;ZJ(=-SEF=!`K9U(=N_:SC/,5^[*DCVD3X)#OO]^SK M]"3=M19NA&5/GY"[>Q`+KMR5$K]ZH$41BT8],Q1+$35E'74',XT.%2@(LDAD%O7)8?X]-QCQ(2CUQ^$E""L,$" M5LQTL>!KA#]WF].TTTEM/6$,YP36J\+F,N/=[K[J_(4-X^EUWSB`T5N(A+-! MQ>"$2!:D\9+^%^#ROWPS02N==*'RUN-TE!2S9YO7";;'!8) M8W`?4O#^]A)9>7,1,TH-FA2:IJ&9<<\-PZRDT7VZ#6*0[$**-;3)#K3&[ZIZ M,5`7?!5-?NH0J<-._+QOL%1%9\^T&9+9[:EAZU86U=/>E4T-BX(Z'TCB=6I\ MB<,4`0!J9OL,(S.J9L#*3,,T\ZE3)=>L%U/=N;/3ULW)^8#FCYA%^D]!7,I`1TB]!7%@`]9C\Z7['-/#XF'LJZ8*H062K#<7LA-4 M84S9;!JJ&8M]R+5R(-'9@.D9/L*7_+`2"F-P(OM'#@8'4?L[N)1_WI2=+CHU M/T:,D.-TX5<_ET'\,4V*50R_%.7`[V@F?M,+\AA+PWWZL!3M$6,''E*LRS]`N]NZR"B,B`Z:)^9R9<5 M!+VEW,^0_PXAM.Z%9B'+*40\%YPMQ)_E#2`D2Q9Q22%J.GV&..E$'I<$@>]4 MH)F(6EAP?3#.#**J162;B&13-]XRCGE%&5\3UFL:04.R"-;\$_@`YI"X(\_* MO%`A<7D*2TBQ\F:_0HVW,3&Z_W&).TLZ0V8T8070:]BNYPH"9F].P]S5VD89=(P3JT*^`JPWR6H.97W+3 M)O(C9J;!CNA/CM4]3PJREGD3S1BO#)YK_4\IG M&]RZ;6\7/>;>V\Q)Z;L_9ZV M\E_WCS7"\V3Y3]?AKA?,FA]FB_$9.]G3!Z9(,SC%K2=G9 MF1(GM#'?RJJ6F&1U1^H45*)'09Z7ZXV$+4&R%):3,A?A;^0YB$N91T1%[4!* M1@9AX*?\^VPX!GVX/?J^ MT"@*RG<6=P.DYB%._8#DV?@(SC2J8O^FT')8CI&/IA^H)Y"+RD&NJL6>;W8) M(N_AH)"??PFR2*5RWH[,7',HO@YSW!Q8-2CP`N&+\AHBY%5"*)'KJXZ=#)X# M%HO[3\<9'[Q2CC:1A*V&?%M;9M/P<":A6:;F=/^1.RVR9!)W/>"-C^8_D5H4U=:7.>10G4U_T*EY3+?[\XN+V\^?'F\^?7]W^^'FXN;J06/2 MFL8H:S4+@=K6:NJD(N^3;9D[WS0;VR&8L29-`)[G[4*EUN(+^8";UM,07V-F MD#G&8B15V./?ESE+J/LD5SBY]S19/QKMW%1A:O+$K4X6B33 MFTU(8X4"']/^]?:VI]C5D!G,FM(^R""G5A+]&"R'RP/M-W.1U+Z7,0H*K6B> MD"]`\D0EXI8(C3#-_4/2#VFA)\6]1O_SF8NX?90I*PI9N`10I>RV=.(Q)%'YMF\Z6# M7+W6XN'0U(*-+E[-SR"C$?KIYM0=.7Z'3;9[P?EE07R31/3E#W0_#=IP.P?) M=@=8H\`\,MFNHDP$:<)I^V(_QLYWL^UJ%7\HVSCGIY9(G%SB8-EC$^V_HVRA MEQ7N#*D($J#HT\CW=K4YXAJUHBK4W0#Z(1%GSR"NJE7UW+`.-L56K-,*@#T. MLB9QNX)1Q$7`-]$>QBO@GF!3^#07Q!463LJ51E@*".SB+-*%LF M1%1X!?=;E+H1Q88$D2\K%J[$*R&5BZ*L)9?[5U'+1LE[%= MJP?PHJ=G(C)/6G^PRVP.*`V7^;#D939 MN:4]AM&Y"JZ3K.^X:"!OSR:B;>XPP*Y?$!#FAPFWF]X/TX9T MVRC&V<0GD@!@=#F1N3K:?]J`E34N_S+Z<\ED/1KNS*UEA@^ND2)@HC(U'($D M-57>4QZ41!7M#.S3J\W01O/#07PZ6T9$0E5K0)IM?PPRJ#";-T;N3A9^I='# MX^W%'WZX_7!Y=?]P]/S=(+T%EOQ.WC[DW]-TF06;%0MO=IN>)I&).=MQ)@[U/EH93W!!P>^JPSY@E+,A7YXDH]`21;\]!+/*^I#$+ MMZ:X*KMO\3G#QHB("^;.5T32]<4T)^F@DS)L_#C-6IQ;)C*C^5W`HD]44X1[ MOZ&+8ML#S-%V)&`3OJ>@&^Y_3ZELK?;=5(&KTP1?"S2&JN"%[8_,,Q*J>O8I45:+7NM),$Q4PMV]@J<2A M^FU&$YUOL;VG529"*);[-+34=IJA%]HAQJ@D-7XS%U-O]156OY^/4XI(+ M?05^TU<-,7_GM$Z75C34TP3D3(=-NX(Y>I-S;[0:='6Z+(;HR%5J!NRLO^UA MJM(X.0L+D$_<5Y/&)7`<+;\60CZQ$\>8'5I%6-73F0>TJ=##URP/@_C/-,BN MDN@R*/;'6-L4!>4T"8`Z]2@\N"1.@#KAY`G0]\5@;'30A'O:C0(F'RX(*](6 M9YR11,9;I.H&M%YW]?SUK[R3% M->Z&0OX6@?IQGGF+(>[D.83FL;QF40&-04P M@J-"TP462S`F3/E5#U<%E281E>U$"80@!A9%90]C<1`[@#S&9T&60= M'"ZW[084<>9!40 M8JFU5N+5,28YZ[(L@"B7M`*DW"3/7)X4$A(,K\N:;UPLS&:1,+/K5<7A-:E@ M2(`T8HJ+=^!.*X7T+,RV@W3LJ-VAHT%_XP/%Q+J[AGD2US!A\QI&9!](\C(N M`@_A2'J%V(6A'LVB0.7RY'\I-H\[L5N(9.?-X@!UQ/J0L8VF@[?#J:*CLB*L M-W&ZI?N5)YYI#H\UC?T7+J>],]2I&NO8,&ZTG;V3RN#M1NB<^6FT^XG+U]!! M@9P^@%97='8G]6-UQP;07/5(O69RM[;J6T;*!*J.,7DK*4*C&]CB^)\?8LXS:Z"3NMC,O%$@` M/%%._IKVYD7;:X`%!?0P0X(!%$6RH.ZRH$T7U'CO`7*2D"]W2RI#OL)=%W*: M/;.0;Q@-U\O#"X]^[>PA`@:-9L9PU72]5E7!3+Z5U2?XX%0+@9"Y*CA](AB< MC'2LCA*H:J&/3GRJ]0C-6,]%I'L>,"GU1WREEA83_-YO3L5]>`DM-G8_,X:W MN]HI%=,SY(<*$[A4&XZ$GA0I(\D30]\4J MK)30#!6P'(C#YHJ_9C'-+H*"+M-L.%-\NY6#//&];%&W6#(ALJ!+*L(^F8:F MW]T$\1I]3_?RN86M@X0;G#X'O8XP9\YKN(7(@8X4VG0%&"S^W@Z]3 M0-/--]L+)MI)U%*Z"[)B>Q=L`;9RDWQ(D^4C9]H(R^LQ8^M/D9%-XP3$Q3/) MPE*"&5'<1$*$0X6-'JJ'YM3YKGHZ?]36.&VU8[6F6"SBUB?@78D[[U^M/^%N M>O88H$ZUBI:SRYT)LADC.BQDG/V:9J^?K0N:WE%&H+*J4B>W"R[B-Y!G^#&M M4`>/*Y5.6![8[](T[C&\T21PN*V)`J.`7'4IFW1!@"L!MH`'J%/AP(V?RJ*K MKF\VG+DS?-'>DU48`O[A;+S8\-SSC.1D1GD?[_=-;F3J6G. M(8VS>BYOW,OIPA\';LWFXGX@`-'!U'30V.,>U+QW3V@SZ]L.\'1@NT14"Y.9 M_;68DFX;7'VP(988TU7U(&[=@T10XIHVO4]#2)`3$BSX888$=5'QZBT0'LWX M/^.M`(O(F)<]%,DNL_[^7Z`(4@08XA:^Q*O'PT%]MVJ"Z4WR,*DI/E)@VC-! M+#XZ6!**ME`N5O]3Q894?(A@Y).-V"O$-LE"WS!A"F!M:,@Y_2D%C!:4(/L8 MO+!UN>XQGN&VR/)8!A%0-^J*.'FNJ9.U).^N?)8#^6U`>30OV%I<*:VY@PU1 M5U4V(&X>\"V?"4_;NL*<6%&5/\1RD>,O5&4:%W$).0X*6L$S`A_!&4;%MDMW M61DG*F>5V,QNUIM8N$H`E':J]Z/.&C_T:FZ5JK)BXZUS)CC3XD9JAN^O; M@W3*6,*.NS!\"DD.S6A'<'#T/9=`V!4_GLA2C@HNR[_;9.DF!7`LGZHP>:_/ M'][#[Y4;5!$XS6DA0;-I!#F"!;TH%7Z1JD+$72YUQU!R06,^B1=E`>)%,+-A M\D/CYKP7\@0$%I&,!3%AZTT0%E#Y""2!8T"0;/\EX/)]EPLT%^]Y)%:A9.\S?XS#8V(N'CI]3T@+5#H2/!*($3.?OM"0%FKM9+I[TRK9). M>G>4U#PV&NKDX;&WQ9DO."TPH0<`@AX$_?D^B.%5QVD"$(R]08R6U5Y-R2-[S1S4%R@GS'.GQR+Z,L!H^@TW>V2SKV'?FW;[XY^4;^K[K&#>JZ MO2?DZW>_.?G7W_S[R==??ST4-$X,3`GFGL#;[2-(*:\($>VYDS5%T=EAY[DB`/-'(09-['%.>D*XKD M+X*F=VF,^KO<#0$?5O3TDUN%\N9S4F)[[4I!6GV&.K^-$1,_V/O>-IN`?)VHA\$+0L!<9D M+3F3JIP2*13O@^)F775Z,H`6T7DOH+0V"C1B:NTM'56CD(J+SVM*/R?!&C*7 M<<>KSZ,U-L=6)S0*@IEG-7T1TUSN.)@3ZQZC&\:4P=.[,_<$L5')7H5!2QN; M;O8RC1UMLGI,SYNSL,?X+3Y"30%[H3`307$!)&O#@HJ4!/S,))?C#?!R-2/< M]LHT+UST;NX)8J^AYC09:XW.<$CW=!VPA.]!>Z44;I*AFATC";C$)UD*ZQ2I MFE4\!42N53OC%?=M1/&,0]7)<=C?T85RT/T^,G3+4G<:&-5+)!SR&YV3'7XE4$7MNB>-]CEG&6_ALK\1>:70D>)A('M=/1!P;T_0 M7*4QGS8YS+(55LK&JUBG/>I[.6;E9N-07:3Z8(*G5Q$&=YBY#U!UV93R]QR!O M[$77_6Y1XR&%(_RGGTNV@:5K=&$VVR]QGM4X\5!N5L6J56^M\+;>VDC5M#R5 M*4.'=5O4"ZY8Y1Y3SN^AL3'=+AXVG$Z?G8WYVH%3,TI,!SY.J.`&:HM+A<6U M]FR^84JN;KT>YQVU+.WFJ,/'V=1'*:V[QT^PXEE1/'5@K+H[$UN-/MYC[-,1TZROXV M02F=36ZR2UC!O7QBNDX0!.'\9CU-,_#,./G]^'\M:,^ M/4!US6$!G;@YKZH:FZ_!00@D,T*K,_$NLU%89AD<0SQ,]CI%>>:"G*;AG;F* MHDQ7!C-)7_]JH+&;>HB#0B#CLG:U.)7ED5-"^VHAD@W_U#>[TZNFM[JA88"< M)R?X&&S'YB;8?7*(U`0=@0Z5F0!>KF=*3#"I3YB\!+9]\R0M04<_%ED)!JQP MSAN3#>/'Z\^0SJ\W(9VFH8/;CR'F#@)AI67)-PM?K,?<\>[97Z_V^2SE%OPD M61,0?%WE0AE.\X:/T!9D)Q3&FFY["SUZ\Z(^3A'[UC5F>&9V"-7C(IRI.I$< MFH9N',%>YA@KDD"ZYFNQ3&Y%(KI@(7/R1.ZF!Q8ETJ9UXVBN:Z\J>MU6C2D= MT_H-:ZSF@P/,!I=KZ\,OV)!,2ZOMJ*!*Z4;BZBW_D6;T(RVDKP/_>!"W&9QU M?\D5NP^QI7='"(=S]RI.$OV[ID4%TA'_SG?L');K==PY8[T7-YV<^Z0T3E%[ M%7U'V^B,OG!5(_M#FN<7099M^=$5LNX/7:]J/L#[P$9A,-/K$[>TNB0XB3D+ M$@*/4\7$%W.SUT;'";8<&U2$/O>P'X.7>QJFS[13_;*_#386OY\E\EH=3D%% M\$(R1=9AT/UT>2TB[.^QQKU>%&1!B\8DDQRW+T<;52BD\,%W1^LLQ:SQ6FGCS"=QBMN;ZI-M6A$ M1;OG@,4]N=G:?\/5H-MG@7KZKX@Y*Q8W13J+G*\^":K)].J'F,:J>C92SCWA M.SUME;_KGSN(VM8*]=$$?'`GN6?:#K7$5;C6L\=,Z8JT3)]7$3\A"=7'J":EFD:2;"(>IW,3\2G@!@)8M@.!8B$_Y;_$OX01)`5`*Y[('LIV9095%J0 M)&IQFO40-A(&1[AOEZ1K%I(GFM`%DU6ZUFD&Q2JYV&E"1=J![V!,0+(@Y+HH MY488A9FLF>\75L5C`6VZ#=IO0@KW`S[GD MR1W<30E5RG;TA<[31<&/8_[$OEK8<:MJNN8%>%\#KF)C=90:Y>;.(Z88V.==_2>+H,, M%H$FXT;.=R6;R'6K*[^$)HD\7+KI$.Z\6S1_/$]_B,1.WB5FRS#A&V^ M=`#?MQ8/8V!5YIOS9495@3?'T<&..Z+=Q[J]\66^3-!&-ZY@I-D=,QCF+J.; M@$55AB5UK\N/90(&)SLP.+TF$3M`P,R83F`FX:N*]6M2Q=#`-%T/@9 M_X73I#F>9KP]'*7.D8112"#Z@*T/M799]:A/#%>8[Y,*&2.C"GPS1(,6-`6$ MAD=C/E.Z+.ECVGC_8C3_E"9JZ@\8E/X;M%E9B80Q+LX`[FB;#YZ(\;FJ$9V,=;"+@YH7A>'MJU?@&E=C+:KWA&9SZC.PS`M(6^&?,;7&]1` M8[0QZ87`A>)+RA5(PS<3TO=\WWQL]#]G4MDZ2%I)8H#D:SYPD'#6)`S*D>K& MP7L7ZV360#<#K=UXS'DZA1NG--MVH0.]31R<)+L,<4\5DIZ'NU5?5[L'N"'E MSGI#L8-T)B$W4'%Y?;'B>N8GRNHHR1O(XR.43Y*%_B#A+=2%'KZMP!)V<7/A MJ'.HY4RP@XN+YXH^9'F7#/RS6UPA8>:-?J+RBSW2./L5)%RI5! M3I#,9'^*I#<7G#W=;)I6[P`CX!LKMME``DKU=#.4W5'?%@??,(F`"[J7Q,7+ MGO8.&%%1?$E<9A"0&JSAL@C`GG&:+$]C]@P5GRH\=`,*GGY)J("` MPW*J,."@AK*QRLI?RW0$4,R)<7]YPTD\E3E+*.>FHF'Y:N;5##'JO(5\L3-< M!_5Y;"KQ.*ZYXOEN$;^WE-.CT'D@DA,/3R^`PU1@ZQGCAGI M'65RX5$B<7.GVT7HS2J?,94-1-`(S%,0@SS7W[2.UT\F#,V44?A:U"Y@\HJ5`%IPG' M:6R2>C^ZJ$UJYJ2?QYB9XW4U/0F_!]`U?7K23CN7<+4#)2<]%^<6W\QJL-\: M:-IQ4Y.>1S)75!#?!8S;KTJ:.F`J0ZWQX`Z]&"AT1TV:`,KT5%2[$=1]LQZ# M$CI`#YO!F-&2Q#V!'BG0BN(!VR+L0[_Q,;;\[9F/6_=Q&8V4MKLW$ M:=3TP\/5XX.?9F%G#VX,(:?AFV7Z_#:B3-H`_V%_Z/FO_GJI[B>O61X&,3QF M7//?[)\3="TG&X$%>Q0H59$FDC8!XD10]\4Z+!10F8CU`#B+^'S,@B0/0AE_ M;QW[V?N5RRA0G5@NXT%)DY$WV\Q(A6C"1,T#-=V2!&T)QDD7-4;M,7V?;J-[ MFG/##5$,WQSXNKEZ@`]-+YC MN>OIW!-JI+::DVJ2O2*RY$0R(\+M`OX$E8EZYE!/(US6FT&FN+.@*A;%K07H MDCM#T:CY1#:FCQLK^NQ9>`:[W\JV8[`3+#[K+F-P^_8QC6C\(RM6EPRNYY+H MSXS&?1`7FZ\0P.,\NG]U?75_ M?W7Y\'A[\0?-(76@(2Z%J98Y9C;4E(D@[=7A4]_K5L)("YTC7(QL&23L;_+U M/8GN^&!5\T]C!S9?X5P,>[%0+D:#C8#^-1EY92\C%-+:><<.U(QPH'!%HS*F MMXL'NH1%_YYNT@PJ;S0`(>^WZH^FC%=3J>'A0KANH"Y%5I15B(AQE%8!\-N^# MG$;-&MFM[+42?Z)/'>N0L,NU`=DYU`U1,_]QS1[N%'\,,HB6R$DC&>8!5X@9 M=*!=+,8IPN-U`JE(S9+A9*JXR%[>')YJ=!J#8Y7$W):&HUSF(T6>;TK[8LDH M=?7G-Y\TQ$?(ZW&7QBSU\E]VQA6ZZP)_"D?LT+EN1CT^MJM7"3F[V.+\_$DR2H+ MB6\6,=#EG@3UPZJ><57(T@7-/)ID&= M+*A_.\Y0]SMKAU;Q\]G)/>4GD7+0/NH_H^UBGQ%ZQR"9HNC2L9HBI=9MLA?U M&-:ZW]U]*^T?_OFL\TJD1OF1>UZ[.A^WR>YX=`ZU$)20U[QG5R]\\>4SZJ+, MBW1-L_R\*#+V5!8T>DROTXRR97(!(9#9\#'EL#S1\V@6E6`/0RP13%4`H:_6 M/XLJ]Z?4C.8UI[>A$GJ*>WSN%]]F#P7@B`2&Z(YFXM9_T`>Q^MB!9S)&2!0J MJ.)4U0?9!)Z!QJ;II.O$C!^Y8R91'S#`GH8'2)KNSO$)NRG37?I`.-$MO*&1 M\A]C7@SKP)SI?9Y@4+6/T#C^0Y)^21[XKI$F-!+%>O;O@1#+QQ7RLM=&,%1TQ,H>.+'[D9'MLI_5G)S'$349.`H>!H$]6 MT-?1O@#AKDH14<%]9;@_)[S3-UQ6;F7/%$*'!,CWA]L/EU?W#U=__'SS^&== MS#":)BZBV%674/'&_<7<20ERD%H0$5M&FJ(0*8M7*%]G&FT%++NU$@36?`?, MZ,-MZ/#FEE_B,.?CQ$/ASAMXNU[XCE=6.5(Q+?SYE(&;;F&R&J*LC"C`054$ M#3_^#,5^F;]!696U2*CG&<&DJG29+DC8#)2R.N`>K4^FF"\'?9M[PECKIU6P M?IP=(B;)#K9R3Y=!!I.SN4#MUT\L@OBEI%:=X7 M+4QT3N!@$;"$1E=!!C4D\_,P+->E\$\NY0@,S#F+#QV`#6V%0ST^25(DV%'W MS>KL%=&%_HT;IODL[YHEK*`?H.8:/];Q`6%/,97YF(=KFQL^0ENF_/M84#7-VO_U>PIOD=9*X]A[4@>DP?!(-(N>%]EP(K?BY3=WLLG=VV9OQO9P= MRS-*4]TDSN.L%+\[P!3]&+RP=;G6;`W-5D[VA1ZV;C8%L8ZN)677&\)$H6TJ MJZ_Y"9"3)=G`SL#/`.5:)O,O5D%!6%Y748>+=EE@GE3I_A/"9/EUY31Y53E= MH\V^O630]%`YS#=I0B&5U>(F"=,U?0Q>U#/2>YK0!=/541_S-3:G^5@QD4\X MBAVY71#)D'".1+$DBJ=/MC1!17LIP*<-Y7'S=]X%6U%I_DN014T0$#Q&R6Q) M]6J13\[EB6!RD+R>^$ZC[I%:>7#%JU].8&,FD!('#JH701R*&V(";6\@)#7) M65BUG2'KYSP:&I$N>+R:?%E;#JMFF_R@KJ;?K$E7^.&UV$*L0\']5WBAVT`? M['(S6G_N(DG+*$%QKV2;C(9LEP#_?`W)HE5&?#_S.8[53T]VEPDC.2=VJYVW M>Y>*P+A/6GSI`.5E+1[&,F?*7^^V,]K-Q^]LS`S+<*-W?&@>6VU02]KO8Q M=+6U^V(BNK[NKR;#VIW/"&X!W7[+O85`%M"`([@Z?P^C60P?H0W%3BALEB@) M[&?RFN652OOXVC=#LM/%OFF-&:$9C:T22(DRE`.MVPYO4D.L\=B6M")=I0YU MBF]!"6Z!<1DG_5%FP)`&.D:O-YLY(Q+RXG;Q?9I&^4/:J6`[U,I!I$$O6]R5 M=%[`H_@2B)(\]:=8JZ'3W>`!C;(]N*(9WFRUGQSN*L;11EO1%U&+NG<,L'?YQVD MTW@$497Q8PGT_0'1'%9MG2NU`QK+]-LW'9C-$5[-*23MRC7>[""0LIJH5W`8 M+2;,.>P+SB8AQ*VF,5=3S(KM1XD\ZK6TH;9(RS.(@+-$29P\U]0K;)4[VW0@ MOPTFC%;UZ,F:!G!G"T>A@O]!882#)8521%]6+%R10"[G9).QD`(\C%::*%*R MB,NP*.'1/2HS@14#&GS!\FPF&!3;GAE6QNDJU5DGV;-=MK.!SQPF/-,+ADI( MLI\7;%,G]IXE[1F^9Z,SGTWJX7&3G^FU-)S_S,8R9PPU;,;7[IXE^,\Q%0Y9 M$C6!$X/GWH$C@3/R^`!'QQW%3/"&+,3GQRS7.NL$*1[$.J;O/!_3&/*XU72K M:)J^N,;AMJ@]QB@"QNX4<5)3)S5Y5SN)$_E-V\?$?LR]7QAUT=PD+.UIQL>, M8,.*(&9_DR?TDHOSD"X*?@2GWV=I/O2&9_P,_]QA*1@6D@^$R0]!%@%E7^QJ MK!(Z[R&CAF=64$J:LR)7N1>X`K39#P:;NP"K:`5!7?\)Y$&2)J>M#`,DY+L: M6[!01:)&4@3?3,ZDF1Z8B\483=^M^4F]1KP+(+;,O\I-.Q^1M%4#K'/,`.47 M'*:SV,",11UQ4(C2!'DM%&'C$@G[8NR'TW5SLS^D9#+!E>A@V8NM^3YM5B(&9\G.QDE_N4%G1$<(#U]_@GQ;&BHJ[4 M!8,6(MIYE,`A^J.-%>CIE&_S:;12.F^;TPP2\;@DF#1UJG%K-(UQSTM&(1Q/ M!E_LQJ[SK3<4RR%`%.5BRT0<*9+B/`RA4"MW&,1ZS[3!)';?X8IKC1$-8S(- M1F3'B52L?#*?43IIE<`:/UXSUM%623RK-,WO@YR%YTETR6(H)#RPG9N^PM>R MMA,+8WJ"I,`^1I(HX2M_#F^_=9&?E8>W2I::Z127'C-B\YG?]S2A61##*T($ M4`28#%`33E\[P/05VOPLQ<*%F`H6P@"#%A/?+,Y2&?L6-VJ09C[)-+?UNP!N MO%:TX"MT;`[GG$['S>!Z<.)AS/>`3:).YU!_)B> MO7MWNWA<40&@!$QRH[["=<"RCT'V$RV&4#98BDZ@D\CNN`!<*K@7!2$`Z,7% M^.<*)29PO:<1W.:W*OHMN#AD+>1Q"]^942^V4$\G^O$,).=$R7T@4R>3:?HJ M<;YND0(+\1[I^ZM1T-[='S7`K45#0FXK!?@8DGTS-2@M-0QHQ(EA< M9MXMXREX197S?YUF%WR+*V,XB3[0[)G;=A^`!D7.`8X3UQ$\OK._[.N)7/DB M<524P&(H@AC6@I!<2>(6^WEX;=AA0@^IE>/@17&:[>)(7' M"WYUAA^2,?8U75^L)R*'!KR1).&.4#.1>9\+TFV$\SL&F:*<#4&U MG5#8U;*-D]BT&(^5?'8/:;#W+;?(8"73C?128?AE=23N=H&P7)77M,]:=:U1 M9FLA!B[1D@K*B"5]2)HC&9`%=6;)CCIA,NGIG9G;N"T4TK1R:^N:LRXFWQHB MUDQ[9@)Q:#]Q4`_3+!#JPCT%)_0"QC7S+HS#IO/=^H^VPX$X4"95F>EK]D(C MB1.%9Z-NT>F^\^.(KW''Q?%B(@%GLAPYXPL3,%1ER.1K8DGA-JU9E=SPDNU! M3VU";EE/$785,@M7AEF5>5.%SSI2SNPGPO$*;AT`IYK\G%$C^>HZ3K\`W)O_ M>)-`&1G`JB;1-4N")(2?PX(]B]*RN\7%\""&)NL@ZL1-QU"`EG*SB45R#.Z; M1S4+N"T1005<+CXQE&!B2BPJT4A0R_:M+S/"M6J[L2XNC6:^.?2)%B`Z/VX_ MLXA&[[>0PO\FV?)=.%1\5I@^@L^UCD!VVK.@IJ?;V8_75/[ MAHX=YQG#S:/_+O,"5K`<=BS0$HLA-:G$I'](<_[[OK[4.1ZMC?\@K/!AZ`=4 M`.JJ:B>7]*&49)"P3V+7^&_A9[');)1PD`5EETC4XRWFD&KO1+4?W/#F#O$! MD:^Y/OGYEHL'-<^4J&F2\Q9Q&0G0:29B]HLB8T^EB`=[3&'KY1_Q88I%/F)Y M$S;;@]2"'K"-_*OK!B16"4 M,TC9I9)U<2O:!,GV7X)-FG^7DX@^%75&6Y'@[*6``YBH#!GQ#3(M",!XV&(K M'ZA;W+R",PVIN5W`0F>$,Q&@7&X9D3HM!,R"73=)V7Q2J%>.RA(!7#1PX@ M"C9"H;#7=B)""U"-71 ML_5L3=9<#'7;J@0AA9+$U5%[-G68SN6'5\OQ1W.&L3%5;H-XF); MU=DZ#\.LI-'[LOB<;`+65S3!]`7N6LM.'-0MEV11%TDC@61"GLJ"E(*-LXLO M=[TQWH/A>C7[796=9EI75V/LSE&`;1]*;:^!N_!7)]Y2':TI21XD'M4I5&R$ MP$>-#^V%;^EL`5]8Y)+!8V(2]5OA?ALGA40Z++'WGZ)L1E11=5TW9)*XX^J% M5+*+PP=Y%30KAJCHYT:UD-?PJ/[$_\%7)%F)MJT`\7>51ZSZO$SXO^*MB'E3 ML7+/-!-_VA4>H=D:V@<`"P,,2%5K@4\(E7R3!%!+B3!9B(&SD55QBU7`_Y00 MNM[$Z9;Z%H$],(Y]Y4D&3'V^0_KGG-XNKI1E#!W$]QJA#]O]3%'3LB+FBR7H MN[I_7-8I>,:\,.533G\N^4)P]2S\>K="&] M-C]EIPN^V;U1!9WL,W;&A(KCD#=1VLR"?:VP<1E#;!W<(`JZOHR]H;M[,0)Z M-<^XZNER$QJ70+N/\>OA*"%1BZ,^':7SI=)YQ_3KYB\CV>8T[726U`G&.6O. MA9#22$#?'E9I5CSR\\`E?=)4&A]H[R+3@EX4S(1ZGV:9K#X`C\?R`!-$ST'B MT@!S'!808Y&O M*D:O26628)%J(11L_+?&8=68#=(T>)@W[P+`XQ6J_NLS:-'[EMW7#OE&K6%] MF&"!7[M[4$;*;G/;"EF_N*L5R6?A+%VP`NXU19`2@*Y5H6:61BH.'4Q/9:$CW)R`$?G: M'(MSK#Z99IJ+OLT]%6SUTRJ@,,H*IT^0BQ_./WU_]7#SZ>'Q]N(//]Q^N+RZ M?[CZX^>;QS]K+LULOD)-DQ%BH2"^D@VY^42:C(CDY&I^..[,@?*6Q"QX8K$( M[Y3!ZFN:+6GFTT0:H/DXW3%H:LE_<._O=+BRS2!@88QVC&9!KJ/N:>>_3L&8A==Q&NRO-OUM'-A+#TL'1B*I$D'6/\/HZ7/7&@;U M?."%9)=\7D;4-LI2#R\GNH]<+"H60KE86F1A`A4U+3F16_]*F8]33,]"8QRN M9D\_\)_X[ZI?\?][XH=A_IO_"U!+`P04````"``1>'U"VJ)U^)8@``#D)@(` M%0`<`'1S;VDM,C`Q,C$R,S%?<')E+GAM;%54"0`#TN154=+D55%U>`L``00E M#@``!#D!``#M75MWVS:V?IY9:_Z#3^E3 M%TU"$DXI0@5(Q^JO/P!)2;P`("B")*#XQ1=IX[*_#Y>]-VX__NMYXU\\`4P@ M"MZ_NG[]YM4%"%SDP6#U_A4DZ/+[[[][=WG]ZE__\[>__OA?EY<7#P`-?0=' MY.+R`MY"'US,(QB"?1X7_WC][=OKZXN+RTN6PH?![S^P'X\.`1>TK("\_V8= MAML?KJZ^?/GR^OD1^Z\17EU]^^;-VZN]X#=_^^M?_A(+__!,8"[!E[=[\>NK M_[V_F[MKL'$N84!")W#3A`3^0.+/[Y#KA$RQZB(OA!+LO\N]V"7[Z/+ZV\NW MUZ^?B9>IZ!+ZN6+"-<#.%D0A=!W_M8LV-+?K;Z\I.)E$+-N:>)22I(A_!X$W"D(8[L;!$N%-S-XW%[%:/X2[+7C_#8&;K0_VGZTQ M6+[_)B0(7NXS9[S\73GOJZ,N6PP(%8L_OZ,?Y(H%SR$(/.#M"V8:M*,MJU!: M(Q^YV4J\\EE[1OA55OE79>5I4_Q-5L3@D838<<-]/K[S"/SWKY237=6M8K;Y M$>"^7J&G*P]`AM`U^X-5__KRS77:J_Y./_HM*7X&5I"5&H0/S@84*BP4RU8P MR^H`YROK8'>?)?TSIO25L/6G$E=;!]/\+MTU]+U]ZB5&FQH`[BN!)#I<1(36 M!FU90L=_=8&P!W`R0G>"_UZ1!`@P1U<&[<4(9 MX'DY2Y$O*,NGX&U7%`QHE3Q6K5O?67&@SW]O&>0%Y?A0_Z,KJ)-J#VEUL../ MZ83Z_#/8"8?UHIQET`N4Y5/P75<4#"/,%+V%A!HJOP('B\<(O?W^9HJ3R91R"QMYH2)^X8LD67\J,#`9^J?W3(UC1Y]Z-[Z MR"D:SWP9*WG(*G9+!T*\XICA$1CTM\<2OI$*DN<,W>=$O,+\B/*(HX:35B1HIR5E)14E;`06?^ M<5*MS\#W?P[0EV`.'(("X(T)B0`6!\A=7$UFC3SI4,>XQ83DJ:&JE!DPIG\6.Z=$L*>>*4>9]4.9J"<([,1$Y$5OPS^O5TO+AZ;!/ M,=@ZT!L];T%``.W*$V;"YK03L*&2TA:2E%!H:3U2DT6@8@E8PX<2\FP9\H)J ML014S+M+]!;6,JYBB$+'CR7[XBS3L!Y0X$JYX\L:P:&,/(&*QLTX4XRV`(>[ M*77!XZ`)-6"VS$\0ST#2),83(U?8N*GI%@8P!'?P"7AC"F6P@M1X2=N5D*&* M1,9S5*6TH9.0=/8Q'_6]$F;U58(Y_J0UBW#W<5$03E MY%8$=]3!,&Z6RE1=+?8C2=`S5W6;I(!!\^-#>Y][ZNR8PUUAH?.%S>&J1I"A MJ+")S."(CN$E[<3D".1MXT>DMG$#WDT$%F@&?+8\-G5P-4>2!%:1)%/<..,\ M;5$SM'-\Y6Y4DK:*'Z'*QMGDRL.;[>.:^H!FNPU_C*2HFW^<-.:PV\0"Y(%A MPSQ6&?&3IS&'/'%KK)C0J@."/1J'7`7K=#/K&!)H+.Y+U@VAM0,?YH8ZF@R> M]4,>_:Y))FTLKK5L,P5/LO>`5!U>N*H:-S!FCCM)M[84Q:RBHJRD<2;%P/-@ M4INI`[UQ,'2V,&15XSM=`FFK6!&J;-RH-0.A`P/@C1PS-.#%2J%2/0^<".P&AS9%BD*_5#22NCTA$05+QO&KE MT_`2JJW<7[*R_&@OAG(^[.TD4UP7&\O=JFF`,?792AY M\\+$IC!5:F1BQUX,A.$,)K>;#*)PC3#\$WA*S)426HWC:2( MKQY32F(G/0H7C1VNA.O4%S_H0R;+R9:FC=T,'6ZX(.?>/'!!??J*.C^!(*KT MK4MB?7MH]KC.(H1?/.,7S[@.`XX/2-J6/B+D2]D>,")EBM!3NC,A*6`%Z3J4S6E5/W9Q@E=Z04>5N MB.6MH%&B;DNWL#>P*X'O'VLJLBCS0CV34-F:.?%;76\!MY@4!&Y#EZ669&PD`!*@PI,HYXXGT/GTH-KL045W'C//BXJH4A(ZVM>)&N(I&= M?$E`,,Z''PKBD(%UU@;M M_Y6F8E[&"ENBH);X!4/K"-N?O-WO@?[@$.C2)GT#?;9X+MJA4)'*"E(K5=?Y M("(_1O09P-6:EC5XHB/#"E1M5E5*8C3V:DI7O8+8VV[5\OE8W;M6.248L7N5 M4R]-8=*?!@\?1_/QPWPQ&?[\T^3N9C2;C_[S:;SX5>"DJJ;J>_^D^?M6:^)O MYS;6I+4.T6:+`M:6!\^PR*=#9N!T5R`8:4DIR(;43D]3/N-.?+@:2^9R+50[26 M!2,DZHE-LYI3RS9^)YW6`X?]7FY[*H6_75M*(JVXOMN)$QI'@=?_#<7)J?N; M"%,=ITGKBE5_`%_BK\2CHU)B.\A6!*+];:S`36Q2_HY*KHC1"/.5TFB2\7', M$'J+\!S@)^B"27#O[*[_R3H#!]?*),;C7*UTZYM4!57X=Q2`M_5P/R:Q%?>, MTAKWM-;&O6Z#SZ2Q&7EYD^]Q'ZM@KHEOCHJ_F\25):-G@%U(A&NF]?,QFLX& M\!BW\^ZXML_.D@]1$,(@HJHWJ-FE0M]D-OHND!Z^G,K19U%VVJ'!./6 MC_8'?%RJ26[ON\HQ-&FZGEM!FYV(=T)*`J!Q$\41FUN$%6X=$,N;<-9#I?7R M>W9)>^.8RMZ3("`G)V(C'WD=C1LA!WZ<.?#V)Q&`Q_9M4*WB&LM/22DFMI$V M55R,.^G&KZ]LT;TL;"-A(KV-V]25B4U/?:>BAPF$K21(H+=QV[ZRVJF=A,]* MVD@-5V/CKM>AZK#+=\$-2'YGC-ET?VZ%55\C@Z_$O*\#J7&F2[GRX^")0H8D M-US+T_3,>OT&+NF8L M\\`QSG,1#TI39W?2<+U/=V9LEF`QSL?AUAE'P,L\RUV'S6+2\R.T!(X%_M%- M!)C[X+,XUM3!K-[I&*/,K22+,^-8!I9Q>T/55P$;;W7HFV<]"YYU`#NCQV,$ M:C//D.C8&B/+R.:M,5*`C'.[J)V1QHH&[A\1Q("J0QMVN&.!UI#=$T<_W6[$ MXWZ-#,P<#10:=/[@L3I@&@,G_"V^<15(?-_`9'D'7>K?,456&``.92HIK.9( M"1+CNJ"ZSHT'6+OI/06P\Y^0;V'@!*Z&"5F6DYF!QYD(CT^_5SAAC;.UIM$T`T_C^@D_AG9`0*V+WZI=7 M=N*/YB`,?5&,K6F./3.KJ\'O(W*-`6X]C+JW7YAI^PR\9!<%OW(A^\$)Z<_) M\D-$:.\G)]_V),FQTVN>)/70=$U9(5O)"TI"T;X6%-+Z'*^"$RTO+:I55;D%9^D`+_UUDM*HE[G$\J,59SH15Q.4AH1"+71=,)_-5-+I!8)&K?0^SKM8]9]=2KCQ70TZ$/^4GZN7(R-:K#GRUGVU+7+%='3Q4OY2KJZ6+:_@*03K."C#Y(5*/6>KI*RQPY> MR4HA6%F-PCGT[^2-P`5V`D*A8#$)/7-V(<\>)^]"3?3-XOF,*Z9S@7"?EY_E M7G-_0"%0[^KJZ7N>T>4Y%4X/D'/I]=FU3;^\7YMR;6RZHCRX'_9C]L5#9 M<%"5HK<3%WR%.CGTZK8K,98_D%$#FW,8'C+K@LU'A&QF/0T"V2IHVWVS MSU'2UWE2?2]PU['H)4EZ[,$2[+F+VS6[:=>=[2-`*RJ^AFYFU;YYM^-GVU,' MY%=&3U?DYBWIE'+YODQRL&)>Z0QLV5WQP:J&,:Z0LL?.JL1.SA)70>(<)MEY M]$C`'Q$M9O2D)[16RK&OU?%B/30MB!>RO98M@@ME>]NNF:]09;<6RO>YO%W% M0'Y7IE#C<^B^@^%P\NEA,7[X.)W$>NS(U6AG>W)1.>-V[PI.5+,6NCMMKT$QK35< M*4)AW(T2^VO2=VJL"<6M(4JLL(D7Z?#7O=6X4DYN#7?J@!AW;*BXM'D+`QB" M._@$O*3RBLN[Y736L*<`@8E712?!+-7A42!N$4DBA8V[\OD.TN[OP>QR0A4_ MTB36<"17W+CKFK-/DJ5+.D-$E.U$Q=36L*<,A\93DZ)%5)=JY>_&F_0@&V"W MU02>@[T*&D`I13P##@$`W$=(U+#4KOJ<26LQLDX1$BT23Z+6:E<8M);2(_# MHZ9VDUN]TLS`.0RK@WFTV3AX-UD>?`>$=Y\=C!UV67$4$F:F4@YT#:1U"^QK M<:QF-36MF*F6*EM(JYV'00-BUH'-=L?T&JC=R8-@S8S[="I/;0-50UU=;,]A M>,O.(K%^";CP3T`R>Y=F8$6'?RJ2A:6%L4]K;0RP*1OKH-_$/+U*BA:GA@(, M'6^UCK'FC:OMM)(Z@^XY#[0U($SG-UV#ZLDE]W9PX<3ZZCKE4+=XZ6&(DS/3 M=F7J26C*%A\:9]GK.8JF[!XO4VT*[#D,:T=CG$X?.:/YR8%^K+!VO[BBI-X= MXHKZZ?:$1<4IN<"5B0VUQ7*5#I+(U&![7!Z8P=4Z)''4JCW7^*1RC?"<5=O, MR2[S:92':S/-'\M.P-&XHP!';6[209+J<'A-(_-80\T6 M42^W:W<3(JHUN)=8'O7@])>BWJ"5TX`_TR@";QIIJ`;$%)_ MY>3Q2R'G3LMKR6 MYMF?PA>+1%0&G2MIXX*6J]NWY MY"^B'Z*`0,*\OX:F056VG=H%5971=1")7XKRPPN<)'W/0W:8`ZK(O]@"7XDM MH(>!&^H:$AB2)(#%W@Z-,%-=P(-0W!0VN!-4M;*MFP*#((@18GW/]X=36\=A,AM=:3CM*^;>Z>RO6"=]E[M+"E-YN*4B9=_3D1TF M04T>7BR#%\N@UI5A6Q@Z/OPSV;@1T0%^CI;A%ZK_1XR(B(_*9*:P([44JI4W MCJ_;"`>0/:`:/_C^S/XB,J+$\E8P)%%7X]5M@GM6UW"[92-LX$W8['P8B#E3 MGEC6:)@KU-1X`QL?XGODL\VPAR+W!F:Q-%D=4FHGX!3;=E;P;X^,#7>R\8?-/=E9XM] M`+Q9221I-"-2%2LN4VL]YE!Z/J^5V$/-4CJ-0=2LFYXFKUAHG1(E1:&<@;67QK8P"[',BIJ`N-3CR2O7]#--P,!TO!G?SQ63X\V(V>)@/ MAHOQY&'><"*KRK;3F:NJ,G:.^"\CH14CH<"4GXUN1[/9Z"9NE!+S12!H"JIB M0UZ@8$>[Y9+-89/E=+^O.3Z!*-P>)Q#OT<"2-Y#\?CB1LKUB/75P?,E<3

3^GLYE%<,(3\KX,82K6NN`YGE-]YHJC1Y9V3X/P(E;!+_M MYG3L>-#(E*T\8O#26(IWAP/%+X@=$4H.WG,@SGUM-IIY35I?JTK((V7R8N:\ M*<`QL;<(LR!(Y+/*S0%^HGX>#^A&V9E-3#.D*E;$VC]D=KRDAW>99-.#9FJY M=WO83*U.F@Z[DBH>/4@O ME6`[VV)/+O;%TW/R;'M5N#MY?;=QP=VN`#>NKKX["57J$4=9?IKE4)UWA>+_>X!E6^M?<-*8,]M6N-E_EUEW" M9*7@'FP>`>;T^-S7IH`I:QW'(R=9O5J'\3-@:P3`&SS1*6(%1L\`NY"`*88N M$(*KD,@FR%4P:-W_+E1B!C8.M4E9`#*(Q\7(\9D#H,I)17J+Z:E"IG7W?K!: M8;"B"N2?"A0R(Y>WB8D*S8T[K_42Z]8?)8S'1HXM6OS6%/PD896,*MKN_=P" M#!%[BQV'F=L_.P3^MVNKH*?5E;3:D\`?!9Y6Z#\R+P9X'-CWWQ@/^$&%#F+? MB?'$@^OXG?&`9=1H/9`]=`(7^#X7LN-WQD.64:,B*MUZS"\.3I4>7&GE..(I M174:USNE@IH\]!HE2V)W)V73M\%I1[2N"4-VQN>^;D=`^Q;E]/FJ!9I&V%W3 MAI1$KX1;.D7RIF`LG-PJU&T=[LQ&T<\P7`^"$0GAAMW(<.M`X9YPE53&0Z^D M>NN.;TI]+C:XWZS+05XJ;CSDRA+4*U1O?3=.>\=_#L(1;9WTQR-YZHQ9`*GZ4UG8<(:3](WC!*> M4%*G0<(3ZJ?5P,SD+SOD)A;N.ZYD1[RO&NV7J-Y7'=7+C>G\$T`Y`5-05)ND MND#P(6)[83(]C`-B6<9X'#EJF;`CCAF)(ANX5G+C":@'AL80G::AFH4.2RM- M`[9!?!4K_F%W%)DZ._;1X`LU1,I3EFRWIFC\[ZATHUM1YU1T%YT\[":J-AYY MPD;35J6H<5>O\]M7LE(VB,(UPNQ-D4_49\$9%X-=%IY?<)BQ]IC..\N,ZBD8 MM;JZ_M*-;C.=4]%ZG%9Q^DN/QYYN#>PS,)K>4P!I/>HKFPN2IB/?PEHOO6W\ M5,%1$3KN9L=1HH'=QJE^[NO9:LOGH6#*M915K?1YNRD/$8\A3K^P:Z&8B?3IU2"VRWH.,^H5Y\[/[O7P9L MN+E,.?].8V7*M=*TZ;BJ.$GL2SUMWPZC'3&NVES8&_DG>3.F?`B=YR!MXPG>&9.+&(RY7MOV' MLP(W8B&$&=HY?KA+CYP1ZB"R#EG=Z.NEMX&-.G"T[B07ZC%P71P![T,4?@JV M#N1Y%U4IC*>@4N76/=X'\*7X5#8["9BA'@)R[WA@Z)!U&DHA"Q0ZOF!W;:/\ MC">L(5RMN^*QP9<$2M%R'#S1XA'>+=`'M/-F%$^*Q9KV>PYQJBF-IT@9@O8O MF\^,G^FH.@[F:SKKL1LS[Z#SR(Z%0NY6?_6TQA-2`X;V3\?RZG*'@M6)C/"2 MVDD(%X36S]1RJQ(?9[Q'0;CV=_LQ=`IP_(DJ,=(\[&1(#DOKAW25ZR2Q#NKG M<3Y455D!'1Z]G0$7!2[MY4X2K5VLP12C)TB8:X;87BBT`0OG&31]4[)^01U' M2>M63U=74BU7&C>MG4G?,3M;`JBGLO,22?U*(JEZ&#BTI-3__P`"L(0A.T0` M@XA.%9,M'<-DYVWJY&`*9]R9]"1(C"-TM%P"EVV`/*@QBV_A4.:S1@96T%D' MD"["OVD=Z`#_!+`@Q%N0,1IG@5JMAVJIV[%QV&;@&T@9ICKP[RO@BAD/*%^Y MUB.Q"[#9(NS@G1Q3KICQF/*5,^[T;*XO'6W`X9IM+!P'-^D>5"HP(`2$A*U< M)4"S>YK9#J*JB?KTC(WF6">`&N.R>EK%D"V3!:'`-A$P7I'("C:K%.][;]<< MK@*XI`)!>#R>,EGN6]FAWDE;&P1>)KC9].4!#45W>WI20X4UG8UJ4!/9&4H= MV?;MB]L1(=')X$O,Y"5F4H.!U&,,5G>(D*&#\6Z),#O:(6)"DL`41J1SL$QA MX]@YW4`^&PNX@8E[4JRC)>(>@,BPY8K:24VLI#A84O/08<@6^#('#ELW?S\" MM*)":^AF;I"]B3`=+-B:17RXK:&96Z>(3LW9.A738[:JE"@Q3VLE[]N\L<,, M/861%W/SQ=RLPX#C`S(#3R"(@'A*+$J9@KUT-BRIUO[MO"",'VT(G*2,M'!> ME%LH:C2T]+BS<;\7'-B]B`9T$I>PVV>?1(P!\1S7S$MB5G3^*"9+%"A51]S_EVV&`U\'\QO;X2TXO?4__M;`"9LE,8 M\=$9;X'F\?*2ESYMR#,#JM.8@K5P_E)0NX/W2P,/QGV2/6%X#\*D9/;/H3+\ MZSO4$AI/@BH`%2::V$!(OV$_'AT"Z"?_#U!+`P04````"``1>'U"-5%K@@01 M``!6L@``$0`<`'1S;VDM,C`Q,C$R,S$N>'-D550)``/2Y%51TN15475X"P`! M!"4.```$.0$``.T=VW+;N/6YG>D_H'FHM@^R+#O9W:3V[BB^9+6U)552DN[3 M#DU"$B84H?#BV-OIOQ<'O(H$04`7TM/ABRV).#<UC1ZQZQ'J M7';Z)Z<=A!V36L197G:(1[L__OCF;;??^?FGO_SYXJ_=+AIA>F4;;N"A+B*W MQ,9H%A`?QSC0ZY.S\WX?H6X7(#QSA=<&8D0<[YV%R65GY?N;=[W>TX-KGWC8 M/%G2QQY[T#L[[?>[I_WN>;\3-5\0.VG^[=NW$W^%76.#`Y^8AGUBTC7`G/7/ M`,+P?9<\!#Z^I>[Z&B^,P/8O.X'S-3!LLB#88F+9>(T=?ZM!YK%ON$OLCXPU M]C:&B94I+J'G_[=NW/?XT;EIH MR?LL0GW>@\`^\;?1`H#PG6(MYL7RWYS]O<(^UP"XQ$P#J*,!0IQO#L>'UIPO#<:AO^&S@ MP5?V?;,ASH+R+W^Z@"YZ%_?3%"\0[]]W@.KRE4?6&QN_BGY;N7AQ^&V2*$K$@,A#GFI`MG&@ZY`#`3;+U$6,"Z:LC`0,["//-P`QYS)@.## MQ^EP"U^Y;0PY));[^\W7@&S`^%Y1QR.>[XT7\Q4SU;9-O[&%YAK[!K&]5XA8 MEZ\TVH<\1DRFP_2GT]/3LQ]/V?HT8Q.1&WWV.<&)8J1HO$",>Y3@1=]%F/]^ MT5*/;\A[QBM]$C&BIU$U-`"^HBPFFP M-9X1:;5AWUO M;CS88EWJ(Y'HMU_4+^!'C`#*4$!9$C"+.1$44D'?A73:*5M0/:QF;%Y8T(>) M660+YIBMZ9RGC(85VLHFZNN\Z?C.G!9MT'0@%U"K8*.=8!DNGV;UVV*&&4PHQ`U5VJ(O-6H M+&SDSMW$<+<7L,'2Q;R?!=&B(H1,E]\7@\30R>1HMQ9"E"!N]:CBL@QFP7IM MN,_C16+OJ/O\V7!9GS*3&OB098;R07EXH8M"EN)X6_-40&>+84!9=:S++=94Q,B(S5U"98GN9YOIY MS64-G=@4M@I4L'\CPV=_QXOW@4<<[`G-7Z&-+"3\H6#]0G!8LF($K4(*H6#P MX.&O`1/UYI']R7IQQH?_2=+]V_&AGK_"*G_MQT:Q>#0\UUBLKCLRO!6:59&$!/*&\H"!$&] M,$:&`-M6IJ:=Q]IU!NC#6YM^4R@SI$UE:V,A=I=4&;@".$I7AHN1%E9'T4I%W90_+)UL)AP@0SV(BE+^-R[\1+JB&1R MWFY,'WE;;A%M$VF:NS/6&^J$JV&R[^GF">)R_!X[3#)?MBM#%5@V#EX+=F/$ M>,$%"C$CAAI%N%&$O-7P+O:";W6SL"_M)HH:(*:`2\41O\'CG7#8G7_.3.0,UI1 M:2W34+BP1M#9CVQ=1"&J[!1J]:526V2V29CN42DJ5L#*C.2YO)H(&XN]DKQ0 M:QE+,X#I;MZL"W.-%]AUL96X,N%63S;_[HCQ0&P")Q**>=T#()/E`0OG!K)[ MD@:;T-J$9MVT7\?*GM9#F)P0605Q0]EL+^8OQ"F*5CUY]6CD MD0N+]PZPLLE9.$$TU$TRMVNX;H%6;HJ5860ID,+F"4G)MFA7H^-)K48EB9&K MJ_''T7PX^C`9WPVOACV>U6UEH5!AET06'\\_9#&V=E/IS/OVGD'Q,?=\&]F,^KYXLCVW MC;#-,TCTH>%\1,G?\C!T9URR25@\::OKS\3)Y3;P5!D.R44A8@VGCV63LE@` M3TO>_T]W2UST,I=AL2];-V5=D/6&NCX*[V>[HR9_(KD]#+YUXRO$NO!3MW_6 M/>^?/'E6!SG":]-*[A_KZ3*0OS(,R+\%\OWOE<@7KAS;@P/JC/9E(G.'F38C MFMCVO?B7;GKC6QD+TDOBE%G)7Q$('Q2(2Z\7 M#(E']P$BA]B\@G?9\=T`;L>#>_3>;?C17IA,EQTK"*^RZ"!^DU&HLB/V[K)`\>&!0ANEWD!%]BJF"")<=-5B/.1'L80"_?G!IL(E9 M(HP9-?$>POV`3#;\0'QUH=?488ZD^UP4>TJ?#1N*797\A:)FVA]('RN#6>0B M8Y\Q6:Y8'#IX9(O-$L]XL\QRK\AO-9KC#*O\0$GZ.U,!2U M5&H>W*H7Q^B.>7V\QXTA#W,JJ"K:/#25`\2ENW=9]?[?JN[0P="(J"JVHOJL MR!XF0@=YDXY[NL-P+Q=>A$97K##KZ2?>"G-5V&-P'P1#F'DRALUL+;/!GC]E MIE?5?@D`&XHZQ)L[=XU%JK`=)JC/Z:@J+IZM""36E\R#&$,%(^%6-4E1#M^( M/)/P_O]G2#K&K(RPJC2ET`U'CP<9B-I8ZQ5Z,KVYO9E.;Z[YS5R:LI4![VGA MY,G8H><%+%@*DZ>+B1L=H>"KK6H&28KB,/:98]?C?F*XW#D^@!0IJIH#KO'] M_7BTRU@20M8XD)C;SNS;[J-H"[[&(92AN]?X$>(YIJORB4)Z>@HE$=6L]C9( MO2.[XFX]S=&NC.V8&H##^>"H?J*P,\`F_O,]<<@Z6*OZ6.7P-;-M/.W'=@Q_ M$'NS"42S-J9Z32#T<2S5,2^`JX'+.7;70^;F-"A*!FOG<:%"($QQS, M4^)]N66N(41<>CTMA*R-5:W.%4+6G0E6.S'$'9!?QG?7-]/9S;\^#N>_:2>& M]R=TH(*&1=<&<431)RSY]WC]@%WE@#,+GK@LE-+B6@51 MO;),,33CJ[[#E1T8-IB(0J*TM1S.@E<<\7X#R?\=JA0VNB0N\G*-Y]HYJ0R`-\TZ-6,NP3[>&^X7[&\9U+W1-%H'UB^#UUC2WEV=GE`[1Q]P M\K5A%("+M[4).F12\*"YB:S@<<,4WIK>>C`O7K8H*:(I70+5Y"R0A8'A,(M^ M`IHJL:,`Z"48K`Q#B@9+"'%D4:J2$[`>;+V-(8X",Q&6\'D]*BBQ8WQ52YW8 MY&NC3!5\Z^.YSX<[B2)\8]\>9U(J\#43G$:[`F`<\YEXB_&<#G8X#*&"J!D1 MLRQ]9,Q2UR=_L&!"IT(I17%4#E<"C#GN)' M[`2I,UG^_$5FA;(S8V(\`\FAPR.4>^:YK&SXD6_38=KAOXA,BB)@HSZ!Y.U5 ME4E,%=!F'9[RFT\J/1\5T.83LE%PS-O,*>PFAH_1I4?CQ6QC$T"83<\J@KS( MH[\#\VM`/'ZIP7@1KFD01,?+M6H9H0I+0S;T&FN<6(1;AN&G&?9]6T?ZO:DT M?D@T>VA&R++V"5$%C,T,^.PAUN22YUN7KN^QNU2NFU5BJ;G(_LM@].%F-ASM M7T57P=2<1W1'/8]--QYXGO?AQAE%N4I@CQL&3K%I;(AOV-&RIWY$,0=V7#;# MR)XO9;?4G6'WD9FQL7-O//=_@+LW5+?[R]&!DUC8AQ"'5D\ MQ_45\V_5K7(0R]LWZ\^G+Q$8F"8-'-@*&U^D6.G1JP$W*F#F\JTJ<81-&V5> MX<5:54)IH:@G1RLY$;_C97BZQ^3W)U.O!Z3/KZ9CM`^!9C(N\7M5!)E*Y,4C'SRE:L7;A=A"G5X@%"W9RK'7 M7B2.FEG1*=AMU4M"B./Z6U4V@G_VG"-BAG.Y[14FWYOMO>M\,YAZ,3^&71BTK^")R^CVMTO ME+NK@]7&:J0!>#;A39;/D:WTHOK2;A5A39P-E>&VF6-!*2-GO0_\C\[&(*IK M8"669H0;X6_Y##QL^MU./-\;%H8;0N*RX9Q"IDWY+M$]:333,;R2&/KRE,6X M4%RD+&*C[^FS-<4>3K=]C34H'O!0E\ M1YWE`>45HGM!XHHV!&C.[!WP-E<(B7=[<%[4:R`YL*,ZMK_"S=X3,`K<4EIS M.H/U$1QSQ?-+(=L*>(XJ!PN7+5[:Y@=A[K$?4H4O"2/JT:,BLKJW`9K4,=F\ MCBY1A$U2<%68!\D>ZNZ2]DU*6=J(&ZL+AZP`RX_8U?#Z\G#-"#!AUMF`-/8U M6;#%&3OJJ2,Q:$/&;8[AS0+LD;X<8M":KT'?XR77NC>F'X04=,]%+WR/`_OX M/U!+`0(>`Q0````(`!%X?4(O9W('-&@``*$?!P`1`!@```````$```"D@0`` M``!T`Q0````(`!%X?4)P%98JUP,``+8>```5`!@```````$```"D@7]H``!T M`L``00E#@``!#D!``!0 M2P$"'@,4````"``1>'U"-3>.1E4;``!2T`$`%0`8```````!````I(&E;``` M='-O:2TR,#$R,3(S,5]D968N>&UL550%``/2Y%51=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`$7A]0D8B,,@H0@``E`0#`!4`&````````0```*2!28@` M`'1S;VDM,C`Q,C$R,S%?;&%B+GAM;%54!0`#TN15475X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`!%X?4+:HG7XEB```.0F`@`5`!@```````$```"D@<#* M``!T`L``00E#@``!#D! M``!02P$"'@,4````"``1>'U"-5%K@@01``!6L@``$0`8```````!````I(&E MZP``='-O:2TR,#$R,3(S,2YX`L``00E#@``!#D!``!0 52P4&``````8`!@`:`@``]/P````` ` end XML 21 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Reconciliation of the provision for income taxes (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Net loss before income taxes per financial statements $ (805,532) $ (970,699)
Income tax rate 45.00% 45.00%
Income tax recovery (362,489) (436,815)
Permanent differences 151,782 148,792
Temporary differences 11,172 0
Change in valuation allowance 199,534 436,815
Provision for income taxes $ 0 $ 0

XML 22 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Restricted Cash
12 Months Ended
Dec. 31, 2012
Restricted Cash  
Restricted Cash

Note 3 – Restricted Cash

 

Other non-current asset is a $10,000 certificate of deposit with an annual interest rate of 0.6%.  This certificate matures on June 17, 2013, and is used as collateral for a Company credit card, pursuant to a security agreement dated June 20, 2011.

EXCEL 23 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W-&8T,#9D,5]E86(R7S1E93!?.64P.%\P,SAB M864X8C'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E M;&%T961?4&%R='E?5')A;G-A8W1I;VYS/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O&5S/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D-O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E1H95]&;VQL;W=I;F=?5F%L=65S7U=E#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%?5]O9E]# M;VUP96YS871O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E1H95]F;VQL;W=I;F=?=&%B;&5?#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%?5]O9E]T:&5?#I.86UE/@T*("`@(#QX.E=O%]%>'!E;CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E1H95]&;VQL;W=I;F=?5&%B;&5?4')O=FED97-? M1SPO>#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E)E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5Q M=6EP;65N=%]#;VYS:7-T#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DQI8V5N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D-!4$E404Q?4U1/0TM?5%)!3E-!0U1)3TY37T1E=#PO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D]U='-T86YD:6YG7T-O;7!E;G-A M=&]R>5]787)R83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D-O;7!E;G-A=&]R>5]787)R86YT#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-T;V-K7T)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN9F]R;6%T:6]N7W)E9V%R9&EN9U]S=&]C:U]O<#$\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K M#I7;W)K#I3='EL97-H965T M($A2968],T0B5V]R:W-H965T3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&8T,#9D,5]E86(R7S1E93!?.64P M.%\P,SAB864X8C'0O:'1M;#L@8VAA M2!296=I M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!&:6QE3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^4VUA;&QE3QS<&%N M/CPO'0^665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^3F\\2!796QL M+6MN;W=N(%-E87-O;F5D($ES'0^3F\\'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!A;F0@97%U:7!M M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA'!E;G-E6%L=&EEF5D+"`S,#4L-#4X M+#,S,R!I7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAAF5D/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`P,"PP,#`\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E(')E8V%P M='5R92!A7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAAF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XR-3`L-3(S+#,S,SQS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S65E('-T;V-K(&]P=&EO;G,@=F5S=&5D(&1U65A'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'!E;G-E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$6UE;G1S/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`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`R,#$R(&YE M="!S86QE6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^5&AE M($-O;7!A;GD@:&%D(&)E96X@<&%Y:6YG(&$@,S`E(')O>6%L='D@;VX@86QL M(&YE="!S86QE6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB2!T;R!P87D@82!D969E29N8G-P.S$L(#(P M,3,L('-E;&P@=&\@=&AE(%53(&UA2!I;B!T:&4@ M;6%N=69A8W1U29N8G-P.S$L(#(P,3,L M(&]F('1H92!!35!302!02!H860@ M<')E=FEO=7-L>2!S;VQD('1O('1H92!54R!A;F0@;F]N+553(&UA29N8G-P.S$L(#(P,30L('1H M92!#;VUP86YY('=I;&P@;F\@;&]N9V5R(&)E(&%B;&4@=&\@=7-E('1H92!I M;BUL:6-E;G-E9"`F(S$T-SM.5$DF(S$T.#L@=')A9&5M87)K(&9O6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^26X@=&AE('1R86YS:71I;VX@9G)O;2!T:&4@17AC;'5S M:79E($%G2!S96QL:6YG+CPO<#X\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/'4^0V%S:#PO=3X\+W`^ M(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB2!C6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB3PO=3X\+W`^(#QP('-T>6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB2!C;VYS:7-T&-E6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYBF%T:6]N/"]U/CPO<#X@/'`@6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^1&5PF%T:6]N(&ES M(&-O;7!U=&5D('5S:6YG('1H92!S=')A:6=H="!L:6YE(&UE=&AO9"!O=F5R M('1H92!T97)M(&]F('1H92!A9W)E96UE;G0N/"]P/B`\<"!S='EL93TS1"=- M05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.SPO<#X@/'`@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB2!P2!S=6-H(&EN M=&%N9VEB;&4@87-S971S+B!(;W=E=F5R+"!T:&4@0V]M<&%N>2!E;G1E2`H:2DF;F)S<#MT:&4@97AC;'5S M:79E('=O7-T96TF(S$T.#L@86YD("AI:2DF;F)S<#MT M:&4@97AC;'5S:79E('=O2!A M;6]R=&EZ960@;W9EF%T:6]N+B`F;F)S<#M/;B!! M=6=U&-L=7-I=F4@=V]R;&1W:61E M(&QI8V5N2!S96UI+6-U6%L='DM M9G)E92!N;VYE>&-L=7-I=F4@=V]R;&1W:61E(&QI8V5N2`H M8G5T(&5X8VQU9&EN9R!T:&4@56YI=&5D(%-T871E6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^)FYB&5S+"(@/"]I/G=H:6-H(&-O9&EF M:65D(%-&05,@,3`Y+"`\:3XB06-C;W5N=&EN9R!F;W(@26YC;VUE(%1A>&5S M(B`\+VD^86YD($9)3B`T."`\:3XF(S$T-SM!8V-O=6YT:6YG(&9O2!I;B!);F-O;64@5&%X97,@)B,Q-3`[(&%N($EN=&5R<')E=&%T M:6]N(&]F($9!4T(@4W1A=&5M96YT($YO+B`Q,#DN)B,Q-#@[(#PO:3Y5;F1E M"!AF5D(&9O"!C;VYS97%U96YC97,@ M871T6EN9R!A;6]U;G1S(&]F(&5X M:7-T:6YG(&%S&%B;&4@:6YC;VUE(&EN M('1H92!Y96%R"!A"!R871EF5D(&EN(&EN8V]M92!I;B!T:&4@<&5R:6]D('1H92!E;F%C M=&UE;G0@;V-C=7)S+B!!('9A;'5A=&EO;B!A;&QO=V%N8V4@:7,@<')O=FED M960@9F]R(&-E2!T:&%N(&YO="!T:&%T('1H92!#;VUP86YY('=I;&P@;F]T M(')E86QI>F4@=&%X(&%S6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/'4^1V]I;F<@ M0V]N8V5R;CPO=3X\+W`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`Z,&EN)SX\+W1D/B`\=&0@ M=VED=&@],T0Q,C,@6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HQ-RXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]2 M1$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E. M1RU43U`Z,&EN)SX\+W1D/B`\=&0@=VED=&@],T0Q,3<@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ-2XW-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/D1E8V5M8F5R M)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@ M,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC96-E.60X.R!0041$24Y'+4)/5%1/ M33HP:6X[($)!0TM'4D]53D0M0T],3U(Z=')A;G-P87)E;G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED M.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!" M04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN M.R!724142#HQ-3EP=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z M(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-2XW-7!T M.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$ M15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B M;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C M93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HQ-RXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52 M+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU4 M3U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HY,BXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^4VAI<'!I;F<@86YD($]T:&5R($5Q M=6EP;65N=#PO<#X\+W1D/B`\=&0@=VED=&@],T0R,2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HQ-RXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]2 M1$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E. M1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=) M3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!"3U)$15(M M3$5&5#HC96-E.60X.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM'4D]53D0M M0T],3U(Z=')A;G-P87)E;G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HQ-3EP=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1% M4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-2XW-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^ M(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^06-C=6UU;&%T960@1&5P6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HQ-2XW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-3EP=#L@4$%$1$E.1RU2 M24=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E M8V4Y9#@[(%!!1$1)3D'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&-L=61I;F<@=&AE(%5N:71E9"!3=&%T97,@;6%R:V5T(&%S('1O('1H92!L M86)O2!O;B!N970@6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB2P@9F]R('1H92!P97)I;V0@9G)O;2!!=6=U2`H8G5T(&5X8VQU9&EN9R!T:&4@56YI=&5D(%-T871E6%L='DM9G)E92!N;VYE>&-L=7-I M=F4@=V]R;&1W:61E(&QI8V5N2`H8G5T(&5X8VQU9&EN9R!T M:&4@56YI=&5D(%-T871E2!T:&4@0V]M<&%N M>28C,30V.W,@96YT:7)E(&%C=&EV92!B=7-I;F5S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!46QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^/'4^4')E9F5R6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^5&AE($-O;7!A;GD@ M:7,@875T:&]R:7IE9"!T;R!I2!P2!I MF5D('1O(&ES60@86YD(%1I;6]T M:'D@1RX@)FYB29N8G-P.S$W+"`R,#$Q('1H92!#;VUP86YY(&ES2!H860@=')A;G-F97)R960@=&\@=&AI6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^3VX@2G5N929N8G-P.S,L(#(P,3$@=&AE($-O;7!A;GD@:7-S=65D(#(P M,"PP,#`@6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^)FYB2!I6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/'4^5V%R2`R,"P@,C`P.2P@=&AE($-O;7!A;GD@9W)A;G1E9"!C97)T86EN(&-O M;7!E;G-A=&]R>2!W87)R86YT2=S('1R861E9"!C;VUM;VX@6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^5&AE(')I2!W87)R86YT2!B;VYD M(')A=&4@:6X@969F96-T(&%T('1H92!T:6UE(&]F(&=R86YT(&9O6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^5&AE(&9O;&QO=VEN9R!V86QU97,@=V5R92!U28C,30V.W,@;W5T6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^17AP96-T960@=F]L871I;&ET>3PO<#X\+W1D/B`\=&0@=VED=&@] M,T0Q,S@@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-#6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^17AP96-T960@=&5R;2`H:6X@>65A6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^4FES:RUF M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT M.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,#,N-7!T.R!0041$24Y'+5)) M1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C M93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^,2XR.24@+2`Q+C@V)3PO<#X\+W1D M/CPO='(^/"]T86)L93X\+V1I=CX@/'`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`Z,&EN)SX\+W1D/B`\=&0@=VED=&@],T0X,B!S='EL M93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y M9#@[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G M(&%L:6=N/3-$8V5N=&5R/E=A6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!" M3U)$15(M3$5&5#HC96-E.60X.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM' M4D]53D0M0T],3U(Z=')A;G-P87)E;G0[(%!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/E1E6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,34N M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX] M,T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^17AE M6QE/3-$)U1%6%0M04Q)1TXZ8V5N M=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C0U,"PP M,#`\+W`^/"]T9#X@/'1D('=I9'1H/3-$-S8@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU-BXR-7!T M.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$ M15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B M;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ M,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/B0S-"PV-3,\+W`^/"]T9#X\ M+W1R/B`\='(^(#QT9"!W:61T:#TS1#$U-"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@ M0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+ M1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!7 M24142#HU-W!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT M.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HV,2XU<'0[(%!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N M/3-$8V5N=&5R/C`\+W`^/"]T9#X@/'1D('=I9'1H/3-$-S8@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HQ,34N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^0V%N8V5L960\+W`^/"]T9#X@/'1D('=I9'1H M/3-$-S`@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@ M0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+ M1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!7 M24142#HU-W!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`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`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`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP M('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^1&5C96UB97(F;F)S<#LS M,2P@,C`Q,3PO<#X\+W1D/B`\=&0@=VED=&@],T0W,"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1) M3D6QE M/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L M:6=N/3-$8V5N=&5R/C0U,"PP,#`\+W`^/"]T9#X@/'1D('=I9'1H/3-$-S8@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C M93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HU-BXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52 M+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU4 M3U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q) M1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R M/B0S-"PV-3,\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#$U-"!S M='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E M8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HU-W!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HV M,2XU<'0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ M,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C`\+W`^/"]T9#X@/'1D('=I M9'1H/3-$-S8@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,34N-7!T.R!0 M041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`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`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP M('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HU-BXR-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB&5R8VES86)L92!A=#PO<#X\+W1D/B`\=&0@=VED=&@] M,T0W,"!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU, M1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HU-W!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`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`Z,&EN M)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N M=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/B0Q+C`P M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#@R('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ8FQA8VL@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HV,2XU<'0[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^)FYB2!I M28C,30V.W,@8V]M;6]N('-T M;V-K('=I=&@@86X@97-T:6UA=&5D(&9A:7(@=F%L=64@;V8@)#8S-BPP,#`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`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/F%V97)A M9V4\+V(^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ M,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/FQI9F4@*'EE87)S*3PO M8CX\+W`^/"]T9#X@/'1D('=I9'1H/3-$-R!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ M,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/E=E:6=H=&5D/"]B/CPO M<#X@/'`@6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HU+C(U<'0[(%!!1$1)3D&5R8VES86)L93PO8CX\+W`^/"]T9#X@/'1D('=I9'1H/3-$-R!S M='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E M8V4Y9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q) M1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R M/CQB/E=E:6=H=&5D/"]B/CPO<#X@/'`@6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/G)E;6%I M;FEN9SPO8CX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!- M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/F-O;G1R86-T M=6%L/"]B/CPO<#X@/'`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`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`\=&0@=VED=&@] M,T0V-B!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU, M1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HU+C(U<'0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HU+C(U<'0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU+C(U<'0[(%!! M1$1)3D6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HT.2XU<'0[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU+C(U<'0[(%!!1$1) M3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HT.2XU<'0[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^)FYB&5R8VES960N M("9N8G-P.SPO<#X@/'`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`P<'0G(&%L:6=N/3-$ M8V5N=&5R/CQB/F%V97)A9V4\+V(^/"]P/B`\<"!S='EL93TS1"=415A4+4%, M24=..F-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB M/FQI9F4@*'EE87)S*3PO8CX\+W`^/"]T9#X@/'1D('=I9'1H/3-$-R!S='EL M93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y M9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB M/E=E:6=H=&5D/"]B/CPO<#X@/'`@6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!- M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/F5X97)C:7-E M/"]B/CPO<#X@/'`@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU+C(U<'0[(%!! M1$1)3D&5R8VES86)L93PO8CX\+W`^/"]T9#X@ M/'1D('=I9'1H/3-$-R!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[ M($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G M(&%L:6=N/3-$8V5N=&5R/CQB/E=E:6=H=&5D/"]B/CPO<#X@/'`@6QE/3-$)U1% M6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/CQB/G)E;6%I;FEN9SPO8CX\+W`^(#QP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N M=&5R/CQB/F-O;G1R86-T=6%L/"]B/CPO<#X@/'`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`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`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`Z,&EN)SX\+W1D/CPO='(^(#QT6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-S%P M=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]2 M1$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HR M-W!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX] M,T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^3W!T:6]N('-H87)E M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT M.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HR-W!T.R!0041$24Y'+5))1TA4 M.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED M.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HY-G!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ&5R8VES960\ M+W`^/"]T9#X@/'1D('=I9'1H/3-$,S8@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY-G!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^0V%N M8V5L960\+W`^/"]T9#X@/'1D('=I9'1H/3-$,S8@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY-G!T M.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$ M15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T M;W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT M.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HR-W!T.R!0041$24Y'+5))1TA4 M.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED M.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-S%P=#L@4$%$1$E.1RU2 M24=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E M8V4Y9#@[(%!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HR-W!T.R!0041$24Y' M+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z M(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T M>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^3W!T:6]N('-H87)E6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HR-W!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52 M+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU4 M3U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ M-S%P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@ M0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D&5R8VES960\+W`^/"]T9#X@/'1D M('=I9'1H/3-$,S8@6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HY-G!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^0V%N8V5L960\+W`^/"]T M9#X@/'1D('=I9'1H/3-$,S8@6QE/3-$ M)T)/4D1%4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC M96-E.60X.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z M=')A;G-P87)E;G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C M93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HQ-S%P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU4 M3U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&8T,#9D M,5]E86(R7S1E93!?.64P.%\P,SAB864X8C'0O:'1M;#L@8VAA2!42!I;B!T:&4@86UO=6YT(&]F M("0S+#`P,"PP,#`N("9N8G-P.U1H:7,@;&EC96YS92!I;F-E<'1I;VX@9F5E M('=AF%T:6]N+B`F;F)S M<#M4:&4@=6YA;6]R=&EZ960@8F%L86YC92!A="!$96-E;6)E2!I;F-U6%B;&4@=&\@82!R96QA=&5D('!A6%L='D@86-C2X@)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^3VX@075G M=7-T(#(T+"`R,#$R+"!T:&4@0V]M<&%N>2!E;G1E60L(&$@2P@87,@6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^)FYB2!A9W)E960@=6YD M97(@=&AE($U$4D$@=&\@;6%K92!D969E60L(&$@2P@8F5G:6YN:6YG($IU;'D@,2P@,C`Q,RX@)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&5S/"]B/CPO<#X@/'`@6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^5&AE($-O;7!A;GD@:&%S(&YE="!O<&5R871I;F<@;&]S M2!I&5S(&%T(&%N(&%P<')O>&EM871E(')A M=&4@;V8@-#4E+B!4:&4@&5S(&%T('1H92!5;FET960@4W1A=&5S($9E9&5R M86P@6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ,#,N-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N M/3-$8V5N=&5R/D1E8V5M8F5R)FYB6QE M/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L M:6=N/3-$8V5N=&5R/B0\+W`^/"]T9#X@/'1D('=I9'1H/3-$,34@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED M.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!" M04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN M.R!724142#HQ,#`N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/ M4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z M,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/D1E M8V5M8F5R)FYB6QE/3-$)U1%6%0M04Q) M1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R M/B0\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#,P,"!S='EL93TS M1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[ M(%!!1$1)3D&5S('!E6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT M.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,2XR-7!T.R!0041$24Y'+5)) M1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C M93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HQ,#,N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/C0U)3PO<#X\+W1D/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!! M1$1)3D6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^26YC;VUE('1A>"!R96-O=F5R>3PO M<#X\+W1D/B`\=&0@=VED=&@],T0Q,S@@6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,2XR-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP M('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,#,N-7!T.R!0041$24Y' M+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z M(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P M<'0G(&%L:6=N/3-$8V5N=&5R/C$U,2PW.#(\+W`^/"]T9#X@/'1D('=I9'1H M/3-$,34@6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ,#`N-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N M/3-$8V5N=&5R/C$T."PW.3(\+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T M:#TS1#,P,"!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1% M4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,#,N-7!T M.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$ M15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B M;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ M,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C$Q+#$W,CPO<#X\+W1D/B`\ M=&0@=VED=&@],T0Q-2!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[ M($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,2XR M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX] M,T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G M(&%L:6=N/3-$8V5N=&5R/C0S-BPX,34\+W`^/"]T9#X\+W1R/B`\='(^(#QT M9"!W:61T:#TS1#,P,"!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[ M($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@,BXR M-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HQ,#,N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/B8C,34P.SPO<#X\+W1D/B`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`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`Z,&EN)R!V M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C0S-BPX,34\ M+W`^/"]T9#X\+W1R/B`\='(^(#QT9"!W:61T:#TS1#(U,2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!! M1$1)3D"!A6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P M<'0G(&%L:6=N/3-$8V5N=&5R/B8C,34P.SPO<#X\+W1D/B`\=&0@=VED=&@] M,T0Q."!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU, M1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\W-&8T,#9D,5]E86(R7S1E93!?.64P.%\P,SAB864X8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@ M0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+ M1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!7 M24142#HQ-#4N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC M96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN M)SX\+W1D/B`\=&0@=VED=&@],T0R,"!S='EL93TS1"="3U)$15(M0D]45$]- M.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HW-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)SX\+W1D/CPO='(^(#QT6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-#4N M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX] M,T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^,C`Q,B9N M8G-P.SH\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C`@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HW M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX] M,T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HW-7!T.R!0041$24Y'+5)) M1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C M93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T M>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C M93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/ M4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z M,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-7!T.R!0041$24Y'+5)) M1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C M93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T M>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HQ-#4N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V M86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^ M)FYB6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-#4N-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP M('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^,C`Q,29N8G-P.SH\+W`^ M/"]T9#X@/'1D('=I9'1H/3-$,C`@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HW-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^ M(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X M.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ'1087)T7S'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^56YD97(@=&AE($U$4D$L('=H:6-H('=A6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^3VX@3F]V96UB M97(@-2P@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&%N($EN=F5S M=&]R(%)E;&%T:6]N'1087)T7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^1F]R('1H92!3=&%T96UE;G1S(&]F($-A2!0;VQI8WD\+W1D/@T*("`@ M("`@("`\=&0@8VQA3PO=3X\+W`^(#QP('-T M>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB2!C;VYS:7-T&-EF%T:6]N/"]U/CPO<#X@/'`@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^1&5PF%T:6]N(&ES(&-O;7!U M=&5D('5S:6YG('1H92!S=')A:6=H="!L:6YE(&UE=&AO9"!O=F5R('1H92!T M97)M(&]F('1H92!A9W)E96UE;G0N/"]P/CQS<&%N/CPO6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^)FYB2!P2!S=6-H(&EN=&%N9VEB;&4@87-S971S+B!(;W=E=F5R+"!T M:&4@0V]M<&%N>2!E;G1E2`H M:2DF;F)S<#MT:&4@97AC;'5S:79E('=O7-T96TF(S$T M.#L@86YD("AI:2DF;F)S<#MT:&4@97AC;'5S:79E('=O2!A;6]R=&EZ960@;W9EF%T:6]N+B`F;F)S<#M/;B!!=6=U&-L=7-I=F4@=V]R;&1W:61E(&QI8V5N2!S96UI+6-U6%L='DM9G)E92!N;VYE>&-L=7-I=F4@=V]R;&1W:61E M(&QI8V5N2`H8G5T(&5X8VQU9&EN9R!T:&4@56YI=&5D(%-T M871E2!A8V-O=6YT&5S('5N9&5R($%30R`W M-#`@/&D^(DEN8V]M92!487AE&5S("8C,34P.R!A;B!);G1E"!B87-E"!A"!R871E'!E8W1E9"!T;R!A<'!L>2!T;R!T87AA8FQE(&EN8V]M92!I;B!T:&4@>65A M'!E8W1E9"!T;R!B92!R96-O=F5R960@;W(@"!A2!W:6QL(&YO="!R96%L:7IE M('1A>"!A6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^5&AE($-O;7!A;GDG2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E28C,30V.W,@'!E;G-E6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB2!S:&]U;&0@9&5T M97)M:6YE(&EF(&$@<')E2=S('!AF5D(&%S(&5Q=6ET>2X@4V5E(&%L2!42!A8V-O=6YT6UE;G1S('1O($YO;BU% M;7!L;WEE97,L(CPO:3X@=VAI8V@@8V]D:69I960@4T9!4R`Q,C,L(&%N9"!T M:&4@16UE2!);G-T M6UE;G0@=')A;G-A8W1I;VYS('=I=&@@;F]N+65M<&QO M>65E2!M96%S=7)A8FQE.B`H82DF;F)S<#MT M:&4@9V]O9',@;W(@2!42!);7!L96UE;G1E9"!3=&%N9&%R9',\+W4^/"]P/B`\<"!S='EL93TS1"=- M05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.SPO<#X@/'`@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5D($%S6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY,BXR M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)SX\+W1D/B`\ M=&0@=VED=&@],T0R,R!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[ M($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HX-RXW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)SX\+W1D/CPO='(^(#QT6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-3EP=#L@ M4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52 M+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-RXR-7!T.R!0041$24Y'+5))1TA4 M.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED M.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N M=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/D1E8V5M M8F5R)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^3V9F:6-E($9U6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-2XW-7!T.R!0041$24Y' M+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z M(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP M('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HX M-RXW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X M.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ-3EP=#L@4$%$1$E.1RU224=(5#HP:6X[ M($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY,BXR M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX] M,T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^36]L9&EN9R!%<75I<&UE;G0@26YT97)E6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HQ-2XW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/ M4D1%4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC96-E M.60X.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z=')A M;G-P87)E;G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HX-RXW M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX] M,T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!"3U)$15(M M3$5&5#HC96-E.60X.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM'4D]53D0M M0T],3U(Z=')A;G-P87)E;G0[(%!!1$1)3D2!A;F0@17%U:7!M96YT+"!N970\ M+W`^/"]T9#X@/'1D('=I9'1H/3-$,C$@6QE/3-$)T)/4D1% M4BU"3U143TTZ8FQA8VL@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY,BXR-7!T.R!0 M041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T M;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@ M,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HX-RXW-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!W87)R86YT6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-#6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HQ,#,N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)SX\ M+W1D/CPO='(^(#QT6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-#6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HQ,#,N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]2 M1$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E. M1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^,3,V+C4S)2`M(#(Q-RXR-B4\+W`^/"]T9#X\+W1R/B`\ M='(^(#QT9"!W:61T:#TS1#$Y-R!S='EL93TS1"="3U)$15(M0D]45$]-.B-E M8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D'!E8W1E9"!D:79I9&5N9',\+W`^/"]T9#X@/'1D('=I M9'1H/3-$,3,X('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HQ,#,N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V M86QI9VX],T1T;W`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`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HV,2XU M<'0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@ M0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+ M1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!7 M24142#HU-BXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC M96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN M)SX\+W1D/CPO='(^(#QT6QE/3-$)T)/ M4D1%4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC96-E M.60X.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z=')A M;G-P87)E;G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R M/E-H87)E6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P M<'0G(&%L:6=N/3-$8V5N=&5R/E=E:6=H=&5D+2`\+W`^(#QP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N M/3-$8V5N=&5R/D%V97)A9V4@/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=. M.F-E;G1E&5R8VES92`\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!- M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/E!R:6-E/"]P/CPO M=&0^(#QT9"!W:61T:#TS1#@R('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA M8VL@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC96-E.60X.R!0041$24Y'+4)/ M5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z=')A;G-P87)E;G0[(%!!1$1) M3D6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/D%V M97)A9V4@/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!- M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/D%G9W)E9V%T92`\ M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN M(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/DEN=')I;G-I8R`\+W`^(#QP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G M(&%L:6=N/3-$8V5N=&5R/E9A;'5E/"]P/CPO=&0^/"]T&5R8VES86)L92!A="!$96-E;6)E6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HU,BXU<'0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN M(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C,N,C8\+W`^/"]T9#X@/'1D('=I M9'1H/3-$-S4@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT M.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,34N-7!T.R!0041$24Y'+5)) M1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C M93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T M>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^1W)A;G1E9#PO<#X\+W1D/B`\ M=&0@=VED=&@],T0W,"!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[ M($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ8V5N M=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C`\+W`^ M/"]T9#X@/'1D('=I9'1H/3-$-S8@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HQ,34N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`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`Z,&EN)R!V86QI9VX],T1B;W1T M;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N M=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C`\+W`^ M/"]T9#X@/'1D('=I9'1H/3-$-S8@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HQ,34N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`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`Z,&EN)R!V86QI9VX],T1B M;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^17AE6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HU-BXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU,BXU<'0[(%!!1$1) M3D6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C(N M,C8\+W`^/"]T9#X@/'1D('=I9'1H/3-$-S4@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ M,34N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X M.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^ M1W)A;G1E9#PO<#X\+W1D/B`\=&0@=VED=&@],T0W,"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1) M3D6QE M/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L M:6=N/3-$8V5N=&5R/C`\+W`^/"]T9#X@/'1D('=I9'1H/3-$-S8@6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ,34N-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`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`Z M,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU-W!T.R!0 M041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`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`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`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP M('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^1&5C96UB97(F;F)S<#LS M,2P@,C`Q,CPO<#X\+W1D/B`\=&0@=VED=&@],T0W,"!S='EL93TS1"="3U)$ M15(M0D]45$]-.F)L86-K(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B-E M8V4Y9#@[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN M(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/C(U,"PP,#`\+W`^/"]T9#X@/'1D M('=I9'1H/3-$-S8@6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@,BXR-7!T M(&1O=6)L93L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HU-BXR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]2 M1$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E. M1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B0@)FYB'10 M87)T7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5S(&EN9F]R;6%T:6]N(')E9V%R9&EN9R!S=&]C M:R!O<'1I;VYS(&]U='-T86YD:6YG("A486)L97,I/&)R/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`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`^ M/"]T9#X@/'1D('=I9'1H/3-$-R!S='EL93TS1"="3U)$15(M0D]45$]-.B-E M8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N M/3-$8V5N=&5R/CQB/D5X97)C:7-E('!R:6-E6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^)FYB6QE M/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L M:6=N/3-$8V5N=&5R/CQB/DYU;6)E6QE/3-$)U1% M6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/CQB/D]U='-T86YD:6YG/"]B/CPO<#X\+W1D/B`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`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/F%V97)A9V4\ M+V(^/"]P/B`\<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E&5R8VES93PO8CX\ M+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN M(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/G!R:6-E/"]B/CPO<#X\+W1D M/B`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`P<'0G(&%L:6=N/3-$ M8V5N=&5R/CQB/F%V97)A9V4\+V(^/"]P/B`\<"!S='EL93TS1"=415A4+4%, M24=..F-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB M/FQI9F4@*'EE87)S*3PO8CX\+W`^/"]T9#X@/'1D('=I9'1H/3-$-R!S='EL M93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y M9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB M/E=E:6=H=&5D/"]B/CPO<#X@/'`@6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!- M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/F5X97)C:7-E M/"]B/CPO<#X@/'`@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU-"XW-7!T.R!0 M041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T M;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^ M)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HU M-"XW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X M.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`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`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP M('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)#PO<#X\+W1D/B`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`\=&0@=VED=&@],T0V-B!S='EL M93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y M9#@[(%!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ'1087)T M7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`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`^/"]T9#X@/'1D('=I9'1H/3-$-R!S='EL93TS M1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/4D1%4BU,1494.B-E8V4Y9#@[ M(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ M,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/D5X97)C:7-E('!R:6-E M6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)' M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/DYU;6)E6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN M(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/D]U='-T86YD:6YG/"]B/CPO M<#X\+W1D/B`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`P<'0G(&%L:6=N/3-$ M8V5N=&5R/CQB/F%V97)A9V4\+V(^/"]P/B`\<"!S='EL93TS1"=415A4+4%, M24=..F-E;G1E&5R8VES93PO8CX\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB M/G!R:6-E/"]B/CPO<#X\+W1D/B`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`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/F%V97)A9V4\+V(^/"]P/B`\ M<"!S='EL93TS1"=415A4+4%,24=..F-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G M(&%L:6=N/3-$8V5N=&5R/CQB/FQI9F4@*'EE87)S*3PO8CX\+W`^/"]T9#X@ M/'1D('=I9'1H/3-$-R!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[ M($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G M(&%L:6=N/3-$8V5N=&5R/CQB/E=E:6=H=&5D/"]B/CPO<#X@/'`@6QE/3-$)U1% M6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/CQB/F5X97)C:7-E/"]B/CPO<#X@/'`@6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED M.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!" M04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN M.R!724142#HU-"XW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/ M4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z M,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HU-"XW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`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`Z,&EN)R!V M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^ M)#PO<#X\+W1D/B`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`\ M=&0@=VED=&@],T0V-B!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[ M($)/4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ'1087)T7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!O9B!T:&4@2!O9B!T:&4@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HR-W!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X M.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)SX\+W1D M/B`\=&0@=VED=&@],T0Q,C@@6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^079A:6QA8FQE(&%T($1E8V5M8F5R M)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@ M0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+ M1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!7 M24142#HY-G!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V M86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY-G!T.R!0041$24Y' M+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z M(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED M.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!" M04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN M.R!724142#HQ-S%P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z M(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$ M1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT M.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-S%P=#L@4$%$1$E.1RU224=( M5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y M9#@[(%!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY-G!T.R!0041$24Y' M+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z M(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T M>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^079A:6QA8FQE(&%T($1E8V5M8F5R)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HY-G!T.R!0 M041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^ M(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HY-G!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^061O<'1I;VX@;V8@,C`Q,B!0 M;&%N/"]P/CPO=&0^(#QT9"!W:61T:#TS1#,V('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HR-W!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=) M3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HQ-S%P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1% M4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HR-W!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]2 M1$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E. M1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ-S%P=#L@4$%$1$E.1RU224=(5#HP:6X[ M($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!! M1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HR-W!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB'1087)T7S'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA"!%>'!E;G-E($%S M($9O;&QO=W,\+W1D/@T*("`@("`@("`\=&0@8VQA28C,30V.W,@:6YC M;VUE('1A>"!E>'!E;G-E(&%S(')E<&]R=&5D(&ES(&%S(&9O;&QO=W,Z/"]P M/B`\<"!S='EL93TS1"=-05)'24XZ,&EN(#!I;B`P<'0G/B9N8G-P.SPO<#X@ M/&1I=B!A;&EG;CTS1&-E;G1E6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HR,C5P=#L@4$%$1$E.1RU2 M24=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E M8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,#,N-7!T M.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$ M15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)SX\+W1D/B`\=&0@ M=VED=&@],T0Q-2!S='EL93TS1"="3U)$15(M0D]45$]-.B-E8V4Y9#@[($)/ M4D1%4BU,1494.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z,&EN.R!724142#HQ,#`N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]2 M1$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E. M1RU43U`Z,&EN)SX\+W1D/CPO='(^(#QT6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HR,C5P=#L@4$%$ M1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5)) M1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HR,C5P=#L@4$%$1$E.1RU224=(5#HP M:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[ M(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,#`N M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX] M,T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)' M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/B@Y-S`L-CDY*3PO<#X\ M+W1D/CPO='(^(#QT6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HR,C5P=#L@4$%$1$E.1RU224=(5#HP M:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[ M(%!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ,2XR-7!T.R!0041$24Y'+5))1TA4.C!I M;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@ M4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HQ,#`N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V M86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/B@T,S8L.#$U M*3PO<#X\+W1D/CPO='(^(#QT6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HR,C5P=#L@4$%$1$E.1RU2 M24=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E M8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HR,C5P=#L@ M4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52 M+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D2!D:69F97)E;F-E6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ M,2XR-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X M.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI M9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C M93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HR,C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU4 M3U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N M/3-$8V5N=&5R/C$Y.2PU,S0\+W`^/"]T9#X@/'1D('=I9'1H/3-$,34@6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA M8VL@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC96-E.60X.R!0041$24Y'+4)/ M5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z=')A;G-P87)E;G0[(%!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HR M,C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@ M0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D&5S(#PO<#X\+W1D/B`\=&0@=VED=&@] M,T0Q,S@@6QE/3-$)T)/4D1% M4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E. M1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0 M041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,2XR-7!T.R!0041$24Y'+5))1TA4 M.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED M.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB'0^/"$M+65G>"TM M/CQP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^5&AE('-I9VYI9FEC M86YT(&-O;7!O;F5N=',@;V8@9&5F97)R960@:6YC;VUE('1A>"!A6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED M.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!" M04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN M.R!724142#HQ.#@N,C5P=#L@4$%$1$E.1RU224=(5#HP:6X[($)/4D1%4BU4 M3U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ,30N-S5P=#L@4$%$1$E.1RU224=(5#HP M:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[ M(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q% M1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/ M3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,#DN M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)SX\+W1D/CPO M='(^(#QT6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U14 M3TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y' M+4Q%1E0Z,&EN.R!724142#HQ.#@N,C5P=#L@4$%$1$E.1RU224=(5#HP:6X[ M($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5))1TA4.B-E8V4Y9#@[(%!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!- M05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/D1E8V5M8F5R)FYB M6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/B0\+W`^/"]T M9#X@/'1D('=I9'1H/3-$,3@@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^5F%L=6%T:6]N(&%L M;&]W86YC93PO<#X\+W1D/B`\=&0@=VED=&@],T0Q-3,@6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@ M0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+ M1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!7 M24142#HQ,RXU<'0[(%!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ8FQA8VL@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC96-E M.60X.R!0041$24Y'+4)/5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z=')A M;G-P87)E;G0[(%!!1$1)3D6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^3F5T(&1E9F5R6QE/3-$)T)/4D1%4BU" M3U143TTZ8FQA8VL@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(V5C93ED M.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS M<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ,30N-S5P=#L@4$%$ M1$E.1RU224=(5#HP:6X[($)/4D1%4BU43U`Z(V5C93ED.#L@0D]21$52+5)) M1TA4.B-E8V4Y9#@[(%!!1$1)3D7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/"$M+65G>"TM/CQP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^5&AE(&9O;&QO=VEN9R!T86)L92!P6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ M-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!" M3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX] M,T1B;W1T;VT^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED M.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!" M04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN M.R!724142#HQ-#4N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/ M4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z M,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^)FYB6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-7!T.R!0041$24Y'+5)) M1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C M93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T M>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-#4N-7!T M.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$ M15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T M;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^3F5T(&1O;65S M=&EC(')E=F5N=65S/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(P('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-7!T.R!0041$24Y'+5)) M1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C M93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C M93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN M.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z M,&EN.R!724142#HQ-#4N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52 M+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU4 M3U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^5&]T86P\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C`@6QE/3-$)T)/4D1%4BU"3U143TTZ8FQA8VL@,BXR-7!T(&1O=6)L93L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HW-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X M.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI M9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C M93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R M86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-7!T.R!0041$ M24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE' M2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^ M(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52 M+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$ M+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ M-#4N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X M.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI M9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^)FYB M6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^)FYB6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HQ-#4N-7!T.R!0041$24Y' M+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z M(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1T;W`^(#QP('-T M>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^3F5T(&1O;65S=&EC(')E=F5N M=65S/"]P/CPO=&0^(#QT9"!W:61T:#TS1#(P('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(V5C93ED.#L@0D]21$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU" M3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$ M24Y'+4Q%1E0Z,&EN.R!724142#HQ-7!T.R!0041$24Y'+5))1TA4.C!I;CL@ M0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$ M1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T;VT^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ(V5C93ED.#L@0D]2 M1$52+4Q%1E0Z(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!72414 M2#HQ-#4N-7!T.R!0041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E M.60X.R!"3U)$15(M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V M86QI9VX],T1T;W`^(#QP('-T>6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^ M5&]T86P\+W`^/"]T9#X@/'1D('=I9'1H/3-$,C`@6QE/3-$)T)/ M4D1%4BU"3U143TTZ8FQA8VL@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z M(V5C93ED.#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z,&EN.R!724142#HW-7!T.R!0 M041$24Y'+5))1TA4.C!I;CL@0D]21$52+51/4#HC96-E.60X.R!"3U)$15(M M4DE'2%0Z(V5C93ED.#L@4$%$1$E.1RU43U`Z,&EN)R!V86QI9VX],T1B;W1T M;VT^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\W-&8T,#9D,5]E86(R7S1E93!?.64P.%\P,SAB864X8C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%RF%T:6]N(&%N9"!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\W-&8T,#9D,5]E86(R7S1E93!?.64P.%\P,SAB864X8C'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!M M87AI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,3'!E8W1E9"!D:79I9&5N9',\+W1D/@T*("`@("`@("`\=&0@8VQA'!E8W1E9"!T97)M M("AI;B!Y96%R&EM M=6T\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&8T,#9D,5]E M86(R7S1E93!?.64P.%\P,SAB864X8C'0O:'1M;#L@8VAA&5R8VES86)L92!A="!$96,N(#,Q+"`R,#$P/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XT-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M&5R M8VES86)L92!A="!$96,N(#,Q+"`R,#$Q/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XT-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES86)L M92!A="!$96,N(#,Q+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XR-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E8W1E9"!V;VQA=&EL:71Y(&]F/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XQ.3$N,#`E/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5R8VES92!P&5R8VES86)L92D\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&5R8VES960N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&5R8VES960N/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&8T,#9D,5]E86(R M7S1E93!?.64P.%\P,SAB864X8C'0O M:'1M;#L@8VAA2!4'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B M;&4@=&\@82!R96QA=&5D('!A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S2!E>'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!T;R!";WED(%)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4@:6X@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4@:6X@;&]N9R!T97)M(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\6UE;G1S('!E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S6UE;G1S('1O=&%L:6YG/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA&5S('!E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA"!A"!A3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&8T,#9D,5]E86(R7S1E M93!?.64P.%\P,SAB864X8C'0O:'1M M;#L@8VAA3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-&8T,#9D,5]E86(R7S1E93!?.64P M.%\P,SAB864X8C'0O:'1M;#L@8VAA M60@86=R965D('1O('-U7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS M.F\],T0B=7)N.G-C:&5M87,M;6EC XML 24 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
License Agreements Consists Of the Following (Details) (USD $)
12 Months Ended
Dec. 31, 2012
Deferred License inception fee. $ 3,000,000
XML 25 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equipment Consists Of the Following (Details) (USD $)
Dec. 31, 2012
Dec. 31, 2011
Computer Hardware $ 10,747 $ 4,612
Office Furniture and Equipment 3,639 3,639
Shipping and Other Equipment 1,575 1,575
Molding Equipment Interests 90,000 0
Total Equipment 105,961 9,826
Accumulated Depreciation (13,508) (2,187)
Property and Equipment, net. $ 92,453 $ 7,639
XML 26 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
CAPITAL STOCK TRANSACTIONS (Details) (USD $)
Dec. 31, 2012
Jun. 17, 2011
Jun. 03, 2011
May 17, 2011
Mar. 31, 2011
PREFERRED STOCK:          
Issued shares of preferred stock 5,000,000        
Issued shares of preferred stock par value $ 0.001        
COMMON STOCK:          
Issued shares of common stock 699,999,999 10,000,000 200,000 525,000 250,523,333
Issued shares of common stock par value $ 0.001        
Voting rights 50.00%        
Issuedshares of common stock, valued per share for consulting services   $ 0.10 $ 0.06    
XML 27 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Outstanding Compensatory Warrants (Details)
Dec. 31, 2012
Expected volatility minimum 136.53%
Expected volatility maximum 217.26%
Expected dividends 0
Expected term (in years) minimum 2
Expected term (in years) maximum 4
Risk-free rate minimum 1.29%
Risk-free rate maximum 1.86%
XML 28 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Significant Accounting Policies
12 Months Ended
Dec. 31, 2012
Significant Accounting Policies  
Significant Accounting Policies

Note 2 – Significant Accounting Policies

 

Estimates

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash

 

For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of December 31, 2011 and 2012.  Other assets include restricted cash of $10,000 that is used to secure a company credit card.

 

Inventory

 

Inventory consists of finished goods, and is stated at the lower of cost or market. The Company records cost of sales using the moving average cost method. There was no excess or obsolete inventory reserve at December 31, 2011 and 2012.

 

Depreciation and Amortization

 

Depreciation is calculated using the straight line method over the estimated useful lives of the assets.  Amortization is computed using the straight line method over the term of the agreement.

 

Intangible Assets

 

Intangible assets consist primarily of intellectual properties such as regulatory product approvals and patents. The Company does not own any such intangible assets. However, the Company entered into the Exclusive Agreements on October 22, 2010 and April 1, 2011, which gave the Company respectively (i) the exclusive worldwide license to make and sell the “Total Splint System” and (ii) the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. The licensor under the Exclusive Agreements is Boyd Research, Inc., a related party to the Company. The 2011Agreement required a deferred $3,000,000 license inception fee, which the Company amortized over a ten year period using the straight line method of amortization.  On August 24, 2012, the Company entered into the New License Agreement, which terminated the Exclusive Agreements and continued, for the remainder of 2012, the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products.  The primary licensor under the New License Agreement is Boyd Research, Inc., a related party to the Company.  The New License Agreement eliminated the 2011 Agreement’s license inception fee.  Beginning on January 1, 2013, the New License Agreement grants the Company a royalty-free nonexclusive worldwide license to make and sell certain products under certain Boyd Parties patent rights and related technology (but excluding the United States market).   See Note 5 – License Agreements.

 

Income Taxes

 

The Company accounts for income taxes under ASC 740 "Income Taxes," which codified SFAS 109, "Accounting for Income Taxes" and FIN 48 “Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.

 

Going Concern

 

The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. Under the New License Agreement the Company’s rights to sell AMPSA Products to the US market (81% of total revenue) expire at the end of 2012.  The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Share Based Expenses

 

ASC 718 "Compensation - Stock Compensation," which codified SFAS 123, prescribes accounting and reporting standards for all stock-based payments awarded to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights.  Such payments may be classified as either equity or liabilities. The Company should determine if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a) the option to settle by issuing equity instruments lacks commercial substance or (b) the present obligation is implied because of an entity's past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity. See also Note 6 – Equity Transactions.

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50 "Equity-Based Payments to Non-Employees," which codified SFAS 123, and the Emerging Issues Task Force consensus in Issue No. 96-18, "Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services". Measurement of share-based payment transactions with non-employees shall be based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction should be determined at the earlier of the performance commitment date or performance completion date.  See also Note 6 – Equity Transactions.

 

Recently Implemented Standards

 

Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

XML 29 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Compensatory Warrants Outstanding Presented (Details)
Shares
Weighted-Average Exercise Price
Weighted-Average Remaining Contractual Term
Aggregate Intrinsic Value
Exercisable at Dec. 31, 2010 450,000 0.78 3.26 34,653
Granted 0      
Exercised 0      
Cancelled 200,000      
Exercisable at Dec. 31, 2011 450,000 0.78 2.26 34,653
Granted 0      
Exercised 0      
Cancelled 200,000      
Exercisable at Dec. 31, 2012 250,000 1.00 1.25  
XML 30 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Event Transactions (Details)
Jan. 17, 2013
Aug. 24, 2012
James P. Boyd agreed to surrender shares   223,991,933
Conditions were met shares were surrendered 223,991,933  
XML 31 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (USD $)
Dec. 31, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 35,011 $ 87,976
Accounts receivable, net 16,358 37,416
Inventories 30,790 48,198
Prepaid expenses and other current assets 14,535 490,037
Total current assets 96,694 663,627
Other non-current assets 12,410 12,350
Property and equipment, net 92,453 7,639
Licensing agreement, net 0 2,775,000
Total assets 201,557 3,458,616
Current liabilities:    
Accounts payable 230,786 56,777
Accrued expenses and other current liabilities 24,814 39,155
Due to related parties 30,013 3,004,090
Royalties payable, related party 48,842 56,211
Total current liabilities 334,454 3,156,233
Long term liabilities:    
Due to related parties. 60,000 0
Total long term liabilities 60,000 0
Shareholders' deficit    
Preferred stock, $.001 par value; 5,000,000 shares authorized 0 0
Common stock, $.001 par value; 699,999,999 shares authorized, 305,458,333 issued and outstanding at December 31, 2012 And 700,000,000 shares authorized, 305,458,333 issued and outstanding at December 31, 2011, respectively 305,458 305,458
Additional paid-in capital 1,285,533 975,281
Deficit accumulated (1,783,888) (978,356)
Total shareholders' deficit (192,897) 302,383
Total liabilities and shareholders' deficit $ 201,557 $ 3,458,616
XML 32 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities    
Net loss $ (805,532) $ (970,699)
Non-cash expenses:    
Amortization 175,000 225,000
Depreciation 11,320 2,187
Stock based compensation to officers 0 42,000
Stock based compensation to consultants 0 1,012,000
Compensation expense - employee stock option plan 310,252 261,838
Amortization recapture as result of settlement (400,000) 0
Changes in operating assets and liabilities:    
(Increase) decrease in inventory 17,408 (48,198)
(Increase) decrease in accounts receivable 21,058 (37,416)
(Increase) decrease in prepaid expenses and other current assets 475,502 (490,037)
(Increase) decrease in other assets (60) (12,350)
Increase (decrease) in accounts payable 174,010 56,777
Increase (decrease) in accrued expenses and other current liabilities (14,341) 39,155
Increase (decrease) in other related party liabilities (11,447) 19,998
Net cash provided by operating activities (46,830) 100,255
Cash flows from investing activities    
Acquisition of fixed assets (6,135) (9,826)
Acquisition of licensing agreement 0 (3,000,000)
Net cash used by investing activities (6,135) (3,009,826)
Cash flows from financing activities    
Borrowing and other advances 0 3,000,000
Repayments 0 (4,819)
Net cash provided by financing activities 0 2,995,181
Increase in cash (52,965) 85,611
Cash at beginning of period 87,976 2,366
Cash at end of period 35,011 87,976
Supplemental disclosure of non-cash investing and financing activities:    
Decrease in license agreement and due to related parties due to settlement 3,000,000 0
Increase in fixed assets and due to related parties 90,000 0
Increase in liabilities from merger 0 35,101
Increase in License agreement and due to related party 0 3,000,000
Supplemental Cash Flow Information:    
Cash paid for interest 36 311
Cash paid for income taxes $ 800 $ 0
XML 33 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock options available under Incentive Plan (Details) (Stock Incentive Plan)
Stock Incentive Plan
Available at Dec. 31, 2010 6,000,000
Option shares granted (7,950,000)
Amendment of 2009 Plan to increase the option shares pool 4,000,000
Exercised. 0
Canceled 0
Available at Dec. 31, 2011 2,050,000
Option shares granted 0
Exercised. 0
Canceled 1,050,000
Adoption of 2012 Plan 12,000,000
Available at Dec. 31, 2012 15,100,000
XML 34 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Information regarding stock options outstanding summary (Tables)
12 Months Ended
Dec. 31, 2012
Information regarding stock options outstanding summary  
Information regarding stock options outstanding summary

The following table summarizes information regarding stock options outstanding as of December 31, 2012:

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise prices

 

 

Number

Outstanding

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

Number

exercisable

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.08

 

 

 

6,900,000

 

 

 

8.67

 

 

$

0.08

 

 

 

6,900,000

 

 

 

8.67 

 

 

$

0.08

 

XML 35 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Related Party Transactions Agreement (Details) (USD $)
Dec. 31, 2012
Aug. 24, 2012
Dec. 31, 2011
License inception fee to a related party     $ 3,000,000
Inception fee unamortized value     2,775,000
Incurred royalty expenses payable to a related party 656,310   496,037
Royalty expenses accrued but unpaid 48,842   56,211
New License Agreement with related parties made cash payments totaling   50,000  
Transferredof inventory to Boyd Research, Inc.,   24,978  
Related Party Payable in short term liabilities   30,000  
Related Party Payable in long term liabilities   60,000  
Related Party Payable in equal monthly payments per month   5,000  
Related Party Payable in equal monthly payments totaling   $ 90,000  
XML 36 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Components Of Income Tax Expense Benefit (Tables)
12 Months Ended
Dec. 31, 2012
Components Of Income Tax Expense Benefit  
Components of Income Tax Expense As Follows

The Company is subject to United States federal and state income taxes at an approximate rate of 45%. The reconciliation of the provision for income taxes at the United States Federal statutory rate compared to the Company’s income tax expense as reported is as follows:

 

 

December 31, 2012

$

 

December 31, 2011

$

Net loss before income taxes per financial statements

(805,532)

 

(970,699)

Income tax rate

45%

 

45%

Income tax recovery

(362,489)

 

(436,815)

Permanent differences

151,782

 

148,792

Temporary differences

11,172

 

 

Change in valuation allowance

199,534

 

436,815

Provision for income taxes

 

Components of deferred income tax assets and liabilities

The significant components of deferred income tax assets and liabilities at December 31, 2012 and 2011 are as follows:

 

 

December 31, 2012

$

 

December 31, 2011

$

Net operating loss carry-forward

636,349

 

436,815

Valuation allowance

(636,349)

 

(436,815)

Net deferred income tax asset

 

XML 37 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 38 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Nature of Business
12 Months Ended
Dec. 31, 2012
Nature of Business  
Nature of Business

Note 1 – Nature of Business

 

Therapeutic Solutions International, Inc. (the “Company”) was organized August 6, 2007 under the name Friendly Auto Dealers, Inc. under the laws of the State of Nevada. In the first quarter of 2011 the Company changed its name from Friendly Auto Dealers, Inc. to Therapeutic Solutions International, Inc., and acquired Splint Decisions Inc., a California corporation organized September 21, 2010 (“Splint”).  Splint is treated as the “accounting acquirer” in the accompanying financial statements.  In the transaction, the Company issued 250,523,333 common shares to the shareholders of Splint; such shares represented, immediately following the transaction, 85% of the outstanding shares of the Company.  The transaction was accounted for as a “reverse merger” and a reverse recapitalization and the issuances of common stock were recorded as a reclassification between paid-in-capital and par value of Common Stock.  

 

On August 24, 2012, the Company entered into a Master Dispute Resolution Agreement (the “MDRA”) with James P. Boyd (“Boyd”), Boyd Research, Inc. and TMD Courses, Inc. (together with Boyd, the “Boyd Parties”) and Timothy G. Dixon (“Dixon”) and Gerry B. Berg, and on August 24, 2012, the Company also entered into a License Agreement with Boyd Research, Inc. and TMD Courses, Inc. (the “New License Agreement”), an Escrow Agreement with Boyd and with Chicago Title Company as escrow agent, and a Voting Agreement with Boyd.  

 

Before the New License Agreement, the Company and certain Boyd Parties were party to an Exclusive License Agreement dated April 1, 2011, as amended on November 1, 2011 (the “2011 Agreement”).  Also, the Company’s predecessor Splint Decisions Inc. and certain Boyd Parties were party to an Exclusive License Agreement dated October 22, 2010, as amended on July 8, 2011 (together with the 2011 Agreement, the “Exclusive Agreements”).  The Exclusive Agreements granted the Company an exclusive worldwide license to certain Boyd Parties patent rights and related technology.  Since April 1, 2011, essentially the Company’s entire active business has consisted of the manufacture and sale of Anterior Midpoint Stop Appliance intraoral devices (“AMPSA Products”) as authorized by the Exclusive Agreements and the New License Agreement.  

 

The New License Agreement terminated the Exclusive Agreements.  However, the New Licensee Agreement grants the Company new licenses under the applicable patent rights and related technology of the Boyd Parties to manufacture and sell the Company’s existing chairside AMPSA Products (but not any such products other than the Company’s currently existing ones) and laboratory-manufactured semi-custom AMPSA Products.  

 

The New License Agreement essentially carries forward the Exclusive Agreements’ terms as to sales to the US market for the remainder of 2012, but under the New License Agreement the Company’s rights to sell AMPSA Products to the US market will expire at the end of 2012.  Specifically, for AMPSA Products sales to the US market, the New License Agreement grants the Company an exclusive license (but no license for the US dental-laboratory field), carrying a 30% royalty on net sales; but such license expires on December 31, 2012.  

 

For sales of the existing AMPSA Products to non-US markets, the New License Agreement grants the Company an exclusive license, which converts to a non-exclusive license on January 1, 2013.  Under the New License Agreement, the Company must pay a 30% royalty on 2012 net sales of the existing AMPSA Products to most non-US markets, but, under the New License Agreement, after 2012 the Company’s net sales to non-US markets will be royalty-free.  

 

The Company had been paying a 30% royalty on all net sales of the existing AMPSA Products (to both the US and non-US markets) under the Exclusive Agreements.  

 

The 2011 Agreement required the Company to pay a deferred $3,000,000 license inception fee.  The New License Agreement eliminated this license inception fee.  

 

The Company expects that the Boyd Parties will manufacture and, beginning on January 1, 2013, sell to the US market the AMPSA Products which the Company had previously sold to the US market (and which, beginning on that date, the Company will no longer be allowed to sell to the US market) and new AMPSA Products as well. The Company also expects that the Boyd Parties may compete with the Company in the manufacture and sale to some or all non-US countries, from and after January 1, 2013, of the AMPSA Products which the Company had previously sold to the US and non-US markets, and the Boyd Parties could sell new AMPSA Products there as well.

 

Beginning January 1, 2014, the Company will no longer be able to use the in-licensed “NTI” trademark for its AMPSA Products.  

 

In the transition from the Exclusive Agreements to the New License Agreement, the Company is giving up its license rights to the “Total Splint System” intraoral devices (which the Company has not successfully commercialized) and to all potential chairside AMPSA Products which could have been commercialized using the Company’s Exclusive Agreements rights but which the Company is not currently selling.

XML 39 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets Parentheticals (USD $)
Dec. 31, 2012
Dec. 31, 2011
Preferred Stock, par value $ 0.001 $ 0.001
Preferred Stock, shares authorized 5,000,000 5,000,000
Common Stock, par value $ 0.001 $ 0.001
Common Stock, shares authorized 699,999,999 700,000,000
Common Stock, shares issued 305,458,333 305,458,333
Common Stock, shares outstanding 305,458,333 305,458,333
XML 40 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2012
ACCOUNTING POLICIES  
Estimates

Estimates

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash Policy

Cash

 

For the Statements of Cash Flows, all highly liquid investments with maturity of three months or less are considered to be cash equivalents. There were no cash equivalents as of December 31, 2011 and 2012.  Other assets include restricted cash of $10,000 that is used to secure a company credit card.

Inventory Policy

Inventory

 

Inventory consists of finished goods, and is stated at the lower of cost or market. The Company records cost of sales using the moving average cost method. There was no excess or obsolete inventory reserve at December 31, 2011 and 2012.

Depreciation and Amortization Policy

Depreciation and Amortization

 

Depreciation is calculated using the straight line method over the estimated useful lives of the assets.  Amortization is computed using the straight line method over the term of the agreement.

Intangible Assets Policy

Intangible Assets

 

Intangible assets consist primarily of intellectual properties such as regulatory product approvals and patents. The Company does not own any such intangible assets. However, the Company entered into the Exclusive Agreements on October 22, 2010 and April 1, 2011, which gave the Company respectively (i) the exclusive worldwide license to make and sell the “Total Splint System” and (ii) the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products. The licensor under the Exclusive Agreements is Boyd Research, Inc., a related party to the Company. The 2011Agreement required a deferred $3,000,000 license inception fee, which the Company amortized over a ten year period using the straight line method of amortization.  On August 24, 2012, the Company entered into the New License Agreement, which terminated the Exclusive Agreements and continued, for the remainder of 2012, the exclusive worldwide license to make and sell the chairside AMPSA Products, as well as (other than in the United States) dental-laboratory semi-custom AMPSA Products.  The primary licensor under the New License Agreement is Boyd Research, Inc., a related party to the Company.  The New License Agreement eliminated the 2011 Agreement’s license inception fee.  Beginning on January 1, 2013, the New License Agreement grants the Company a royalty-free nonexclusive worldwide license to make and sell certain products under certain Boyd Parties patent rights and related technology (but excluding the United States market).   See Note 5 – License Agreements.

Income Taxes Policy

Income Taxes

 

The Company accounts for income taxes under ASC 740 "Income Taxes," which codified SFAS 109, "Accounting for Income Taxes" and FIN 48 “Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109.” Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.

Going Concern

Going Concern

 

The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. Under the New License Agreement the Company’s rights to sell AMPSA Products to the US market (81% of total revenue) expire at the end of 2012.  The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Share Based Expenses Policy

Share Based Expenses

 

ASC 718 "Compensation - Stock Compensation," which codified SFAS 123, prescribes accounting and reporting standards for all stock-based payments awarded to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights.  Such payments may be classified as either equity or liabilities. The Company should determine if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a) the option to settle by issuing equity instruments lacks commercial substance or (b) the present obligation is implied because of an entity's past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity. See also Note 6 – Equity Transactions.

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50 "Equity-Based Payments to Non-Employees," which codified SFAS 123, and the Emerging Issues Task Force consensus in Issue No. 96-18, "Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services". Measurement of share-based payment transactions with non-employees shall be based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction should be determined at the earlier of the performance commitment date or performance completion date.  See also Note 6 – Equity Transactions.

Recently Implemented Standards

Recently Implemented Standards

 

Accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

XML 41 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information (USD $)
12 Months Ended
Dec. 31, 2012
Mar. 26, 2013
Jun. 28, 2012
Document and Entity Information      
Entity Registrant Name THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.    
Document Type 10-K    
Document Period End Date Dec. 31, 2012    
Amendment Flag false    
Entity Central Index Key 0001419051    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   83,466,400  
Entity Public Float     $ 2,019,250
Entity Filer Category Smaller Reporting Company    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Document Fiscal Year Focus 2012    
Document Fiscal Period Focus FY    
XML 42 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Cost And Accumulated Depreciation of Fixed Assets (Tables)
12 Months Ended
Dec. 31, 2012
Cost And Accumulated Depreciation of Fixed Assets  
Cost And Accumulated Depreciation of Fixed Assets

The cost and accumulated depreciation of fixed assets and equipment at December 31, 2012 and 2011 are summarized below:

 

 

 

December 31, 2012

 

December 31, 2011

Computer Hardware

$

10,747

$

4,612

Office Furniture and Equipment

 

3,639

 

3,639

Shipping and Other Equipment

 

1,575

 

1,575

Molding Equipment Interests

 

90,000

 

0

Total

 

105,961

 

9,826

Accumulated Depreciation

 

(13,508)

 

(2,187)

Property and Equipment, net

$

92,453

$

7,639

XML 43 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Net domestic revenues $ 1,837,480 $ 1,362,006
Net international revenues 354,155 325,926
Total revenues 2,191,635 1,687,932
Cost of goods sold 80,129 59,949
Gross profit 2,111,506 1,627,984
Operating expenses:    
Selling 106,527 145,573
General and administrative 138,490 104,292
Salaries, wages, and related costs 1,188,531 934,590
Royalties 656,310 496,037
Amortization and depreciation 186,320 227,187
Consulting fees 478,068 563,489
Legal and professional fees 583,023 198,558
Total operating expenses 3,337,270 2,669,727
Loss from operations (1,225,763) (1,041,743)
Other income (expense):    
Expense recapture as result of settlement 400,000 0
Net other income (expense) 20,268 71,404
Interest expense (36) (360)
Total other income (expense) 420,232 71,045
Net loss $ (805,532) $ (970,699)
Basic and diluted loss per common share $ 0.0009 $ (0.0139)
Weighted average shares outstanding 81,466,400 [1] 69,771,159 [1]
[1] Reflects cancellation of 223,991,933 shares in January 2013
XML 44 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Transactions
12 Months Ended
Dec. 31, 2012
Equity Transactions  
Equity Transactions

Note 6 – Equity Transactions

 

Preferred Stock

 

The Company is authorized to issue 5,000,000 shares of $.001 par value preferred stock. The Company has not issued any preferred stock.

 

Common Stock

 

The Company is authorized to issue 699,999,999 shares of $.001 par value common stock.  All shares have equal voting rights, are non-assessable, and have one vote per share.  Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they choose to do so, elect all of the directors of the Company.  

 

In the first quarter of 2011 the Company issued 250,523,333 shares of common stock to James P. Boyd and Timothy G.  Dixon, the shareholders of Splint Decisions Inc., to acquire Splint Decisions Inc.  

 

On May 17, 2011 the Company issued 525,000 shares of common stock, to Gerry Berg and Timothy G. Dixon to replace shares which they had transferred to third parties at the request of James P. Boyd in the first quarter of 2011.  

 

On June 3, 2011 the Company issued 200,000 shares of common stock, valued at $0.06 per share, to a broker-dealer for consulting services.  

 

On June 17, 2011 the Company issued 10,000,000 shares of common stock, valued at $0.10 per share, to an equity markets consulting firm for consulting services.  

 

Warrants

 

On February 20, 2009, the Company granted certain compensatory warrants.  The fair value of each compensatory warrant granted is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following table. Expected volatilities are based on volatilities from the Company's traded common stock since February 20, 2009.  

 

The risk-free rate for the periods within the contractual life of the compensatory warrants is based on the U.S. Treasury bond rate in effect at the time of grant for bonds with maturity dates at the estimated term of the warrants.  

 

The following values were used to calculate the intrinsic values of the Company’s outstanding compensatory warrants as of their issuance dates:  

 

Expected volatility

136.53% - 217.26%

Expected dividends

0

Expected term (in years)

2 - 4

Risk-free rate

1.29% - 1.86%

 

A summary of these compensatory warrants outstanding at December 31, 2011 and 2012 and changes during the periods then ended is presented below:

 

Warrants

Shares

Weighted-

Average

Exercise

Price

Weighted-

Average

Remaining

Contractual

Term

Aggregate

Intrinsic

Value

Exercisable at December 31, 2010

450,000

$0.78

3.26

$34,653

Granted

0

 

 

 

Exercised

0

 

 

 

Canceled

0

 

 

 

 

 

 

 

 

Exercisable at

 

 

 

 

December 31, 2011

450,000

$0.78

2.26

$34,653

Granted

0

 

 

 

Exercised

0

 

 

 

Cancelled

200,000

 

 

 

 

 

 

 

 

Exercisable at

 

 

 

 

December 31, 2012

250,000

$1.00

1.25

$    -

 

Stock Based Compensation

 

On August 31, 2011, the Company issued options to purchase an aggregate of 7,950,000 shares of the Company’s common stock with an estimated fair value of $636,000 to its officers and employees.  The options have an exercise price of $0.08 per share.  As of December 31, 2011, 1,614,000 options had vested and no options were exercised.  Subject to continuation of service, the remaining option shares were to vest monthly over the next 32 months; and the options expire ten years from the date of grant unless earlier terminated.  Compensation cost, using the graded vesting attribute method in accordance with ASC 718, is recognized over the requisite service period during which each tranche of shares is earned (36 months). The value of each tranche is amortized on a sum of the years digits basis; $261,838 was expensed in the year ended December 31, 2011. 

 

The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model with dividend yield of 0%; expected volatility of 191%; risk-free interest rate of 2.23%; contractual life of ten years; and an exercise price ($0.08) equal to 100% of the grant-date common stock fair market value.  Expected volatility is calculated based on the historic trade day stock market closing price of the preceding 406 trading days.

 

The expected term of options granted is estimated at half of the contractual term as noted in the individual option agreements and represents the period of time that options granted are expected to be outstanding.

 

The following table summarizes information regarding stock options outstanding as of December 31, 2011:

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise prices

 

 

Number

Outstanding

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

Number

exercisable

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.08

 

 

 

7,950,000

 

 

 

9.67

 

 

$

0.08

 

 

 

1,614,000

 

 

 

9.67 

 

 

$

0.08

 

 

As of December 31, 2012 (due in part to a December 31, 2012 acceleration of the vesting of all remaining outstanding but unvested options), 6,900,000 options had vested and no options were exercised.  

 

The following table summarizes information regarding stock options outstanding as of December 31, 2012:

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise prices

 

 

Number

Outstanding

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

Number

exercisable

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.08

 

 

 

6,900,000

 

 

 

8.67

 

 

$

0.08

 

 

 

6,900,000

 

 

 

8.67 

 

 

$

0.08

 

 

A summary of the stock options available under the 2009 Stock Incentive Plan and 2012 Stock Incentive Plan at December 31, 2011 and 2012 and changes during the periods then ended is presented below:

 

Available at December 31, 2010

 

6,000,000

Option shares granted

 

(7,950,000)

Amendment of 2009 Plan to increase the option shares pool

 

4,000,000

Exercised

 

-

Canceled

 

-

 

 

 

Available at December 31, 2011

 

2,050,000

Option shares granted

 

0

Adoption of 2012 Plan

 

12,000,000

Exercised

 

-

Canceled

 

1,050,000

 

 

 

Available at December 31, 2012

 

15,100,000

XML 45 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
License Agreements
12 Months Ended
Dec. 31, 2012
License Agreements  
License Agreements

Note 5 – License Agreements

 

The Exclusive Agreements granted the Company an exclusive worldwide license to make and sell under certain Boyd Parties patent rights and related technology (but excluding the United States market as to the laboratory-products semi-custom field of use), with a 30% royalty on net sales (subject to reduction under certain conditions) and, for the 2011 Agreement, a deferred $3,000,000 license inception fee.  

 

The New License Agreement granted the Company, for the period from August 24, 2012 to December 31, 2012, an exclusive worldwide license to make and sell under certain Boyd Parties patent rights and related technology (but excluding the United States market as to the laboratory-products semi-custom field of use), with a 30% royalty on net sales (subject to reduction under certain conditions).  Also, the New License Agreement granted the Company, for the period from January 1, 2013 forward, a royalty-free nonexclusive worldwide license to make and sell certain products under certain Boyd Parties patent rights and related technology (but excluding the United States market).  The New License Agreement eliminated the 2011 Agreement’s license inception fee.

 

From April 1, 2011 through December 31, 2012, essentially the Company’s entire active business consisted of the manufacture and sale of AMPSA Products as authorized by the Exclusive Agreements and the New License Agreement.  The Exclusive Agreements licensor and the New License Agreement licensors are wholly owned by James P. Boyd, a related party of the Company.

XML 46 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
A summary of the stock options available (Tables)
12 Months Ended
Dec. 31, 2012
A summary of the stock options available  
A summary of the stock options available

A summary of the stock options available under the 2009 Stock Incentive Plan and 2012 Stock Incentive Plan at December 31, 2011 and 2012 and changes during the periods then ended is presented below:

 

Available at December 31, 2010

 

6,000,000

Option shares granted

 

(7,950,000)

Amendment of 2009 Plan to increase the option shares pool

 

4,000,000

Exercised

 

-

Canceled

 

-

 

 

 

Available at December 31, 2011

 

2,050,000

Option shares granted

 

0

Adoption of 2012 Plan

 

12,000,000

Exercised

 

-

Canceled

 

1,050,000

 

 

 

Available at December 31, 2012

 

15,100,000

XML 47 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
The Following Values Were Used to Calculate The Intrinsic Values (Tables)
12 Months Ended
Dec. 31, 2012
The Following Values Were Used to Calculate The Intrinsic Values  
The Following Values Were Used to Calculate The Intrinsic Values

The following values were used to calculate the intrinsic values of the Company’s outstanding compensatory warrants as of their issuance dates:  

 

Expected volatility

136.53% - 217.26%

Expected dividends

0

Expected term (in years)

2 - 4

Risk-free rate

1.29% - 1.86%

XML 48 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Geographic Information
12 Months Ended
Dec. 31, 2012
Geographic Information  
Geographic Information

Note 9 – Geographic Information

 

The following table provides information related to our 2012 and 2011 revenues:

 

2012 :

 

 

 

 

 

Net domestic revenues

$

1,837,480

Net international revenues

 

354,926

Total

$

2,191,635

 

 

 

2011 :

 

 

 

 

 

Net domestic revenues

$

1,362,006

Net international revenues

 

325,926

Total

$

1,687,932

XML 49 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Related Party Transactions
12 Months Ended
Dec. 31, 2012
Related Party Transactions  
Related Party Transactions

Note 7 – Related Party Transactions

 

At December 31, 2011, under the 2011 Agreement, the Company was obligated for a license inception fee to a related party in the amount of $3,000,000.  This license inception fee was amortized over a ten-year period using the straight line method of amortization.  The unamortized balance at December 31, 2011 was $2,775,000.  Amortization ceased as of August 24, 2012 as a result of the New License Agreement’s elimination of the license inception fee.

 

Under the 2011 Agreement and the New License Agreement, the Company incurred royalty expenses payable to a related party of $656,310 for 2012 and $496,037 for 2011. The royalty accrued but unpaid at December 31, 2012 and 2011 was $48,842 and $56,211, respectively.   Such accrued but unpaid amounts were paid in full in 2012 and 2013.

 

On August 24, 2012, the Company entered into the MDRA and the New License Agreement with various related parties.  During 2012, the Company made cash payments totaling $50,000 to James P. Boyd, a related party, as required by the MDRA. The Company also transferred $24,978 of inventory to Boyd Research, Inc., an affiliated person of James P. Boyd, a related party, under the MDRA.

 

In addition, the Company agreed under the MDRA to make deferred payments of $5,000 per month for 18 months (totaling $90,000; $30,000 is in short-term liabilities and $60,000 is in long-term liabilities) to an affiliated person of James P. Boyd, a related party, beginning July 1, 2013.  This obligation does not bear interest and is unsecured.  

XML 50 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
12 Months Ended
Dec. 31, 2012
Income Taxes  
Income Tax Disclosure [Text Block]

Note 8 – Income Taxes

 

The Company has net operating losses carried forward of $636,349 (2011 – $640,051) available to offset taxable income in future years which expire beginning in fiscal 2031.

 

The Company is subject to United States federal and state income taxes at an approximate rate of 45%. The reconciliation of the provision for income taxes at the United States Federal statutory rate compared to the Company’s income tax expense as reported is as follows:

 

 

December 31, 2012

$

 

December 31, 2011

$

Net loss before income taxes per financial statements

(805,532)

 

(970,699)

Income tax rate

45%

 

45%

Income tax recovery

(362,489)

 

(436,815)

Permanent differences

151,782

 

148,792

Temporary differences

11,172

 

 

Change in valuation allowance

199,534

 

436,815

Provision for income taxes

 

 

The significant components of deferred income tax assets and liabilities at December 31, 2012 and 2011 are as follows:

 

 

December 31, 2012

$

 

December 31, 2011

$

Net operating loss carry-forward

636,349

 

436,815

Valuation allowance

(636,349)

 

(436,815)

Net deferred income tax asset

 

XML 51 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Events
12 Months Ended
Dec. 31, 2012
Subsequent Events  
Subsequent Events

Note 10 – Subsequent Events  

 

Under the MDRA, which was entered into on August 24, 2012, James P. Boyd agreed to surrender 223,991,933 shares of Company common stock when certain conditions were met.  On January 17, 2013 all the conditions were met, and so the 223,991,933 shares were surrendered to the Company and on January 18, 2013 the Company cancelled such shares.

 

On November 5, 2012, the Company entered into an Investor Relations Consulting Agreement with Constellation Asset Advisors, Inc. (“CAA”) and issued a Warrant to CAA.  In 2013 the Company and CAA agreed to cancel the Investor Relations Consulting Agreement and the Warrant.  Such cancellation is treated as if it occurred on November 5, 2012.

XML 52 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Information regarding stock options outstanding (Details) (USD $)
Dec. 31, 2012
Dec. 31, 2011
Exercise Prices $ 0.08 $ 0.08
Number Outstanding 6,900,000 7,950,000
Weighted average remaining contractual life (years) 8.67 9.67
Weighted average exercise price (options outstanding) $ 0.08 $ 0.08
Number exercisable 6,900,000 1,614,000
Weighted average remaining contractual life (in years) 8.67 9.67
Weighted average exercise price (number exercisable) $ 0.08 $ 0.08
XML 53 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
The following table summarizes information regarding stock options outstanding (Tables)
12 Months Ended
Dec. 31, 2012
The following table summarizes information regarding stock options outstanding  
The following table summarizes information regarding stock options outstanding

The following table summarizes information regarding stock options outstanding as of December 31, 2011:

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise prices

 

 

Number

Outstanding

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

Number

exercisable

 

 

Weighted

average

remaining

contractual

life (years)

 

 

Weighted

average

exercise

price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.08

 

 

 

7,950,000

 

 

 

9.67

 

 

$

0.08

 

 

 

1,614,000

 

 

 

9.67 

 

 

$

0.08

 

XML 54 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Organization and Presentation (Details) (USD $)
Dec. 31, 2012
Dec. 31, 2011
Sep. 21, 2010
Issued common shares to the shareholders of Splint     250,523,333
Deferred license inception fee $ 3,000,000 $ 3,000,000  
XML 55 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Stockholders' Equity (USD $)
Common Stock Shares
Common Stock Amount
USD ($)
Additional Paid in Capital
USD ($)
Earnings (Deficit) Accumulated
USD ($)
Total
USD ($)
Balance at Dec. 31, 2010 28,710,000 28,710 (28,708) (7,657) (7,655)
Stock issued for service on February 11, 2011 15,500,000 15,500 1,224,500 0 1,240,000
Recapitalization 250,523,333 250,523 (1,525,624) 0 (1,275,101)
Stock issued for service on May 17, 2011 525,000 525 41,475 0 42,000
Stock issued for service on June 3, 2011 200,000 200 11,800 0 12,000
Stock issued for service on June 17, 2011 10,000,000 10,000 990,000 0 1,000,000
Employee stock options vested during the year   $ 0 $ 261,838 $ 0 $ 261,838
Net Loss, December 31, 2011   0 0 (970,699) (970,699)
Balance at Dec. 31, 2011 305,458,333 305,458 975,281 (978,356) 302,383
Employee stock options vested during the year   0 310,252 0 310,252
Net Loss, December 31, 2012   $ 0 $ 0 $ (805,532) $ (805,532)
Balance at Dec. 31, 2012 305,458,333 305,458 1,285,533 (1,783,888) (192,897)
XML 56 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equipment
12 Months Ended
Dec. 31, 2012
Equipment  
Equipment

Note 4 – Equipment

 

The cost and accumulated depreciation of fixed assets and equipment at December 31, 2012 and 2011 are summarized below:

 

 

 

December 31, 2012

 

December 31, 2011

Computer Hardware

$

10,747

$

4,612

Office Furniture and Equipment

 

3,639

 

3,639

Shipping and Other Equipment

 

1,575

 

1,575

Molding Equipment Interests

 

90,000

 

0

Total

 

105,961

 

9,826

Accumulated Depreciation

 

(13,508)

 

(2,187)

Property and Equipment, net

$

92,453

$

7,639

 

Depreciation is calculated using the straight line method over the estimated useful lives of the assets.

XML 57 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Restricted Cash Consists Of (Details) (USD $)
Dec. 31, 2012
Other non-current asset certificate of deposit $ 10,000
Annual interest rate 60.00%
XML 58 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 56 205 1 true 10 0 false 4 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://www.therapeutical.com/20121231/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 000020 - Statement - Consolidated Balance Sheets Sheet http://www.therapeutical.com/20121231/role/idr_ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 000030 - Statement - Consolidated Balance Sheets Parentheticals Sheet http://www.therapeutical.com/20121231/role/idr_ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets Parentheticals false false R4.htm 000040 - Statement - Consolidated Statements of Operations Sheet http://www.therapeutical.com/20121231/role/idr_ConsolidatedStatementsOfOperations Consolidated Statements of Operations false false R5.htm 000050 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.therapeutical.com/20121231/role/idr_ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity false false R6.htm 000060 - Statement - Consolidated Statements of Cash Flows Sheet http://www.therapeutical.com/20121231/role/idr_ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R7.htm 000070 - Disclosure - Nature of Business Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureNatureOfBusiness Nature of Business false false R8.htm 000080 - Disclosure - Significant Accounting Policies Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureSignificantAccountingPolicies Significant Accounting Policies false false R9.htm 000090 - Disclosure - Restricted Cash Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureRestrictedCash Restricted Cash false false R10.htm 000100 - Disclosure - Equipment Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureEquipment Equipment false false R11.htm 000110 - Disclosure - License Agreements Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureLicenseAgreements License Agreements false false R12.htm 000120 - Disclosure - Equity Transactions Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureEquityTransactions Equity Transactions false false R13.htm 000130 - Disclosure - Related Party Transactions Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureRelatedPartyTransactions Related Party Transactions false false R14.htm 000140 - Disclosure - Income Taxes Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureIncomeTaxes Income Taxes false false R15.htm 000150 - Disclosure - Geographic Information Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureGeographicInformation Geographic Information false false R16.htm 000160 - Disclosure - Subsequent Events Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureSubsequentEvents Subsequent Events false false R17.htm 000170 - Disclosure - ACCOUNTING POLICIES (Policies) Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureACCOUNTINGPOLICIESPolicies ACCOUNTING POLICIES (Policies) false false R18.htm 000180 - Disclosure - Cost And Accumulated Depreciation of Fixed Assets (Tables) Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureCostAndAccumulatedDepreciationOfFixedAssetsTables Cost And Accumulated Depreciation of Fixed Assets (Tables) false false R19.htm 000190 - Disclosure - The Following Values Were Used to Calculate The Intrinsic Values (Tables) Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureTheFollowingValuesWereUsedToCalculateTheIntrinsicValuesTables The Following Values Were Used to Calculate The Intrinsic Values (Tables) false false R20.htm 000200 - Disclosure - A summary of Compensatory Warrants Outstanding (Tables) Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureASummaryOfCompensatoryWarrantsOutstandingTables A summary of Compensatory Warrants Outstanding (Tables) false false R21.htm 000210 - Disclosure - The following table summarizes information regarding stock options outstanding (Tables) Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureTheFollowingTableSummarizesInformationRegardingStockOptionsOutstandingTables The following table summarizes information regarding stock options outstanding (Tables) false false R22.htm 000220 - Disclosure - Information regarding stock options outstanding summary (Tables) Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureInformationRegardingStockOptionsOutstandingSummaryTables Information regarding stock options outstanding summary (Tables) false false R23.htm 000230 - Disclosure - A summary of the stock options available (Tables) Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureASummaryOfTheStockOptionsAvailableTables A summary of the stock options available (Tables) false false R24.htm 000240 - Disclosure - Components Of Income Tax Expense Benefit (Tables) Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureComponentsOfIncomeTaxExpenseBenefitTables Components Of Income Tax Expense Benefit (Tables) false false R25.htm 000250 - Disclosure - The Following Table Provides Geographic Information (Tables) Sheet http://www.therapeutical.com/20121231/role/idr_DisclosureTheFollowingTableProvidesGeographicInformationTables The Following Table Provides Geographic Information (Tables) false false R26.htm 000260 - Statement - Organization and Presentation (Details) Sheet http://www.therapeutical.com/20121231/role/idr_OrganizationAndPresentationDetails Organization and Presentation (Details) false false R27.htm 000270 - Statement - Restricted Cash Consists Of (Details) Sheet http://www.therapeutical.com/20121231/role/idr_RestrictedCashConsistsOfDetails Restricted Cash Consists Of (Details) false false R28.htm 000280 - Statement - Equipment Consists Of the Following (Details) Sheet http://www.therapeutical.com/20121231/role/idr_EquipmentConsistsOfTheFollowingDetails Equipment Consists Of the Following (Details) false false R29.htm 000290 - Statement - License Agreements Consists Of the Following (Details) Sheet http://www.therapeutical.com/20121231/role/idr_LicenseAgreementsConsistsOfTheFollowingDetails License Agreements Consists Of the Following (Details) false false R30.htm 000300 - Statement - CAPITAL STOCK TRANSACTIONS (Details) Sheet http://www.therapeutical.com/20121231/role/idr_CAPITALSTOCKTRANSACTIONSDetails CAPITAL STOCK TRANSACTIONS (Details) false false R31.htm 000310 - Statement - Outstanding Compensatory Warrants (Details) Sheet http://www.therapeutical.com/20121231/role/idr_OutstandingCompensatoryWarrantsDetails Outstanding Compensatory Warrants (Details) false false R32.htm 000320 - Statement - Compensatory Warrants Outstanding Presented (Details) {Stockholders'Equity} Sheet http://www.therapeutical.com/20121231/role/idr_CompensatoryWarrantsOutstandingPresentedDetailsStockholdersEquity Compensatory Warrants Outstanding Presented (Details) false false R33.htm 000330 - Statement - Stock Based Compensation Consists Of The Following (Details) Sheet http://www.therapeutical.com/20121231/role/idr_StockBasedCompensationConsistsOfTheFollowingDetails Stock Based Compensation Consists Of The Following (Details) false false R34.htm 000340 - Statement - Information regarding stock options outstanding (Details) Sheet http://www.therapeutical.com/20121231/role/idr_InformationRegardingStockOptionsOutstandingDetails Information regarding stock options outstanding (Details) false false R35.htm 000350 - Statement - Stock options available under Incentive Plan (Details) {Stockholders'Equity} Sheet http://www.therapeutical.com/20121231/role/idr_StockOptionsAvailableUnderIncentivePlanDetailsStockholdersEquity Stock options available under Incentive Plan (Details) false false R36.htm 000360 - Statement - Related Party Transactions Agreement (Details) Sheet http://www.therapeutical.com/20121231/role/idr_RelatedPartyTransactionsAgreementDetails Related Party Transactions Agreement (Details) false false R37.htm 000370 - Statement - Reconciliation of the provision for income taxes (Details) Sheet http://www.therapeutical.com/20121231/role/idr_ReconciliationOfTheProvisionForIncomeTaxesDetails Reconciliation of the provision for income taxes (Details) false false R38.htm 000380 - Statement - Significant components of deferred income tax assets and liabilities (Details) Sheet http://www.therapeutical.com/20121231/role/idr_SignificantComponentsOfDeferredIncomeTaxAssetsAndLiabilitiesDetails Significant components of deferred income tax assets and liabilities (Details) false false R39.htm 000390 - Statement - Geographic Information During The Period (Details) Sheet http://www.therapeutical.com/20121231/role/idr_GeographicInformationDuringThePeriodDetails Geographic Information During The Period (Details) false false R40.htm 000400 - Statement - Subsequent Event Transactions (Details) Sheet http://www.therapeutical.com/20121231/role/idr_SubsequentEventTransactionsDetails Subsequent Event Transactions (Details) false false All Reports Book All Reports Process Flow-Through: 000020 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 000030 - Statement - Consolidated Balance Sheets Parentheticals Process Flow-Through: 000040 - Statement - Consolidated Statements of Operations Process Flow-Through: 000060 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: 000260 - Statement - Organization and Presentation (Details) Process Flow-Through: 000270 - Statement - Restricted Cash Consists Of (Details) Process Flow-Through: 000280 - Statement - Equipment Consists Of the Following (Details) Process Flow-Through: 000290 - Statement - License Agreements Consists Of the Following (Details) Process Flow-Through: 000300 - Statement - CAPITAL STOCK TRANSACTIONS (Details) Process Flow-Through: 000310 - Statement - Outstanding Compensatory Warrants (Details) Process Flow-Through: 000330 - Statement - Stock Based Compensation Consists Of The Following (Details) Process Flow-Through: 000340 - Statement - Information regarding stock options outstanding (Details) Process Flow-Through: 000360 - Statement - Related Party Transactions Agreement (Details) Process Flow-Through: 000370 - Statement - Reconciliation of the provision for income taxes (Details) Process Flow-Through: 000380 - Statement - Significant components of deferred income tax assets and liabilities (Details) Process Flow-Through: 000390 - Statement - Geographic Information During The Period (Details) Process Flow-Through: 000400 - Statement - Subsequent Event Transactions (Details) tsoi-20121231.xml tsoi-20121231.xsd tsoi-20121231_cal.xml tsoi-20121231_def.xml tsoi-20121231_lab.xml tsoi-20121231_pre.xml true true XML 59 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Significant components of deferred income tax assets and liabilities (Details) (USD $)
Dec. 31, 2012
Dec. 31, 2011
Net operating loss carry-forward $ 636,349 $ 436,815
Valuation allowance. (636,349) (436,815)
Net deferred income tax asset $ 0 $ 0
XML 60 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
A summary of Compensatory Warrants Outstanding (Tables)
12 Months Ended
Dec. 31, 2012
A summary of Compensatory Warrants Outstanding  
A summary of Compensatory Warrants Outstanding

A summary of these compensatory warrants outstanding at December 31, 2011 and 2012 and changes during the periods then ended is presented below:

 

Warrants

Shares

Weighted-

Average

Exercise

Price

Weighted-

Average

Remaining

Contractual

Term

Aggregate

Intrinsic

Value

Exercisable at December 31, 2010

450,000

$0.78

3.26

$34,653

Granted

0

 

 

 

Exercised

0

 

 

 

Canceled

0

 

 

 

 

 

 

 

 

Exercisable at

 

 

 

 

December 31, 2011

450,000

$0.78

2.26

$34,653

Granted

0

 

 

 

Exercised

0

 

 

 

Cancelled

200,000

 

 

 

 

 

 

 

 

Exercisable at

 

 

 

 

December 31, 2012

250,000

$1.00

1.25

$    -